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Abstract  
Diagnosis-Related Groups (DRGs) have been widely adopted to increase transparency and 
encourage the efficient use of hospital resources. As a case-mix-based funding model, a crucial issue 
to establish an effective DRG system relies upon the accuracy and completeness of coded clinical 
data held in administrative databases. In particular, additional diagnoses representing comorbidities 
are crucial to determine the patient’s severity of illness, whereas surgical procedures have a major 
role on driving DRG classification. Coding guidelines provide a scope on what secondary diagnoses 
and procedures should be coded. However, evidence elsewhere has shown that comorbidities are 
usually under-reported in clinical datasets, whereas certain types of procedures tend to be neglected 
because they can be considered irrelevant in terms of DRG classification and reimbursement, such as 
those which are usually performed in routine (e.g. electrocardiography, computed tomography, 
ultrasound), leading to inter-hospital dissimilarities in coding.  As these issues have an impact on the 
correct allocation of patients to the DRGs, acknowledging the specific effects of additional diagnoses, 
namely those representing comorbidities, and of different types of procedures on DRG classification 
and hospital funding should be of most concern in DRG-based hospital payment systems. 
The principal motivation for this thesis was to provide information concerning coding of 
comorbidities and procedures and thus assist hospital stakeholders to improve the quality of coded 
clinical data and help to implement or optimize their DRG systems. The first objective was to assess 
variations between Portuguese hospitals regarding coding of diagnoses and procedures, in order to 
identify possible miscoding practices that could be affecting APR-DRG (All-Patient Refined Diagnosis-
Related Groups) classification, which is the DRG variant that is currently used in Portugal. The second 
objective was to study the individual impact of Charlson and Elixhauser comorbidities on APR-DRG 
classification and hospital funding. The third and last objective was to perform the same analysis to 
assess the effects of different types of diagnostic and therapeutic procedures on APR-DRG grouping. 
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To achieve the first objective, we employed chi-square test with Bonferroni correction for 
multiple comparison to verify whether hospitals differed significantly in the frequencies of diagnosis 
and procedure codes. For the second objective, we opted for a Machine Learning (ML)-based 
approach to explore the APR-DRG technical remuneration structure and thus investigate how the 
different Charlson and Elixhauser comorbidities drive and modify APR-DRG grouping and thereby 
hospital funding. We opted for this automatic learning approach to employ a generic and 
reproducible method, which can be applied to different data sources and DRG versions. In the third 
objective, we used the same ML-based method to acknowledge the effects of different types of 
diagnostic and therapeutic procedures. In this case, we assessed four procedure categories defined 
by the Agency for Health Care Research and Quality (AHRQ), which indicates whether a procedure is 
for diagnostic or therapeutic reasons and whether it is minor or major in terms of invasiveness and 
resource use.  We also extended the third objective to evaluate coded clinical data from a Brazilian 
inpatient database to perform those analyses in a country that has not implemented DRGs and thus 
verify the applicability of the proposed ML-based approach.  
Using data on burn injury hospitalizations in Portugal in the period 2011-2015, we found 
significant inter-hospital variations in coding of diagnosis and mainly non-operating room procedures 
that could potentially be associated with miscoding practices impacting APR-DRG classification. The 
comprehensiveness of coding should be monitored, and using separate code counts within specific 
APR-DRGs for different types of hospitals would be useful to perform this task. Furthermore, 
comprehensive reporting of preexisting or newly acquired comorbidities should be encouraged in 
hospitals as they have a crucial impact on identifying costly episodes, with a higher severity of illness 
episodes thereby impacting hospital funding. We recommend that future guidelines to be used by 
medical coders should include more specific rules concerning coding of comorbidities.  Moreover, 
our findings were useful to understand how specific procedures influence APR-DRG classification, 
reinforcing that reporting even routine procedures should be encouraged in hospital settings. In 
xv 
 
addition, the results obtained with the ML approach were consistent with overall APR-DRG grouping 
logics, potentially being regarded as a generic and reproducible methodology that can be applied to 
assess different data sources from different DRG systems, including from countries that have not 
implemented a DRG system yet. Finally, all those findings should collaborate with initiatives of 
implementing or optimizing existing DRG systems and further enhance the quality of coded clinical 
data. 
 
 
Keywords: Inpatients; Diagnosis-Related Groups; International Classification of Diseases; Clinical 
Coding; Hospital Administration; Comorbidities; Inpatient Procedures; Machine Learning; Support 
Vector Machine 
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Resumo 
Os Grupos de Diagnósticos Homogéneos (GDH) têm sido amplamente adotados com o 
objetivo de aumentar a transparência dos serviços prestados nos hospitais e incentivar o uso eficiente 
dos recursos hospitalares. Visto que se trata de um modelo de financiamento baseado em case-mix, 
a eficácia dos sistemas baseados em GDH depende da qualidade e completude dos dados clínicos 
codificados mantidos em bases de dados administrativas. Em particular, os diagnósticos secundários 
que representam comorbilidades são cruciais para determinar a gravidade da doença do paciente, 
enquanto que os procedimentos cirúrgicos têm um papel determinante na classificação em GDH. As 
guidelines de codificação fornecem um escopo sobre que diagnósticos e procedimentos secundários 
devem ser codificados. No entanto, diversos estudos têm mostrado que as comorbilidades são 
geralmente sub-codificadas em bases de dados hospitalares, enquanto certos tipos de 
procedimentos tendem a ser negligenciados pois são considerados pouco importantes no âmbito da 
classificação em GDH e do financiamento, nomeadamente procedimentos de rotina (ex., 
eletrocardiograma, tomografia computadorizada, ultrassonografia), levando a discrepâncias na 
codificação entre os hospitais. Tendo em vista o impacto dessas questões no agrupamento em GDH, 
reconhecer como os diagnósticos secundários, nomeadamente aqueles que representam 
comorbilidades, e os diferentes tipos de procedimentos são considerados na lógica do agrupamento, 
bem como o seu impacto no financiamento hospitalar, deve ser de grande relevância para 
implementar ou optimizar sistemas baseados em GDH. 
A principal motivação para esta tese foi reunir informações relevantes relativamente à 
codificação de comorbilidades e procedimentos de modo a auxiliar na melhoria da qualidade dos 
dados clínicos codificados e, desta forma, apoiar a implementação ou optimização de sistemas 
baseados em GDH.  O primeiro objetivo foi avaliar as variações na codificação de diagnósticos e 
procedimentos entre hospitais portugueses de modo a identificar possíveis práticas de codificação 
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que poderiam vir a afetar a classificação no sistema APR-DRG (All Patient-Refined Diagnosis-Related 
Groups), que corresponde a versão do sistema GDH atualmente em vigor em Portugal. O segundo 
objetivo foi estudar individualmente o impacto das comorbilidades de Charlson e Elixhauser no 
agrupamento em APR-DRG e no financiamento hospitalar. O terceiro e último objetivo foi realizar a 
mesma análise para investigar os efeitos de diferentes tipos de procedimentos diagnósticos e 
terapêuticos no agrupamento.  
Relativamente ao primeiro objetivo, utilizamos o teste de qui-quadrado com correção de 
Bonferroni para comparações múltiplas para verificar se as diferenças na frequência de códigos de 
diagnósticos e procedimentos entre os hospitais eram estatisticamente significativas e, portanto, 
rastrear os códigos que apresentavam maior variabilidade. Relativamente ao segundo objetivo, 
optamos por uma abordagem baseada em Machine Learning (ML) para explorar a estrutura técnica 
do sistema APR-DRG e, deste modo, caracterizar os efeitos das diferentes comorbilidades de Charlson 
e Elixhauser no agrupamento e perceber como as mesmas alteram os GDH e, consequentemente, o 
financiamento hospitalar. Optamos por essa abordagem por ser um método genérico e reprodutível, 
que pode ser aplicado a diferentes bases de dados e diferentes versões de GDH. No terceiro objetivo, 
o mesmo método baseado em ML foi empregue para caracterizar os efeitos de diferentes tipos de 
procedimentos diagnósticos e terapêuticos no agrupamento. Neste caso, avaliamos quatro 
categorias de procedimentos definidos pela Agency for Health Care Research and Quality (AHRQ), 
que define se um procedimento deve ser utilizado para fins diagnósticos ou terapêuticos e se é minor 
ou major em termos de invasividade e consumo de recursos. O terceiro objetivo foi também 
estendido para avaliar dados clínicos codificados de uma base hospitalar do Brasil para assim analisar 
os dados de um país que não tem experiência com os GDH e verificar a aplicabilidade do método 
baseado em ML proposto. 
Utilizando dados de internamento por queimaduras em Portugal entre os anos de 2011 e 
2015, foram encontradas variações significativas na codificação de diagnósticos e procedimentos não 
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cirúrgicos entre os hospitais avaliados, o que poderá potencialmente estar associado a práticas 
incorretas de codificação, com potencial impacto no agrupamento em GDH. A codificação completa 
de códigos diagnósticos e procedimentos deve ser monitorizada, podendo-se utilizar a contagem 
individual dos códigos no âmbito de cada GDH e ajustar as contagens para os diferentes tipos de 
hospital. Para além disso, incentivar a recolha completa de informações sobre comorbilidades pré-
existentes ou adquiridas durante a hospitalização deve ser promovido nos hospitais, tendo em conta 
o potencial impacto destas condições clínicas na determinação da severidade da doença e, portanto, 
no financiamento hospitalar. Recomendamos que futuras guidelines a serem usadas pelos médicos 
codificadores incluam regras mais especificas e voltadas para a codificação de comorbilidades. Este 
trabalho também permitiu caracterizar a influência de procedimentos específicos na classificação em 
APR-DRG, reforçando que mesmo a codificação de procedimentos de rotina deve ser encorajada em 
ambientes hospitalares. Além disso, os resultados obtidos com o uso do ML foram consistentes com 
a lógica de agrupamento do APR-DRG e apresentou-se como uma metodologia genérica e 
reprodutível, que pode ser aplicada para avaliar diferentes fontes de dados, de diferentes sistemas 
e, portanto, pode ser inclusive empregada para avaliar dados administrativos hospitalares em países 
que não implementaram um sistema baseado em GDH. Por fim, os nossos achados devem colaborar 
com iniciativas de implementação ou optimização de sistemas baseados em GDH já existentes e 
auxiliar na melhoria da qualidade dos dados clínicos codificados. 
 
 
 
Palavras-chave: Internamentos; Grupos de Diagnóstico Homogéneos; Classificação Internacional de 
Doenças; Codificação Clínica; Gestão Hospitalar; Comorbilidades; Procedimentos Hospitalares; 
Machine Learning; Support Vector Machine 
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1. Outline 
This thesis was based on three different studies, each of which focused in three 
specific objectives that combined would address the main goal of this research, which 
consist in providing evidence on required features that should be present in 
administrative databases concerning coding of diagnoses and inpatient procedures for 
proper use of Diagnosis-Related Groups (DRGs). This document is organized as follows:  
The next chapter, Chapter 2, presents a rationale and the theoretical background on 
DRG classification, its evolution over time and the relation between this system and 
clinical coding. 
Chapter 3 summarizes the principal motivation and states the specific objectives of 
this thesis.  
Chapter 4 presents a study aimed at investigating inter-hospital variability regarding 
coding of diagnoses and procedures and the possible impact of the observed coding 
discrepancies on DRG classification. 
Chapter 5 presents a study that employed a machine learning-based method to 
explore the All Patients-Refined Diagnosis-Related Groups (APR-DRGs) technical 
remuneration structure and characterize the impact of each Charlson and Elixhauser 
comorbidity on DRG classification and hospital funding. 
Chapter 6 presents a study that employed the method introduced in the study 
described in chapter 5, but to characterize the impact of different categories of inpatient 
procedures on DRG classification and hospital funding. 
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Finally, Chapter 7 presents the discussion, conclusions and recommendations based 
on the findings derived from the three studies described in chapters 4, 5 and 6. 
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2. Rationale 
2.1. Diagnosis Related Groups (DRGs): concept and purposes 
In several countries, when a patient is admitted to a hospital, the facility is 
reimbursed according to a system based on Diagnosis Related Groups (DRG), which is a 
patient classification scheme mainly designed to group inpatient episodes into clinically 
and economically homogeneous clusters, the so-called DRGs, each of which presenting 
similar resource consumption patterns [Mathauer and Wittenbecher, 2013; Lagman et 
al., 2007; Aiello and Roddy, 2017]. The grouping process is done through a flowchart-
based method implemented in a software called DRG grouper. For each inpatient 
episode, several variables characterizing the clinical pathway and demographic 
characteristics collected at the time of discharge should be entered in the grouper 
software for DRG classification, namely the principal and secondary diagnoses, 
procedures, age, sex, and, in the case of newborns, the birthweight. Diagnoses and 
procedures should be coded by using the International Statistical Classification of 
Diseases and Related Health Problems (ICD). Hospitals can then be remunerated 
according to the DRG each inpatient was assigned to at the time of discharge. 
Reimbursement rates for each DRG are calculated through a payment formula that 
considers the base rate multiplied by a DRG-specific relative cost weight [Gartner et al., 
2015]. Although DRGs are mainly used to reimburse providers for acute inpatient care, 
they can also be used for paying non-inpatient care and even for other purposes beyond 
resource use, cost and payment, such as performance comparisons across hospitals and 
calculation of risk-adjusted health outcomes [Chong et al., 2011].  
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The main purpose of the implementation of DRGs was to provide an insight on 
the provision of health services within hospitals and encourage the efficient use of 
resources by paying hospitals based on the number and type of cases treated [Busse et 
al, 2011; Tan et al., 2014].  The DRG system was first developed at the Yale University in 
the late sixties and was first implemented in 1983 in the United States, within a hospital 
prospective payment system for Medicare [Langenbrunner et al., 1989]. Since then, 
especially after the 1990’s, several versions of DRGs have been gradually adapted and 
implemented in high-income economies, such as Australia, Canada and Europe 
[Mihailovic et al., 2016]. Meanwhile, more low and middle-income countries have also 
introduced or begun to explore a DRG-based payment system, mostly for reimbursing 
acute inpatient care [Mathauer and Wittenbecher, 2013]. The DRGs’ overall acceptance 
is related to many factors, namely: (i) their contribution to contain hospital costs by 
reducing the average length of stay [Busse et al, 2011]; (ii) promoting transparency by 
condensing the large number and variety of patients treated in hospitals into a 
manageable number of clinically and economically homogeneous groups of patients 
[Busse  et al., 2013]; and (iii) leading hospitals to use resources efficiently by increasing 
the case volumes while reducing the average length of stay [Mathauer and Wittenbecher, 
2013]. Furthermore, DRGs can be regarded as flexible tools, as the core DRG 
methodology has been adapted in different country settings, according to particular 
needs and available information [La Forgia GM and Couttolenc, 2008]. 
However, the whole process associated with the assignment of inpatient episodes 
to the different DRGs is difficult to understand and may not be clear to many physicians 
and other hospital professionals that deal with inpatient coding and documentation. In 
the basic DRG structure, the algorithm first determines one major diagnostic category 
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(MDC) according to the principal diagnosis (i.e., the reason for hospitalization). MDCs 
were developed by dividing all principal diagnosis into mutually exclusive diagnosis areas 
(i.e., diseases and disorders of the respiratory system). If the principal diagnosis is not 
accurately reported and no MDC is identified, an error DRG is returned. For very high-
cost procedures (i.e., organ transplantation), the episode is instead assigned to a pre-
MDC, which comprises a set of exceptionally high-cost DRGs. Following the determination 
of MDC (or pre-MDC), comorbidities and clinical procedures lead the episode to a specific 
medical or surgical DRG within the assigned MDC. The patient´s age, sex, discharge status 
or birthweight (in the case of newborns) can further lead to different DRG subtypes 
[Gartner et al., 2015]. Among surgical DRGs, the subtypes include DRGs representing 
major surgery, minor surgery, other surgery and surgery not related with the principal 
diagnosis. Among medical DRGs, subtypes include DRGs comprising neoplasms, specific 
conditions relating to the organ system (represented by the MDC), symptoms and other 
conditions [Centers for Medicare and Medicaid Services, 2011]. 
 
2.2. Evolution of DRGs  
The DRG system was first developed at the Yale Center for Health Studies in the 
late sixties to encourage physicians to use hospital resources more economically, register 
the relationship between medical and administrative decisions and define hospital 
services and products by diagnosis [Rimler et al., 2015]. In 1980, an experimental 
prospective hospital payment system using the DRGs was implemented in the state of 
New Jersey, in which hospitals were paid according to a fixed DRG-specific amount for 
each patient they treated [Rimler et al., 2015]. Based on the New Jersey experiences, in 
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1983 the American Congress decided to adopt a prospective payment system based on 
DRGs for Medicare reimbursements [Averill et al., 1998]. 
The initial DRGs developed at Yale encompassed all types of patients admitted to 
an acute care hospital. Nevertheless, with the implementation of a DRG-based 
prospective payment system for Medicare in 1983, the Health Care Financing 
Administration (HCFA) redesigned the Yale DRGs and created the Medicare DRGs to focus 
on problems primarily related to elderly patients and thereby address health issues within 
the Medicare population [Averill et al., 1998]. HCFA later funded a project at Yale 
University to revise the use of complications and comorbidities (CCs) in the Medicare 
DRGs. This project mapped all secondary diagnoses regarded as a CC that accounts for a 
significant increase in hospital resource use. A total of 136 secondary diagnosis groups 
were further created with this mapping, with which one of them being assigned to a 
specific CC complexity level. For medical episodes, each secondary diagnosis groups was 
assigned to one out of three CC complexity levels (non-CC, moderate or major CC and 
catastrophic CC). For surgical episodes, each secondary diagnosis group was attributed 
to one out of four CC complexity levels (non-CC, moderate CC, major CC and catastrophic 
CC). This DRG system developed by the Yale project is referred as Refined DRGs (RDRGs) 
[Averill et al., 1998]. 
In 1987, the state of New York approved a legislation that enacted a DRG-based 
prospective payment system for all non-Medicare patients, then requiring the New York 
State Department of Health (NYDH) to assess the applicability of the Medicare DRGs to a 
non-Medicare population, namely for neonates and patients with Human 
Immunodeficiency Virus (HIV) infections. Nevertheless, the evaluation concluded that 
Medicare DRGs were not applicable for a non-Medicare population and thus NYDH 
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agreed with 3M Health Information Systems (3M HIS) to research and develop all 
necessary DRG modifications. The new DRG definitions developed and introduced by 
NYDH and 3M is referred as All-Patient Diagnosis-Related Groups (AP-DRGs), which added 
a set of neonate DRGs using birth weight categories as primary variables and other two 
MDCs comprising cases of HIV infection and complications, as well as for multiple 
traumas. Another important modification introduced by the AP-DRG system involved 
patients who are on long-term mechanical ventilation requiring tracheostomy, which 
comprise a group of extremely expensive hospitalizations. In this sense, patients with a 
tracheostomy were put into one out of two tracheostomy AP-DRGs (depending on 
whether a tracheostomy with long term mechanical ventilation was performed with or 
without extensive procedure), regardless of the MDC they were assigned to. Moreover, 
patients with certain mouth, larynx, or pharynx diseases with the tracheostomy 
performed for therapeutic reasons are assigned to separate DRGs. Another group of very 
expensive patients addressed with the AP-DRG consisted in those that underwent 
transplants of liver, bone marrow, heart, kidney and lungs, which are procedures that can 
be performed for diagnoses in different MDCs. Thus, in the AP-DRG system, these cases 
were assigned to a DRG independent of the MDC representing the principal diagnosis 
[Averill et al., 1998].   
Other updates added some enhancements for the AP-DRG system. In many MDCs, 
the presence of a major CC was responsible for a dominant effect on resource use. 
Therefore, to recognize the impact of major CCs, a single major CC DRG across all surgical 
and medical patients were formed for some MDCs, resulting in the creation of 60 specific 
major CC DRGs. Additionally, the AP-DRG system also included several pediatric 
modifications, as well as significant modifications for cystic fibrosis, nutritional disorders, 
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high risk obstetric care, acute leukemia, hemophilia and sickle cell anemia [Averill et al., 
1998]. 
In 2007, the Centers for Medicare & Medicaid Services (CMS) remodeled the 
Medicare DRGs, leading to the creation of the Medicare Severity Diagnosis-Related 
Groups (MS-DRG), allowing for further stratification within each base DRG according to 
different severity levels. For instance, not all episodes of lower extremity bypass are 
identical in terms of severity. Therefore, in order to differentiate variations in severity 
within a specific DRG, the MS-DRG introduced a DRG variant based on CCs and major 
complications and comorbidities (MCCs) assignments. The CC and MCC are subdivisions 
for each DRG that represent increasing costs, with MCC having the highest 
reimbursement, followed by CC, and then no CC/MCC [Aiello et al., 2017].  
A new concept of patient stratification was introduced afterwards with the 
creation of the All-Patient Refined Diagnosis-Related Groups (APR-DRG) system [Aiello et 
al., 2017]. In the APR-DRG system, the basic AP-DRG structure was modified so that four 
subclasses specifying the Severity of Illness (SOI) and Risk of Mortality (ROM) could be 
added to each AP-DRG. Like in the previous versions, inpatient episodes are assigned to 
a base DRG mostly according to the principal diagnosis, if it is a medical case, or an 
operating room procedure, if it is a surgical case, with each base DRG representing a 
group of patients with the same hospitalization reasons. Following the base DRG 
assignment, the episodes are further stratified by adding one SOI and one ROM level, 
both ranging sequentially from 1 to 4 (1 - minor; 2 - moderate; 3 - major; 4 - extreme), 
representing increasing reimbursement demands.  While SOI refers to the degree of loss 
of function or physiologic decompensation of an organ system, ROM was designed to 
reflect the likelihood of death [Averill et al., 2013]. 
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The determination of both SOI and ROM is performed in the same way, in a 
process which is divided into three complex phases, with each phase comprising several 
steps. In the first phase, all secondary diagnoses that are closely related to the principal 
diagnosis are discarded and a pre-defined severity level is attributed to each one of the 
remaining secondary diagnoses. In APR-DRG, each ICD code representing a secondary 
diagnosis is associated with a pre-defined severity level, also ranging from 1 (minor) to 4 
(extreme).  For instance, the pre-defined severity level for bronchitis is minor (1). The pre-
defined severity level of asthma with status asthmaticus, however, is considered 
moderate (2) and may increase further to major (3) and extreme (4) for viral pneumonia 
and respiratory failure, respectively. In the second phase, all secondary diagnoses that 
are related to other secondary diagnoses are also eliminated. A preliminary SOI level for 
the episode is defined afterwards as the highest severity level among all the remaining 
secondary diagnoses. If the highest severity level found is 3 or 4, the preliminary SOI will 
be set to the immediate lower level, unless that episode presents a high number of 
secondary diagnoses with severity 3 or 4. In the last phase, the final SOI level is 
determined by systematically changing the preliminary SOI according to the 
combinations of principal diagnosis, age, presence of operating and non-operating-room 
procedures, multiple operating-room procedures, the base DRG itself and categories of 
secondary diagnoses [Averill et al., 2013]. 
In summary, both SOI and ROM levels were developed according to the underlying 
conditions of a patient and the effects of such conditions on the outcome and the risk of 
dying from the treatment. Besides their use for hospital payment, SOI and ROM 
subclasses have been used and studied for risk adjustment of in-hospital mortality 
[Iezzoni et al., 1996; Iezzoni et al., 1998; Baram et al., 2008; Romano and Chan, 2000; 
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McCormick et al., 2018]. Those levels, however, cannot be compared across the different 
disease classifications within the APR-DRG structure, as SOI and ROM levels are both 
disease-specific and their significance differs according to the base APR-DRG the episode 
was assigned to. In other words, an episode grouped into APR-DRG 203 (chest pain) with 
a SOI level 4 is certainly not as critical as one assigned to SOI 4 but grouped into APR-DRG 
204 (syncope and collapse). 
As other DRG versions, the APR-DRG system is currently organized into 25 Major 
Diagnostic Categories (MDC), with a total of 314 base APR-DRGs (version 31) across the 
25 MDCs [Averill et al., 2013].  The MS-DRG and APR-DRG are the most commonly 
employed system for reporting and billing at the present time and the APR-DRG system, 
in particular, is currently employed for reimbursement purposes in some European 
countries, such as Portugal, Belgium, Spain and Italy, some Arab countries and in over 30 
states in the US [Dewilde et al., 2018]. 
 
2.3. Medical coding and DRGs 
The DRG system was conceived to provide a reproducible method to reimburse 
inpatient care based on patient complexity and resource utilization, while promoting cost 
containment [Busse et al, 2011]. Since its creation, the basic DRG structure has undergone 
numerous revisions, leading to a less stable and a more complex and often confusing 
process [Aiello et al., 2017]. In addition to that, there are several types of coding errors 
with potential impact on DRG allocation. The most common include selecting the wrong 
principal diagnosis, omitting additional codes that should be reported and choosing less 
specific diagnosis and procedure codes [Reid et al., 1999]. Another sources of coding 
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errors that can impact DRGs are misspecification, miscoding and resequencing of 
diagnoses [Aelvoet et al., 2009]. If a patient is admitted due to a pneumonia and an 
unrelated post-admission myocardial infarction is selected as the principal diagnosis, 
there is a case of misspecification [Aelvoet et al., 2009].  If a transient ischemic attack is 
coded as a cerebrovascular accident, the error is denominated miscoding, whereas 
changing the principal diagnosis from acute bronchitis to chronic obstructive lung disease 
is an example of resequencing [Hsia et al., 1998].  
There are also deliberate coding errors which are denominated in the literature as 
upcoding, and its contrary, under-coding [Doremus and Michenzi, 1983]. Upcoding is the 
practice of deliberately miscode patient data to receive higher payments, moving patients 
from lower-paying DRGs into higher-paying DRGs [Dafny 2005]. [Pongpirul and Robinson, 
2013] described three types of upcoding: (1) a hospital coder may try to explore the 
discharge summary to come up with the best possible codes, which includes switching 
between the principal and secondary diagnosis [Steinbusch, 2007; Serden et al., 2009]; 
(2) a hospital coder may look for reimbursable conditions in the medical records 
[Silverman et al., 2004]; and (3) hospital coders may exaggerate the choice of codes 
without supportive evidence in the patient record, which includes the addition of 
secondary diagnoses, making the patient’s condition look more complicated [Steinbusch, 
2007; Serden et al., 2009].  Undercoding is a miscode practice that leads inpatient 
episodes to be assigned to lower resource intensity DRGs [Aelvoet et al., 2009]. In APR-
DRG, hospitals are reimbursed based on the length of stay, which is compared against the 
national mean length of stay of patients in the same APR-DRG and SOI level. Lengthy 
hospital stays are penalized in terms of reimbursement; thus, it may be rewarding to 
undercode the discharge record to regroup the episode into another APR-DRG with a 
32 
 
shorter LOS or lower SOI in the same APR-DRG to make it an outlier, achieving the 
complete reimbursement [Aelvoet et al., 2009].   
In this sense, it is essential that physicians and other hospital professionals 
responsible for inpatient coding and documentation become facile with the whole 
process behind DRG classification in order to work towards better and complete 
documentation and coding of diagnoses and procedures, optimizing then the 
performance of the DRG grouper to achieve fairer hospital funding. The principal 
diagnosis, which is the reason for the admission, is the most crucial for correct grouping 
and reimbursement as it drives MDC and the DRG in several cases. However, the impact 
of a comprehensive recording of secondary diagnosis codes on the performance of the 
DRG was found in previous studies to be striking [Reid et al., 1999]. Under-reporting of 
additional diagnoses will impact more those DRG versions that use 
complications/comorbidities and resource intensity classes more widely. For instance, in 
APR-DRG, all additional diagnoses can contribute to the severity of illness and increased 
cost weights, with comorbidities being what typically drive SOI and ROM levels. Dewilde 
et al (2018) confirmed that patients grouped into higher SOI levels in APR-DRG present a 
higher number of comorbidities affecting different organ systems, resulting in a higher 
volume of resource utilization. In fact, the authors also found that the number of 
comorbidities registered in the patient’s record determine the severity level of the 
episode. Rimier et al (2015) stated that the presence of comorbidities can justify changes 
in DRG classification, such as the case of diabetes without complication, whose financial 
compensation more than doubles when associated with cases of end-stage renal disease 
[Rimier et al., 2015]. 
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 Thus, accurate and complete coding of comorbidities is particularly important in 
APR-DRG classification as the patient’s SOI has a significant role in hospital payment 
[Spurgeon et a., 2011]. Due to their important role on determining patient outcomes, 
several methods have been developed to measure and control comorbidities, with 
Charlson and Elixhauser scores being the two most commonly used [Li et al., 2008; Chang 
et al., 2016]. The Charlson’s method was developed by reviewing inpatient hospital charts 
and assessing the relevance of several clinical conditions in the prediction of mortality 
and a total of 17 comorbid categories were created. A weighted score was assigned to 
each of 17 comorbidities and the Charlson index was developed as an indicator of disease 
burden. The Elixhauser approach investigated groups of ICD-9-CM diagnosis codes to 
identify categories of comorbidities and further measured their association with 
mortality. The performance of the Charlson and Elixhauser measures in predicting poor 
outcomes has been evaluated and validated by several studies and are regarded as good 
predictors of patient outcomes [Li et al., 2008]. 
Despite their clinical significance, evidence elsewhere has shown that certain 
comorbidities are generally under-reported in administrative databases [Austin et al., 
2005], while the prevalence of others is overestimated when compared with the 
information of medical charts [Spurgeon et al., 2011; Malenka et al., 1994; Iezzoni et al., 
1992; Hawker et al., 1997; Kieszak et al., 1999; Powell 2001; Waite et al., 1994; Normand 
et al., 1995; Romano et al., 1994; Humphries et al., 2000;Blumenthal et al., 1996; Sarfati 
et al., 2010; Preen et al., 2004; Newschaffer et al., 1997; McCarthy et al., 2000;Mears et 
al., 2002; Chong et al., 2011]. Overall, asymptomatic conditions tend to be under-
reported in administrative datasets [Powell et al., 2001; Romano et al., 1994], while 
certain acute medical conditions or complications tend to be regarded by medical coders 
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as more important than others, thereby originating this coding bias [Iezzoni et al., 1992]. 
In this context, several studies have evaluated the degree of agreement between the 
information on comorbidities obtained from administrative datasets and that obtained 
from medical charts. The prevalence of comorbidities obtained from administrative data 
was found to be typically lower than that obtained from medical charts for most of the 
evaluated comorbid conditions [Chong et al., 2011]. Comparing with chart review data, 
[Quan et al., 2002] demonstrated that administrative data from a Canadian hospital 
discharge underreported 29 out of 32 Charlson and Elixhauser comorbidities when ICD-
9-CM (International Statistical Classification of Diseases and Related Health Problems, 9th 
Revision, Clinical Modification) is used, whereas this number increased to 31 with ICD-10-
CM (International Statistical Classification of Diseases and Related Health Problems, 10th 
Revision, Clinical Modification) data [Quan et al., 2002]. 
Apart from additional diagnoses, the presence of surgical procedures consistently 
affects hospital resources and has a major role on driving the grouper.  For this reason, 
the classic DRG structure was divided into medical and surgical DRGs following the MDC 
assignment, with the latter branch comprising DRGs that are mainly characterized by the 
specific code representing the main operating room procedure performed. Moreover, 
since patients can be submitted to multiple procedures related or not with their principal 
diagnosis, a hierarchical order of surgical DRGs within each MDC was defined to address 
those situations in which certain procedures are more relevant than others for grouping 
purposes [Centers for Medicare and Medicaid Services, 2016].  
Significant procedures in terms of DRG classification are those which are surgical 
in nature, requiring an operating room to be performed. On the contrary, coders are 
encouraged not to code routine procedures, which are those occurring in most 
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hospitalizations or multiple times during a hospital stay, as they are regarded to have little 
impact on the performance of groupers. This can bring a risk to assign episodes to certain 
DRGs which combines certain diagnosis with non-operating room procedures, such as 
catheterization and mechanical ventilation. Furthermore, non-operating room 
procedures can help to identify patients with higher resource consumption and costs, 
being thus potential modifiers of the DRG [Hughes et al., 1990]. For instance, the presence 
of flow-direct pulmonary artery catheter in patients with acute heart failure, combined 
with a secondary diagnosis of hypotension, which typically occurs after an acute 
myocardial infarction, might indicate a more complicated episode within those grouped 
into the acute myocardial infarction DRG [Centers for Medicare and Medicaid Services, 
2016]. 
In this sense, the Agency for Health Care Research and Quality (AHRQ) has created 
four procedure categories that indicates whether a procedure is for diagnostic or 
therapeutic reasons and whether it is minor or major in terms of invasiveness and 
resource use: minor diagnostic, which consists of non-operating room procedures that 
are performed for diagnostic reasons; minor therapeutic, which also contains non-
operating room procedures but that are for therapeutic reasons; major diagnostic, which 
comprises all operating-room procedures considered valid by the DRG grouper and that 
are performed for diagnostic reasons; and major therapeutic, which corresponds to all 
operating-room procedures considered valid by the DRG grouper and are performed for 
therapeutic reasons [Agency For Health Care Research and Quality, 2015]. 
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3. Objectives 
The principal motivation for this thesis was to provide ways to assess and extract 
information from administrative datasets concerning coding of comorbidities and 
procedures to assist hospital stakeholders to improve the quality of their data and thus 
help to implement or optimize their DRG systems. This thesis has three main objectives: 
 
Objective 1: Medical coding quality assessment in hospital administrative datasets (Chapter 
4) 
To assess variations in coding patterns of diagnoses and procedures in hospital 
administrative datasets in order to identify possible miscoding practices that could be 
affecting APR-DRG classification. 
 
Objective 2: How the patient’s underlying comorbidities drive APR-DRG classification? 
(Chapter 5) 
To investigate the APR-DRG (All-Patient Refined Diagnosis-Related Groups) 
technical remuneration structure and characterize how it responds to the different 
Charlson and Elixhauser comorbidities. 
 
Objective 3: How the APR-DRG system responds to the different types of hospital 
procedures? (Chapter 6) 
To assess and characterize the effects of different types of diagnostic and 
therapeutic procedures on APR-DRG grouping and its hospital funding. 
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4. Medical coding quality assessment in hospital 
administrative datasets 
 
This first objective of this thesis was to assess variations in coding patterns of 
diagnoses and procedures in hospital administrative datasets to identify possible 
miscoding practices that could be affecting APR-DRG classification. We restricted this 
study to the MDC 22 (Burns), which is a small diagnosis area and thereby would facilitate 
a more detailed analysis of possible inter-hospital variabilities in coding. We found that 
proper coding of extensive third-degree burns might be related with some discrepant 
frequencies of certain APR-DRGs across the evaluated hospitals. Significant differences in 
reporting certain comorbidities and common hospital procedures, especially non-
operating room procedures, might have influenced some of the observed discrepancies 
in SOI frequencies across the hospitals. Moreover, there seems to be a lack of standard in 
coding of debridement procedures among the evaluated hospitals. Overall, we found 
relevant variations in coding patterns that could potentially be associated with miscoding 
practices impacting APR-DRG classification in MDC 22. 
 
One study was conducted: 
 Quality of coding within clinical datasets: a case-study using burn-related hospitalizations.  
Accepted in Burns on September 12, 2018. 
Julio Souza, João Vasco Santos, Fernando Lopes, Alberto Freitas 
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5. How the different patient’s underlying 
comorbidities drive APR-DRG classification? 
 
The second objective of the thesis focused on the individual effect of different 
comorbidities on APR-DRG classification and hospital funding in the context of respiratory 
(MDC 4) and cardiovascular diseases (MDC 5). Using six years of coded clinical data from 
a nationwide Portuguese inpatient database and a machine learning-based approach, we 
explored the APR-DRG system to understand its response to each Charlson and Elixhauser 
comorbidity. We also estimated the amount of hospital payments that could have been 
lost when comorbidities are under-reported. In our scenario, most Charlson and 
Elixhauser comorbidities did considerably influence SOI determination but little impacted 
base APR-DRG assignment and the degree of influence of each comorbidity varied greatly 
according to the base APR-DRG.  Furthermore, our results based on the SVM models were 
consistent with overall APR-DRG grouping logics. 
 
One study was conducted: 
Importance of coding comorbidities for APR-DRG assignment: focus on cardiovascular and 
respiratory diseases. 
Accepted in Health Information Management Journal on December 28, 2018. 
Julio Souza, João Vasco Santos, Veronica Bolón Canedo, Amparo Betanzos, Domingos 
Alves, Alberto Freitas 
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Abstract 
Background The All Patient-Refined Diagnosis-Related Groups (APR-DRGs) has 
adjusted the basic DRG structure by incorporating four severity of illness (SOI) levels, 
which are used for determining hospital payment. A comprehensive report of all 
relevant diagnoses, namely the patient´s underlying comorbidities, is a key factor for 
ensuring that SOI determination will be adequate. Objective In this study, we aimed at 
characterizing the individual impact of comorbidities on APR-DRG classification and 
hospital funding in the context of respiratory and cardiovascular diseases. Methods 
Using six years of coded clinical data from a nation-wide Portuguese inpatient database 
and Support Vector Machine (SVM) models, we simulated and explored the APR-DRG 
classification to understand its response to individual removal of Charlson and 
Elixhauser comorbidities. We also estimated the amount of hospital payments that could 
have been lost when comorbidities are under-reported. Results In our scenario, most 
Charlson and Elixhauser comorbidities did considerably influence SOI determination 
but little impacted base APR-DRG assignment. The degree of influence of each 
comorbidity on SOI was, however, quite specific to the base APR-DRG. Under-coding 
of all studied comorbidities led to losses in hospital payments. Furthermore, our results 
based on the SVM models were consistent with overall APR-DRG grouping logics. 
Conclusion and implications Comprehensive reporting of preexisting or newly 
acquired comorbidities should be encouraged in hospitals as they have an important 
influence on SOI assignment and thus on hospital funding. Furthermore, we recommend 
that future guidelines to be used by medical coders should include specific rules 
concerning coding of comorbidities.  
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Introduction 
The quality of coded clinical data is a relevant issue in the context of health care 
management. The accuracy and completeness of reporting all additional diagnoses in a 
hospital stay is of most concern as appropriate and fair hospital funding may depend 
upon the reliability of grouping coded inpatient episodes into clinically homogeneous 
groups with similar resource use, the so-called Diagnosis-Related Groups (DRGs) 
(Cheng, 2009; Mathauer, 2013). The DRG classification was designed at the Yale 
University in the late 60s (Buss, 2011) and was first used in 1983 as part of a 
prospective payment system for reimbursing Medicare patients (Langenbrunner, 1989). 
The original DRGs were redesigned afterwards, resulting in the creation of the 
Medicare Severity Diagnosis Related Groups (MS-DRGs), which added three distinct 
complication levels (major complication and comorbidities, complications and 
comorbidities and no complications and comorbidities) in order to obtain smaller and 
more clinically homogenous groups (Centers for Medicare and Medical Services, 2018).  
A new methodology of DRG stratification was later introduced with the All-Patient 
Refined Diagnosis-Related Groups (APR-DRG) classification, which modified the basic 
DRG structure by including four levels of severity of illness (SOI) (Aiello, 2017), which 
refers to the degree of loss of function or physiologic decompensation of an organ 
system, and risk of mortality (ROM), which reflects the likelihood of dying (Averill, 
2013). Both SOI and ROM are characterized by a score ranging from 1 to 4 (1 - minor; 
2 - moderate; 3 - major; 4 – extreme), representing increasing reimbursement demands. 
The APR-DRG classification is currently employed for reimbursement purposes in 
some European countries, such as Belgium, Spain, Portugal and Italy, some Arab 
countries and in over 30 states in the US (Dewilde 2018). Figure 1 shows the overall 
APR-DRG grouping logic. 
 
In the APR-DRG classification, episodes within a given a Major Diagnostic Category 
(MDC), which correspond to a specific diagnosis area, will be assigned to a disease or 
procedure-specific base APR-DRG. Medical episodes will be grouped into a base APR-
DRG mostly according to the principal diagnosis, whereas surgical episodes will be 
grouped according to an operating room procedure (Averill, 2013). The base APR-DRG 
is further stratified into SOI and ROM levels considering combinations of base APR-
DRG, diagnoses, age and procedures (Averill, 2013). Despite the influence of nearly all 
patient features, secondary diagnoses representing comorbidities and complications are 
what typically drive SOI and ROM levels (Aiello, 2017). In fact, episodes with higher 
SOI levels usually present multiple comorbidities affecting different organ systems 
(Averill, 2013). Thus, accurate and complete coding of comorbidities is particularly 
important in APR-DRG classification as the patient’s SOI has a significant role in 
hospital payment (Spurgeon 2011). For instance, in Portugal, a hospital that treats a 
patient assigned to APR-DRG 1944, which represents heart failure patients (base APR-
DRG 194) with an extreme SOI, will be paid with an amount about 5, 3 and 2 times 
higher than cases assigned to the same base APR-DRG with SOI levels 1, 2 and 3, 
respectively (Administração Central do Sistema de Saúde, 2017).   
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Due to their important role on determining patient outcomes, several methods have been 
developed to measure comorbidities, with Charlson and Elixhauser scores being the two 
most commonly used (Li 2008; Chang 2016). The Charlson’s method was developed by 
reviewing inpatient hospital charts and assessing the relevance of several clinical 
conditions in the prediction of mortality and a total of 17 comorbid categories were 
created. A weighted score was assigned to each of 17 comorbidities and the Charlson 
index was developed as an indicator of disease burden. The Elixhauser investigated 
groups of ICD-9-CM diagnosis codes to identify categories of comorbidities and further 
measured their association with mortality. The performance of the Charlson and 
Elixhauser measures in predicting poor outcomes has been evaluated and validated by 
several studies and are regarded as good predictors of patient outcomes (Li 2008). 
 
Despite their clinical significance, evidence elsewhere has shown that certain 
comorbidities are generally under-reported in administrative databases (Austin 2005), 
while the prevalence of others is overestimated when compared with the information of 
medical charts (Spurgeon 2011; Malenka, 1994; Iezzoni, 1992; Hawker 1997; Kieszak 
1999; Powell 2001; Waite 1994; Normand 1995; Romano 1994; Humphries 
2000;Blumenthal 1996; Sarfati 2010; Preen 2004; Newschaffer 1997; McCarthy, 
2000;Mears, 2002; Chong, 2011). Overall, asymptomatic conditions tend to be under-
reported in administrative datasets (Powell, 2001; Romano, 1994), while certain acute 
medical conditions or complications tend to be regarded by medical coders as more 
important than others, thereby originating this coding bias (Iezzoni, 1992). In this 
context, several studies have evaluated the degree of agreement between the information 
on comorbidities obtained from administrative datasets and that obtained from medical 
charts. The prevalence of comorbidities obtained from administrative data was found to 
be typically lower than that obtained from medical charts for most of the evaluated 
conditions (Chong, 2011). Comparing with chart review data, Quan et al (2002) 
demonstrated that administrative data from a Canadian hospital discharge underreported 
29 out of 32 Charlson and Elixhauser comorbidities when ICD-9-CM (International 
Statistical Classification of Diseases and Related Health Problems, 9th Revision, 
Clinical Modification) is used, whereas this number increased to 31 with ICD-10-CM 
(International Statistical Classification of Diseases and Related Health Problems, 10th 
Revision, Clinical Modification) data (Quan, 2002). 
In this paper, we present a machine learning approach to explore the technical structure 
of the APR-DRG classification in order to characterize the impact of under-reporting 
secondary diagnoses representing Elixhauser and Charlson comorbidities on APR-DRG 
classification and hospital funding.  
 
 
Methods 
Inpatient Data 
Inpatient data used in this study were extracted from Portugal’s national DRG database, 
which currently does not impose a limit on the number of secondary diagnoses to be 
reported per episode and contains coded hospitalization data provided by all National 
Health Service (NHS) public hospitals in mainland Portugal. We collected data of all 
inpatient episodes assigned to MDC 4 (Diseases and Disorders of the Respiratory 
System) and 5 (Diseases and Disorders of the Circulatory System) that occurred 
between 2011 and 2016, which corresponded to the period in which APR-DRG data 
were available. We applied this methodology on respiratory (MDC 4) and 
cardiovascular diseases (MDC 5) because they were the two diagnosis areas with the 
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highest number of hospitalizations among all MDCs, accounting for over one million 
hospitalizations during the studied period, with a total of 577,313 episodes assigned to 
MDC 4 and other 526,611 episodes in MDC 5. Thus, we believe that both areas are 
relevant for hospitals and public authorities due to this high hospitalization burden. 
Each inpatient episode contained all variables required for APR-DRG grouping, namely 
principal diagnosis and up to 30 secondary diagnoses, up to 30 operating and non-
operating room procedures (as the original APR-DRG grouper only considers the first 
30 secondary diagnoses and procedures), discharge status, sex and age. All diagnoses 
and procedures were coded in ICD-9-CM classification system (International 
Classification of Diseases, 9th Revision, Clinical Modification). Our sample included 
hospitalizations grouped across 49 base APR-DRGs (version 31), 17 respiratory APR-
DRGs (MDC 4) and 32 cardiovascular APR-DRGs (MDC 5). 
 
SVM classification models for simulating APR-DRG classification 
We employed Support Vector Machine (SVM) algorithm on Portuguese inpatient data 
originally grouped with the 3M APR-DRG grouper software to programmatically learn 
how these hospitalizations were assigned to their APR-DRGs. SVM models learn how 
to group episodes by finding a separating boundary between them, the so-called 
hyperplanes (Son, 2016), to segregate the different classes (APR-DRGs). The main 
advantage of this algorithm is that it can overcome high dimensionality problems 
occurring when there is a large number of input variables relative to the number of 
available observations (Verplancke, 2016), which is the case of APR-DRG assignment, 
as its algorithm relies on several input variables such as discharge status, a wide variety 
of diagnosis and procedure codes and other intrinsic patient characteristics (e.g. age and 
sex) (Averill, 2013). Additionally, SVM has demonstrated high performance in solving 
classification problems in bioinformatics (Chu, 2008). 
For each studied MDC, we built two classification models: one aimed at assigning the 
coded episodes to a base APR-DRG and the other one to attribute the SOI level. As 
ROM subclass is not used for payment and we were interested in investigating the 
individual impact of comorbidities on hospital payments, we did not assess changes in 
ROM levels in our study. All variables required for APR-DRG assignment were used to 
build the SVM models. The first model (base APR-DRG assignment) included age as a 
numeric variable, sex and discharge status as categorical variables, as well as all ICD-9-
CM diagnosis and procedure codes present in the dataset. As SOI algorithm does not 
consider sex and discharge status, the second model (SOI assignment) only included age 
as numeric variable, the base APR-DRG itself as a categorical variable and all diagnosis 
and procedure codes. In both models, each diagnosis and procedure code was treated as 
a separate binary variable (1 if the episode reported the code, 0 otherwise). We trained 
SVM classifiers on two thirds of the inpatient data for the period 2011-2015 (training 
set) and evaluated their performance on the remaining third (testing set). As evaluation 
metrics, we estimated the percentage of correctly classified episodes, recall and 
precision. Although the testing phase provides us with a reasonable estimate of the 
model performance, we tested the models on unseen data from 2016 and estimated the 
percentage of correctly classified episodes to add critical validation to the models and 
assess their capacity of generalization. The evaluation metrics of the SVM models are 
presented in table 6, in supplementary material. 
 
Sensitivity Analysis  
Using the previously constructed SVM models, we performed a first classification 
phase using the complete dataset, with all available codes. A second classification phase 
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was conducted afterwards, but all secondary diagnosis codes representing Charlson and 
Elixhauser comorbidities were individually removed to assess grouping changes. We 
calculated and compared the model’s sensitivity before and after removing each 
comorbidity. We further employed paired-sample Wilcoxon signed-ranks test to verify 
whether differences in sensitivity before and after removing each comorbidity were 
statistically significant. We considered each APR-DRG combined with a respective SOI 
level as a unit of analysis to employ this statistical test. We also assessed the proportion 
of episodes that changed their base-APR-DRGs or SOI level as a result of missing 
comorbidities. All comorbidity codes were selected through Charlson and Elixhauser 
ICD-9-CM enhanced definitions presented by Quan et al (2005). Those definitions 
identify a set of conditions characterized by high-prevalence or severity and have been 
extensively used as alternatives to the complexity of acute episodes (Jackson, 2015). All 
17 Charlson’s comorbidities and all 30 Elixhauser’s comorbidities were considered in 
this study. 
Besides evaluating changes in APR-DRG classification, we also studied the financial 
impact of under-reporting for each studied comorbidity by estimating the total hospital 
payments that could have been lost when these comorbidity codes are missing. For this 
analysis, we used official APR-DRG prices derived from the 2017 APR-DRG prices 
and weights table defined for NHS public hospitals in Portugal (Administração Central 
do Sistema de Saúde, 2017).  
 
Ethical considerations 
Since inpatient data used in this study was completely anonymized and only contained 
the discharge year, diagnosis and procedure codes, sex, age, discharge status and an 
arbitrary episode identification number, there was no need for ethical approval. 
 
 
Results 
A total of 935,139 inpatient episodes were included in our sample for constructing and 
testing the SVM models, which corresponded to all inpatient episodes assigned to MDC 
4 (485,233 episodes) and MDC 5 (446,906 episodes) between 2011 and 2015. Overall, 
the SVM models showed a good sensitivity when employed on the complete dataset 
(first classification phase), with overall rates above 0.8 (Table 1). Using unseen 
hospitalization data from the whole year of 2016, we verified that SVM models 
presented a high capacity of generalization, achieving a percentage of correctly 
classified cases of more than 90% for nearly all base APR-DRGs and over 80% for all 
SOI levels (see Table 6 in supplementary material). 
The removal of most comorbidities caused a reduction in the model´s sensitivity in both 
studied MDCs (Table 1). Metastatic solid tumor/metastatic cancer accounted for the 
highest impact in both MDCs, reducing the model’s sensitivity by almost a half (49.0%) 
(Tables 1 and 2). Furthermore, the removal of most Charlson comorbidities (12 out of 
17) and nearly half of the Elixhauser comorbidities (14 out of 30) caused a significant 
reduction in sensitivity (p-value < 0.05). In general, the same comorbidities 
significantly impacted APR-DRG assignment in both MDCs, apart from: Charlson’s 
diabetes, either with or without complication, which only significantly impacted the 
sensitivity for cardiovascular APR-DRGs; and AIDS/HIV, which only significantly 
impacted the sensitivity for respiratory APR-DRGs (Tables 1 and 2). A total of 2 
Charlson’s comorbidities and 16 Elixahuser’s comorbidities did not cause any 
significant impact on APR-DRG classification (see Tables 1 and 2). 
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In terms of financial impact, we observed that removing any comorbidity would cause a 
considerable difference in the total amount to be reimbursed to hospitals (Table 3). 
Considering the entire period of 2011-2015, the absence of Charlson’s comorbidity 
renal disease alone would account for a difference of more than 107 million € in the 
total hospital payments for treating MDC 4 patients (Table 3). This same comorbidity 
also presented the highest impact on reimbursement for MDC 5 patients, with an 
estimated difference in hospital payments of more than 45 million € (Table 3). The top-
5 comorbidities that would have accounted for the highest differences in hospital 
payments for charging MDC 4 patients included metastatic solid tumor/metastatic 
cancer (-22.2%), renal disease (-18.3%), moderate or severe liver disease (-17.8%), 
pulmonary circulatory disorders (-14.1%) and weight loss (-13.7%) (Table 3). The top-5 
comorbidities accounting for the highest differences in hospital payments for charging 
MDC 5 patients were moderate or severe liver disease (-16.9%), metastatic solid 
tumor/metastatic cancer (-15.1%), renal disease (-11.5%), congestive heart failure (-
10.7%) and any malignancy or fluid and electrolyte disorders (-9.7%) (Table 3). 
 
Moreover, removing either Charlson or Elixhauser comorbidities had a much higher 
impact on SOI assignment than on base APR-DRG assignment, regardless of the 
diagnosis area, as a very small percentage (close to zero) of episodes changed their base 
APR-DRG in the absence of comorbidities (Tables 4 and 5). Tables 4 and 5 present the 
number of episodes (and the percentage of total) that changed their base-APR-DRG or 
SOI level when a given comorbidity was missing in MDC 4 and 5 data, respectively. 
The classification results obtained with the SVM models using the complete dataset 
were used as reference. SOI columns correspond to cases that maintained their base-
APR-DRG but changed their SOI level, whereas the last column corresponds to cases 
that changed to another base APR-DRG.  
 
Overall, the highest percentage of episodes that changed their SOI level were those 
initially grouped into the higher SOI levels, though the magnitude of change varied 
considerably according to the comorbidity. Among MDC 4 episodes, the top-5 
comorbidities that accounted for the highest percentage changes in SOI 4 were renal 
disease (64%), pulmonary circulation disorders (53.3%), moderate or severe liver 
disease (48.8%), weight loss (43.2%) and myocardial infarction (35.8%). In SOI 3, the 
top-5 comorbidities were renal disease (61.4%), moderate or severe liver disease 
(45.6%), metastatic solid tumor/metastatic cancer (45.6%), weight loss (35.8%) and any 
malignancy (27.7%). Among MDC 5 episodes, the top-5 comorbidities for SOI 4 were 
renal disease (48.1%), moderate or severe liver disease (44.5%), fluid and electrolyte 
disorders (33.0%), myocardial infarction (27.0%) and liver disease (25.4%). In SOI 3, 
the top-5 comorbidities were metastatic solid tumor/metastatic cancer (47.9%), renal 
disease (42.2%), weight loss (37.1%), moderate or severe liver disease (30.4%) and 
myocardial infarction (27.4%). Under-coding these comorbidities would thus lead to the 
highest changes in the proportion of episodes grouped into higher SOI levels. 
 
To evaluate the influence of each comorbidity across the different base APR-DRGs, 
considering that their influence is disease-specific, we presented in tables 7 and 8 (in 
supplementary material), by each base APR-DRG, the number of episodes (and the 
percentage of the total) that changed their SOI levels or shifted to another base APR-
DRG following the removal of each studied comorbidity. Table 7 shows the results for 
each respiratory APR-DRG, while table 8 contains the same analysis for each 
cardiovascular APR-DRG, Overall, even when assessing at base APR-DRG level, 
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higher SOI levels were still the most affected and little to no changes in base AR-DRG 
were observed (Tables 7 and 8). Moreover, the percentage change in SOI level varied 
greatly according to the base APR-DRG for most comorbidities. Certain comorbidities, 
however, were crucial for SOI assignment, regardless of the base AR-DRG, such as 
renal disease, which considerably influenced the classification into higher SOI levels for 
all respiratory APR-DRGs and almost all cardiovascular APR-DRGs (Tables 7 and 8). 
On the other hand, comorbid conditions such as uncomplicated hypertension or 
depression little influenced SOI assignment in any respiratory or cardiovascular APR-
DRG (Tables 7 and 8). Other comorbidities were against the trend and did considerably 
impact base APR-DRG assignment, such as the case of comorbidity myocardial 
infarction, which changed the base-APR-DRG in 29.3% of the episodes initially 
grouped into APR-DRG 190 (Acute Myocardial Infarction) (Table 8).  
 
 
Discussion 
Pursuing higher quality of clinical administrative data and investing in medical coding 
are highly needed for ensuring that the correct amount of hospital funding will be 
allocated, especially in countries that employ DRG-based payment systems. The APR-
DRG classification has provided means to achieve this goal by subdividing base APR-
DRGs into SOI levels to obtain smaller and more homogeneous clusters in terms of 
resource use. SOI assignment is highly dependent on all necessary diagnosis codes, as 
its complex algorithm considers the interactions between all diagnoses, age and 
procedures (Averill, 2013). In this context, a comprehensive report of all relevant 
diagnoses, namely the patient´s underlying comorbidities, can be a key factor for 
ensuring that SOI level and thereby hospital funding will be adequate.  
 
Since January 2015, Portugal uses APR-DRGs for budget allocation and reimbursement 
of hospital care (Administração Central do Sistema de Saúde, 2014), with a percentage 
share of hospital revenues related to DRGs at about 80% (Mihailovic, 2016). In 
Portugal, each inpatient episode should be coded by a trained coder based upon a 
discharge summary, which is mandatory in all hospitals within the NHS, complemented 
by other information from daily medical reports, emergency room records, as well as 
surgical and pathological anatomy reports (Administração Central do Sistema de 
Saúde_B, 2014). Medical coding of diagnoses in Portugal is based on the official 
guidelines provided by The Centers for Medicare and Medicaid Services (CMS) and the 
National Center for Health Statistics (NCHS), two departments within the U.S. Federal 
Government’s Department of Health and Human Services (DHHS) (Centers for Disease 
Control and Prevention, 2011). Those guidelines do not contain specific rules for coding 
comorbidities, but they provide specific information on coding additional diagnoses, 
including preexisting conditions, which can thereby influence coding of comorbidities. 
In those guidelines, additional diagnoses mean “all conditions that coexist at the time of 
admission, that develop subsequently, or that affect the treatment received and/or the 
length of stay. Diagnoses that relate to an earlier episode which have no bearing on the 
current hospital stay are to be excluded.” Furthermore, these guidelines clearly state that 
additional diagnoses to be coded are those requiring clinical evaluation, therapeutic 
treatment, diagnostic procedures, extended length of stay or increased nursing and 
monitoring care, which can be the case with comorbidities Centers for Disease Control 
and Prevention, 2011).  
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Using the same database employed in our study, Freitas et al (2016) found that the 
number of comorbidities reported by inpatient episode has increased, with the average 
number of Elixhauser and Charlson comorbidities by episode increasing, respectively, 
by 81% and 48% in the period 2000-2010 (Freitas, 2016), though this increasing trend 
was not equal for all comorbidities. The proportion of episodes with Charlson’s 
AIDS/HIV and peptic ulcer disease, as well as Elixhauser’s drug abuse, blood loss 
anemia, peptic ulcer disease excluding bleeding and complicated diabetes has decreased 
over the studied period (Freitas, 2016). On the contrary, the proportion of episodes with 
Charlson’s myocardial infarction, dementia and renal disease, as well as Elixhauser’s 
complicated and uncomplicated hypertension, uncomplicated diabetes, hypothyroidism, 
renal failure, coagulopathy, obesity and depression have increased above 100% (Freitas, 
2016). Those discrepancies in reporting certain comorbidities found by Freitas et al 
(2016), which was also described elsewhere in the literature (Chong, 2011), should be 
more closely watched. Thus, investigating and acknowledging how each comorbidity 
affects the different base APR-DRGs and knowing whether and which comorbidities are 
key within the grouping logic, is a relevant matter to improve medical coding. To the 
best of our knowledge, this was the first study to employ a machine learning approach 
to explore the APR-DRG classification in order to provide information on the individual 
impact of each Charlson and Elixhauser comorbidity on APR-DRGs, raising awareness 
on the importance of a comprehensive report of these conditions. 
 
We first built SVM models to simulate the APR-DRG classification and assess the 
model’s sensitivity to the removal of each studied comorbidity. As removing these 
codes caused little to no impact on base APR-DRG classification, our analyses focused 
on changes in SOI levels. Our findings were consistent with the general grouping logic 
of the APR-DRG as the sensitivity for calculating higher SOI levels was clearly the 
most negatively affected by the removal of comorbidities and base APR-DRG 
classification, which is mainly determined by the principal diagnosis or operating-room 
procedure, was little affected by the absence of comorbidities (Tables 2 and 3). Dewilde 
et al (2018) also found that certain comorbidities were strongly associated with higher 
SOI levels and thus with higher funding. Moreover, while Dewilde et al (2018) focused 
on ischemic stroke APR-DRG, our results strengthened these previous findings on the 
role and importance of comorbidities regarding SOI determination by adding evidence 
that included all respiratory and cardiovascular APR-DRGs. We initially considered, 
however, that the impact of removing comorbidities was disproportional and specific to 
the base APR-DRG, which was later confirmed when assessing grouping changes at 
base APR-DRG level (Tables 7 and 8), indicating that certain comorbidities might be 
crucial for attributing a SOI level within a given APR-DRG, while it would not 
influence SOI in others. Thus, these findings are in accordance with the basic clinical 
principle of the APR-DRG classification as our scenario showed that the role of 
comorbidities for the calculation of SOI levels was disease-specific and the significance 
of comorbidities depends on the underlying problem, which is characterized by the base 
APR-DRG. The consistency of our results strengthens the methodology based on the 
constructed SVM models. 
 
In APR-DRG, the subcategorizations into SOI levels were created to achieve more 
correct funding within each base APR-DRG, considering that the mix of resources used 
at different SOI levels leads to substantial differences in total costs. Hospitals that admit 
proportionally more patients with higher severity of illness would be underfunded when 
clinical data fail to provide a more precise SOI calculation. In fact, the distribution of 
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episodes across the different SOI levels might have a substantial impact on hospital 
budgets. Measuring how under-coding of comorbidities alone can affect hospital 
payment is thereby relevant for hospitals and medical coders as such conditions usually 
drive SOI assignment. Thus, we estimated the amount of hospital payments in the 
period 2011-2015 that could have been lost when each comorbidity is not present in the 
data. We found that all comorbidities would lead hospitals to receive less money (see 
Table 3).  
 
In summary, our findings clearly showed how incomplete coding of comorbidities alone 
could substantially affect SOI assignment and thus hospital funding. In addition to that, 
we should also keep in mind that incomplete reporting of comorbidities could make 
unfeasible the reutilization of clinical data for health care quality measurement, which 
often relies on coded clinical data for the calculation of quality indicators (e.g. risk-
adjusted in-hospital mortality), for biomedical research, namely for studies that employ 
more sophisticated methodologies, such as the calculation of risk-adjusted health 
outcomes, and for other tasks related to health care management, as the use of APR-
DRGs in conjunction with SOI can be applied for evaluating resource use and 
establishing patient care guidelines (Averill, 2013). Therefore, collecting information on 
preexisting or acquired comorbidities should always be encouraged in hospitals and the 
construction of specific guidelines for coding of comorbidities is highly recommended 
to achieve a more comprehensive report of such conditions and thus improve quality of 
clinical data and hospital funding in APR-DRG-based payment systems. 
 
Limitations of the study 
We used clinical data from an administrative database as gold standard and thus our 
findings are limited to the reality abstracted from this data. Certain comorbidities might 
have had little or no significant impact on APR-DRG grouping because they could have 
been under-reported and thus the SVM models, which were constructed through patters 
learned from the data, would minimize their importance in terms of classification, being 
less sensitive to their absence. Another important limitation is that our methodology is 
mostly based on results obtained from the SVM models, as we used their classification 
results obtained with the complete dataset as baseline to estimate and compare changes 
in APR-DRGs and hospital payments. Therefore, possible errors or shortcomings 
associated with the original SVM models may have influenced or been replicated in our 
results.  
 
 
Conclusion 
Using a machine learning approach, we found that most Charlson and Elixhauser 
comorbidities did considerably influence SOI assignment and the absence of all studied 
conditions may lead to losses in hospital payments at some extend. The degree of 
influence of each comorbidity, however, is quite specific to the base APR-DRG. 
Furthermore, our results based on the SVM models were consistent with overall APR-
DRG grouping logic. Our findings reinforced that a comprehensive reporting of the 
patient’s underlying comorbidities is relevant for APR-DRG grouping as our findings, 
in line with previous research, showed that such groups of diagnoses have an important 
influence on SOI determination, potentially undermining the correct identification of 
most resource-consuming patients and thus hospital funding. Better documentation of 
comorbidities should enable more accurate and complete medical coding, which in turn 
should lead to more accurate grouping into higher SOI levels. In this sense, hospitals 
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should be oriented to collect all information on any preexisting or newly acquired 
comorbidity and we recommend that future guidelines to be used by medical coders 
should include specific rules concerning medical coding of comorbidities. 
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Table 1. Overall rates of sensitivity (true positives/total number of episodes) and percentage change in sensitivity for respiratory APR-DRGs classification 
 
 
 
 
Sensitivity rate - Phase 1 
(Data with Comorbidity) 
 
Sensitivity rate - Phase 2 
 (Data without Comorbidity) 
 
Sensitivity 
Change (%) 
 
p-value 
 
Charlson comorbidities  
 
Myocardial infarction 
 
0.90 (12,170/13,519 episodes) 0.80 (10,874/13,519 episodes) -10.7 <0.001 
Congestive heart failure 
 
0.93 (101,000/109,017 episodes) 0.77 (84,321/109,017 episodes) -16.5 0.028 
Peripheral vascular disease 0.88 (11,130/12,621 episodes) 0.87 (11,026/12,621 episodes) -0.9 0.004 
Cerebrovascular disease 0.91 (50,148/55,124 episodes) 0.82 (45,174/55,124 episodes) -10.0 0.012 
Dementia 0.92 (31,590/34,183 episodes) 0.88 (30,163/34,183 episodes) -4.5 0.771 
Chronic pulmonary disease 0.88 (75,353/85,892 episodes) 0.86 (73,694/85,892 episodes) -2.2 <0.001 
Rheumatic disease 0.87 (4,950/5,680 episodes) 0.83 (4,730/5,680 episodes) -4.4 0.059 
Peptic ulcer disease 0.89 (2,193/2,453 episodes) 0.89 (2,188/2,453 episodes) -0.2 0.809 
Mild liver disease 0.87 (12,144/13,959 episodes) 0.80 (11,091/13,959 episodes) -8.6 <0.001 
Diabetes without chronic complication 0.90 (81,014/90,494 episodes) 0.85 (77,160/90,494 episodes) -4.7 0.085 
Diabetes with chronic complication 0.90 (11,734/13,086 episodes) 0.86 (11,200/13,086 episodes) -4.6 0.229 
Hemiplegia 0.85 (5,135/6,043 episodes) 0.73 (4,431/6,043 episodes) -13.8 <0.001 
Renal disease 0.89 (212,485/239,827 episodes) 0.60 (144,087/239,827 episodes) -32.2 <0.001 
Any malignancy 0.88 (29,263/33,255 episodes) 0.64 (21,421/33,255 episodes) -26.8 <0.001 
Moderate or severe liver disease 0.88 (1,809/2,061 episodes) 0.56 (1,149/2,061 episodes) -36.6 <0.001 
Metastatic solid tumor 0.83 (22,090/26,653 episodes) 0.42 (1,1287/26,653 episodes) -49.0 <0.001 
AIDS/HIV 0.85 (460/543 episodes) 0.73 (396/543 episodes) -13.9 0.006 
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Elixhauser comorbidities 
Congestive heart failure 0.93 (101,000/109,017 episodes) 0.77 (84,321/109,017 episodes) -16.5 0.028 
Cardiac arrhythmias 0.91 (93,993/103,460 episodes) 0.87 (89,456/103,460 episodes) -4.7 0.142 
Valvular disease 0.89 (22,071/24,722 episodes) 0.88 (21,785/24,722 episodes) -1.3 0.059 
Pulmonary circulation disorders 0.82 (11,982/14,574 episodes) 0.66 (9,658/14,574 episodes) -19.3 0.006 
Peripheral vascular disorders 0.88 (11,130/12,621 episodes) 0.87 (11,026/12,621 episodes) -0.9 0.004 
Hypertension uncomplicated 0.89 (132,937/149,570 episodes) 0.89 (132,944/149,570 episodes) 0.0 0.631 
Paralysis 0.85 (5,135/6,043 episodes) 0.73 (4,431/6,043 episodes) -13.8 <0.001 
Other neurological disorders 0.89 (34,685/38,796 episodes) 0.83 (32,312/38,796 episodes) -6.8 <0.001 
Chronic pulmonary disease 0.88 (75,353/85,892 episodes) 0.86 (73,694/85,892 episodes) -2.2 <0.001 
Diabetes uncomplicated 0.90 (78,354/87,546 episodes) 0.85 (74,618/87,546 episodes) -4.8 0.086 
Diabetes complicated 0.90 (13,996/15,603 episodes) 0.86 (13,333/15,603 episodes) -4.7 0.216 
Hypothyroidism 0.90 (15,562/17,331 episodes) 0.90 (15,574/17,331 episodes) 0.1 0.087 
Renal failure 0.90 (51,378/56,882 episodes) 0.85 (48,076/56,882 episodes) -6.4 <0.001 
Liver disease 0.87 (14,402/16,491 episodes) 0.77 (12,621/16,491 episodes) -12.4 <0.001 
Peptic ulcer disease excluding bleeding 0.89 (1,702/1,908 episodes) 0.89 (1,704/1,908 episodes) 0.1 0.970 
AIDS_HIV 0.85 (445/526 episodes) 0.73 (382/526 episodes) -14.2 0.018 
Lymphoma 0.91 (3,849/4,213 episodes) 0.67 (2,816/4,213 episodes) -26.9 <0.001 
Metastatic cancer 0.83 (22,090/26,653 episodes) 0.42 (11,287/26,653 episodes) -49.0 <0.001 
Solid tumor without metastasis 0.89 (11,642/13,112 episodes) 0.72 (9,463/13,112 episodes) -18.7 <0.001 
Rheumatoid arthritis/collagen vascular diseases 0.89 (12,174/13,733 episodes) 0.84 (11,568/13,733 episodes) -5.0 0.071 
Coagulopathy 0.88 (9,239/10,535 episodes) 0.83 (8,706/10,535 episodes) -5.8 0.105 
Obesity 0.88 (31,670/35,986 episodes) 0.88 (31,651/35,986 episodes) 0.0 0.860 
Weight loss 0.89 (13,835/15,469 episodes) 0.67 (10,310/15,469 episodes) -25.5 <0.001 
Fluid and electrolyte disorders 0.90 (92,445/102,707 episodes) 0.78 (80,213/102,707 episodes) -13.2 <0.001 
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Blood loss anemia 0.91 (2,562/2,821 episodes) 0.86 (2,437/2,821 episodes) -4.8 0.462 
Deficiency anemia 0.90 (16,069/17,894 episodes) 0.89 (15,900/17,894 episodes) -1.0 0.798 
Alcohol abuse 0.88 (19,743/22,543 episodes) 0.86 (19,479/22,543 episodes) -1.4 0.163 
Drug abuse 0.90 (2,945/3,256 episodes) 0.90 (2,931/3,256 episodes) -0.4 0.509 
Psychoses 0.87 (3,680/4,209 episodes) 0.86 (3,634/4,209 episodes) -1.3 0.337 
Depression 0.89 (21,528/24,280 episodes) 0.89 (21,522/24,280 episodes) -0.1 0.923 
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Table 2. Overall rates of sensitivity (true positives/total number of episodes) and percentage change in sensitivity for cardiovascular APR-DRGs classification 
 
 
 
 
Sensitivity rate - Phase 1  
(Data with Comorbidity) 
 
Sensitivity rates - Phase 2 
(Data without Comorbidity) 
 
Sensitivity 
Change 
(%) 
 
p-value 
 
Charlson comorbidities  
 
Myocardial infarction 
 
0.87 (34,157/39,509 episodes) 0.76 (30,080/39,509 episodes) -12.0 <0.001 
Congestive heart failure 
 
0.88 (79,264/90,581 episodes) 0.61 (55,470/90,581 episodes) -30.1 <0.001 
Peripheral vascular disease 0.88 (22,098/25,167 episodes) 0.86 (21,577/25,167 episodes) -2.4 <0.001 
Cerebrovascular disease 0.88 (25,571/29,234 episodes) 0.78 (22,690/29,234 episodes) -11.3 <0.001 
Dementia 0.90 (7,886/8,759 episodes) 0.85 (7,434/8,759 episodes) -5.7 0.436 
Chronic pulmonary disease 0.88 (48,718/55,295 episodes) 0.86 (47,454/55,295 episodes) -2.6 <0.001 
Rheumatic disease 0.87 (3,413/3,942 episodes) 0.82 (3,249/3,942 episodes) -4.8 0.005 
Peptic ulcer disease 0.88 (2,146/2,445 episodes) 0.88 (2,145/2,445 episodes) -0.1 0.942 
Mild liver disease 0.87 (8,296/9,569 episodes) 0.78 (7,470/9,569 episodes) -9.9 <0.001 
Diabetes without chronic complication 0.87 (90,489/103,826 episodes) 0.83 (86,463/103,826 episodes) -4.5 <0.001 
Diabetes with chronic complication 0.88 (18,504/21,159 episodes) 0.82 (17,384/21,159 episodes) -6.1 0.024 
Hemiplegia 0.88 (1,456/1,648 episodes) 0.82 (1,358/1,648 episodes) -6.7 <0.001 
Renal disease 0.88 (110,834/12,6652 episodes) 0.72 (91,070/126,652 episodes) -17.8 <0.001 
Any malignancy 0.88 (9,808/11,204 episodes) 0.63 (7,062/1,1204 episodes) -28.0 <0.001 
Moderate or severe liver disease 0.86 (1,142/1,324 episodes) 0.66 (875/1,324 episodes) -23.4 <0.001 
Metastatic solid tumor 0.82 (2,308/2,822 episodes) 0.54 (1,530/2,822 episodes) -33.7 <0.001 
AIDS/HIV 0.83 (498/603 episodes) 0.78 (473/603 episodes) -5.1 0.160 
     
76 
 
Elixhauser comorbidities 
Congestive heart failure 0.88 (79,264/90,581 episodes) 0.61 (55,470/90,581 episodes) -16.5 0.028 
Cardiac arrhythmias 0.87 (122,375/140,278 episodes) 0.80 (112,829/140,278 episodes) -4.7 0.142 
Valvular disease 0.87 (60406/69518 episodes) 0.84 (58,637/69,518 episodes) -1.3 0.059 
Pulmonary circulation disorders 0.89 (17,231/19,296 episodes) 0.80 (15,495/19,296 episodes) -19.3 0.006 
Peripheral vascular disorders 0.88 (22,098/25,167 episodes) 0.86 (21,577/25,167 episodes) -0.9 0.004 
Hypertension uncomplicated 0.90 (168,239/187,971 episodes) 0.90 (168,330/187,971 episodes) 0.0 0.631 
Paralysis 0.88 (1,456/1,648 episodes) 0.82 (1,358/1,648 episodes) -13.8 <0.001 
Other neurological disorders 0.88 (1,1057/12,547 episodes) 0.81 (10,137/12,547 episodes) -6.8 <0.001 
Chronic pulmonary disease 0.88 (48,718/55,295 episodes) 0.86 (47,454/55,295 episodes) -2.2 <0.001 
Diabetes uncomplicated 0.87 (88,394/101,426 episodes) 0.83 (84,493/101,426 episodes) -4.8 0.086 
Diabetes complicated 0.88 (19,992/22,860 episodes) 0.82 (18,721/22,860 episodes) -4.7 0.216 
Hypothyroidism 0.89 (16,478/18,505 episodes) 0.89 (16,477/18,505 episodes) 0.1 0.087 
Renal failure 0.88 (58,273/66,490 episodes) 0.79 (52,754/66,490 episodes) -6.4 <0.001 
Liver disease 0.87 (9,848/11,342 episodes) 0.77 (87,22/11,342 episodes) -12.4 <0.001 
Peptic ulcer disease excluding bleeding 0.88 (1,656/1,878 episodes) 0.88 (1,660/1,878 episodes) 0.1 0.970 
AIDS_H1V 0.83 (497/601 episodes) 0.79 (472/601 episodes) -14.2 0.018 
Lymphoma 0.88 (1,285/1,464 episodes) 0.68 (991/1,464 episodes) -26.9 <0.001 
Metastatic cancer 0.82 (2,308/2,822 episodes) 0.54 (1,530/2,822 episodes) -49 <0.001 
Solid tumor without metastasis 0.90 (4,769/5,340 episodes) 0.69 (3,657/5,340 episodes) -18.7 <0.001 
Rheumatoid arthritis/collagen vascular diseases 0.87 (5,813/6,654 episodes) 0.83 (5,537/6,654 episodes) -5.0 0.071 
Coagulopathy 0.88 (7,597/8,677 episodes) 0.82 (7,119/8,677 episodes) -5.8 0.105 
Obesity 0.89 (48,760/55,000 episodes) 0.89 (48,774/55,000 episodes) 0.0 0.860 
Weight loss 0.87 (1,925/2,210 episodes) 0.72 (1,586/2,210 episodes) -25.5 <0.001 
Fluid and electrolyte disorders 0.87 (36,654/41,979 episodes) 0.75 (31,343/41,979 episodes) -13.2 <0.001 
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Blood loss anemia 0.87 (1,939/2,222 episodes) 0.83 (1,852/2,222 episodes) -4.8 0.462 
Deficiency anemia 0.88 (11,211/12,691 episodes) 0.87 (11,072/12,691 episodes) -1.0 0.798 
Alcohol abuse 0.86 (13,954/16,275 episodes) 0.85 (13,770/16,275 episodes) -1.4 0.163 
Drug abuse 0.90 (1,139/1,260 episodes) 0.90 (1,125/1,260 episodes) -0.4 0.509 
Psychoses 0.88 (1,280/1,463 episodes) 0.87 (1,277/1,463 episodes) -1.3 0.337 
Depression 0.89 (14,656/16,466 episodes) 0.89 (14,643/16,466 episodes) -0.1 0.923 
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Table 3.  Overall percentage change in hospital charges, by MDC 
 
 
 
 
Estimated Differences in 
Hospital Payments (in 
million euros) – MDC 4 
% Hospital 
Payments Change 
– MDC 4  
 
Estimated Differences in 
Hospital Payments (in 
million euros) – MDC 5 
% Hospital 
Payments Change 
– MDC 5 
 
 
Charlson Comorbidity     
Myocardial infarction -2.368 -6.7 -10.906 -8.4 
Congestive heart failure -15.207 -5.9 -31.619 -10.7 
Peripheral vascular disease -290.393 -0.9 -1.424 -1.5 
Cerebrovascular disease -8.848 -6.7 -7.373 -7.7 
Dementia -2.784 -3.6 -0.672 -3.2 
Chronic pulmonary disease -4.319 -2.2 -2.787 -1.7 
Rheumatic disease -0.314 -2.4 -0.295 -2.7 
Peptic ulcer disease -0.003 ~0.0 0.013 +0.2 
Mild liver disease -2.428 -6.2 -2.069 -6.2 
Diabetes without chronic complication -7.550  -3.7 -8.267 -2.9 
Diabetes with chronic complication -0.906  -2.8 -2.257 -3.6 
Hemiplegia -1.232  -7.8 -0.194 -2.1 
Renal disease -107.659 -18.3 -45.412 -11.5 
Any malignancy -8.456 -10.5 -3.030 -9.7 
Moderate or severe liver disease -1.185 -17.8 -0.830 -16.9 
Metastatic solid tumor -17.147 -22.2 -1.223 -15.1 
AIDS/HIV -0.071 -5.8 -0.069 -3.7 
     
Elixhauser Comorbidities     
Congestive heart failure -15.207 -5.9 -31.619 -10.7 
Cardiac arrhythmias -8.245 -3.3 -23.480 -5.5 
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Valvular disease -0.475 -0.8 -3.721 -1.7 
Pulmonary circulation disorders -6.124 -14.1 -4.109 -6.4 
Peripheral vascular disorders -0.290  -0.9 -1.424 -1.5 
Hypertension uncomplicated 0.200 +0.1 0.343 +0.1 
Paralysis -1.232 -7.8 -0.194 -2.1 
Other neurological disorders -4.342 -4.7 -1.969 -4.8 
Chronic pulmonary disease -4.319 -2.2 -2.787 -1.7 
Diabetes uncomplicated -7.296 -3.7 -8.020 -2.9 
Diabetes complicated -1.165 -3.1 -2.545 -3.7 
Hypothyroidism 0.012 ~0.0 0.042 +0.1 
Renal failure -4.899 -3.7 -8.479 -4.5 
Liver disease -3.608 -8.0 -2.935 -7.5 
Peptic ulcer disease excluding bleeding -0.024 -0.5 0.019 0.3 
AIDS_HIV -0.069 -6.0 -0.069 -3.7 
Lymphoma -0.791 -8.0 -0.267 -7.0 
Metastatic cancer -17.147 -22.2 -1.223 -15.1 
Solid tumor without metastasis -2.277 -7.3 -1.161 -8.0 
Rheumatoid arthritis/collagen vascular diseases -0.923 -2.7 -0.451 -2.0 
Coagulopathy -1.066 -3.3 -1.316 -3.6 
Obesity 0.268 +0.3 0.747 +0.5 
Weight loss -6.316 -13.7 -0.646 -8.1 
Fluid and electrolyte disorders -22.257 -8.2 -13.823 -9.7 
Blood loss anemia -0.238 -3.7 -0.172 -2.6 
Deficiency anemia -0.401 -1.0 -0.293 -0.9 
Alcohol abuse -0.217 -0.4 -0.027 -0.1 
Drug abuse -0.059 -0.7 -0.029 -0.7 
Psychoses 0.123 +1.2 0.021 +0.5 
Depression 0.056 +0.1 0.084 +0.2 
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Table 4. Number and percentage of episodes that changed their base APR-DRG or SOI level after removing comorbidities, MDC 4 (Diseases and 
Disorders of the Respiratory System) 
 
Charlson comorbidities 
     
 
SOI 1 SOI 2 SOI 3 SOI 4 Base APR-DRG 
Myocardial infarction 9/1568 (0.6%) 39/5349 (0.7%) 908/5189 (17.5%) 506/1413 (35.8%) 2/13519 (0%) 
Congestive heart failure 0/542 (0%) 13018/55369 (23.5%) 8303/46658 (17.8%) 293/6448 (4.5%) 7/109017 (0%) 
Peripheral vascular disease 12/1294 (0.9%) 182/5532 (3.3%) 189/4947 (3.8%) 29/848 (3.4%) 0/12621 (0%) 
Cerebrovascular disease 9/1964 (0.5%) 3142/25602 (12.3%) 4337/23872 (18.2%) 872/3686 (23.7%) 4/55124 (0%) 
Dementia 2/483 (0.4%) 1834/17173 (10.7%) 1883/14707 (12.8%) 7/1820 (0.4%) 0/34183 (0%) 
Chronic pulmonary disease 180/18215 (1%) 1991/35117 (5.7%) 2548/28663 (8.9%) 234/3897 (6%) 17/85892 (0%) 
Rheumatic disease 9/1151 (0.8%) 294/2473 (11.9%) 190/1793 (10.6%) 2/263 (0.8%) 1/5680 (0%) 
Peptic ulcer disease 14/420 (3.3%) 31/1005 (3.1%) 27/844 (3.2%) 3/184 (1.6%) 1/2453 (0%) 
Mild liver disease 21/2403 (0.9%) 744/5066 (14.7%) 897/4987 (18%) 304/1503 (20.2%) 7/13959 (0.1%) 
Diabetes without chronic complication 14/11872 (0.1%) 4058/41621 (9.7%) 4923/32805 (15%) 98/4196 (2.3%) 4/90494 (0%) 
Diabetes with chronic complication 10/585 (1.7%) 601/6314 (9.5%) 607/5288 (11.5%) 11/899 (1.2%) 1/13086 (0%) 
Hemiplegia 12/1372 (0.9%) 539/1948 (27.7%) 557/2107 (26.4%) 114/616 (18.5%) 2/6043 (0%) 
Renal disease 342/44697 (0.8%) 17584/84634 (20.8%) 57858/94192 (61.4%) 10434/16304 (64%) 67/239827 (0%) 
Any malignancy 18/630 (2.9%) 6063/17564 (34.5%) 3667/13236 (27.7%) 215/1825 (11.8%) 7/33255 (0%) 
Moderate or severe liver disease 0/29 (0%) 171/605 (28.3%) 514/1128 (45.6%) 146/299 (48.8%) 1/2061 (0%) 
Metastatic solid tumor 3/244 (1.2%) 8074/13652 (59.1%) 5154/11302 (45.6%) 196/1455 (13.5%) 5/26653 (0%) 
AIDS/HIV 0/205 (0%) 68/172 (39.5%) 32/149 (21.5%) 0/17 (0%) 0/543 (0%) 
      
Elixhauser comorbidities 
     
Congestive heart failure 0/542 (0%) 13018/55369 (23.5%) 8303/46658 (17.8%) 293/6448 (4.5%) 7/109017 (0%) 
Cardiac arrhythmias 22/5557 (0.4%) 4499/49047 (9.2%) 5424/42534 (12.8%) 110/6322 (1.7%) 8/103460 (0%) 
Valvular disease 82/2076 (3.9%) 482/11546 (4.2%) 386/9500 (4.1%) 11/1600 (0.7%) 2/24722 (0%) 
81 
 
Pulmonary circulation disorders 2/407 (0.5%) 876/4848 (18.1%) 1925/7269 (26.5%) 1092/2050 (53.3%) 6/14574 (0%) 
Peripheral vascular disorders 12/1294 (0.9%) 182/5532 (3.3%) 189/4947 (3.8%) 29/848 (3.4%) 0/12621 (0%) 
Hypertension uncomplicated 826/29840 (2.8%) 35/68194 (0.1%) 243/45402 (0.5%) 10/6134 (0.2%) 5/149570 (0%) 
Paralysis 12/1372 (0.9%) 539/1948 (27.7%) 557/2107 (26.4%) 114/616 (18.5%) 2/6043 (0%) 
Other neurological disorders 13/4423 (0.3%) 1991/17280 (11.5%) 2283/14575 (15.7%) 325/2518 (12.9%) 3/38796 (0%) 
Chronic pulmonary disease 180/18215 (1%) 1991/35117 (5.7%) 2548/28663 (8.9%) 234/3897 (6%) 17/85892 (0%) 
Diabetes uncomplicated 14/11712 (0.1%) 3856/40047 (9.6%) 4775/31751 (15%) 97/4036 (2.4%) 4/87546 (0%) 
Diabetes complicated 9/742 (1.2%) 811/7665 (10.6%) 757/6163 (12.3%) 12/1033 (1.2%) 1/15603 (0%) 
Hypothyroidism 97/2720 (3.6%) 40/7622 (0.5%) 24/6104 (0.4%) 8/885 (0.9%) 2/17331 (0%) 
Renal failure 64/3031 (2.1%) 1716/26141 (6.6%) 3041/23990 (12.7%) 368/3720 (9.9%) 5/56882 (0%) 
Liver disease 23/3299 (0.7%) 965/5881 (16.4%) 1400/5664 (24.7%) 444/1647 (27%) 7/16491 (0%) 
Peptic ulcer disease excluding bleeding 8/366 (2.2%) 21/787 (2.7%) 19/641 (3%) 3/114 (2.6%) 1/1908 (0.1%) 
AIDS_HIV 0/198 (0%) 67/170 (39.4%) 32/142 (22.5%) 0/16 (0%) 0/526 (0%) 
Lymphoma 11/121 (9.1%) 947/2643 (35.8%) 240/1207 (19.9%) 4/242 (1.7%) 4/4213 (0.1%) 
Metastatic cancer 3/244 (1.2%) 8074/13652 (59.1%) 5154/11302 (45.6%) 196/1455 (13.5%) 5/26653 (0%) 
Solid tumor without metastasis 2/199 (1%) 1792/6908 (25.9%) 970/5339 (18.2%) 21/666 (3.2%) 2/13112 (0%) 
Rheumatoid arthritis/collagen vascular diseases 22/1790 (1.2%) 756/5678 (13.3%) 588/5236 (11.2%) 6/1029 (0.6%) 3/13733 (0%) 
Coagulopathy 5/674 (0.7%) 564/3918 (14.4%) 576/4664 (12.3%) 38/1279 (3%) 0/10535 (0%) 
Obesity 400/7684 (5.2%) 85/14268 (0.6%) 29/12289 (0.2%) 2/1745 (0.1%) 8/35986 (0%) 
Weight loss 8/1148 (0.7%) 690/3585 (19.2%) 3224/9004 (35.8%) 749/1732 (43.2%) 2/15469 (0%) 
Fluid and electrolyte disorders 18/5957 (0.3%) 3201/37382 (8.6%) 11473/49268 (23.3%) 3348/10100 (33.1%) 4/102707 (0%) 
Blood loss anemia 1/227 (0.4%) 114/1364 (8.4%) 163/1107 (14.7%) 2/123 (1.6%) 0/2821 (0%) 
Deficiency anemia 5/2229 (0.2%) 251/7788 (3.2%) 318/6925 (4.6%) 4/952 (0.4%) 0/17894 (0%) 
Alcohol abuse 251/6554 (3.8%) 392/8103 (4.8%) 390/6531 (6%) 19/1355 (1.4%) 3/22543 (0%) 
Drug abuse 4/1677 (0.2%) 51/831 (6.1%) 47/609 (7.7%) 4/139 (2.9%) 3/3256 (0.1%) 
Psychoses 100/1155 (8.7%) 64/1622 (3.9%) 35/1189 (2.9%) 0/243 (0%) 1/4209 (0%) 
Depression 170/6262 (2.7%) 57/9869 (0.6%) 34/7038 (0.5%) 15/1111 (1.4%) 5/24280 (0%) 
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Table 5. Number and percentage of episodes that changed their base APR-DRG or SOI level after removing comorbidities, MDC 5 (Diseases and 
Disorders of the Circulatory System) 
 
Charlson comorbidities 
     
 
SOI 1 SOI 2 SOI 3 SOI 4 Base APR-DRG 
      
Myocardial infarction 846/13745 (6.2%) 1743/15052 (11.6%) 2369/8658 (27.4%) 554/2054 (27%) 1647/39509 (4.2%) 
Congestive heart failure 2/4887 (0%) 26670/56463 (47.2%) 4325/24375 (17.7%) 230/4856 (4.7%) 15/90581 (0%) 
Peripheral vascular disease 77/8136 (0.9%) 754/10498 (7.2%) 279/5175 (5.4%) 84/1358 (6.2%) 7/25167 (0%) 
Cerebrovascular disease 32/4528 (0.7%) 1973/13169 (15%) 1983/9422 (21%) 532/2115 (25.2%) 10/29234 (0%) 
Dementia 1/373 (0.3%) 570/4503 (12.7%) 339/3469 (9.8%) 8/414 (1.9%) 0/8759 (0%) 
Chronic pulmonary disease 41/9750 (0.4%) 2351/27353 (8.6%) 848/15408 (5.5%) 39/2784 (1.4%) 7/55295 (0%) 
Rheumatic disease 7/1163 (0.6%) 320/1846 (17.3%) 66/799 (8.3%) 0/134 (0%) 0/3942 (0%) 
Peptic ulcer disease 13/677 (1.9%) 41/1065 (3.8%) 18/551 (3.3%) 2/152 (1.3%) 0/2445 (0%) 
Mild liver disease 25/1138 (2.2%) 622/4233 (14.7%) 487/2939 (16.6%) 255/1259 (20.3%) 6/9569 (0.1%) 
Diabetes without chronic complication 27/35833 (0.1%) 7220/44345 (16.3%) 2618/20240 (12.9%) 31/3408 (0.9%) 7/103826 (0%) 
Diabetes with chronic complication 39/2517 (1.5%) 1680/10968 (15.3%) 761/6472 (11.8%) 19/1202 (1.6%) 5/21159 (0%) 
Hemiplegia 1/236 (0.4%) 94/416 (22.6%) 49/638 (7.7%) 10/358 (2.8%) 0/1648 (0%) 
Renal disease 284/21939 (1.3%) 4677/53230 (8.8%) 17437/41343 (42.2%) 4876/10140 (48.1%) 26/126652 (0%) 
Any malignancy 5/352 (1.4%) 2302/6357 (36.2%) 917/3912 (23.4%) 62/583 (10.6%) 1/11204 (0%) 
Moderate or severe liver disease 2/26 (7.7%) 109/554 (19.7%) 160/526 (30.4%) 97/218 (44.5%) 0/1324 (0%) 
Metastatic solid tumor 2/26 (7.7%) 346/1151 (30.1%) 700/1460 (47.9%) 31/185 (16.8%) 2/2822 (0.1%) 
AIDS/HIV 0/223 (0%) 57/264 (21.6%) 24/97 (24.7%) 0/19 (0%) 0/603 (0%) 
      
Elixhauser comorbidities 
     
Congestive heart failure 2/4887 (0%) 26670/56463 (47.2%) 4325/24375 (17.7%) 230/4856 (4.7%) 15/90581 (0%) 
Cardiac arrhythmias 52/27464 (0.2%) 11381/68691 (16.6%) 7134/37251 (19.2%) 396/6872 (5.8%) 37/140278 (0%) 
83 
 
Valvular disease 77/13554 (0.6%) 3284/35067 (9.4%) 1136/17390 (6.5%) 58/3507 (1.7%) 19/69518 (0%) 
Pulmonary circulation disorders 3/1021 (0.3%) 1174/10218 (11.5%) 1029/6578 (15.6%) 348/1479 (23.5%) 5/19296 (0%) 
Peripheral vascular disorders 77/8136 (0.9%) 754/10498 (7.2%) 279/5175 (5.4%) 84/1358 (6.2%) 7/25167 (0%) 
Hypertension uncomplicated 679/97348 (0.7%) 120/62485 (0.2%) 135/23592 (0.6%) 14/4546 (0.3%) 12/187971 (0%) 
Paralysis 1/236 (0.4%) 94/416 (22.6%) 49/638 (7.7%) 10/358 (2.8%) 0/1648 (0%) 
Other neurological disorders 9/1869 (0.5%) 996/5533 (18%) 518/3854 (13.4%) 141/1291 (10.9%) 1/12547 (0%) 
Chronic pulmonary disease 41/9750 (0.4%) 2351/27353 (8.6%) 848/15408 (5.5%) 39/2784 (1.4%) 7/55295 (0%) 
Diabetes uncomplicated 27/35508 (0.1%) 6988/43114 (16.2%) 2589/19569 (13.2%) 23/3235 (0.7%) 7/101426 (0%) 
Diabetes complicated 38/2830 (1.3%) 1934/11846 (16.3%) 788/6865 (11.5%) 30/1319 (2.3%) 5/22860 (0%) 
Hypothyroidism 3/4336 (0.1%) 68/8755 (0.8%) 37/4609 (0.8%) 4/805 (0.5%) 3/18505 (0%) 
Renal failure 31/7020 (0.4%) 3853/33684 (11.4%) 3676/22023 (16.7%) 226/3763 (6%) 14/66490 (0%) 
Liver disease 32/1728 (1.9%) 772/4920 (15.7%) 642/3298 (19.5%) 352/1396 (25.2%) 6/11342 (0.1%) 
Peptic ulcer disease excluding bleeding 5/595 (0.8%) 35/841 (4.2%) 3/360 (0.8%) 2/82 (2.4%) 0/1878 (0%) 
AIDS_HIV 0/221 (0%) 57/264 (21.6%) 24/97 (24.7%) 0/19 (0%) 0/601 (0%) 
Lymphoma 1/68 (1.5%) 289/915 (31.6%) 47/411 (11.4%) 2/70 (2.9%) 0/1464 (0%) 
Metastatic cancer 2/26 (7.7%) 346/1151 (30.1%) 700/1460 (47.9%) 31/185 (16.8%) 2/2822 (0.1%) 
Solid tumor without metastasis 1/128 (0.8%) 1024/3107 (33%) 321/1846 (17.4%) 12/259 (4.6%) 1/5340 (0%) 
Rheumatoid arthritis/collagen vascular diseases 9/1553 (0.6%) 477/2826 (16.9%) 120/1718 (7%) 3/557 (0.5%) 0/6654 (0%) 
Coagulopathy 2/806 (0.2%) 538/3698 (14.5%) 384/3029 (12.7%) 56/1144 (4.9%) 1/8677 (0%) 
Obesity 556/21072 (2.6%) 178/21153 (0.8%) 19/10694 (0.2%) 5/2081 (0.2%) 3/55000 (0%) 
Weight loss 7/220 (3.2%) 56/563 (9.9%) 356/1165 (30.6%) 55/262 (21%) 0/2210 (0%) 
Fluid and electrolyte disorders 5/2624 (0.2%) 1194/14458 (8.3%) 5204/19252 (27%) 1864/5645 (33%) 7/41979 (0%) 
Blood loss anemia 1/252 (0.4%) 132/1133 (11.7%) 81/689 (11.8%) 0/148 (0%) 0/2222 (0%) 
Deficiency anemia 4/1384 (0.3%) 310/6561 (4.7%) 98/4052 (2.4%) 10/694 (1.4%) 1/12691 (0%) 
Alcohol abuse 232/5347 (4.3%) 441/6960 (6.3%) 165/3077 (5.4%) 4/891 (0.4%) 1/16275 (0%) 
Drug abuse 6/693 (0.9%) 16/350 (4.6%) 20/156 (12.8%) 4/61 (6.6%) 0/1260 (0%) 
Psychoses 24/478 (5%) 10/538 (1.9%) 11/349 (3.2%) 0/98 (0%) 0/1463 (0%) 
Depression 39/6294 (0.6%) 50/6369 (0.8%) 6/3219 (0.2%) 0/584 (0%) 1/16466 (0%) 
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Table 6 - Overview of evaluation metrics obtained with SVM for base APR-DRG and SOI classification 
 
MDC 4 Classification (Diseases and Disorders of the Respiratory System) 
Base APR-DRG Assignment 
APR-DRG Precision Recall % Correctly Classified % Correctly Classified (2016 
unseen data) 
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0.999 0.998 99.8 99.7 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0.997 0.997 99.7 94.1 
142 - Interstitial Lung Disease 0.993 0.999 99.9 72.2 
141 - Asthma 0.999 1.000 100.0 99.1 
140 - Chronic Obstructive Pulmonary Disease 0.999 1.000 100.0 100.0 
139 - Other Pneumonia 0.998 0.999 99.9 99.9 
138 - Bronchiolitis & RSV Pneumonia 0.987 1.000 100.0 100 
137 - Major Respiratory Infections & Inflammations 0.989 0.998 99.8 99.8 
136 - Respiratory Malignancy 0.997 0.999 99.9 99.9 
135 - Major Chest & Respiratory Trauma 0.995 0.996 99.6 99.9 
134 - Pulmonary Embolism 0.994 1.000 100 100.0 
133 - Pulmonary Edema & Respiratory Failure 0.990 0.998 99.8 99.9 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0.967 1.000 100 100.0 
131 - Cystic Fibrosis - Pulmonary Disease 0.985 1.000 100 100.0 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ Hours 0.963 0.845 84.5 99.6 
121 - Other Respiratory & Chest Procedures 1.000 0.955 95.5 99.6 
120 - Major Respiratory & Chest Procedures 1.000 0.992 99.2 99.7 
     
     
Severity of Illness (SOI) subclass Assignment 
Severity of Illness (SOI) Precision Recall % Correctly Classified % Correctly Classified (2016 
unseen data) 
1 (Minor) 0.918 0.922 92.2 92.1 
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2 (Moderate) 0.870 0.867 86.7 85.3 
3 (Major) 0.878 0.882 88.2 89.2 
4 (Extreme) 0.903 0.879 87.9 88.4 
     
     
MDC 5 Classification (Diseases and Disorders of the Circulatory System) 
Base APR-DRG Assignment 
APR-DRG Precision Recall % Correctly Classified % Correctly Classified (2016 
unseen data) 
199 - Hypertension 0.992 0.999 99.9 91.5 
198 - Angina Pectoris & Coronary Atherosclerosis 0.997 0.999 99.9 98.1 
197 - Peripheral & Other Vascular Disorders 0.993 1.000 100.0 98.1 
196 - Cardiac Arrest 0.980 0.990 99.0 99.8 
194 - Heart Failure 0.999 1.000 100.0 96.9 
193 - Acute & Subacute Endocarditis 0.960 1.000 100.0 100 
192 - Cardiac Catheterization for Ischemic Heart Disease 0.998 1.000 100.0 95.8 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart Disease 0.996 0.998 99.8 95.9 
190 - Acute Myocardial Infarction 0.997 1.000 100.0 97.5 
180 - Other Circulatory System Procedures 0.998 0.989 98.9 100 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0.991 0.983 98.3 99.2 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0.988 0.989 98.9 99.9 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0.999 1.000 100.0 99.8 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0.999 1.000 100.0 98.7 
173 - Other Vascular Procedures 0.998 0.992 99.2 97.4 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or Shock 0.992 0.999 99.9 97.8 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure or Shock 0.963 0.973 97.3 99.9 
207 - Other Circulatory System Diagnoses 0.997 0.992 99.2 99.6 
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206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or Proc 0.979 0.994 99.4 99.9 
205 - Cardiomyopathy 0.997 0.994 99.4 100 
204 - Syncope & Collapse 0.995 0.998 99.8 100 
203 - Chest Pain 0.997 1.000 100.0 99.5 
169 - Major Thoracic & Abdominal Vascular Procedures 0.990 0.960 96.0 99.9 
201 - Cardiac Arrhythmia & Conduction Disorders 0.998 0.995 99.5 100 
200 - Cardiac Congenital & Valvular Disorders 0.993 0.996 99.6 100 
167 - Other Cardiothoracic Procedures 0.980 0.949 94.9 99.4 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0.995 0.999 99.9 98.7 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac Procedure 0.994 0.978 97.8 100 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0.999 0.997 99.7 100 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0.981 0.972 97.2 99.6 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0.999 0.977 97.7 100 
160 - Major Cardiothoracic Repair of Heart Anomaly 1.000 0.929 92.9 99.2 
     
     
Severity of Illness (SOI) subclass Assignment 
Severity of Illness (SOI) Precision Recall % Correctly Classified % Correctly Classified (2016 
unseen data) 
1 (Minor) 0.923 0.945 94.5 94.2 
2 (Moderate) 0.855 0.839 83.9 84.3 
3 (Major) 0.822 0.813 81.3 83.8 
4 (Extreme) 0.902 0.819 81.9 81.2 
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Table 7 - Number and percentage of episodes that changed their base APR-DRG or SOI level after removing comorbidities, by APR-DRG, MDC 4 (Diseases and 
Disorders of the Respiratory System 
 
Charlson comorbidities 
 
SOI 1 SOI 2 SOI 3 SOI 4 Base APR-DRG 
Myocardial infarction 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/369 (0%) 8/1112 (0.7%) 131/817 (16%) 57/122 (46.7%) 0/2420 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/70 (0%) 0/85 (0%) 6/59 (10.2%) 4/7 (57.1%) 0/221 (0%) 
142 - Interstitial Lung Disease 1/17 (5.9%) 1/41 (2.4%) 3/29 (10.3%) 1/6 (16.7%) 0/93 (0%) 
141 - Asthma 0/21 (0%) 0/13 (0%) 9/30 (30%) 3/6 (50%) 0/70 (0%) 
140 - Chronic Obstructive Pulmonary Disease 1/171 (0.6%) 4/533 (0.8%) 64/591 (10.8%) 52/143 (36.4%) 0/1438 (0%) 
139 - Other Pneumonia 5/352 (1.4%) 19/2510 (0.8%) 530/2581 (20.5%) 287/724 (39.6%) 0/6167 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/3 (0%) 0/6 (0%) 2/6 (33.3%) 0/0 ( - ) 0/15 (0%) 
137 - Major Respiratory Infections & Inflammations 1/44 (2.3%) 1/328 (0.3%) 56/340 (16.5%) 38/102 (37.3%) 0/814 (0%) 
136 - Respiratory Malignancy 0/130 (0%) 1/261 (0.4%) 16/247 (6.5%) 4/51 (7.8%) 0/689 (0%) 
135 - Major Chest & Respiratory Trauma 0/77 (0%) 0/44 (0%) 2/20 (10%) 2/3 (66.7%) 0/144 (0%) 
134 - Pulmonary Embolism 1/78 (1.3%) 1/188 (0.5%) 33/138 (23.9%) 9/37 (24.3%) 0/441 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/65 (0%) 2/120 (1.7%) 28/187 (15%) 15/57 (26.3%) 0/429 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/14 (0%) 2/39 (5.1%) 26/121 (21.5%) 31/142 (21.8%) 2/316 (0.6%) 
121 - Other Respiratory & Chest Procedures 0/74 (0%) 0/30 (0%) 2/19 (10.5%) 3/9 (33.3%) 0/132 (0%) 
120 - Major Respiratory & Chest Procedures 0/83 (0%) 0/39 (0%) 0/4 (0%) 0/4 (0%) 0/130 (0%) 
      
Congestive heart failure 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/115 (0%) 4115/12188 
(33.8%) 
1644/7871 (20.9%) 43/615 (7%) 1/20789 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/17 (0%) 190/479 (39.7%) 148/710 (20.8%) 1/52 (1.9%) 0/1258 (0%) 
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142 - Interstitial Lung Disease 0/4 (0%) 52/307 (16.9%) 47/368 (12.8%) 2/46 (4.3%) 0/725 (0%) 
141 - Asthma 0/16 (0%) 295/481 (61.3%) 60/286 (21%) 1/30 (3.3%) 0/813 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/90 (0%) 3558/8535 (41.7%) 1084/7394 (14.7%) 39/835 (4.7%) 0/16854 (0%) 
139 - Other Pneumonia 0/88 (0%) 3088/25345 
(12.2%) 
3965/22195 
(17.9%) 
163/3259 (5%) 1/50887 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/6 (0%) 23/112 (20.5%) 15/47 (31.9%) 1/3 (33.3%) 0/168 (0%) 
137 - Major Respiratory Infections & Inflammations 0/23 (0%) 321/3445 (9.3%) 487/3246 (15%) 18/569 (3.2%) 1/7283 (0%) 
136 - Respiratory Malignancy 0/21 (0%) 268/803 (33.4%) 163/967 (16.9%) 4/104 (3.8%) 1/1895 (0.1%) 
135 - Major Chest & Respiratory Trauma 0/16 (0%) 199/328 (60.7%) 27/128 (21.1%) 0/33 (0%) 0/505 (0%) 
134 - Pulmonary Embolism 0/35 (0%) 493/1803 (27.3%) 241/1151 (20.9%) 8/160 (5%) 1/3149 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/22 (0%) 148/965 (15.3%) 283/1557 (18.2%) 3/112 (2.7%) 0/2656 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/0 ( - ) 0/1 (0%) 0/2 (0%) 0/0 ( - ) 0/3 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/29 (0%) 145/379 (38.3%) 116/629 (18.4%) 8/584 (1.4%) 2/1621 (0.1%) 
121 - Other Respiratory & Chest Procedures 0/33 (0%) 67/114 (58.8%) 20/95 (21.1%) 2/28 (7.1%) 0/270 (0%) 
120 - Major Respiratory & Chest Procedures 0/27 (0%) 56/84 (66.7%) 3/12 (25%) 0/18 (0%) 0/141 (0%) 
      
Peripheral vascular disease 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 2/265 (0.8%) 39/1031 (3.8%) 33/703 (4.7%) 3/68 (4.4%) 0/2067 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/44 (0%) 9/106 (8.5%) 6/79 (7.6%) 0/13 (0%) 0/242 (0%) 
142 - Interstitial Lung Disease 0/13 (0%) 1/49 (2%) 0/29 (0%) 0/4 (0%) 0/95 (0%) 
141 - Asthma 0/12 (0%) 1/13 (7.7%) 2/13 (15.4%) 0/1 (0%) 0/39 (0%) 
140 - Chronic Obstructive Pulmonary Disease 2/216 (0.9%) 15/548 (2.7%) 28/621 (4.5%) 2/80 (2.5%) 0/1465 (0%) 
139 - Other Pneumonia 4/275 (1.5%) 72/2545 (2.8%) 77/2262 (3.4%) 12/412 (2.9%) 0/5494 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/2 (0%) 0/7 (0%) 0/2 (0%) 0/0 ( - ) 0/11 (0%) 
137 - Major Respiratory Infections & Inflammations 2/49 (4.1%) 5/437 (1.1%) 12/434 (2.8%) 5/86 (5.8%) 0/1006 (0%) 
136 - Respiratory Malignancy 1/124 (0.8%) 15/333 (4.5%) 12/355 (3.4%) 2/41 (4.9%) 0/853 (0%) 
135 - Major Chest & Respiratory Trauma 0/60 (0%) 1/40 (2.5%) 2/22 (9.1%) 0/6 (0%) 0/128 (0%) 
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134 - Pulmonary Embolism 1/66 (1.5%) 11/223 (4.9%) 9/167 (5.4%) 4/21 (19%) 0/477 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/21 (0%) 3/93 (3.2%) 3/135 (2.2%) 0/26 (0%) 0/275 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/1 (0%) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/9 (0%) 5/31 (16.1%) 4/85 (4.7%) 1/73 (1.4%) 0/198 (0%) 
121 - Other Respiratory & Chest Procedures 0/66 (0%) 4/38 (10.5%) 1/29 (3.4%) 0/8 (0%) 0/141 (0%) 
120 - Major Respiratory & Chest Procedures 0/71 (0%) 1/36 (2.8%) 0/11 (0%) 0/9 (0%) 0/127 (0%) 
      
Cerebrovascular disease 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 2/821 (0.2%) 1288/6259 (20.6%) 922/4712 (19.6%) 81/358 (22.6%) 0/12150 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/61 (0%) 45/264 (17%) 51/279 (18.3%) 9/34 (26.5%) 0/638 (0%) 
142 - Interstitial Lung Disease 0/10 (0%) 4/68 (5.9%) 6/47 (12.8%) 3/12 (25%) 0/137 (0%) 
141 - Asthma 2/45 (4.4%) 12/62 (19.4%) 4/43 (9.3%) 3/6 (50%) 0/156 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/193 (0%) 235/1387 (16.9%) 194/1348 (14.4%) 44/230 (19.1%) 0/3158 (0%) 
139 - Other Pneumonia 1/372 (0.3%) 1187/12548 (9.5%) 2120/12202 
(17.4%) 
423/1876 (22.5%) 0/26998 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/4 (0%) 2/25 (8%) 4/27 (14.8%) 1/3 (33.3%) 0/59 (0%) 
137 - Major Respiratory Infections & Inflammations 2/89 (2.2%) 147/3550 (4.1%) 673/3580 (18.8%) 157/632 (24.8%) 2/7851 (0%) 
136 - Respiratory Malignancy 0/95 (0%) 61/414 (14.7%) 122/532 (22.9%) 40/119 (33.6%) 0/1160 (0%) 
135 - Major Chest & Respiratory Trauma 1/105 (1%) 39/115 (33.9%) 14/51 (27.5%) 1/12 (8.3%) 0/283 (0%) 
134 - Pulmonary Embolism 1/52 (1.9%) 79/560 (14.1%) 134/457 (29.3%) 50/99 (50.5%) 0/1168 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/17 (0%) 30/219 (13.7%) 45/375 (12%) 16/72 (22.2%) 0/683 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/0 ( - ) 0/0 ( - ) 1/1 (100%) 0/0 ( - ) 0/1 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/15 (0%) 8/75 (10.7%) 40/165 (24.2%) 37/195 (19%) 1/450 (0.2%) 
121 - Other Respiratory & Chest Procedures 0/45 (0%) 4/40 (10%) 6/41 (14.6%) 7/26 (26.9%) 1/152 (0.7%) 
120 - Major Respiratory & Chest Procedures 0/40 (0%) 1/16 (6.2%) 1/12 (8.3%) 0/12 (0%) 0/80 (0%) 
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Dementia 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/295 (0%) 822/4208 (19.5%) 422/2882 (14.6%) 0/221 (0%) 0/7606 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/6 (0%) 29/133 (21.8%) 24/139 (17.3%) 0/17 (0%) 0/295 (0%) 
142 - Interstitial Lung Disease 0/1 (0%) 2/42 (4.8%) 3/23 (13%) 0/2 (0%) 0/68 (0%) 
141 - Asthma 0/11 (0%) 7/22 (31.8%) 5/16 (31.2%) 0/2 (0%) 0/51 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/47 (0%) 139/791 (17.6%) 73/700 (10.4%) 0/86 (0%) 0/1624 (0%) 
139 - Other Pneumonia 1/54 (1.9%) 632/8753 (7.2%) 1022/8156 (12.5%) 5/1053 (0.5%) 0/18016 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/0 ( - ) 0/33 (0%) 2/22 (9.1%) 0/5 (0%) 0/60 (0%) 
137 - Major Respiratory Infections & Inflammations 1/20 (5%) 98/2508 (3.9%) 260/2178 (11.9%) 2/328 (0.6%) 0/5034 (0%) 
136 - Respiratory Malignancy 0/12 (0%) 24/87 (27.6%) 16/109 (14.7%) 0/12 (0%) 0/220 (0%) 
135 - Major Chest & Respiratory Trauma 0/18 (0%) 14/55 (25.5%) 0/13 (0%) 0/2 (0%) 0/88 (0%) 
134 - Pulmonary Embolism 0/7 (0%) 57/398 (14.3%) 32/260 (12.3%) 0/34 (0%) 0/699 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/1 (0%) 10/102 (9.8%) 19/156 (12.2%) 0/14 (0%) 0/273 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/1 (0%) 0/29 (0%) 3/39 (7.7%) 0/43 (0%) 0/112 (0%) 
121 - Other Respiratory & Chest Procedures 0/6 (0%) 0/11 (0%) 2/14 (14.3%) 0/1 (0%) 0/32 (0%) 
120 - Major Respiratory & Chest Procedures 0/4 (0%) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/5 (0%) 
      
Chronic pulmonary disease 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 32/3418 (0.9%) 271/5431 (5%) 359/3560 (10.1%) 23/269 (8.6%) 2/12678 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
6/1111 (0.5%) 63/665 (9.5%) 74/569 (13%) 3/64 (4.7%) 1/2409 (0%) 
142 - Interstitial Lung Disease 2/186 (1.1%) 16/450 (3.6%) 33/372 (8.9%) 1/38 (2.6%) 0/1046 (0%) 
141 - Asthma 1/282 (0.4%) 32/170 (18.8%) 19/207 (9.2%) 0/10 (0%) 0/669 (0%) 
140 - Chronic Obstructive Pulmonary Disease 25/1567 (1.6%) 405/2942 (13.8%) 411/3847 (10.7%) 127/487 (26.1%) 0/8843 (0%) 
139 - Other Pneumonia 67/5489 (1.2%) 642/17504 (3.7%) 1017/13314 (7.6%) 41/1755 (2.3%) 1/38062 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/167 (0%) 3/62 (4.8%) 4/34 (11.8%) 0/4 (0%) 0/267 (0%) 
137 - Major Respiratory Infections & Inflammations 13/907 (1.4%) 68/2417 (2.8%) 139/2045 (6.8%) 13/321 (4%) 1/5690 (0%) 
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136 - Respiratory Malignancy 8/1184 (0.7%) 99/1920 (5.2%) 111/1715 (6.5%) 7/226 (3.1%) 1/5045 (0%) 
135 - Major Chest & Respiratory Trauma 5/384 (1.3%) 20/202 (9.9%) 12/97 (12.4%) 0/12 (0%) 2/695 (0.3%) 
134 - Pulmonary Embolism 3/490 (0.6%) 190/1266 (15%) 118/794 (14.9%) 4/109 (3.7%) 0/2659 (0%) 
133 - Pulmonary Edema & Respiratory Failure 7/351 (2%) 90/1155 (7.8%) 155/1265 (12.3%) 2/107 (1.9%) 0/2878 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/1 (0%) 0/1 (0%) 1/3 (33.3%) 0/0 ( - ) 0/5 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/69 (0%) 21/77 (27.3%) 6/86 (7%) 0/1 (0%) 0/233 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
3/139 (2.2%) 24/303 (7.9%) 49/512 (9.6%) 11/421 (2.6%) 7/1375 (0.5%) 
121 - Other Respiratory & Chest Procedures 3/1166 (0.3%) 24/232 (10.3%) 27/168 (16.1%) 1/40 (2.5%) 1/1606 (0.1%) 
120 - Major Respiratory & Chest Procedures 5/1304 (0.4%) 23/320 (7.2%) 13/75 (17.3%) 1/33 (3%) 1/1732 (0.1%) 
      
Rheumatic disease 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/253 (0%) 74/484 (15.3%) 34/273 (12.5%) 0/10 (0%) 0/1020 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
1/53 (1.9%) 12/37 (32.4%) 6/32 (18.8%) 0/5 (0%) 0/127 (0%) 
142 - Interstitial Lung Disease 0/33 (0%) 6/59 (10.2%) 1/48 (2.1%) 0/8 (0%) 0/148 (0%) 
141 - Asthma 0/28 (0%) 4/24 (16.7%) 6/24 (25%) 0/3 (0%) 0/79 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/113 (0%) 15/193 (7.8%) 15/197 (7.6%) 0/8 (0%) 0/511 (0%) 
139 - Other Pneumonia 6/335 (1.8%) 133/1181 (11.3%) 83/845 (9.8%) 2/135 (1.5%) 1/2496 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/0 ( - ) 1/5 (20%) 0/2 (0%) 0/0 ( - ) 0/7 (0%) 
137 - Major Respiratory Infections & Inflammations 1/63 (1.6%) 9/162 (5.6%) 13/121 (10.7%) 0/25 (0%) 0/371 (0%) 
136 - Respiratory Malignancy 0/29 (0%) 10/75 (13.3%) 5/64 (7.8%) 0/6 (0%) 0/174 (0%) 
135 - Major Chest & Respiratory Trauma 0/39 (0%) 5/13 (38.5%) 1/2 (50%) 0/1 (0%) 0/55 (0%) 
134 - Pulmonary Embolism 0/92 (0%) 19/148 (12.8%) 11/67 (16.4%) 0/6 (0%) 0/313 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/11 (0%) 2/44 (4.5%) 7/67 (10.4%) 0/6 (0%) 0/128 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/0 ( - ) 0/0 ( - ) 1/2 (50%) 0/0 ( - ) 0/2 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
1/7 (14.3%) 2/28 (7.1%) 1/33 (3%) 0/46 (0%) 0/114 (0%) 
121 - Other Respiratory & Chest Procedures 0/60 (0%) 2/12 (16.7%) 6/12 (50%) 0/4 (0%) 0/88 (0%) 
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120 - Major Respiratory & Chest Procedures 0/35 (0%) 0/8 (0%) 0/4 (0%) 0/0 ( - ) 0/47 (0%) 
      
Peptic ulcer disease 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/72 (0%) 7/195 (3.6%) 2/121 (1.7%) 1/8 (12.5%) 0/396 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
1/23 (4.3%) 2/19 (10.5%) 0/14 (0%) 0/3 (0%) 0/59 (0%) 
142 - Interstitial Lung Disease 0/4 (0%) 0/5 (0%) 0/1 (0%) 0/3 (0%) 0/13 (0%) 
141 - Asthma 2/12 (16.7%) 0/6 (0%) 0/4 (0%) 0/0 ( - ) 0/22 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/46 (0%) 4/86 (4.7%) 4/100 (4%) 2/25 (8%) 0/257 (0%) 
139 - Other Pneumonia 8/101 (7.9%) 10/437 (2.3%) 9/375 (2.4%) 0/70 (0%) 0/983 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/0 ( - ) 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/2 (0%) 
137 - Major Respiratory Infections & Inflammations 1/23 (4.3%) 5/92 (5.4%) 5/84 (6%) 0/21 (0%) 0/220 (0%) 
136 - Respiratory Malignancy 0/34 (0%) 3/95 (3.2%) 4/58 (6.9%) 0/12 (0%) 0/199 (0%) 
135 - Major Chest & Respiratory Trauma 0/17 (0%) 0/6 (0%) 0/2 (0%) 0/1 (0%) 0/26 (0%) 
134 - Pulmonary Embolism 1/21 (4.8%) 0/34 (0%) 0/22 (0%) 0/0 ( - ) 0/77 (0%) 
133 - Pulmonary Edema & Respiratory Failure 1/2 (50%) 0/12 (0%) 1/31 (3.2%) 0/4 (0%) 0/49 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/1 (0%) 0/6 (0%) 2/22 (9.1%) 0/32 (0%) 1/61 (1.6%) 
121 - Other Respiratory & Chest Procedures 0/31 (0%) 0/7 (0%) 0/5 (0%) 0/4 (0%) 0/47 (0%) 
120 - Major Respiratory & Chest Procedures 0/33 (0%) 0/4 (0%) 0/4 (0%) 0/1 (0%) 0/42 (0%) 
      
Mild liver disease 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 2/365 (0.5%) 128/826 (15.5%) 155/742 (20.9%) 29/112 (25.9%) 0/2045 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
1/128 (0.8%) 46/201 (22.9%) 18/136 (13.2%) 5/23 (21.7%) 0/488 (0%) 
142 - Interstitial Lung Disease 0/35 (0%) 12/53 (22.6%) 7/51 (13.7%) 2/11 (18.2%) 0/150 (0%) 
141 - Asthma 0/40 (0%) 8/27 (29.6%) 4/31 (12.9%) 0/2 (0%) 0/100 (0%) 
140 - Chronic Obstructive Pulmonary Disease 2/224 (0.9%) 78/472 (16.5%) 79/613 (12.9%) 19/104 (18.3%) 0/1413 (0%) 
139 - Other Pneumonia 13/823 (1.6%) 301/2241 (13.4%) 375/2104 (17.8%) 125/633 (19.7%) 0/5801 (0%) 
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138 - Bronchiolitis & RSV Pneumonia 0/11 (0%) 2/9 (22.2%) 0/4 (0%) 1/2 (50%) 0/26 (0%) 
137 - Major Respiratory Infections & Inflammations 2/288 (0.7%) 52/489 (10.6%) 129/510 (25.3%) 35/180 (19.4%) 1/1467 (0.1%) 
136 - Respiratory Malignancy 1/112 (0.9%) 23/263 (8.7%) 47/303 (15.5%) 27/86 (31.4%) 1/764 (0.1%) 
135 - Major Chest & Respiratory Trauma 0/111 (0%) 18/61 (29.5%) 5/42 (11.9%) 0/9 (0%) 0/223 (0%) 
134 - Pulmonary Embolism 0/114 (0%) 39/247 (15.8%) 32/163 (19.6%) 13/45 (28.9%) 0/569 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/20 (0%) 7/52 (13.5%) 16/105 (15.2%) 11/42 (26.2%) 0/219 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/12 (0%) 2/10 (20%) 2/15 (13.3%) 0/0 ( - ) 1/37 (2.7%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/17 (0%) 11/56 (19.6%) 19/123 (15.4%) 33/232 (14.2%) 4/428 (0.9%) 
121 - Other Respiratory & Chest Procedures 0/68 (0%) 9/37 (24.3%) 7/40 (17.5%) 3/18 (16.7%) 0/163 (0%) 
120 - Major Respiratory & Chest Procedures 0/35 (0%) 8/22 (36.4%) 2/5 (40%) 1/4 (25%) 0/66 (0%) 
      
Diabetes without chronic complication 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 2/2576 (0.1%) 958/8271 (11.6%) 958/5598 (17.1%) 7/379 (1.8%) 0/16824 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/436 (0%) 109/664 (16.4%) 128/608 (21.1%) 0/43 (0%) 0/1751 (0%) 
142 - Interstitial Lung Disease 0/108 (0%) 26/338 (7.7%) 37/256 (14.5%) 1/25 (4%) 0/727 (0%) 
141 - Asthma 2/461 (0.4%) 37/314 (11.8%) 45/292 (15.4%) 0/18 (0%) 0/1085 (0%) 
140 - Chronic Obstructive Pulmonary Disease 1/1596 (0.1%) 432/4064 (10.6%) 469/3956 (11.9%) 8/350 (2.3%) 0/9966 (0%) 
139 - Other Pneumonia 3/2937 (0.1%) 1752/19860 (8.8%) 2352/15397 
(15.3%) 
52/2089 (2.5%) 0/40283 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/10 (0%) 8/86 (9.3%) 7/43 (16.3%) 0/5 (0%) 0/144 (0%) 
137 - Major Respiratory Infections & Inflammations 1/581 (0.2%) 198/3567 (5.6%) 382/2916 (13.1%) 15/488 (3.1%) 0/7552 (0%) 
136 - Respiratory Malignancy 0/746 (0%) 150/1545 (9.7%) 201/1399 (14.4%) 9/180 (5%) 0/3870 (0%) 
135 - Major Chest & Respiratory Trauma 3/721 (0.4%) 75/316 (23.7%) 21/119 (17.6%) 0/20 (0%) 0/1176 (0%) 
134 - Pulmonary Embolism 0/411 (0%) 153/1214 (12.6%) 118/716 (16.5%) 2/90 (2.2%) 0/2431 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/206 (0%) 90/767 (11.7%) 125/943 (13.3%) 1/99 (1%) 0/2015 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/40 (0%) 1/25 (4%) 5/30 (16.7%) 0/1 (0%) 0/96 (0%) 
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130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
1/81 (1.2%) 24/228 (10.5%) 51/396 (12.9%) 3/375 (0.8%) 2/1080 (0.2%) 
121 - Other Respiratory & Chest Procedures 1/480 (0.2%) 25/181 (13.8%) 17/115 (14.8%) 0/22 (0%) 2/798 (0.3%) 
120 - Major Respiratory & Chest Procedures 0/482 (0%) 20/181 (11%) 7/21 (33.3%) 0/12 (0%) 0/696 (0%) 
      
Diabetes with chronic complication 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 3/178 (1.7%) 181/1455 (12.4%) 129/962 (13.4%) 0/82 (0%) 0/2677 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
1/25 (4%) 19/103 (18.4%) 6/86 (7%) 0/13 (0%) 0/227 (0%) 
142 - Interstitial Lung Disease 0/7 (0%) 3/29 (10.3%) 1/19 (5.3%) 1/1 (100%) 0/56 (0%) 
141 - Asthma 0/23 (0%) 10/31 (32.3%) 5/33 (15.2%) 0/1 (0%) 0/88 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/56 (0%) 53/522 (10.2%) 53/548 (9.7%) 0/70 (0%) 0/1196 (0%) 
139 - Other Pneumonia 4/145 (2.8%) 253/3217 (7.9%) 302/2676 (11.3%) 4/465 (0.9%) 0/6503 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/0 ( - ) 2/24 (8.3%) 0/15 (0%) 0/1 (0%) 0/40 (0%) 
137 - Major Respiratory Infections & Inflammations 1/23 (4.3%) 25/478 (5.2%) 47/441 (10.7%) 3/101 (3%) 0/1043 (0%) 
136 - Respiratory Malignancy 0/15 (0%) 7/99 (7.1%) 10/100 (10%) 0/14 (0%) 0/228 (0%) 
135 - Major Chest & Respiratory Trauma 0/38 (0%) 10/37 (27%) 2/12 (16.7%) 0/3 (0%) 0/90 (0%) 
134 - Pulmonary Embolism 0/12 (0%) 18/127 (14.2%) 9/111 (8.1%) 2/11 (18.2%) 0/261 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/15 (0%) 10/96 (10.4%) 27/181 (14.9%) 0/25 (0%) 0/317 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
1/17 (5.9%) 3/50 (6%) 11/81 (13.6%) 1/103 (1%) 1/251 (0.4%) 
121 - Other Respiratory & Chest Procedures 0/17 (0%) 1/24 (4.2%) 3/17 (17.6%) 0/6 (0%) 0/64 (0%) 
120 - Major Respiratory & Chest Procedures 0/14 (0%) 6/22 (27.3%) 2/6 (33.3%) 0/3 (0%) 0/45 (0%) 
      
Hemiplegia 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 2/460 (0.4%) 181/429 (42.2%) 112/360 (31.1%) 20/61 (32.8%) 0/1310 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/33 (0%) 15/36 (41.7%) 11/36 (30.6%) 1/8 (12.5%) 0/113 (0%) 
142 - Interstitial Lung Disease 0/2 (0%) 2/3 (66.7%) 0/9 (0%) 0/1 (0%) 0/15 (0%) 
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141 - Asthma 0/31 (0%) 4/10 (40%) 1/5 (20%) 0/2 (0%) 0/48 (0%) 
140 - Chronic Obstructive Pulmonary Disease 1/42 (2.4%) 10/50 (20%) 19/99 (19.2%) 7/25 (28%) 0/216 (0%) 
139 - Other Pneumonia 6/627 (1%) 225/761 (29.6%) 257/899 (28.6%) 52/275 (18.9%) 1/2562 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/32 (0%) 9/18 (50%) 3/7 (42.9%) 0/0 ( - ) 0/57 (0%) 
137 - Major Respiratory Infections & Inflammations 1/66 (1.5%) 42/271 (15.5%) 77/292 (26.4%) 16/88 (18.2%) 0/717 (0%) 
136 - Respiratory Malignancy 0/13 (0%) 7/256 (2.7%) 40/244 (16.4%) 5/44 (11.4%) 0/557 (0%) 
135 - Major Chest & Respiratory Trauma 0/8 (0%) 0/1 (0%) 0/3 (0%) 0/3 (0%) 0/15 (0%) 
134 - Pulmonary Embolism 2/15 (13.3%) 3/33 (9.1%) 6/37 (16.2%) 2/14 (14.3%) 0/99 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/14 (0%) 27/51 (52.9%) 12/53 (22.6%) 4/20 (20%) 0/138 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/2 (0%) 1/1 (100%) 1/1 (100%) 0/0 ( - ) 0/4 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/10 (0%) 9/17 (52.9%) 15/45 (33.3%) 5/63 (7.9%) 1/135 (0.7%) 
121 - Other Respiratory & Chest Procedures 0/7 (0%) 1/3 (33.3%) 3/13 (23.1%) 2/10 (20%) 0/33 (0%) 
120 - Major Respiratory & Chest Procedures 0/10 (0%) 3/8 (37.5%) 0/4 (0%) 0/2 (0%) 0/24 (0%) 
144 - Respiratory System Signs, Symptoms & Other Diagnoses 56/6331 (0.9%) 3064/13366 
(22.9%) 
7968/12884 
(61.8%) 
937/1276 (73.4%) 2/33857 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
11/2336 (0.5%) 435/1811 (24%) 804/1678 (47.9%) 124/209 (59.3%) 1/6034 (0%) 
142 - Interstitial Lung Disease 2/506 (0.4%) 217/1065 (20.4%) 830/1023 (81.1%) 80/116 (69%) 0/2710 (0%) 
141 - Asthma 8/2945 (0.3%) 545/1057 (51.6%) 1004/1169 (85.9%) 51/75 (68%) 0/5246 (0%) 
140 - Chronic Obstructive Pulmonary Disease 29/4284 (0.7%) 2918/9507 (30.7%) 10640/14531 
(73.2%) 
1350/1639 (82.4%) 0/29961 (0%) 
139 - Other Pneumonia 150/12531 (1.2%) 6615/37228 
(17.8%) 
25940/41505 
(62.5%) 
5034/7626 (66%) 2/98890 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/2994 (0%) 610/791 (77.1%) 198/242 (81.8%) 19/21 (90.5%) 0/4048 (0%) 
137 - Major Respiratory Infections & Inflammations 16/2235 (0.7%) 817/6627 (12.3%) 4482/8203 (54.6%) 1102/1865 (59.1%) 2/18930 (0%) 
136 - Respiratory Malignancy 12/2654 (0.5%) 687/5407 (12.7%) 2556/5655 (45.2%) 549/870 (63.1%) 3/14586 (0%) 
135 - Major Chest & Respiratory Trauma 6/1295 (0.5%) 127/594 (21.4%) 153/330 (46.4%) 50/88 (56.8%) 1/2307 (0%) 
134 - Pulmonary Embolism 18/1505 (1.2%) 447/3060 (14.6%) 1212/2369 (51.2%) 250/389 (64.3%) 1/7323 (0%) 
133 - Pulmonary Edema & Respiratory Failure 19/610 (3.1%) 90/1720 (5.2%) 351/2116 (16.6%) 79/273 (28.9%) 1/4719 (0%) 
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132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/29 (0%) 15/23 (65.2%) 12/12 (100%) 0/0 ( - ) 0/64 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/148 (0%) 98/166 (59%) 158/189 (83.6%) 3/3 (100%) 1/506 (0.2%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
6/580 (1%) 584/1006 (58.1%) 1103/1543 (71.5%) 673/1604 (42%) 44/4733 (0.9%) 
121 - Other Respiratory & Chest Procedures 5/1710 (0.3%) 186/648 (28.7%) 354/602 (58.8%) 89/155 (57.4%) 5/3115 (0.2%) 
120 - Major Respiratory & Chest Procedures 4/2004 (0.2%) 129/558 (23.1%) 93/141 (66%) 44/95 (46.3%) 4/2798 (0.1%) 
      
Any malignancy 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 5/132 (3.8%) 1483/3638 (40.8%) 630/2010 (31.3%) 21/170 (12.4%) 0/5950 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/46 (0%) 623/1148 (54.3%) 205/590 (34.7%) 11/39 (28.2%) 1/1823 (0.1%) 
142 - Interstitial Lung Disease 0/8 (0%) 28/87 (32.2%) 17/72 (23.6%) 0/6 (0%) 0/173 (0%) 
141 - Asthma 0/4 (0%) 37/65 (56.9%) 2/21 (9.5%) 0/0 ( - ) 0/90 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/20 (0%) 427/1037 (41.2%) 218/1099 (19.8%) 7/96 (7.3%) 0/2252 (0%) 
139 - Other Pneumonia 7/137 (5.1%) 1876/7379 (25.4%) 1660/6319 (26.3%) 111/941 (11.8%) 0/14776 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/6 (0%) 8/26 (30.8%) 3/10 (30%) 0/1 (0%) 0/43 (0%) 
137 - Major Respiratory Infections & Inflammations 2/27 (7.4%) 321/1321 (24.3%) 299/1130 (26.5%) 28/212 (13.2%) 0/2690 (0%) 
136 - Respiratory Malignancy 2/71 (2.8%) 523/1132 (46.2%) 207/657 (31.5%) 14/74 (18.9%) 0/1934 (0%) 
135 - Major Chest & Respiratory Trauma 0/3 (0%) 38/73 (52.1%) 8/23 (34.8%) 2/4 (50%) 0/103 (0%) 
134 - Pulmonary Embolism 0/20 (0%) 301/871 (34.6%) 217/615 (35.3%) 15/74 (20.3%) 0/1580 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/5 (0%) 56/217 (25.8%) 109/404 (27%) 2/42 (4.8%) 0/668 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 0/0 ( - ) 0/2 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
1/8 (12.5%) 31/76 (40.8%) 27/121 (22.3%) 3/139 (2.2%) 5/344 (1.5%) 
121 - Other Respiratory & Chest Procedures 1/68 (1.5%) 185/304 (60.9%) 59/153 (38.6%) 1/21 (4.8%) 1/546 (0.2%) 
120 - Major Respiratory & Chest Procedures 0/75 (0%) 126/190 (66.3%) 6/10 (60%) 0/6 (0%) 0/281 (0%) 
      
Moderate or severe liver disease 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/10 (0%) 41/136 (30.1%) 110/216 (50.9%) 19/30 (63.3%) 0/392 (0%) 
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143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/2 (0%) 17/58 (29.3%) 23/57 (40.4%) 4/7 (57.1%) 0/124 (0%) 
142 - Interstitial Lung Disease 0/1 (0%) 1/7 (14.3%) 5/11 (45.5%) 0/1 (0%) 0/20 (0%) 
141 - Asthma 0/2 (0%) 2/2 (100%) 2/2 (100%) 0/0 ( - ) 0/6 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/0 ( - ) 17/38 (44.7%) 21/78 (26.9%) 6/13 (46.2%) 0/129 (0%) 
139 - Other Pneumonia 0/6 (0%) 47/228 (20.6%) 230/482 (47.7%) 74/134 (55.2%) 0/850 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/1 (0%) 1/2 (50%) 0/1 (0%) 0/0 ( - ) 0/4 (0%) 
137 - Major Respiratory Infections & Inflammations 0/0 ( - ) 14/55 (25.5%) 66/117 (56.4%) 16/41 (39%) 0/213 (0%) 
136 - Respiratory Malignancy 0/1 (0%) 9/30 (30%) 21/65 (32.3%) 13/22 (59.1%) 0/118 (0%) 
135 - Major Chest & Respiratory Trauma 0/0 ( - ) 4/10 (40%) 7/11 (63.6%) 1/1 (100%) 0/22 (0%) 
134 - Pulmonary Embolism 0/1 (0%) 1/13 (7.7%) 13/30 (43.3%) 1/4 (25%) 0/48 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/1 (0%) 0/3 (0%) 5/24 (20.8%) 2/4 (50%) 0/32 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/0 ( - ) 4/4 (100%) 2/3 (66.7%) 0/0 ( - ) 0/7 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/0 ( - ) 3/5 (60%) 5/23 (21.7%) 8/37 (21.6%) 1/65 (1.5%) 
121 - Other Respiratory & Chest Procedures 0/2 (0%) 6/7 (85.7%) 4/8 (50%) 2/5 (40%) 0/22 (0%) 
120 - Major Respiratory & Chest Procedures 0/2 (0%) 4/7 (57.1%) 0/0 ( - ) 0/0 ( - ) 0/9 (0%) 
      
Metastatic solid tumor 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 1/9 (11.1%) 307/1138 (27%) 469/979 (47.9%) 11/81 (13.6%) 0/2207 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/2 (0%) 242/611 (39.6%) 244/474 (51.5%) 7/32 (21.9%) 0/1119 (0%) 
142 - Interstitial Lung Disease 0/0 ( - ) 7/15 (46.7%) 9/25 (36%) 1/2 (50%) 0/42 (0%) 
141 - Asthma 0/0 ( - ) 0/3 (0%) 3/7 (42.9%) 0/0 ( - ) 0/10 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/1 (0%) 31/140 (22.1%) 83/242 (34.3%) 0/17 (0%) 0/400 (0%) 
139 - Other Pneumonia 0/0 ( - ) 283/1816 (15.6%) 1024/2713 (37.7%) 48/372 (12.9%) 0/4901 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/0 ( - ) 1/3 (33.3%) 2/4 (50%) 0/0 ( - ) 0/7 (0%) 
137 - Major Respiratory Infections & Inflammations 0/1 (0%) 74/371 (19.9%) 176/478 (36.8%) 7/64 (10.9%) 0/914 (0%) 
136 - Respiratory Malignancy 2/30 (6.7%) 6119/7989 (76.6%) 2650/5367 (49.4%) 106/737 (14.4%) 2/14123 (0%) 
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135 - Major Chest & Respiratory Trauma 0/0 ( - ) 3/9 (33.3%) 7/13 (53.8%) 0/1 (0%) 0/23 (0%) 
134 - Pulmonary Embolism 0/0 ( - ) 97/384 (25.3%) 205/408 (50.2%) 5/42 (11.9%) 0/834 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/0 ( - ) 14/67 (20.9%) 100/210 (47.6%) 2/18 (11.1%) 0/295 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/0 ( - ) 10/20 (50%) 15/50 (30%) 0/31 (0%) 0/101 (0%) 
121 - Other Respiratory & Chest Procedures 0/126 (0%) 319/435 (73.3%) 146/296 (49.3%) 6/46 (13%) 3/903 (0.3%) 
120 - Major Respiratory & Chest Procedures 0/75 (0%) 567/651 (87.1%) 21/36 (58.3%) 3/12 (25%) 0/774 (0%) 
      
AIDS/HIV 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/91 (0%) 28/64 (43.8%) 9/26 (34.6%) 0/3 (0%) 0/184 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/4 (0%) 4/7 (57.1%) 1/2 (50%) 0/0 ( - ) 0/13 (0%) 
142 - Interstitial Lung Disease 0/3 (0%) 1/1 (100%) 0/1 (0%) 0/0 ( - ) 0/5 (0%) 
141 - Asthma 0/6 (0%) 3/5 (60%) 1/2 (50%) 0/0 ( - ) 0/13 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/39 (0%) 13/22 (59.1%) 7/52 (13.5%) 0/3 (0%) 0/116 (0%) 
139 - Other Pneumonia 0/11 (0%) 0/0 ( - ) 0/3 (0%) 0/1 (0%) 0/15 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
137 - Major Respiratory Infections & Inflammations 0/5 (0%) 2/6 (33.3%) 2/7 (28.6%) 0/2 (0%) 0/20 (0%) 
136 - Respiratory Malignancy 0/18 (0%) 2/38 (5.3%) 8/43 (18.6%) 0/3 (0%) 0/102 (0%) 
135 - Major Chest & Respiratory Trauma 0/8 (0%) 3/5 (60%) 0/0 ( - ) 0/0 ( - ) 0/13 (0%) 
134 - Pulmonary Embolism 0/3 (0%) 8/14 (57.1%) 2/6 (33.3%) 0/0 ( - ) 0/23 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/3 (0%) 0/0 ( - ) 2/6 (33.3%) 0/3 (0%) 0/12 (0%) 
121 - Other Respiratory & Chest Procedures 0/6 (0%) 1/2 (50%) 0/1 (0%) 0/0 ( - ) 0/9 (0%) 
120 - Major Respiratory & Chest Procedures 0/6 (0%) 3/7 (42.9%) 0/0 ( - ) 0/2 (0%) 0/15 (0%) 
      
Elixhauser comorbidities 
 
SOI 1 SOI 2 SOI 3 SOI 4 Base APR-DRG 
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Congestive heart failure 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/115 (0%) 4115/12188 
(33.8%) 
1644/7871 (20.9%) 43/615 (7%) 1/20789 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/17 (0%) 190/479 (39.7%) 148/710 (20.8%) 1/52 (1.9%) 0/1258 (0%) 
142 - Interstitial Lung Disease 0/4 (0%) 52/307 (16.9%) 47/368 (12.8%) 2/46 (4.3%) 0/725 (0%) 
141 - Asthma 0/16 (0%) 295/481 (61.3%) 60/286 (21%) 1/30 (3.3%) 0/813 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/90 (0%) 3558/8535 (41.7%) 1084/7394 (14.7%) 39/835 (4.7%) 0/16854 (0%) 
139 - Other Pneumonia 0/88 (0%) 3088/25345 
(12.2%) 
3965/22195 
(17.9%) 
163/3259 (5%) 1/50887 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/6 (0%) 23/112 (20.5%) 15/47 (31.9%) 1/3 (33.3%) 0/168 (0%) 
137 - Major Respiratory Infections & Inflammations 0/23 (0%) 321/3445 (9.3%) 487/3246 (15%) 18/569 (3.2%) 1/7283 (0%) 
136 - Respiratory Malignancy 0/21 (0%) 268/803 (33.4%) 163/967 (16.9%) 4/104 (3.8%) 1/1895 (0.1%) 
135 - Major Chest & Respiratory Trauma 0/16 (0%) 199/328 (60.7%) 27/128 (21.1%) 0/33 (0%) 0/505 (0%) 
134 - Pulmonary Embolism 0/35 (0%) 493/1803 (27.3%) 241/1151 (20.9%) 8/160 (5%) 1/3149 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/22 (0%) 148/965 (15.3%) 283/1557 (18.2%) 3/112 (2.7%) 0/2656 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/0 ( - ) 0/1 (0%) 0/2 (0%) 0/0 ( - ) 0/3 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/29 (0%) 145/379 (38.3%) 116/629 (18.4%) 8/584 (1.4%) 2/1621 (0.1%) 
121 - Other Respiratory & Chest Procedures 0/33 (0%) 67/114 (58.8%) 20/95 (21.1%) 2/28 (7.1%) 0/270 (0%) 
120 - Major Respiratory & Chest Procedures 0/27 (0%) 56/84 (66.7%) 3/12 (25%) 0/18 (0%) 0/141 (0%) 
      
Cardiac arrhythmias 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 4/1321 (0.3%) 1115/10115 (11%) 1062/6944 (15.3%) 12/551 (2.2%) 0/18931 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
1/246 (0.4%) 169/695 (24.3%) 117/661 (17.7%) 1/69 (1.4%) 1/1671 (0.1%) 
142 - Interstitial Lung Disease 0/37 (0%) 18/261 (6.9%) 18/258 (7%) 1/32 (3.1%) 0/588 (0%) 
141 - Asthma 0/224 (0%) 48/294 (16.3%) 37/223 (16.6%) 0/27 (0%) 0/768 (0%) 
140 - Chronic Obstructive Pulmonary Disease 2/834 (0.2%) 591/5239 (11.3%) 584/5230 (11.2%) 11/594 (1.9%) 0/11897 (0%) 
139 - Other Pneumonia 6/1026 (0.6%) 1639/23823 (6.9%) 2599/20903 
(12.4%) 
43/3126 (1.4%) 0/48878 (0%) 
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138 - Bronchiolitis & RSV Pneumonia 0/72 (0%) 9/91 (9.9%) 4/49 (8.2%) 0/3 (0%) 0/215 (0%) 
137 - Major Respiratory Infections & Inflammations 1/212 (0.5%) 181/3916 (4.6%) 389/3755 (10.4%) 17/672 (2.5%) 0/8555 (0%) 
136 - Respiratory Malignancy 0/279 (0%) 161/1127 (14.3%) 178/1303 (13.7%) 3/187 (1.6%) 0/2896 (0%) 
135 - Major Chest & Respiratory Trauma 0/331 (0%) 90/345 (26.1%) 20/152 (13.2%) 1/45 (2.2%) 0/873 (0%) 
134 - Pulmonary Embolism 3/316 (0.9%) 248/1713 (14.5%) 184/1055 (17.4%) 5/179 (2.8%) 0/3263 (0%) 
133 - Pulmonary Edema & Respiratory Failure 2/108 (1.9%) 123/789 (15.6%) 142/1221 (11.6%) 4/163 (2.5%) 0/2281 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/1 (0%) 1/1 (100%) 0/7 (0%) 0/0 ( - ) 0/9 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
1/63 (1.6%) 29/278 (10.4%) 64/594 (10.8%) 9/603 (1.5%) 5/1538 (0.3%) 
121 - Other Respiratory & Chest Procedures 1/254 (0.4%) 39/171 (22.8%) 14/138 (10.1%) 2/44 (4.5%) 1/607 (0.2%) 
120 - Major Respiratory & Chest Procedures 1/233 (0.4%) 38/189 (20.1%) 12/41 (29.3%) 1/27 (3.7%) 1/490 (0.2%) 
      
Valvular disease 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 16/407 (3.9%) 109/2440 (4.5%) 78/1525 (5.1%) 2/146 (1.4%) 0/4518 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
4/148 (2.7%) 21/181 (11.6%) 9/168 (5.4%) 0/24 (0%) 0/521 (0%) 
142 - Interstitial Lung Disease 3/23 (13%) 7/117 (6%) 1/97 (1%) 0/14 (0%) 0/251 (0%) 
141 - Asthma 1/73 (1.4%) 9/90 (10%) 3/77 (3.9%) 0/7 (0%) 0/247 (0%) 
140 - Chronic Obstructive Pulmonary Disease 8/189 (4.2%) 58/1338 (4.3%) 46/1365 (3.4%) 2/239 (0.8%) 0/3131 (0%) 
139 - Other Pneumonia 30/479 (6.3%) 149/5210 (2.9%) 171/4258 (4%) 5/691 (0.7%) 1/10638 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/18 (0%) 0/14 (0%) 0/7 (0%) 0/1 (0%) 0/40 (0%) 
137 - Major Respiratory Infections & Inflammations 6/90 (6.7%) 17/615 (2.8%) 20/590 (3.4%) 0/119 (0%) 0/1414 (0%) 
136 - Respiratory Malignancy 1/52 (1.9%) 16/222 (7.2%) 19/237 (8%) 2/35 (5.7%) 1/546 (0.2%) 
135 - Major Chest & Respiratory Trauma 1/61 (1.6%) 8/63 (12.7%) 2/40 (5%) 0/5 (0%) 0/169 (0%) 
134 - Pulmonary Embolism 10/289 (3.5%) 44/795 (5.5%) 18/449 (4%) 0/63 (0%) 0/1596 (0%) 
133 - Pulmonary Edema & Respiratory Failure 2/72 (2.8%) 32/315 (10.2%) 10/451 (2.2%) 0/52 (0%) 0/890 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/1 (0%) 0/3 (0%) 0/3 (0%) 0/0 ( - ) 0/7 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/22 (0%) 4/70 (5.7%) 7/194 (3.6%) 0/179 (0%) 0/465 (0%) 
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121 - Other Respiratory & Chest Procedures 0/77 (0%) 6/42 (14.3%) 2/30 (6.7%) 0/18 (0%) 0/167 (0%) 
120 - Major Respiratory & Chest Procedures 0/75 (0%) 2/31 (6.5%) 0/9 (0%) 0/7 (0%) 0/122 (0%) 
      
Pulmonary circulation disorders 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/58 (0%) 116/749 (15.5%) 245/903 (27.1%) 86/156 (55.1%) 0/1866 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/13 (0%) 19/80 (23.8%) 44/135 (32.6%) 26/40 (65%) 1/268 (0.4%) 
142 - Interstitial Lung Disease 0/4 (0%) 13/155 (8.4%) 32/231 (13.9%) 19/35 (54.3%) 0/425 (0%) 
141 - Asthma 0/8 (0%) 13/40 (32.5%) 21/72 (29.2%) 6/10 (60%) 0/130 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/86 (0%) 287/1109 (25.9%) 348/1864 (18.7%) 194/386 (50.3%) 0/3445 (0%) 
139 - Other Pneumonia 0/47 (0%) 112/1491 (7.5%) 660/2333 (28.3%) 411/772 (53.2%) 0/4643 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/5 (0%) 4/10 (40%) 2/8 (25%) 1/2 (50%) 0/25 (0%) 
137 - Major Respiratory Infections & Inflammations 0/11 (0%) 11/153 (7.2%) 95/324 (29.3%) 70/122 (57.4%) 1/610 (0.2%) 
136 - Respiratory Malignancy 0/10 (0%) 26/96 (27.1%) 174/302 (57.6%) 185/224 (82.6%) 0/632 (0%) 
135 - Major Chest & Respiratory Trauma 0/2 (0%) 3/14 (21.4%) 8/24 (33.3%) 3/7 (42.9%) 1/47 (2.1%) 
134 - Pulmonary Embolism 1/113 (0.9%) 192/641 (30%) 121/419 (28.9%) 9/57 (15.8%) 0/1230 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/12 (0%) 49/213 (23%) 118/447 (26.4%) 21/49 (42.9%) 0/721 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/0 ( - ) 0/1 (0%) 1/1 (100%) 0/0 ( - ) 0/2 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/0 ( - ) 2/6 (33.3%) 1/7 (14.3%) 0/0 ( - ) 0/13 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/11 (0%) 17/57 (29.8%) 33/148 (22.3%) 36/149 (24.2%) 3/365 (0.8%) 
121 - Other Respiratory & Chest Procedures 1/19 (5.3%) 8/19 (42.1%) 16/42 (38.1%) 17/27 (63%) 0/107 (0%) 
120 - Major Respiratory & Chest Procedures 0/8 (0%) 4/14 (28.6%) 6/9 (66.7%) 8/14 (57.1%) 0/45 (0%) 
      
Peripheral vascular disorders 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 2/265 (0.8%) 39/1031 (3.8%) 33/703 (4.7%) 3/68 (4.4%) 0/2067 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/44 (0%) 9/106 (8.5%) 6/79 (7.6%) 0/13 (0%) 0/242 (0%) 
142 - Interstitial Lung Disease 0/13 (0%) 1/49 (2%) 0/29 (0%) 0/4 (0%) 0/95 (0%) 
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141 - Asthma 0/12 (0%) 1/13 (7.7%) 2/13 (15.4%) 0/1 (0%) 0/39 (0%) 
140 - Chronic Obstructive Pulmonary Disease 2/216 (0.9%) 15/548 (2.7%) 28/621 (4.5%) 2/80 (2.5%) 0/1465 (0%) 
139 - Other Pneumonia 4/275 (1.5%) 72/2545 (2.8%) 77/2262 (3.4%) 12/412 (2.9%) 0/5494 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/2 (0%) 0/7 (0%) 0/2 (0%) 0/0 ( - ) 0/11 (0%) 
137 - Major Respiratory Infections & Inflammations 2/49 (4.1%) 5/437 (1.1%) 12/434 (2.8%) 5/86 (5.8%) 0/1006 (0%) 
136 - Respiratory Malignancy 1/124 (0.8%) 15/333 (4.5%) 12/355 (3.4%) 2/41 (4.9%) 0/853 (0%) 
135 - Major Chest & Respiratory Trauma 0/60 (0%) 1/40 (2.5%) 2/22 (9.1%) 0/6 (0%) 0/128 (0%) 
134 - Pulmonary Embolism 1/66 (1.5%) 11/223 (4.9%) 9/167 (5.4%) 4/21 (19%) 0/477 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/21 (0%) 3/93 (3.2%) 3/135 (2.2%) 0/26 (0%) 0/275 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/1 (0%) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/9 (0%) 5/31 (16.1%) 4/85 (4.7%) 1/73 (1.4%) 0/198 (0%) 
121 - Other Respiratory & Chest Procedures 0/66 (0%) 4/38 (10.5%) 1/29 (3.4%) 0/8 (0%) 0/141 (0%) 
120 - Major Respiratory & Chest Procedures 0/71 (0%) 1/36 (2.8%) 0/11 (0%) 0/9 (0%) 0/127 (0%) 
      
Hypertension uncomplicated 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 171/5917 (2.9%) 5/12687 (0%) 48/7160 (0.7%) 1/579 (0.2%) 0/26343 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
17/1157 (1.5%) 1/1204 (0.1%) 3/821 (0.4%) 0/78 (0%) 0/3260 (0%) 
142 - Interstitial Lung Disease 5/254 (2%) 0/586 (0%) 0/400 (0%) 0/27 (0%) 0/1267 (0%) 
141 - Asthma 13/1104 (1.2%) 1/563 (0.2%) 1/488 (0.2%) 0/28 (0%) 0/2183 (0%) 
140 - Chronic Obstructive Pulmonary Disease 86/3955 (2.2%) 3/6517 (0%) 25/6119 (0.4%) 0/587 (0%) 0/17178 (0%) 
139 - Other Pneumonia 360/7517 (4.8%) 2/31701 (0%) 111/20516 (0.5%) 3/2855 (0.1%) 0/62589 (0%) 
138 - Bronchiolitis & RSV Pneumonia 1/22 (4.5%) 0/127 (0%) 1/57 (1.8%) 0/4 (0%) 0/210 (0%) 
137 - Major Respiratory Infections & Inflammations 33/1057 (3.1%) 20/5758 (0.3%) 25/4088 (0.6%) 5/715 (0.7%) 4/11618 (0%) 
136 - Respiratory Malignancy 28/1695 (1.7%) 1/3025 (0%) 11/2238 (0.5%) 0/313 (0%) 0/7271 (0%) 
135 - Major Chest & Respiratory Trauma 22/2031 (1.1%) 0/630 (0%) 2/189 (1.1%) 0/38 (0%) 0/2888 (0%) 
134 - Pulmonary Embolism 55/1773 (3.1%) 0/2895 (0%) 3/1284 (0.2%) 0/166 (0%) 0/6118 (0%) 
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133 - Pulmonary Edema & Respiratory Failure 16/480 (3.3%) 2/1297 (0.2%) 6/1220 (0.5%) 0/148 (0%) 0/3145 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/2 (0%) 0/4 (0%) 0/4 (0%) 0/0 ( - ) 0/10 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
6/169 (3.6%) 0/376 (0%) 3/534 (0.6%) 1/507 (0.2%) 1/1586 (0.1%) 
121 - Other Respiratory & Chest Procedures 5/1340 (0.4%) 0/386 (0%) 4/231 (1.7%) 0/51 (0%) 0/2008 (0%) 
120 - Major Respiratory & Chest Procedures 8/1367 (0.6%) 0/437 (0%) 0/53 (0%) 0/38 (0%) 0/1895 (0%) 
      
Paralysis 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 2/460 (0.4%) 181/429 (42.2%) 112/360 (31.1%) 20/61 (32.8%) 0/1310 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/33 (0%) 15/36 (41.7%) 11/36 (30.6%) 1/8 (12.5%) 0/113 (0%) 
142 - Interstitial Lung Disease 0/2 (0%) 2/3 (66.7%) 0/9 (0%) 0/1 (0%) 0/15 (0%) 
141 - Asthma 0/31 (0%) 4/10 (40%) 1/5 (20%) 0/2 (0%) 0/48 (0%) 
140 - Chronic Obstructive Pulmonary Disease 1/42 (2.4%) 10/50 (20%) 19/99 (19.2%) 7/25 (28%) 0/216 (0%) 
139 - Other Pneumonia 6/627 (1%) 225/761 (29.6%) 257/899 (28.6%) 52/275 (18.9%) 1/2562 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/32 (0%) 9/18 (50%) 3/7 (42.9%) 0/0 ( - ) 0/57 (0%) 
137 - Major Respiratory Infections & Inflammations 1/66 (1.5%) 42/271 (15.5%) 77/292 (26.4%) 16/88 (18.2%) 0/717 (0%) 
136 - Respiratory Malignancy 0/13 (0%) 7/256 (2.7%) 40/244 (16.4%) 5/44 (11.4%) 0/557 (0%) 
135 - Major Chest & Respiratory Trauma 0/8 (0%) 0/1 (0%) 0/3 (0%) 0/3 (0%) 0/15 (0%) 
134 - Pulmonary Embolism 2/15 (13.3%) 3/33 (9.1%) 6/37 (16.2%) 2/14 (14.3%) 0/99 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/14 (0%) 27/51 (52.9%) 12/53 (22.6%) 4/20 (20%) 0/138 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/2 (0%) 1/1 (100%) 1/1 (100%) 0/0 ( - ) 0/4 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/10 (0%) 9/17 (52.9%) 15/45 (33.3%) 5/63 (7.9%) 1/135 (0.7%) 
121 - Other Respiratory & Chest Procedures 0/7 (0%) 1/3 (33.3%) 3/13 (23.1%) 2/10 (20%) 0/33 (0%) 
120 - Major Respiratory & Chest Procedures 0/10 (0%) 3/8 (37.5%) 0/4 (0%) 0/2 (0%) 0/24 (0%) 
      
Other neurological disorders 
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144 - Respiratory System Signs, Symptoms & Other Diagnoses 3/1309 (0.2%) 643/3867 (16.6%) 472/2661 (17.7%) 51/239 (21.3%) 0/8076 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/104 (0%) 36/166 (21.7%) 38/190 (20%) 3/28 (10.7%) 0/488 (0%) 
142 - Interstitial Lung Disease 0/22 (0%) 6/51 (11.8%) 4/34 (11.8%) 2/8 (25%) 0/115 (0%) 
141 - Asthma 0/131 (0%) 18/57 (31.6%) 8/34 (23.5%) 2/6 (33.3%) 0/228 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/238 (0%) 152/894 (17%) 108/893 (12.1%) 18/137 (13.1%) 0/2162 (0%) 
139 - Other Pneumonia 7/1614 (0.4%) 804/8393 (9.6%) 1068/7226 (14.8%) 170/1232 (13.8%) 1/18465 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/178 (0%) 10/55 (18.2%) 7/17 (41.2%) 0/0 ( - ) 0/250 (0%) 
137 - Major Respiratory Infections & Inflammations 1/255 (0.4%) 105/2529 (4.2%) 349/2268 (15.4%) 47/422 (11.1%) 0/5474 (0%) 
136 - Respiratory Malignancy 1/80 (1.2%) 47/434 (10.8%) 39/361 (10.8%) 3/73 (4.1%) 0/948 (0%) 
135 - Major Chest & Respiratory Trauma 0/187 (0%) 36/108 (33.3%) 8/43 (18.6%) 1/12 (8.3%) 0/350 (0%) 
134 - Pulmonary Embolism 0/74 (0%) 54/375 (14.4%) 62/290 (21.4%) 6/54 (11.1%) 0/793 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/42 (0%) 34/165 (20.6%) 73/313 (23.3%) 5/73 (6.8%) 0/593 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/2 (0%) 0/2 (0%) 0/2 (0%) 0/0 ( - ) 0/6 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/6 (0%) 2/6 (33.3%) 1/4 (25%) 0/0 ( - ) 0/16 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
1/57 (1.8%) 31/128 (24.2%) 42/198 (21.2%) 14/203 (6.9%) 1/586 (0.2%) 
121 - Other Respiratory & Chest Procedures 0/75 (0%) 7/32 (21.9%) 3/33 (9.1%) 3/25 (12%) 1/165 (0.6%) 
120 - Major Respiratory & Chest Procedures 0/49 (0%) 6/18 (33.3%) 1/8 (12.5%) 0/6 (0%) 0/81 (0%) 
144 - Respiratory System Signs, Symptoms & Other Diagnoses 32/3418 (0.9%) 271/5431 (5%) 359/3560 (10.1%) 23/269 (8.6%) 2/12678 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
6/1111 (0.5%) 63/665 (9.5%) 74/569 (13%) 3/64 (4.7%) 1/2409 (0%) 
142 - Interstitial Lung Disease 2/186 (1.1%) 16/450 (3.6%) 33/372 (8.9%) 1/38 (2.6%) 0/1046 (0%) 
141 - Asthma 1/282 (0.4%) 32/170 (18.8%) 19/207 (9.2%) 0/10 (0%) 0/669 (0%) 
140 - Chronic Obstructive Pulmonary Disease 25/1567 (1.6%) 405/2942 (13.8%) 411/3847 (10.7%) 127/487 (26.1%) 0/8843 (0%) 
139 - Other Pneumonia 67/5489 (1.2%) 642/17504 (3.7%) 1017/13314 (7.6%) 41/1755 (2.3%) 1/38062 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/167 (0%) 3/62 (4.8%) 4/34 (11.8%) 0/4 (0%) 0/267 (0%) 
137 - Major Respiratory Infections & Inflammations 13/907 (1.4%) 68/2417 (2.8%) 139/2045 (6.8%) 13/321 (4%) 1/5690 (0%) 
136 - Respiratory Malignancy 8/1184 (0.7%) 99/1920 (5.2%) 111/1715 (6.5%) 7/226 (3.1%) 1/5045 (0%) 
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135 - Major Chest & Respiratory Trauma 5/384 (1.3%) 20/202 (9.9%) 12/97 (12.4%) 0/12 (0%) 2/695 (0.3%) 
134 - Pulmonary Embolism 3/490 (0.6%) 190/1266 (15%) 118/794 (14.9%) 4/109 (3.7%) 0/2659 (0%) 
133 - Pulmonary Edema & Respiratory Failure 7/351 (2%) 90/1155 (7.8%) 155/1265 (12.3%) 2/107 (1.9%) 0/2878 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/1 (0%) 0/1 (0%) 1/3 (33.3%) 0/0 ( - ) 0/5 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/69 (0%) 21/77 (27.3%) 6/86 (7%) 0/1 (0%) 0/233 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
3/139 (2.2%) 24/303 (7.9%) 49/512 (9.6%) 11/421 (2.6%) 7/1375 (0.5%) 
121 - Other Respiratory & Chest Procedures 3/1166 (0.3%) 24/232 (10.3%) 27/168 (16.1%) 1/40 (2.5%) 1/1606 (0.1%) 
120 - Major Respiratory & Chest Procedures 5/1304 (0.4%) 23/320 (7.2%) 13/75 (17.3%) 1/33 (3%) 1/1732 (0.1%) 
      
Diabetes uncomplicated 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 2/2531 (0.1%) 911/8008 (11.4%) 937/5416 (17.3%) 6/362 (1.7%) 0/16317 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/432 (0%) 102/645 (15.8%) 127/595 (21.3%) 0/41 (0%) 0/1713 (0%) 
142 - Interstitial Lung Disease 0/106 (0%) 26/333 (7.8%) 36/251 (14.3%) 1/25 (4%) 0/715 (0%) 
141 - Asthma 2/456 (0.4%) 36/310 (11.6%) 45/290 (15.5%) 0/18 (0%) 0/1074 (0%) 
140 - Chronic Obstructive Pulmonary Disease 1/1579 (0.1%) 414/3964 (10.4%) 454/3869 (11.7%) 8/336 (2.4%) 0/9748 (0%) 
139 - Other Pneumonia 3/2881 (0.1%) 1644/18931 (8.7%) 2269/14856 
(15.3%) 
52/2018 (2.6%) 0/38686 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/10 (0%) 7/82 (8.5%) 7/41 (17.1%) 0/5 (0%) 0/138 (0%) 
137 - Major Respiratory Infections & Inflammations 1/570 (0.2%) 186/3419 (5.4%) 372/2788 (13.3%) 15/466 (3.2%) 0/7243 (0%) 
136 - Respiratory Malignancy 0/739 (0%) 148/1509 (9.8%) 194/1360 (14.3%) 9/172 (5.2%) 0/3780 (0%) 
135 - Major Chest & Respiratory Trauma 3/717 (0.4%) 75/313 (24%) 21/118 (17.8%) 0/18 (0%) 0/1166 (0%) 
134 - Pulmonary Embolism 0/407 (0%) 151/1188 (12.7%) 113/700 (16.1%) 2/89 (2.2%) 0/2384 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/206 (0%) 87/748 (11.6%) 122/918 (13.3%) 1/95 (1.1%) 0/1967 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/39 (0%) 1/22 (4.5%) 5/30 (16.7%) 0/1 (0%) 0/92 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
1/80 (1.2%) 24/218 (11%) 49/386 (12.7%) 3/357 (0.8%) 2/1041 (0.2%) 
121 - Other Respiratory & Chest Procedures 1/478 (0.2%) 25/179 (14%) 17/112 (15.2%) 0/22 (0%) 2/791 (0.3%) 
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120 - Major Respiratory & Chest Procedures 0/481 (0%) 19/178 (10.7%) 7/21 (33.3%) 0/11 (0%) 0/691 (0%) 
      
Diabetes complicated 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 3/221 (1.4%) 229/1669 (13.7%) 148/1108 (13.4%) 1/98 (1%) 0/3096 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
1/29 (3.4%) 28/116 (24.1%) 7/95 (7.4%) 0/15 (0%) 0/255 (0%) 
142 - Interstitial Lung Disease 0/9 (0%) 3/32 (9.4%) 2/24 (8.3%) 1/1 (100%) 0/66 (0%) 
141 - Asthma 0/28 (0%) 11/33 (33.3%) 5/34 (14.7%) 0/1 (0%) 0/96 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/73 (0%) 71/613 (11.6%) 72/616 (11.7%) 0/78 (0%) 0/1380 (0%) 
139 - Other Pneumonia 3/200 (1.5%) 366/4020 (9.1%) 384/3138 (12.2%) 4/524 (0.8%) 0/7882 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/0 ( - ) 3/27 (11.1%) 0/17 (0%) 0/1 (0%) 0/45 (0%) 
137 - Major Respiratory Infections & Inflammations 1/34 (2.9%) 37/609 (6.1%) 58/546 (10.6%) 3/122 (2.5%) 0/1311 (0%) 
136 - Respiratory Malignancy 0/22 (0%) 11/131 (8.4%) 17/133 (12.8%) 0/22 (0%) 0/308 (0%) 
135 - Major Chest & Respiratory Trauma 0/43 (0%) 10/40 (25%) 2/13 (15.4%) 0/4 (0%) 0/100 (0%) 
134 - Pulmonary Embolism 0/16 (0%) 19/151 (12.6%) 14/127 (11%) 2/12 (16.7%) 0/306 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/15 (0%) 13/113 (11.5%) 31/196 (15.8%) 0/29 (0%) 0/353 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/1 (0%) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/4 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
1/19 (5.3%) 3/59 (5.1%) 12/89 (13.5%) 1/116 (0.9%) 1/283 (0.4%) 
121 - Other Respiratory & Chest Procedures 0/18 (0%) 1/26 (3.8%) 3/20 (15%) 0/6 (0%) 0/70 (0%) 
120 - Major Respiratory & Chest Procedures 0/14 (0%) 6/23 (26.1%) 2/7 (28.6%) 0/4 (0%) 0/48 (0%) 
      
Hypothyroidism 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 19/522 (3.6%) 12/1598 (0.8%) 5/1050 (0.5%) 1/80 (1.2%) 0/3250 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
4/125 (3.2%) 1/136 (0.7%) 1/126 (0.8%) 0/12 (0%) 0/399 (0%) 
142 - Interstitial Lung Disease 1/32 (3.1%) 0/63 (0%) 0/60 (0%) 0/6 (0%) 0/161 (0%) 
141 - Asthma 5/177 (2.8%) 0/90 (0%) 0/67 (0%) 0/6 (0%) 0/340 (0%) 
140 - Chronic Obstructive Pulmonary Disease 10/274 (3.6%) 4/683 (0.6%) 3/756 (0.4%) 0/78 (0%) 0/1791 (0%) 
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139 - Other Pneumonia 40/778 (5.1%) 18/3566 (0.5%) 13/2787 (0.5%) 2/438 (0.5%) 0/7569 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/32 (0%) 0/13 (0%) 0/3 (0%) 0/2 (0%) 0/50 (0%) 
137 - Major Respiratory Infections & Inflammations 4/108 (3.7%) 1/591 (0.2%) 2/503 (0.4%) 1/80 (1.2%) 0/1282 (0%) 
136 - Respiratory Malignancy 3/92 (3.3%) 2/228 (0.9%) 0/167 (0%) 1/30 (3.3%) 0/517 (0%) 
135 - Major Chest & Respiratory Trauma 0/70 (0%) 0/27 (0%) 0/14 (0%) 0/3 (0%) 0/114 (0%) 
134 - Pulmonary Embolism 7/243 (2.9%) 0/321 (0%) 0/197 (0%) 1/22 (4.5%) 0/783 (0%) 
133 - Pulmonary Edema & Respiratory Failure 1/31 (3.2%) 1/180 (0.6%) 0/242 (0%) 1/19 (5.3%) 0/472 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/3 (0%) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/5 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/3 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
3/30 (10%) 0/59 (0%) 0/91 (0%) 1/95 (1.1%) 1/275 (0.4%) 
121 - Other Respiratory & Chest Procedures 0/117 (0%) 1/40 (2.5%) 0/39 (0%) 0/7 (0%) 1/203 (0.5%) 
120 - Major Respiratory & Chest Procedures 0/85 (0%) 0/24 (0%) 0/1 (0%) 0/7 (0%) 0/117 (0%) 
      
Renal failure 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 9/913 (1%) 535/5734 (9.3%) 641/4172 (15.4%) 35/341 (10.3%) 1/11160 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/128 (0%) 67/360 (18.6%) 68/422 (16.1%) 5/37 (13.5%) 1/947 (0.1%) 
142 - Interstitial Lung Disease 0/17 (0%) 12/106 (11.3%) 10/96 (10.4%) 1/16 (6.2%) 0/235 (0%) 
141 - Asthma 0/39 (0%) 9/96 (9.4%) 16/89 (18%) 0/8 (0%) 0/232 (0%) 
140 - Chronic Obstructive Pulmonary Disease 2/354 (0.6%) 197/2264 (8.7%) 246/2441 (10.1%) 44/328 (13.4%) 0/5387 (0%) 
139 - Other Pneumonia 38/890 (4.3%) 617/13556 (4.6%) 1557/12541 
(12.4%) 
219/2080 (10.5%) 0/29067 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/6 (0%) 8/68 (11.8%) 15/41 (36.6%) 2/6 (33.3%) 0/121 (0%) 
137 - Major Respiratory Infections & Inflammations 2/137 (1.5%) 90/2059 (4.4%) 231/2005 (11.5%) 29/379 (7.7%) 0/4580 (0%) 
136 - Respiratory Malignancy 4/130 (3.1%) 40/449 (8.9%) 82/508 (16.1%) 13/78 (16.7%) 0/1165 (0%) 
135 - Major Chest & Respiratory Trauma 1/71 (1.4%) 18/94 (19.1%) 7/51 (13.7%) 0/10 (0%) 0/226 (0%) 
134 - Pulmonary Embolism 2/95 (2.1%) 52/677 (7.7%) 71/545 (13%) 8/72 (11.1%) 1/1389 (0.1%) 
133 - Pulmonary Edema & Respiratory Failure 3/72 (4.2%) 36/421 (8.6%) 65/757 (8.6%) 5/79 (6.3%) 0/1329 (0%) 
108 
 
131 - Cystic Fibrosis - Pulmonary Disease 0/4 (0%) 0/0 ( - ) 0/3 (0%) 0/0 ( - ) 0/7 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
3/43 (7%) 15/146 (10.3%) 19/251 (7.6%) 7/257 (2.7%) 2/697 (0.3%) 
121 - Other Respiratory & Chest Procedures 0/76 (0%) 11/69 (15.9%) 11/57 (19.3%) 0/16 (0%) 0/218 (0%) 
120 - Major Respiratory & Chest Procedures 0/56 (0%) 9/42 (21.4%) 2/11 (18.2%) 0/13 (0%) 0/122 (0%) 
      
Liver disease 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 2/487 (0.4%) 175/958 (18.3%) 255/823 (31%) 48/125 (38.4%) 0/2393 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
1/177 (0.6%) 71/228 (31.1%) 46/155 (29.7%) 8/25 (32%) 0/585 (0%) 
142 - Interstitial Lung Disease 0/45 (0%) 13/67 (19.4%) 10/59 (16.9%) 2/14 (14.3%) 0/185 (0%) 
141 - Asthma 0/67 (0%) 10/37 (27%) 6/41 (14.6%) 0/3 (0%) 0/148 (0%) 
140 - Chronic Obstructive Pulmonary Disease 2/312 (0.6%) 102/567 (18%) 103/722 (14.3%) 25/116 (21.6%) 0/1717 (0%) 
139 - Other Pneumonia 15/1085 (1.4%) 378/2537 (14.9%) 601/2334 (25.7%) 195/692 (28.2%) 0/6648 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/13 (0%) 4/11 (36.4%) 0/5 (0%) 1/2 (50%) 0/31 (0%) 
137 - Major Respiratory Infections & Inflammations 2/451 (0.4%) 67/582 (11.5%) 189/568 (33.3%) 50/190 (26.3%) 1/1791 (0.1%) 
136 - Respiratory Malignancy 1/160 (0.6%) 33/353 (9.3%) 70/377 (18.6%) 40/105 (38.1%) 1/995 (0.1%) 
135 - Major Chest & Respiratory Trauma 0/135 (0%) 23/62 (37.1%) 12/44 (27.3%) 1/9 (11.1%) 0/250 (0%) 
134 - Pulmonary Embolism 0/136 (0%) 41/258 (15.9%) 44/187 (23.5%) 14/45 (31.1%) 0/626 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/26 (0%) 7/63 (11.1%) 20/126 (15.9%) 13/42 (31%) 0/257 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/12 (0%) 5/10 (50%) 4/16 (25%) 0/0 ( - ) 1/38 (2.6%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/24 (0%) 15/67 (22.4%) 28/152 (18.4%) 41/252 (16.3%) 4/495 (0.8%) 
121 - Other Respiratory & Chest Procedures 0/101 (0%) 12/48 (25%) 10/49 (20.4%) 5/20 (25%) 0/218 (0%) 
120 - Major Respiratory & Chest Procedures 0/68 (0%) 9/33 (27.3%) 2/6 (33.3%) 1/7 (14.3%) 0/114 (0%) 
      
Peptic ulcer disease excluding bleeding 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/67 (0%) 5/157 (3.2%) 1/94 (1.1%) 1/5 (20%) 0/323 (0%) 
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143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/18 (0%) 2/17 (11.8%) 0/13 (0%) 0/2 (0%) 0/50 (0%) 
142 - Interstitial Lung Disease 0/4 (0%) 0/5 (0%) 0/1 (0%) 0/1 (0%) 0/11 (0%) 
141 - Asthma 2/12 (16.7%) 0/6 (0%) 0/3 (0%) 0/0 ( - ) 0/21 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/42 (0%) 2/72 (2.8%) 4/83 (4.8%) 2/19 (10.5%) 0/216 (0%) 
139 - Other Pneumonia 5/80 (6.2%) 8/332 (2.4%) 7/284 (2.5%) 0/48 (0%) 0/744 (0%) 
137 - Major Respiratory Infections & Inflammations 0/19 (0%) 2/60 (3.3%) 2/53 (3.8%) 0/12 (0%) 0/144 (0%) 
136 - Respiratory Malignancy 0/30 (0%) 2/85 (2.4%) 3/47 (6.4%) 0/10 (0%) 0/172 (0%) 
135 - Major Chest & Respiratory Trauma 0/16 (0%) 0/6 (0%) 0/2 (0%) 0/1 (0%) 0/25 (0%) 
134 - Pulmonary Embolism 0/18 (0%) 0/26 (0%) 0/16 (0%) 0/0 ( - ) 0/60 (0%) 
133 - Pulmonary Edema & Respiratory Failure 1/1 (100%) 0/8 (0%) 1/26 (3.8%) 0/2 (0%) 0/37 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/1 (0%) 0/2 (0%) 1/13 (7.7%) 0/11 (0%) 1/27 (3.7%) 
121 - Other Respiratory & Chest Procedures 0/30 (0%) 0/7 (0%) 0/4 (0%) 0/2 (0%) 0/43 (0%) 
120 - Major Respiratory & Chest Procedures 0/28 (0%) 0/4 (0%) 0/2 (0%) 0/1 (0%) 0/35 (0%) 
      
AIDS_HIV 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/91 (0%) 28/64 (43.8%) 9/26 (34.6%) 0/3 (0%) 0/184 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/3 (0%) 4/7 (57.1%) 1/2 (50%) 0/0 ( - ) 0/12 (0%) 
142 - Interstitial Lung Disease 0/3 (0%) 1/1 (100%) 0/1 (0%) 0/0 ( - ) 0/5 (0%) 
141 - Asthma 0/6 (0%) 3/5 (60%) 1/1 (100%) 0/0 ( - ) 0/12 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/39 (0%) 13/22 (59.1%) 7/48 (14.6%) 0/3 (0%) 0/112 (0%) 
139 - Other Pneumonia 0/10 (0%) 0/0 ( - ) 0/1 (0%) 0/1 (0%) 0/12 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
137 - Major Respiratory Infections & Inflammations 0/2 (0%) 2/5 (40%) 2/7 (28.6%) 0/2 (0%) 0/16 (0%) 
136 - Respiratory Malignancy 0/18 (0%) 2/38 (5.3%) 8/43 (18.6%) 0/3 (0%) 0/102 (0%) 
135 - Major Chest & Respiratory Trauma 0/8 (0%) 3/5 (60%) 0/0 ( - ) 0/0 ( - ) 0/13 (0%) 
134 - Pulmonary Embolism 0/3 (0%) 8/14 (57.1%) 2/6 (33.3%) 0/0 ( - ) 0/23 (0%) 
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133 - Pulmonary Edema & Respiratory Failure 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/2 (0%) 0/0 ( - ) 2/6 (33.3%) 0/3 (0%) 0/11 (0%) 
121 - Other Respiratory & Chest Procedures 0/6 (0%) 1/2 (50%) 0/1 (0%) 0/0 ( - ) 0/9 (0%) 
120 - Major Respiratory & Chest Procedures 0/5 (0%) 2/6 (33.3%) 0/0 ( - ) 0/1 (0%) 0/12 (0%) 
      
Lymphoma 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 1/26 (3.8%) 253/589 (43%) 36/177 (20.3%) 0/16 (0%) 0/808 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/10 (0%) 51/79 (64.6%) 8/29 (27.6%) 0/0 ( - ) 0/118 (0%) 
142 - Interstitial Lung Disease 0/2 (0%) 9/21 (42.9%) 5/14 (35.7%) 0/4 (0%) 0/41 (0%) 
141 - Asthma 0/1 (0%) 6/9 (66.7%) 0/4 (0%) 0/0 ( - ) 0/14 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/8 (0%) 45/106 (42.5%) 12/56 (21.4%) 1/8 (12.5%) 0/178 (0%) 
139 - Other Pneumonia 7/31 (22.6%) 442/1406 (31.4%) 141/694 (20.3%) 1/132 (0.8%) 0/2263 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/0 ( - ) 4/8 (50%) 0/0 ( - ) 0/0 ( - ) 0/8 (0%) 
137 - Major Respiratory Infections & Inflammations 1/6 (16.7%) 49/207 (23.7%) 17/99 (17.2%) 0/30 (0%) 0/342 (0%) 
136 - Respiratory Malignancy 0/4 (0%) 19/47 (40.4%) 4/24 (16.7%) 0/1 (0%) 0/76 (0%) 
135 - Major Chest & Respiratory Trauma 0/1 (0%) 3/8 (37.5%) 1/2 (50%) 0/0 ( - ) 0/11 (0%) 
134 - Pulmonary Embolism 0/1 (0%) 33/87 (37.9%) 8/43 (18.6%) 0/2 (0%) 0/133 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/1 (0%) 6/25 (24%) 4/40 (10%) 0/5 (0%) 0/71 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
1/1 (100%) 10/21 (47.6%) 1/18 (5.6%) 2/43 (4.7%) 3/83 (3.6%) 
121 - Other Respiratory & Chest Procedures 1/25 (4%) 10/18 (55.6%) 2/5 (40%) 0/1 (0%) 1/49 (2%) 
120 - Major Respiratory & Chest Procedures 0/4 (0%) 7/12 (58.3%) 1/1 (100%) 0/0 ( - ) 0/17 (0%) 
      
Metastatic cancer 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 1/9 (11.1%) 307/1138 (27%) 469/979 (47.9%) 11/81 (13.6%) 0/2207 (0%) 
111 
 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/2 (0%) 242/611 (39.6%) 244/474 (51.5%) 7/32 (21.9%) 0/1119 (0%) 
142 - Interstitial Lung Disease 0/0 ( - ) 7/15 (46.7%) 9/25 (36%) 1/2 (50%) 0/42 (0%) 
141 - Asthma 0/0 ( - ) 0/3 (0%) 3/7 (42.9%) 0/0 ( - ) 0/10 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/1 (0%) 31/140 (22.1%) 83/242 (34.3%) 0/17 (0%) 0/400 (0%) 
139 - Other Pneumonia 0/0 ( - ) 283/1816 (15.6%) 1024/2713 (37.7%) 48/372 (12.9%) 0/4901 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/0 ( - ) 1/3 (33.3%) 2/4 (50%) 0/0 ( - ) 0/7 (0%) 
137 - Major Respiratory Infections & Inflammations 0/1 (0%) 74/371 (19.9%) 176/478 (36.8%) 7/64 (10.9%) 0/914 (0%) 
136 - Respiratory Malignancy 2/30 (6.7%) 6119/7989 (76.6%) 2650/5367 (49.4%) 106/737 (14.4%) 2/14123 (0%) 
135 - Major Chest & Respiratory Trauma 0/0 ( - ) 3/9 (33.3%) 7/13 (53.8%) 0/1 (0%) 0/23 (0%) 
134 - Pulmonary Embolism 0/0 ( - ) 97/384 (25.3%) 205/408 (50.2%) 5/42 (11.9%) 0/834 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/0 ( - ) 14/67 (20.9%) 100/210 (47.6%) 2/18 (11.1%) 0/295 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/0 ( - ) 10/20 (50%) 15/50 (30%) 0/31 (0%) 0/101 (0%) 
121 - Other Respiratory & Chest Procedures 0/126 (0%) 319/435 (73.3%) 146/296 (49.3%) 6/46 (13%) 3/903 (0.3%) 
120 - Major Respiratory & Chest Procedures 0/75 (0%) 567/651 (87.1%) 21/36 (58.3%) 3/12 (25%) 0/774 (0%) 
      
Solid tumor without metastasis 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/46 (0%) 435/1345 (32.3%) 181/839 (21.6%) 4/69 (5.8%) 0/2299 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/11 (0%) 156/391 (39.9%) 46/226 (20.4%) 3/13 (23.1%) 0/641 (0%) 
142 - Interstitial Lung Disease 0/1 (0%) 8/30 (26.7%) 3/26 (11.5%) 0/1 (0%) 0/58 (0%) 
141 - Asthma 0/0 ( - ) 12/27 (44.4%) 1/8 (12.5%) 0/0 ( - ) 0/35 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/2 (0%) 143/481 (29.7%) 65/506 (12.8%) 0/41 (0%) 0/1030 (0%) 
139 - Other Pneumonia 0/15 (0%) 447/2770 (16.1%) 420/2522 (16.7%) 9/344 (2.6%) 0/5651 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/3 (0%) 3/7 (42.9%) 3/5 (60%) 0/1 (0%) 0/16 (0%) 
137 - Major Respiratory Infections & Inflammations 0/3 (0%) 70/499 (14%) 87/454 (19.2%) 1/74 (1.4%) 0/1030 (0%) 
136 - Respiratory Malignancy 2/52 (3.8%) 245/620 (39.5%) 71/325 (21.8%) 1/34 (2.9%) 0/1031 (0%) 
135 - Major Chest & Respiratory Trauma 0/0 ( - ) 20/40 (50%) 1/6 (16.7%) 0/2 (0%) 0/48 (0%) 
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134 - Pulmonary Embolism 0/11 (0%) 127/406 (31.3%) 43/195 (22.1%) 2/29 (6.9%) 0/641 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/2 (0%) 18/86 (20.9%) 30/140 (21.4%) 0/14 (0%) 0/242 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/3 (0%) 8/28 (28.6%) 6/33 (18.2%) 1/35 (2.9%) 2/99 (2%) 
121 - Other Respiratory & Chest Procedures 0/19 (0%) 52/105 (49.5%) 11/51 (21.6%) 0/6 (0%) 0/181 (0%) 
120 - Major Respiratory & Chest Procedures 0/31 (0%) 48/73 (65.8%) 2/2 (100%) 0/3 (0%) 0/109 (0%) 
      
Rheumatoid arthritis/collagen vascular diseases 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 7/446 (1.6%) 252/1303 (19.3%) 116/939 (12.4%) 0/91 (0%) 0/2779 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
1/70 (1.4%) 14/55 (25.5%) 8/62 (12.9%) 0/9 (0%) 0/196 (0%) 
142 - Interstitial Lung Disease 0/41 (0%) 10/77 (13%) 2/55 (3.6%) 0/10 (0%) 0/183 (0%) 
141 - Asthma 0/47 (0%) 7/35 (20%) 7/33 (21.2%) 0/3 (0%) 0/118 (0%) 
140 - Chronic Obstructive Pulmonary Disease 1/155 (0.6%) 45/335 (13.4%) 38/349 (10.9%) 0/40 (0%) 0/879 (0%) 
139 - Other Pneumonia 10/513 (1.9%) 306/2826 (10.8%) 304/2787 (10.9%) 4/521 (0.8%) 1/6647 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/6 (0%) 2/26 (7.7%) 3/17 (17.6%) 0/1 (0%) 0/50 (0%) 
137 - Major Respiratory Infections & Inflammations 2/105 (1.9%) 30/459 (6.5%) 48/456 (10.5%) 0/143 (0%) 0/1163 (0%) 
136 - Respiratory Malignancy 0/42 (0%) 14/105 (13.3%) 12/109 (11%) 0/10 (0%) 1/266 (0.4%) 
135 - Major Chest & Respiratory Trauma 0/83 (0%) 31/88 (35.2%) 6/41 (14.6%) 0/11 (0%) 0/223 (0%) 
134 - Pulmonary Embolism 0/120 (0%) 24/216 (11.1%) 20/144 (13.9%) 0/19 (0%) 0/499 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/14 (0%) 6/67 (9%) 11/121 (9.1%) 1/23 (4.3%) 0/225 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/0 ( - ) 0/0 ( - ) 1/2 (50%) 0/0 ( - ) 0/2 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
1/19 (5.3%) 11/57 (19.3%) 6/93 (6.5%) 1/134 (0.7%) 1/303 (0.3%) 
121 - Other Respiratory & Chest Procedures 0/75 (0%) 4/19 (21.1%) 6/19 (31.6%) 0/11 (0%) 0/124 (0%) 
120 - Major Respiratory & Chest Procedures 0/54 (0%) 0/10 (0%) 0/9 (0%) 0/3 (0%) 0/76 (0%) 
      
Coagulopathy 
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144 - Respiratory System Signs, Symptoms & Other Diagnoses 0/151 (0%) 145/820 (17.7%) 129/710 (18.2%) 3/105 (2.9%) 0/1786 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/24 (0%) 22/65 (33.8%) 10/83 (12%) 0/13 (0%) 0/185 (0%) 
142 - Interstitial Lung Disease 0/5 (0%) 1/29 (3.4%) 5/35 (14.3%) 1/9 (11.1%) 0/78 (0%) 
141 - Asthma 0/23 (0%) 7/21 (33.3%) 2/16 (12.5%) 0/0 ( - ) 0/60 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/51 (0%) 42/280 (15%) 47/406 (11.6%) 0/75 (0%) 0/812 (0%) 
139 - Other Pneumonia 4/215 (1.9%) 185/1786 (10.4%) 263/2225 (11.8%) 13/521 (2.5%) 0/4747 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/10 (0%) 0/5 (0%) 1/4 (25%) 0/0 ( - ) 0/19 (0%) 
137 - Major Respiratory Infections & Inflammations 0/46 (0%) 38/322 (11.8%) 35/415 (8.4%) 5/125 (4%) 0/908 (0%) 
136 - Respiratory Malignancy 0/30 (0%) 32/223 (14.3%) 32/298 (10.7%) 2/63 (3.2%) 0/614 (0%) 
135 - Major Chest & Respiratory Trauma 0/23 (0%) 16/52 (30.8%) 3/39 (7.7%) 1/11 (9.1%) 0/125 (0%) 
134 - Pulmonary Embolism 0/50 (0%) 39/194 (20.1%) 29/172 (16.9%) 2/39 (5.1%) 0/455 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/1 (0%) 8/30 (26.7%) 6/115 (5.2%) 1/37 (2.7%) 0/183 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/0 ( - ) 0/1 (0%) 0/2 (0%) 0/1 (0%) 0/4 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/7 (0%) 7/41 (17.1%) 8/113 (7.1%) 8/255 (3.1%) 0/416 (0%) 
121 - Other Respiratory & Chest Procedures 0/26 (0%) 15/31 (48.4%) 6/27 (22.2%) 2/17 (11.8%) 0/101 (0%) 
120 - Major Respiratory & Chest Procedures 1/12 (8.3%) 7/18 (38.9%) 0/4 (0%) 0/8 (0%) 0/42 (0%) 
      
Obesity 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 61/1188 (5.1%) 16/2777 (0.6%) 2/2056 (0.1%) 0/186 (0%) 0/6207 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
7/241 (2.9%) 4/253 (1.6%) 0/255 (0%) 0/33 (0%) 1/782 (0.1%) 
142 - Interstitial Lung Disease 1/74 (1.4%) 0/140 (0%) 0/101 (0%) 0/8 (0%) 0/323 (0%) 
141 - Asthma 13/664 (2%) 1/282 (0.4%) 2/272 (0.7%) 0/16 (0%) 0/1234 (0%) 
140 - Chronic Obstructive Pulmonary Disease 57/1138 (5%) 20/2454 (0.8%) 8/2862 (0.3%) 0/293 (0%) 0/6747 (0%) 
139 - Other Pneumonia 155/2123 (7.3%) 19/5548 (0.3%) 7/4291 (0.2%) 0/668 (0%) 0/12630 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/15 (0%) 0/24 (0%) 1/10 (10%) 0/0 ( - ) 0/49 (0%) 
137 - Major Respiratory Infections & Inflammations 15/214 (7%) 2/643 (0.3%) 4/535 (0.7%) 1/118 (0.8%) 2/1510 (0.1%) 
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136 - Respiratory Malignancy 5/172 (2.9%) 0/268 (0%) 1/285 (0.4%) 0/39 (0%) 0/764 (0%) 
135 - Major Chest & Respiratory Trauma 5/180 (2.8%) 0/83 (0%) 0/49 (0%) 0/11 (0%) 0/323 (0%) 
134 - Pulmonary Embolism 40/843 (4.7%) 7/779 (0.9%) 1/406 (0.2%) 0/62 (0%) 1/2090 (0%) 
133 - Pulmonary Edema & Respiratory Failure 29/241 (12%) 13/742 (1.8%) 1/849 (0.1%) 0/66 (0%) 0/1898 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/1 (0%) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/2 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
8/101 (7.9%) 3/160 (1.9%) 1/267 (0.4%) 1/223 (0.4%) 4/751 (0.5%) 
121 - Other Respiratory & Chest Procedures 3/267 (1.1%) 0/63 (0%) 1/40 (2.5%) 0/14 (0%) 0/384 (0%) 
120 - Major Respiratory & Chest Procedures 1/221 (0.5%) 0/52 (0%) 0/10 (0%) 0/8 (0%) 0/291 (0%) 
      
Weight loss 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 2/189 (1.1%) 118/566 (20.8%) 461/1259 (36.6%) 79/140 (56.4%) 0/2154 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/56 (0%) 21/84 (25%) 46/128 (35.9%) 4/18 (22.2%) 0/286 (0%) 
142 - Interstitial Lung Disease 0/24 (0%) 5/41 (12.2%) 13/46 (28.3%) 3/12 (25%) 0/123 (0%) 
141 - Asthma 0/14 (0%) 1/2 (50%) 1/5 (20%) 0/0 ( - ) 0/21 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/110 (0%) 60/222 (27%) 180/516 (34.9%) 89/151 (58.9%) 0/999 (0%) 
139 - Other Pneumonia 5/219 (2.3%) 162/1305 (12.4%) 1390/4011 (34.7%) 335/785 (42.7%) 0/6320 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/42 (0%) 1/4 (25%) 2/9 (22.2%) 1/1 (100%) 0/56 (0%) 
137 - Major Respiratory Infections & Inflammations 1/243 (0.4%) 128/616 (20.8%) 582/1537 (37.9%) 142/328 (43.3%) 1/2724 (0%) 
136 - Respiratory Malignancy 0/145 (0%) 164/587 (27.9%) 450/1061 (42.4%) 71/156 (45.5%) 0/1949 (0%) 
135 - Major Chest & Respiratory Trauma 0/4 (0%) 2/3 (66.7%) 2/9 (22.2%) 0/1 (0%) 0/17 (0%) 
134 - Pulmonary Embolism 0/13 (0%) 5/36 (13.9%) 17/83 (20.5%) 5/15 (33.3%) 0/147 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/5 (0%) 4/20 (20%) 41/130 (31.5%) 2/16 (12.5%) 0/171 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/0 ( - ) 1/4 (25%) 1/2 (50%) 0/0 ( - ) 0/6 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/26 (0%) 1/42 (2.4%) 3/70 (4.3%) 0/0 ( - ) 0/138 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/5 (0%) 6/22 (27.3%) 19/75 (25.3%) 9/80 (11.2%) 0/182 (0%) 
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121 - Other Respiratory & Chest Procedures 0/39 (0%) 8/23 (34.8%) 15/53 (28.3%) 7/15 (46.7%) 0/130 (0%) 
120 - Major Respiratory & Chest Procedures 0/14 (0%) 3/8 (37.5%) 1/10 (10%) 2/14 (14.3%) 1/46 (2.2%) 
      
Fluid and electrolyte disorders 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 5/1538 (0.3%) 886/8182 (10.8%) 2132/8260 (25.8%) 384/952 (40.3%) 1/18932 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
1/102 (1%) 49/337 (14.5%) 156/623 (25%) 33/90 (36.7%) 0/1152 (0%) 
142 - Interstitial Lung Disease 0/22 (0%) 11/125 (8.8%) 35/214 (16.4%) 24/53 (45.3%) 0/414 (0%) 
141 - Asthma 0/197 (0%) 179/316 (56.6%) 81/278 (29.1%) 25/52 (48.1%) 0/843 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/610 (0%) 486/2585 (18.8%) 1320/5097 (25.9%) 690/1135 (60.8%) 0/9427 (0%) 
139 - Other Pneumonia 9/2174 (0.4%) 985/18730 (5.3%) 5317/24117 (22%) 1549/4889 (31.7%) 1/49910 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/114 (0%) 99/183 (54.1%) 36/88 (40.9%) 4/13 (30.8%) 0/398 (0%) 
137 - Major Respiratory Infections & Inflammations 0/495 (0%) 121/4036 (3%) 1145/5356 (21.4%) 327/1226 (26.7%) 0/11113 (0%) 
136 - Respiratory Malignancy 0/312 (0%) 68/1282 (5.3%) 258/1878 (13.7%) 75/357 (21%) 0/3829 (0%) 
135 - Major Chest & Respiratory Trauma 0/63 (0%) 29/109 (26.6%) 23/108 (21.3%) 11/38 (28.9%) 1/318 (0.3%) 
134 - Pulmonary Embolism 2/89 (2.2%) 100/729 (13.7%) 146/831 (17.6%) 59/205 (28.8%) 0/1854 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/48 (0%) 74/387 (19.1%) 593/1548 (38.3%) 61/233 (26.2%) 0/2216 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/2 (0%) 1/1 (100%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/6 (0%) 4/10 (40%) 1/12 (8.3%) 0/1 (0%) 0/29 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
1/63 (1.6%) 75/246 (30.5%) 208/685 (30.4%) 95/765 (12.4%) 1/1759 (0.1%) 
121 - Other Respiratory & Chest Procedures 0/81 (0%) 19/84 (22.6%) 14/146 (9.6%) 8/59 (13.6%) 0/370 (0%) 
120 - Major Respiratory & Chest Procedures 0/41 (0%) 15/40 (37.5%) 8/27 (29.6%) 3/32 (9.4%) 0/140 (0%) 
      
Blood loss anemia 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 1/49 (2%) 31/286 (10.8%) 28/170 (16.5%) 0/8 (0%) 0/513 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/13 (0%) 4/27 (14.8%) 4/15 (26.7%) 0/1 (0%) 0/56 (0%) 
142 - Interstitial Lung Disease 0/1 (0%) 0/7 (0%) 0/6 (0%) 0/0 ( - ) 0/14 (0%) 
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141 - Asthma 0/3 (0%) 1/4 (25%) 0/3 (0%) 0/1 (0%) 0/11 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/26 (0%) 4/73 (5.5%) 8/77 (10.4%) 0/6 (0%) 0/182 (0%) 
139 - Other Pneumonia 0/60 (0%) 51/685 (7.4%) 90/585 (15.4%) 1/71 (1.4%) 0/1401 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/6 (0%) 0/0 ( - ) 0/0 ( - ) 0/0 ( - ) 0/6 (0%) 
137 - Major Respiratory Infections & Inflammations 0/21 (0%) 6/155 (3.9%) 25/136 (18.4%) 0/16 (0%) 0/328 (0%) 
136 - Respiratory Malignancy 0/17 (0%) 11/65 (16.9%) 3/49 (6.1%) 0/1 (0%) 0/132 (0%) 
135 - Major Chest & Respiratory Trauma 0/5 (0%) 1/10 (10%) 0/4 (0%) 0/1 (0%) 0/20 (0%) 
134 - Pulmonary Embolism 0/14 (0%) 2/25 (8%) 3/27 (11.1%) 0/1 (0%) 0/67 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/0 ( - ) 2/14 (14.3%) 2/21 (9.5%) 0/4 (0%) 0/39 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/4 (0%) 1/7 (14.3%) 0/8 (0%) 1/12 (8.3%) 0/31 (0%) 
121 - Other Respiratory & Chest Procedures 0/4 (0%) 0/4 (0%) 0/4 (0%) 0/0 ( - ) 0/12 (0%) 
120 - Major Respiratory & Chest Procedures 0/4 (0%) 0/2 (0%) 0/2 (0%) 0/1 (0%) 0/9 (0%) 
      
Deficiency anemia 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 1/444 (0.2%) 69/1628 (4.2%) 65/1165 (5.6%) 0/93 (0%) 0/3330 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/52 (0%) 7/112 (6.2%) 4/98 (4.1%) 0/12 (0%) 0/274 (0%) 
142 - Interstitial Lung Disease 0/25 (0%) 0/38 (0%) 1/29 (3.4%) 0/4 (0%) 0/96 (0%) 
141 - Asthma 0/68 (0%) 4/34 (11.8%) 0/22 (0%) 0/1 (0%) 0/125 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/179 (0%) 17/574 (3%) 24/658 (3.6%) 0/96 (0%) 0/1507 (0%) 
139 - Other Pneumonia 4/827 (0.5%) 110/4042 (2.7%) 168/3572 (4.7%) 2/502 (0.4%) 0/8943 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/121 (0%) 0/15 (0%) 1/6 (16.7%) 0/0 ( - ) 0/142 (0%) 
137 - Major Respiratory Infections & Inflammations 0/236 (0%) 16/736 (2.2%) 28/718 (3.9%) 2/111 (1.8%) 0/1801 (0%) 
136 - Respiratory Malignancy 0/60 (0%) 6/167 (3.6%) 6/196 (3.1%) 0/31 (0%) 0/454 (0%) 
135 - Major Chest & Respiratory Trauma 0/18 (0%) 1/22 (4.5%) 0/12 (0%) 0/2 (0%) 0/54 (0%) 
134 - Pulmonary Embolism 0/133 (0%) 15/275 (5.5%) 12/145 (8.3%) 0/16 (0%) 0/569 (0%) 
133 - Pulmonary Edema & Respiratory Failure 0/9 (0%) 2/89 (2.2%) 5/191 (2.6%) 0/11 (0%) 0/300 (0%) 
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131 - Cystic Fibrosis - Pulmonary Disease 0/4 (0%) 0/4 (0%) 0/12 (0%) 0/0 ( - ) 0/20 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/10 (0%) 3/32 (9.4%) 4/69 (5.8%) 0/61 (0%) 0/172 (0%) 
121 - Other Respiratory & Chest Procedures 0/31 (0%) 1/18 (5.6%) 0/29 (0%) 0/8 (0%) 0/86 (0%) 
120 - Major Respiratory & Chest Procedures 0/12 (0%) 0/2 (0%) 0/3 (0%) 0/4 (0%) 0/21 (0%) 
      
Alcohol abuse 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 33/980 (3.4%) 64/1211 (5.3%) 64/749 (8.5%) 1/86 (1.2%) 0/3026 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
4/280 (1.4%) 25/194 (12.9%) 8/121 (6.6%) 1/22 (4.5%) 0/617 (0%) 
142 - Interstitial Lung Disease 2/32 (6.2%) 3/53 (5.7%) 4/32 (12.5%) 1/7 (14.3%) 1/124 (0.8%) 
141 - Asthma 1/72 (1.4%) 3/26 (11.5%) 1/22 (4.5%) 0/4 (0%) 0/124 (0%) 
140 - Chronic Obstructive Pulmonary Disease 30/912 (3.3%) 54/1077 (5%) 48/1235 (3.9%) 4/179 (2.2%) 0/3403 (0%) 
139 - Other Pneumonia 108/1939 (5.6%) 154/3264 (4.7%) 165/2506 (6.6%) 7/509 (1.4%) 0/8218 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/5 (0%) 1/9 (11.1%) 0/5 (0%) 0/0 ( - ) 0/19 (0%) 
137 - Major Respiratory Infections & Inflammations 28/912 (3.1%) 27/875 (3.1%) 51/665 (7.7%) 2/156 (1.3%) 0/2608 (0%) 
136 - Respiratory Malignancy 18/359 (5%) 25/718 (3.5%) 18/560 (3.2%) 1/80 (1.2%) 0/1717 (0%) 
135 - Major Chest & Respiratory Trauma 5/380 (1.3%) 5/104 (4.8%) 4/63 (6.3%) 0/12 (0%) 0/559 (0%) 
134 - Pulmonary Embolism 11/176 (6.2%) 5/199 (2.5%) 10/131 (7.6%) 1/24 (4.2%) 0/530 (0%) 
133 - Pulmonary Edema & Respiratory Failure 6/65 (9.2%) 8/128 (6.2%) 9/152 (5.9%) 0/25 (0%) 0/370 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
2/85 (2.4%) 11/130 (8.5%) 4/225 (1.8%) 1/218 (0.5%) 2/658 (0.3%) 
121 - Other Respiratory & Chest Procedures 1/193 (0.5%) 2/60 (3.3%) 4/52 (7.7%) 0/20 (0%) 0/325 (0%) 
120 - Major Respiratory & Chest Procedures 2/164 (1.2%) 5/55 (9.1%) 0/13 (0%) 0/13 (0%) 0/245 (0%) 
      
Drug abuse 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 1/184 (0.5%) 7/73 (9.6%) 4/41 (9.8%) 1/7 (14.3%) 0/305 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/189 (0%) 2/23 (8.7%) 2/21 (9.5%) 0/1 (0%) 0/234 (0%) 
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142 - Interstitial Lung Disease 0/11 (0%) 1/9 (11.1%) 0/3 (0%) 0/1 (0%) 0/24 (0%) 
141 - Asthma 2/73 (2.7%) 3/14 (21.4%) 4/20 (20%) 0/2 (0%) 0/109 (0%) 
140 - Chronic Obstructive Pulmonary Disease 0/196 (0%) 9/123 (7.3%) 6/146 (4.1%) 0/15 (0%) 0/480 (0%) 
139 - Other Pneumonia 0/389 (0%) 6/231 (2.6%) 9/141 (6.4%) 2/27 (7.4%) 0/788 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/2 (0%) 
137 - Major Respiratory Infections & Inflammations 1/306 (0.3%) 6/113 (5.3%) 3/62 (4.8%) 0/24 (0%) 0/505 (0%) 
136 - Respiratory Malignancy 0/70 (0%) 2/157 (1.3%) 8/89 (9%) 0/11 (0%) 0/327 (0%) 
135 - Major Chest & Respiratory Trauma 0/62 (0%) 2/8 (25%) 0/4 (0%) 0/2 (0%) 0/76 (0%) 
134 - Pulmonary Embolism 0/28 (0%) 4/17 (23.5%) 0/11 (0%) 0/1 (0%) 1/57 (1.8%) 
133 - Pulmonary Edema & Respiratory Failure 0/23 (0%) 3/20 (15%) 2/13 (15.4%) 0/3 (0%) 0/59 (0%) 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
0/35 (0%) 5/23 (21.7%) 8/43 (18.6%) 1/38 (2.6%) 2/139 (1.4%) 
121 - Other Respiratory & Chest Procedures 0/68 (0%) 1/12 (8.3%) 0/9 (0%) 0/2 (0%) 0/91 (0%) 
120 - Major Respiratory & Chest Procedures 0/42 (0%) 0/7 (0%) 1/6 (16.7%) 0/4 (0%) 0/59 (0%) 
      
Psychoses 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 17/253 (6.7%) 9/297 (3%) 4/157 (2.5%) 0/12 (0%) 0/719 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
0/32 (0%) 2/26 (7.7%) 1/15 (6.7%) 0/1 (0%) 0/74 (0%) 
142 - Interstitial Lung Disease 0/1 (0%) 0/6 (0%) 0/9 (0%) 0/3 (0%) 0/19 (0%) 
141 - Asthma 1/37 (2.7%) 1/13 (7.7%) 1/17 (5.9%) 0/1 (0%) 0/68 (0%) 
140 - Chronic Obstructive Pulmonary Disease 12/131 (9.2%) 4/142 (2.8%) 5/176 (2.8%) 0/25 (0%) 0/474 (0%) 
139 - Other Pneumonia 52/408 (12.7%) 31/686 (4.5%) 11/480 (2.3%) 0/91 (0%) 0/1665 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/3 (0%) 0/2 (0%) 0/4 (0%) 0/0 ( - ) 0/9 (0%) 
137 - Major Respiratory Infections & Inflammations 7/94 (7.4%) 2/205 (1%) 3/113 (2.7%) 0/38 (0%) 0/450 (0%) 
136 - Respiratory Malignancy 2/45 (4.4%) 11/143 (7.7%) 6/106 (5.7%) 0/21 (0%) 0/315 (0%) 
135 - Major Chest & Respiratory Trauma 0/33 (0%) 0/7 (0%) 0/7 (0%) 0/1 (0%) 0/48 (0%) 
119 
 
134 - Pulmonary Embolism 5/54 (9.3%) 1/37 (2.7%) 0/25 (0%) 0/6 (0%) 0/122 (0%) 
133 - Pulmonary Edema & Respiratory Failure 2/12 (16.7%) 2/26 (7.7%) 1/42 (2.4%) 0/1 (0%) 0/81 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
2/19 (10.5%) 1/26 (3.8%) 3/33 (9.1%) 0/40 (0%) 1/118 (0.8%) 
121 - Other Respiratory & Chest Procedures 0/13 (0%) 0/2 (0%) 0/4 (0%) 0/1 (0%) 0/20 (0%) 
120 - Major Respiratory & Chest Procedures 0/20 (0%) 0/4 (0%) 0/1 (0%) 0/2 (0%) 0/27 (0%) 
      
Depression 
     
144 - Respiratory System Signs, Symptoms & Other Diagnoses 28/1069 (2.6%) 10/1806 (0.6%) 3/1004 (0.3%) 1/81 (1.2%) 0/3960 (0%) 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor 
Diagnoses 
1/232 (0.4%) 1/196 (0.5%) 1/128 (0.8%) 0/18 (0%) 0/574 (0%) 
142 - Interstitial Lung Disease 3/116 (2.6%) 0/120 (0%) 0/100 (0%) 0/11 (0%) 0/347 (0%) 
141 - Asthma 5/408 (1.2%) 3/141 (2.1%) 2/141 (1.4%) 0/12 (0%) 0/702 (0%) 
140 - Chronic Obstructive Pulmonary Disease 19/680 (2.8%) 9/1045 (0.9%) 4/1063 (0.4%) 3/118 (2.5%) 0/2906 (0%) 
139 - Other Pneumonia 74/1675 (4.4%) 23/4179 (0.6%) 8/2812 (0.3%) 4/439 (0.9%) 0/9105 (0%) 
138 - Bronchiolitis & RSV Pneumonia 0/4 (0%) 0/13 (0%) 0/3 (0%) 0/1 (0%) 0/21 (0%) 
137 - Major Respiratory Infections & Inflammations 14/293 (4.8%) 2/683 (0.3%) 3/495 (0.6%) 2/116 (1.7%) 0/1587 (0%) 
136 - Respiratory Malignancy 3/294 (1%) 4/676 (0.6%) 6/557 (1.1%) 3/98 (3.1%) 0/1625 (0%) 
135 - Major Chest & Respiratory Trauma 0/286 (0%) 0/64 (0%) 0/33 (0%) 0/5 (0%) 0/388 (0%) 
134 - Pulmonary Embolism 16/564 (2.8%) 1/559 (0.2%) 2/300 (0.7%) 0/29 (0%) 1/1452 (0.1%) 
133 - Pulmonary Edema & Respiratory Failure 3/76 (3.9%) 2/195 (1%) 1/199 (0.5%) 0/25 (0%) 0/495 (0%) 
131 - Cystic Fibrosis - Pulmonary Disease 0/15 (0%) 0/2 (0%) 0/10 (0%) 0/0 ( - ) 0/27 (0%) 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ 
Hours 
2/52 (3.8%) 2/74 (2.7%) 4/124 (3.2%) 1/128 (0.8%) 3/378 (0.8%) 
121 - Other Respiratory & Chest Procedures 2/277 (0.7%) 0/53 (0%) 0/58 (0%) 1/18 (5.6%) 1/406 (0.2%) 
120 - Major Respiratory & Chest Procedures 0/221 (0%) 0/63 (0%) 0/11 (0%) 0/12 (0%) 0/307 (0%) 
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Table 8. Number and percentage of episodes that changed their base APR-DRG or SOI level after removing comorbidities, by APR-DRG, MDC 5 (Diseases and 
Disorders of the Circulatory System) 
 
Charlson comorbidities 
 
SOI 1 SOI 2 SOI 3 SOI 4 Base APR-DRG 
Myocardial infarction 
     
199 - Hypertension 0/53 (0%) 4/64 (6.2%) 9/33 (27.3%) 1/2 (50%) 0/152 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 85/1293 (6.6%) 46/1086 (4.2%) 10/246 (4.1%) 0/37 (0%) 88/2662 (3.3%) 
197 - Peripheral & Other Vascular Disorders 5/410 (1.2%) 2/311 (0.6%) 29/175 (16.6%) 8/50 (16%) 2/946 (0.2%) 
196 - Cardiac Arrest 0/6 (0%) 1/12 (8.3%) 14/39 (35.9%) 7/57 (12.3%) 0/114 (0%) 
194 - Heart Failure 30/766 (3.9%) 37/4720 (0.8%) 478/3352 (14.3%) 208/773 (26.9%) 0/9611 (0%) 
193 - Acute & Subacute Endocarditis 0/9 (0%) 3/16 (18.8%) 6/19 (31.6%) 5/13 (38.5%) 0/57 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 9/1653 (0.5%) 16/582 (2.7%) 0/78 (0%) 1/8 (12.5%) 0/2321 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
5/325 (1.5%) 36/276 (13%) 152/341 (44.6%) 30/105 (28.6%) 0/1047 (0%) 
190 - Acute Myocardial Infarction 670/1605 (41.7%) 545/1928 (28.3%) 356/1486 (24%) 50/220 (22.7%) 1550/5239 (29.6%) 
180 - Other Circulatory System Procedures 0/111 (0%) 2/41 (4.9%) 2/28 (7.1%) 1/17 (5.9%) 0/197 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/48 (0%) 0/51 (0%) 1/9 (11.1%) 0/3 (0%) 0/111 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 1/86 (1.2%) 0/82 (0%) 2/13 (15.4%) 1/5 (20%) 0/186 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 12/2372 (0.5%) 486/945 (51.4%) 685/894 (76.6%) 93/189 (49.2%) 1/4400 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 2/1053 (0.2%) 10/842 (1.2%) 42/203 (20.7%) 11/103 (10.7%) 0/2201 (0%) 
173 - Other Vascular Procedures 3/610 (0.5%) 8/504 (1.6%) 35/135 (25.9%) 16/91 (17.6%) 0/1340 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
5/536 (0.9%) 17/390 (4.4%) 44/108 (40.7%) 14/35 (40%) 1/1069 (0.1%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/14 (0%) 1/35 (2.9%) 1/22 (4.5%) 0/7 (0%) 1/78 (1.3%) 
207 - Other Circulatory System Diagnoses 0/74 (0%) 4/83 (4.8%) 10/43 (23.3%) 4/10 (40%) 0/210 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
1/54 (1.9%) 4/63 (6.3%) 9/29 (31%) 3/11 (27.3%) 0/157 (0%) 
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205 - Cardiomyopathy 0/21 (0%) 1/63 (1.6%) 7/24 (29.2%) 0/4 (0%) 0/112 (0%) 
204 - Syncope & Collapse 0/71 (0%) 1/77 (1.3%) 5/25 (20%) 2/3 (66.7%) 0/176 (0%) 
203 - Chest Pain 0/5 (0%) 0/3 (0%) 0/1 (0%) 0/0 ( - ) 0/9 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/120 (0%) 4/72 (5.6%) 7/34 (20.6%) 6/64 (9.4%) 0/290 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 6/564 (1.1%) 46/784 (5.9%) 116/599 (19.4%) 17/62 (27.4%) 1/2009 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/30 (0%) 6/98 (6.1%) 48/83 (57.8%) 6/13 (46.2%) 0/224 (0%) 
167 - Other Cardiothoracic Procedures 0/30 (0%) 5/35 (14.3%) 3/20 (15%) 7/14 (50%) 1/99 (1%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
5/945 (0.5%) 356/729 (48.8%) 181/266 (68%) 22/47 (46.8%) 1/1987 (0.1%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/185 (0%) 78/234 (33.3%) 25/100 (25%) 8/17 (47.1%) 0/536 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 3/80 (3.8%) 16/397 (4%) 49/132 (37.1%) 16/42 (38.1%) 0/651 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/8 (0%) 5/85 (5.9%) 32/65 (49.2%) 12/33 (36.4%) 1/191 (0.5%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 4/608 (0.7%) 3/441 (0.7%) 11/56 (19.6%) 4/18 (22.2%) 0/1123 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/0 ( - ) 0/3 (0%) 0/0 ( - ) 1/1 (100%) 0/4 (0%) 
      
Congestive heart failure 
     
199 - Hypertension 0/24 (0%) 160/398 (40.2%) 35/172 (20.3%) 0/15 (0%) 0/609 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/264 (0%) 1583/3149 (50.3%) 155/840 (18.5%) 11/154 (7.1%) 0/4407 (0%) 
197 - Peripheral & Other Vascular Disorders 1/74 (1.4%) 538/1296 (41.5%) 126/635 (19.8%) 6/133 (4.5%) 1/2138 (0%) 
196 - Cardiac Arrest 0/9 (0%) 40/93 (43%) 14/111 (12.6%) 3/130 (2.3%) 0/343 (0%) 
194 - Heart Failure 0/656 (0%) 2948/14286 
(20.6%) 
1192/9503 (12.5%) 73/1616 (4.5%) 0/26061 (0%) 
193 - Acute & Subacute Endocarditis 0/7 (0%) 80/183 (43.7%) 27/155 (17.4%) 2/89 (2.2%) 0/434 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/269 (0%) 996/1414 (70.4%) 48/149 (32.2%) 2/27 (7.4%) 0/1859 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/438 (0%) 2243/3090 (72.6%) 158/779 (20.3%) 4/201 (2%) 2/4508 (0%) 
190 - Acute Myocardial Infarction 0/160 (0%) 1235/3503 (35.3%) 1159/4644 (25%) 41/749 (5.5%) 2/9056 (0%) 
180 - Other Circulatory System Procedures 0/30 (0%) 131/228 (57.5%) 20/93 (21.5%) 2/47 (4.3%) 2/398 (0.5%) 
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177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/70 (0%) 203/291 (69.8%) 13/42 (31%) 1/13 (7.7%) 0/416 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/153 (0%) 532/628 (84.7%) 39/111 (35.1%) 2/10 (20%) 1/902 (0.1%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/319 (0%) 1114/1572 (70.9%) 95/536 (17.7%) 7/141 (5%) 0/2568 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/203 (0%) 1026/2462 (41.7%) 136/621 (21.9%) 31/372 (8.3%) 0/3658 (0%) 
173 - Other Vascular Procedures 0/66 (0%) 582/1190 (48.9%) 57/287 (19.9%) 4/140 (2.9%) 0/1683 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/449 (0%) 2072/3206 (64.6%) 85/400 (21.2%) 5/101 (5%) 0/4156 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/33 (0%) 41/112 (36.6%) 16/81 (19.8%) 0/18 (0%) 0/244 (0%) 
207 - Other Circulatory System Diagnoses 0/56 (0%) 357/884 (40.4%) 45/372 (12.1%) 4/80 (5%) 0/1392 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/39 (0%) 143/289 (49.5%) 29/118 (24.6%) 3/48 (6.2%) 0/494 (0%) 
205 - Cardiomyopathy 0/35 (0%) 639/1058 (60.4%) 45/238 (18.9%) 0/44 (0%) 0/1375 (0%) 
204 - Syncope & Collapse 0/34 (0%) 129/367 (35.1%) 12/72 (16.7%) 0/2 (0%) 0/475 (0%) 
203 - Chest Pain 0/29 (0%) 66/112 (58.9%) 5/13 (38.5%) 0/0 ( - ) 0/154 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/23 (0%) 119/196 (60.7%) 14/77 (18.2%) 1/99 (1%) 0/395 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/662 (0%) 5003/8125 (61.6%) 511/2847 (17.9%) 14/241 (5.8%) 1/11875 (0%) 
200 - Cardiac Congenital & Valvular Disorders 1/37 (2.7%) 1032/1770 (58.3%) 98/432 (22.7%) 3/90 (3.3%) 2/2329 (0.1%) 
167 - Other Cardiothoracic Procedures 0/101 (0%) 190/315 (60.3%) 18/85 (21.2%) 0/17 (0%) 1/518 (0.2%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/33 (0%) 557/758 (73.5%) 30/114 (26.3%) 0/23 (0%) 0/928 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/4 (0%) 78/202 (38.6%) 5/64 (7.8%) 2/19 (10.5%) 0/289 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/78 (0%) 1622/3415 (47.5%) 83/506 (16.4%) 4/148 (2.7%) 1/4147 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/3 (0%) 84/326 (25.8%) 19/146 (13%) 3/46 (6.5%) 2/521 (0.4%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/502 (0%) 1088/1472 (73.9%) 28/103 (27.2%) 2/38 (5.3%) 0/2115 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/27 (0%) 39/73 (53.4%) 8/29 (27.6%) 0/5 (0%) 0/134 (0%) 
      
Peripheral vascular disease 
     
199 - Hypertension 0/67 (0%) 6/70 (8.6%) 1/39 (2.6%) 0/1 (0%) 0/177 (0%) 
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198 - Angina Pectoris & Coronary Atherosclerosis 3/400 (0.8%) 34/445 (7.6%) 6/127 (4.7%) 5/30 (16.7%) 0/1002 (0%) 
197 - Peripheral & Other Vascular Disorders 11/1482 (0.7%) 52/1013 (5.1%) 20/401 (5%) 13/108 (12%) 1/3004 (0%) 
196 - Cardiac Arrest 0/2 (0%) 0/5 (0%) 0/11 (0%) 0/20 (0%) 0/38 (0%) 
194 - Heart Failure 8/187 (4.3%) 78/2819 (2.8%) 67/2076 (3.2%) 14/351 (4%) 0/5433 (0%) 
193 - Acute & Subacute Endocarditis 0/9 (0%) 1/24 (4.2%) 1/22 (4.5%) 0/10 (0%) 0/65 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 1/409 (0.2%) 24/239 (10%) 9/34 (26.5%) 1/11 (9.1%) 0/693 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
2/263 (0.8%) 32/264 (12.1%) 6/125 (4.8%) 7/38 (18.4%) 0/690 (0%) 
190 - Acute Myocardial Infarction 14/463 (3%) 108/896 (12.1%) 35/869 (4%) 9/145 (6.2%) 0/2373 (0%) 
180 - Other Circulatory System Procedures 0/106 (0%) 7/105 (6.7%) 2/61 (3.3%) 2/33 (6.1%) 2/305 (0.7%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/12 (0%) 1/18 (5.6%) 0/9 (0%) 0/0 ( - ) 0/39 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/11 (0%) 1/17 (5.9%) 0/4 (0%) 0/2 (0%) 0/34 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 1/587 (0.2%) 32/285 (11.2%) 13/153 (8.5%) 5/34 (14.7%) 0/1059 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/350 (0%) 11/394 (2.8%) 12/146 (8.2%) 6/89 (6.7%) 0/979 (0%) 
173 - Other Vascular Procedures 20/1842 (1.1%) 85/1208 (7%) 27/249 (10.8%) 11/176 (6.2%) 2/3475 (0.1%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/215 (0%) 32/252 (12.7%) 3/54 (5.6%) 0/17 (0%) 0/538 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/1 (0%) 1/20 (5%) 1/14 (7.1%) 0/8 (0%) 1/43 (2.3%) 
207 - Other Circulatory System Diagnoses 1/40 (2.5%) 6/70 (8.6%) 4/39 (10.3%) 1/5 (20%) 0/154 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
2/203 (1%) 8/96 (8.3%) 4/39 (10.3%) 0/11 (0%) 0/349 (0%) 
205 - Cardiomyopathy 0/8 (0%) 1/37 (2.7%) 0/9 (0%) 0/0 ( - ) 0/54 (0%) 
204 - Syncope & Collapse 0/39 (0%) 8/74 (10.8%) 2/14 (14.3%) 0/1 (0%) 0/128 (0%) 
203 - Chest Pain 0/17 (0%) 1/14 (7.1%) 1/2 (50%) 0/0 ( - ) 0/33 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 5/363 (1.4%) 6/133 (4.5%) 8/81 (9.9%) 4/120 (3.3%) 0/697 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 2/145 (1.4%) 26/397 (6.5%) 15/231 (6.5%) 1/36 (2.8%) 0/809 (0%) 
200 - Cardiac Congenital & Valvular Disorders 1/55 (1.8%) 10/101 (9.9%) 3/32 (9.4%) 0/6 (0%) 0/194 (0%) 
167 - Other Cardiothoracic Procedures 1/14 (7.1%) 4/38 (10.5%) 7/28 (25%) 1/13 (7.7%) 1/93 (1.1%) 
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166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/241 (0%) 12/157 (7.6%) 1/46 (2.2%) 0/17 (0%) 0/461 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/49 (0%) 2/107 (1.9%) 3/37 (8.1%) 1/13 (7.7%) 0/206 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 5/486 (1%) 151/1032 (14.6%) 20/166 (12%) 2/41 (4.9%) 0/1725 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/23 (0%) 6/81 (7.4%) 7/45 (15.6%) 1/17 (5.9%) 0/166 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/46 (0%) 8/86 (9.3%) 1/11 (9.1%) 0/4 (0%) 0/147 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/4 (0%) 
      
Cerebrovascular disease 
     
199 - Hypertension 1/142 (0.7%) 57/170 (33.5%) 24/71 (33.8%) 1/7 (14.3%) 0/390 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 1/208 (0.5%) 90/610 (14.8%) 73/275 (26.5%) 29/69 (42%) 1/1162 (0.1%) 
197 - Peripheral & Other Vascular Disorders 0/332 (0%) 157/645 (24.3%) 98/433 (22.6%) 22/94 (23.4%) 1/1504 (0.1%) 
196 - Cardiac Arrest 0/3 (0%) 2/14 (14.3%) 6/30 (20%) 2/46 (4.3%) 0/93 (0%) 
194 - Heart Failure 4/129 (3.1%) 295/4965 (5.9%) 608/4459 (13.6%) 154/732 (21%) 0/10285 (0%) 
193 - Acute & Subacute Endocarditis 0/8 (0%) 11/43 (25.6%) 59/103 (57.3%) 27/71 (38%) 0/225 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 4/318 (1.3%) 47/216 (21.8%) 19/42 (45.2%) 4/11 (36.4%) 0/587 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
1/228 (0.4%) 42/286 (14.7%) 38/154 (24.7%) 16/60 (26.7%) 0/728 (0%) 
190 - Acute Myocardial Infarction 5/229 (2.2%) 162/912 (17.8%) 343/1507 (22.8%) 95/297 (32%) 0/2945 (0%) 
180 - Other Circulatory System Procedures 0/43 (0%) 14/44 (31.8%) 6/24 (25%) 5/17 (29.4%) 3/128 (2.3%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/13 (0%) 9/33 (27.3%) 7/19 (36.8%) 1/6 (16.7%) 0/71 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/29 (0%) 13/28 (46.4%) 5/23 (21.7%) 1/3 (33.3%) 0/83 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 1/327 (0.3%) 57/233 (24.5%) 30/120 (25%) 15/45 (33.3%) 0/725 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/242 (0%) 66/430 (15.3%) 107/203 (52.7%) 42/140 (30%) 0/1015 (0%) 
173 - Other Vascular Procedures 3/314 (1%) 116/522 (22.2%) 66/190 (34.7%) 14/88 (15.9%) 2/1114 (0.2%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
2/452 (0.4%) 238/746 (31.9%) 73/170 (42.9%) 12/52 (23.1%) 0/1420 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/4 (0%) 6/27 (22.2%) 2/27 (7.4%) 2/6 (33.3%) 0/64 (0%) 
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207 - Other Circulatory System Diagnoses 0/74 (0%) 42/182 (23.1%) 14/68 (20.6%) 5/20 (25%) 0/344 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/21 (0%) 9/51 (17.6%) 18/54 (33.3%) 4/27 (14.8%) 0/153 (0%) 
205 - Cardiomyopathy 0/8 (0%) 6/48 (12.5%) 4/26 (15.4%) 1/8 (12.5%) 0/90 (0%) 
204 - Syncope & Collapse 3/170 (1.8%) 117/363 (32.2%) 24/75 (32%) 2/3 (66.7%) 0/611 (0%) 
203 - Chest Pain 0/14 (0%) 7/27 (25.9%) 4/7 (57.1%) 0/0 ( - ) 0/48 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 1/82 (1.2%) 11/59 (18.6%) 12/41 (29.3%) 9/52 (17.3%) 1/234 (0.4%) 
201 - Cardiac Arrhythmia & Conduction Disorders 4/472 (0.8%) 313/1413 (22.2%) 195/803 (24.3%) 33/104 (31.7%) 0/2792 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/44 (0%) 13/160 (8.1%) 32/103 (31.1%) 10/30 (33.3%) 0/337 (0%) 
167 - Other Cardiothoracic Procedures 0/25 (0%) 5/30 (16.7%) 9/26 (34.6%) 1/6 (16.7%) 0/87 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
1/327 (0.3%) 19/182 (10.4%) 20/80 (25%) 2/20 (10%) 0/609 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/58 (0%) 8/134 (6%) 5/62 (8.1%) 1/13 (7.7%) 0/267 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 1/178 (0.6%) 31/463 (6.7%) 65/162 (40.1%) 16/56 (28.6%) 1/859 (0.1%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/7 (0%) 4/88 (4.5%) 11/49 (22.4%) 4/24 (16.7%) 1/168 (0.6%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/26 (0%) 6/42 (14.3%) 6/16 (37.5%) 1/6 (16.7%) 0/90 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/1 (0%) 0/3 (0%) 0/0 ( - ) 1/2 (50%) 0/6 (0%) 
      
Dementia 
     
199 - Hypertension 1/21 (4.8%) 17/68 (25%) 3/29 (10.3%) 0/0 ( - ) 0/118 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/18 (0%) 39/303 (12.9%) 19/143 (13.3%) 0/23 (0%) 0/487 (0%) 
197 - Peripheral & Other Vascular Disorders 0/52 (0%) 66/242 (27.3%) 27/188 (14.4%) 0/23 (0%) 0/505 (0%) 
196 - Cardiac Arrest 0/1 (0%) 1/6 (16.7%) 1/5 (20%) 0/7 (0%) 0/19 (0%) 
194 - Heart Failure 0/17 (0%) 118/2358 (5%) 160/2014 (7.9%) 5/223 (2.2%) 0/4612 (0%) 
193 - Acute & Subacute Endocarditis 0/0 ( - ) 0/7 (0%) 2/14 (14.3%) 0/3 (0%) 0/24 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/5 (0%) 5/15 (33.3%) 0/3 (0%) 0/0 ( - ) 0/23 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/2 (0%) 4/26 (15.4%) 6/19 (31.6%) 0/0 ( - ) 0/47 (0%) 
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190 - Acute Myocardial Infarction 0/3 (0%) 32/193 (16.6%) 75/510 (14.7%) 3/48 (6.2%) 0/754 (0%) 
180 - Other Circulatory System Procedures 0/5 (0%) 1/8 (12.5%) 1/8 (12.5%) 0/3 (0%) 0/24 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/2 (0%) 0/6 (0%) 0/5 (0%) 0/0 ( - ) 0/13 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/2 (0%) 3/13 (23.1%) 1/5 (20%) 0/1 (0%) 0/21 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/3 (0%) 4/21 (19%) 0/10 (0%) 0/5 (0%) 0/39 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/6 (0%) 11/41 (26.8%) 1/16 (6.2%) 0/7 (0%) 0/70 (0%) 
173 - Other Vascular Procedures 0/11 (0%) 11/53 (20.8%) 2/18 (11.1%) 0/10 (0%) 0/92 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/91 (0%) 69/237 (29.1%) 3/53 (5.7%) 0/7 (0%) 0/388 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 2/7 (28.6%) 0/4 (0%) 0/1 (0%) 0/12 (0%) 
207 - Other Circulatory System Diagnoses 0/5 (0%) 7/38 (18.4%) 2/26 (7.7%) 0/7 (0%) 0/76 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/2 (0%) 8/27 (29.6%) 1/16 (6.2%) 0/3 (0%) 0/48 (0%) 
205 - Cardiomyopathy 0/1 (0%) 4/17 (23.5%) 0/4 (0%) 0/4 (0%) 0/26 (0%) 
204 - Syncope & Collapse 0/23 (0%) 29/105 (27.6%) 3/17 (17.6%) 0/0 ( - ) 0/145 (0%) 
203 - Chest Pain 0/1 (0%) 1/10 (10%) 1/2 (50%) 0/0 ( - ) 0/13 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/0 ( - ) 1/6 (16.7%) 0/2 (0%) 0/6 (0%) 0/14 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/87 (0%) 126/624 (20.2%) 28/326 (8.6%) 0/30 (0%) 0/1067 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/9 (0%) 9/59 (15.3%) 3/29 (10.3%) 0/2 (0%) 0/99 (0%) 
167 - Other Cardiothoracic Procedures 0/0 ( - ) 1/2 (50%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/2 (0%) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/4 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/4 (0%) 1/8 (12.5%) 0/2 (0%) 0/0 ( - ) 0/14 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/1 (0%) 0/2 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
      
Chronic pulmonary disease 
     
199 - Hypertension 0/107 (0%) 18/158 (11.4%) 6/95 (6.3%) 0/7 (0%) 0/367 (0%) 
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198 - Angina Pectoris & Coronary Atherosclerosis 1/338 (0.3%) 56/727 (7.7%) 16/218 (7.3%) 1/44 (2.3%) 0/1327 (0%) 
197 - Peripheral & Other Vascular Disorders 1/533 (0.2%) 70/607 (11.5%) 19/271 (7%) 1/65 (1.5%) 0/1476 (0%) 
196 - Cardiac Arrest 0/7 (0%) 3/25 (12%) 3/47 (6.4%) 0/52 (0%) 0/131 (0%) 
194 - Heart Failure 12/1157 (1%) 753/14524 (5.2%) 470/10161 (4.6%) 27/1477 (1.8%) 0/27319 (0%) 
193 - Acute & Subacute Endocarditis 0/23 (0%) 3/66 (4.5%) 4/46 (8.7%) 0/30 (0%) 0/165 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 1/538 (0.2%) 78/344 (22.7%) 5/66 (7.6%) 0/13 (0%) 0/961 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
2/850 (0.2%) 255/1191 (21.4%) 30/412 (7.3%) 1/97 (1%) 0/2550 (0%) 
190 - Acute Myocardial Infarction 8/394 (2%) 105/1032 (10.2%) 114/1256 (9.1%) 2/220 (0.9%) 0/2902 (0%) 
180 - Other Circulatory System Procedures 1/579 (0.2%) 9/95 (9.5%) 4/60 (6.7%) 0/30 (0%) 1/764 (0.1%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/25 (0%) 7/52 (13.5%) 1/19 (5.3%) 0/4 (0%) 0/100 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 2/68 (2.9%) 9/47 (19.1%) 2/14 (14.3%) 0/5 (0%) 0/134 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 1/673 (0.1%) 56/461 (12.1%) 14/172 (8.1%) 0/42 (0%) 1/1348 (0.1%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/574 (0%) 51/643 (7.9%) 20/192 (10.4%) 1/79 (1.3%) 0/1488 (0%) 
173 - Other Vascular Procedures 0/607 (0%) 88/672 (13.1%) 5/137 (3.6%) 1/140 (0.7%) 0/1556 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
3/762 (0.4%) 135/884 (15.3%) 15/178 (8.4%) 1/37 (2.7%) 0/1861 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/14 (0%) 3/56 (5.4%) 5/47 (10.6%) 0/7 (0%) 0/124 (0%) 
207 - Other Circulatory System Diagnoses 3/203 (1.5%) 28/388 (7.2%) 10/197 (5.1%) 0/36 (0%) 1/824 (0.1%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/38 (0%) 19/107 (17.8%) 2/56 (3.6%) 0/31 (0%) 0/232 (0%) 
205 - Cardiomyopathy 0/47 (0%) 16/278 (5.8%) 2/86 (2.3%) 0/14 (0%) 0/425 (0%) 
204 - Syncope & Collapse 0/83 (0%) 14/158 (8.9%) 1/36 (2.8%) 0/2 (0%) 0/279 (0%) 
203 - Chest Pain 0/80 (0%) 3/30 (10%) 0/7 (0%) 0/0 ( - ) 0/117 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/133 (0%) 13/128 (10.2%) 5/63 (7.9%) 0/83 (0%) 0/407 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 4/931 (0.4%) 216/2014 (10.7%) 59/867 (6.8%) 3/93 (3.2%) 0/3905 (0%) 
200 - Cardiac Congenital & Valvular Disorders 1/128 (0.8%) 69/612 (11.3%) 9/177 (5.1%) 0/33 (0%) 1/950 (0.1%) 
167 - Other Cardiothoracic Procedures 0/130 (0%) 24/130 (18.5%) 1/43 (2.3%) 0/12 (0%) 0/315 (0%) 
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166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/217 (0%) 34/167 (20.4%) 3/51 (5.9%) 0/13 (0%) 0/448 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/36 (0%) 2/78 (2.6%) 0/37 (0%) 0/14 (0%) 0/165 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 1/356 (0.3%) 179/1288 (13.9%) 14/261 (5.4%) 1/72 (1.4%) 0/1977 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/15 (0%) 14/180 (7.8%) 7/82 (8.5%) 0/21 (0%) 3/298 (1%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/80 (0%) 20/178 (11.2%) 1/30 (3.3%) 0/7 (0%) 0/295 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/24 (0%) 1/33 (3%) 1/24 (4.2%) 0/4 (0%) 0/85 (0%) 
      
Rheumatic disease 
     
199 - Hypertension 0/20 (0%) 6/12 (50%) 1/5 (20%) 0/0 ( - ) 0/37 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/45 (0%) 9/65 (13.8%) 2/12 (16.7%) 0/4 (0%) 0/126 (0%) 
197 - Peripheral & Other Vascular Disorders 0/146 (0%) 25/111 (22.5%) 3/36 (8.3%) 0/12 (0%) 0/305 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 0/1 (0%) 0/4 (0%) 0/4 (0%) 0/9 (0%) 
194 - Heart Failure 2/35 (5.7%) 62/659 (9.4%) 23/410 (5.6%) 0/48 (0%) 0/1152 (0%) 
193 - Acute & Subacute Endocarditis 0/2 (0%) 1/7 (14.3%) 2/9 (22.2%) 0/3 (0%) 0/21 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/73 (0%) 7/28 (25%) 0/3 (0%) 0/1 (0%) 0/105 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/70 (0%) 19/74 (25.7%) 2/12 (16.7%) 0/2 (0%) 0/158 (0%) 
190 - Acute Myocardial Infarction 3/52 (5.8%) 38/123 (30.9%) 9/108 (8.3%) 0/19 (0%) 0/302 (0%) 
180 - Other Circulatory System Procedures 0/88 (0%) 8/19 (42.1%) 1/7 (14.3%) 0/4 (0%) 0/118 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/3 (0%) 1/3 (33.3%) 0/1 (0%) 0/2 (0%) 0/9 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/8 (0%) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/11 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/81 (0%) 10/37 (27%) 0/17 (0%) 0/1 (0%) 0/136 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/100 (0%) 11/92 (12%) 2/14 (14.3%) 0/6 (0%) 0/212 (0%) 
173 - Other Vascular Procedures 0/72 (0%) 14/74 (18.9%) 2/13 (15.4%) 0/9 (0%) 0/168 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/78 (0%) 19/65 (29.2%) 4/12 (33.3%) 0/1 (0%) 0/156 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/3 (0%) 0/3 (0%) 0/1 (0%) 0/7 (0%) 
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207 - Other Circulatory System Diagnoses 1/35 (2.9%) 16/83 (19.3%) 1/14 (7.1%) 0/5 (0%) 0/137 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
1/11 (9.1%) 5/24 (20.8%) 0/6 (0%) 0/1 (0%) 0/42 (0%) 
205 - Cardiomyopathy 0/1 (0%) 1/1 (100%) 1/2 (50%) 0/1 (0%) 0/5 (0%) 
204 - Syncope & Collapse 0/18 (0%) 3/24 (12.5%) 0/5 (0%) 0/0 ( - ) 0/47 (0%) 
203 - Chest Pain 0/12 (0%) 2/7 (28.6%) 1/1 (100%) 0/0 ( - ) 0/20 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/7 (0%) 2/5 (40%) 0/2 (0%) 0/3 (0%) 0/17 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/124 (0%) 24/148 (16.2%) 6/69 (8.7%) 0/4 (0%) 0/345 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/8 (0%) 4/31 (12.9%) 1/9 (11.1%) 0/0 ( - ) 0/48 (0%) 
167 - Other Cardiothoracic Procedures 0/8 (0%) 2/7 (28.6%) 0/4 (0%) 0/0 ( - ) 0/19 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/20 (0%) 8/20 (40%) 2/5 (40%) 0/0 ( - ) 0/45 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/5 (0%) 1/13 (7.7%) 0/2 (0%) 0/0 ( - ) 0/20 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/33 (0%) 17/84 (20.2%) 1/11 (9.1%) 0/0 ( - ) 0/128 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/2 (0%) 2/9 (22.2%) 1/2 (50%) 0/1 (0%) 0/14 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/6 (0%) 3/13 (23.1%) 1/1 (100%) 0/1 (0%) 0/21 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 0/2 (0%) 
      
Peptic ulcer disease 
     
199 - Hypertension 0/7 (0%) 1/9 (11.1%) 0/4 (0%) 0/1 (0%) 0/21 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/39 (0%) 1/44 (2.3%) 0/19 (0%) 0/6 (0%) 0/108 (0%) 
197 - Peripheral & Other Vascular Disorders 2/45 (4.4%) 2/37 (5.4%) 1/24 (4.2%) 0/7 (0%) 0/113 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 0/1 (0%) 0/3 (0%) 0/0 ( - ) 0/4 (0%) 
194 - Heart Failure 2/31 (6.5%) 10/404 (2.5%) 7/272 (2.6%) 1/49 (2%) 0/756 (0%) 
193 - Acute & Subacute Endocarditis 0/2 (0%) 0/12 (0%) 1/3 (33.3%) 0/6 (0%) 0/23 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/56 (0%) 2/14 (14.3%) 0/2 (0%) 0/1 (0%) 0/73 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
1/23 (4.3%) 3/30 (10%) 1/14 (7.1%) 0/7 (0%) 0/74 (0%) 
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190 - Acute Myocardial Infarction 1/56 (1.8%) 9/98 (9.2%) 3/92 (3.3%) 1/13 (7.7%) 0/259 (0%) 
180 - Other Circulatory System Procedures 0/31 (0%) 0/3 (0%) 0/5 (0%) 0/2 (0%) 0/41 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/2 (0%) 0/6 (0%) 0/0 ( - ) 0/0 ( - ) 0/8 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/5 (0%) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/8 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 1/49 (2%) 3/17 (17.6%) 0/4 (0%) 0/3 (0%) 0/73 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/56 (0%) 0/50 (0%) 1/13 (7.7%) 0/9 (0%) 0/128 (0%) 
173 - Other Vascular Procedures 0/45 (0%) 0/51 (0%) 0/10 (0%) 0/17 (0%) 0/123 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/33 (0%) 2/42 (4.8%) 0/8 (0%) 0/5 (0%) 0/88 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/5 (0%) 0/2 (0%) 0/0 ( - ) 0/7 (0%) 
207 - Other Circulatory System Diagnoses 1/17 (5.9%) 1/12 (8.3%) 0/4 (0%) 0/2 (0%) 0/35 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
1/12 (8.3%) 0/2 (0%) 0/4 (0%) 0/0 ( - ) 0/18 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 1/14 (7.1%) 0/5 (0%) 0/0 ( - ) 0/19 (0%) 
204 - Syncope & Collapse 0/13 (0%) 1/8 (12.5%) 0/1 (0%) 0/1 (0%) 0/23 (0%) 
203 - Chest Pain 0/10 (0%) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/13 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/15 (0%) 0/6 (0%) 0/4 (0%) 0/11 (0%) 0/36 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 2/48 (4.2%) 4/89 (4.5%) 1/36 (2.8%) 0/2 (0%) 0/175 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/7 (0%) 0/13 (0%) 2/5 (40%) 0/1 (0%) 0/26 (0%) 
167 - Other Cardiothoracic Procedures 1/4 (25%) 0/3 (0%) 1/2 (50%) 0/0 ( - ) 0/9 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/31 (0%) 0/15 (0%) 0/3 (0%) 0/1 (0%) 0/50 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/2 (0%) 0/8 (0%) 0/1 (0%) 0/1 (0%) 0/12 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 1/38 (2.6%) 1/53 (1.9%) 0/7 (0%) 0/4 (0%) 0/102 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 0/6 (0%) 0/1 (0%) 0/3 (0%) 0/10 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/0 ( - ) 0/7 (0%) 0/3 (0%) 0/0 ( - ) 0/10 (0%) 
      
Mild liver disease 
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199 - Hypertension 1/41 (2.4%) 9/42 (21.4%) 3/23 (13%) 1/4 (25%) 0/110 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/32 (0%) 23/106 (21.7%) 14/55 (25.5%) 8/31 (25.8%) 0/224 (0%) 
197 - Peripheral & Other Vascular Disorders 0/139 (0%) 45/195 (23.1%) 11/108 (10.2%) 3/33 (9.1%) 0/475 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 1/7 (14.3%) 5/19 (26.3%) 10/45 (22.2%) 0/71 (0%) 
194 - Heart Failure 13/104 (12.5%) 240/2296 (10.5%) 294/1744 (16.9%) 114/482 (23.7%) 0/4626 (0%) 
193 - Acute & Subacute Endocarditis 0/11 (0%) 7/36 (19.4%) 7/41 (17.1%) 3/33 (9.1%) 0/121 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/47 (0%) 15/44 (34.1%) 0/4 (0%) 1/5 (20%) 0/100 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
1/53 (1.9%) 23/137 (16.8%) 16/80 (20%) 10/43 (23.3%) 2/313 (0.6%) 
190 - Acute Myocardial Infarction 3/45 (6.7%) 27/129 (20.9%) 23/230 (10%) 26/109 (23.9%) 0/513 (0%) 
180 - Other Circulatory System Procedures 2/49 (4.1%) 3/22 (13.6%) 1/23 (4.3%) 0/20 (0%) 0/114 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/12 (0%) 1/5 (20%) 1/4 (25%) 1/8 (12.5%) 0/29 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/31 (0%) 1/4 (25%) 0/2 (0%) 0/2 (0%) 0/39 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 1/40 (2.5%) 21/58 (36.2%) 4/23 (17.4%) 1/9 (11.1%) 0/130 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/51 (0%) 19/92 (20.7%) 10/34 (29.4%) 3/71 (4.2%) 1/248 (0.4%) 
173 - Other Vascular Procedures 1/59 (1.7%) 27/105 (25.7%) 6/36 (16.7%) 3/47 (6.4%) 0/247 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
1/87 (1.1%) 29/121 (24%) 6/31 (19.4%) 4/22 (18.2%) 0/261 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/10 (0%) 4/7 (57.1%) 2/6 (33.3%) 1/23 (4.3%) 
207 - Other Circulatory System Diagnoses 0/54 (0%) 21/109 (19.3%) 11/63 (17.5%) 6/27 (22.2%) 1/253 (0.4%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/14 (0%) 5/28 (17.9%) 2/23 (8.7%) 2/14 (14.3%) 0/79 (0%) 
205 - Cardiomyopathy 1/17 (5.9%) 5/78 (6.4%) 4/34 (11.8%) 5/24 (20.8%) 0/153 (0%) 
204 - Syncope & Collapse 0/32 (0%) 14/54 (25.9%) 5/14 (35.7%) 0/0 ( - ) 0/100 (0%) 
203 - Chest Pain 0/13 (0%) 3/10 (30%) 3/5 (60%) 0/0 ( - ) 0/28 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/10 (0%) 1/13 (7.7%) 3/21 (14.3%) 2/47 (4.3%) 0/91 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/130 (0%) 63/353 (17.8%) 39/212 (18.4%) 35/95 (36.8%) 0/790 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/11 (0%) 8/49 (16.3%) 3/25 (12%) 4/16 (25%) 0/101 (0%) 
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167 - Other Cardiothoracic Procedures 0/3 (0%) 1/14 (7.1%) 0/4 (0%) 2/4 (50%) 0/25 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/14 (0%) 3/9 (33.3%) 1/5 (20%) 2/4 (50%) 0/32 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
1/7 (14.3%) 0/15 (0%) 0/6 (0%) 0/3 (0%) 0/31 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/22 (0%) 5/63 (7.9%) 8/34 (23.5%) 5/31 (16.1%) 0/150 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 0/11 (0%) 0/11 (0%) 2/16 (12.5%) 1/38 (2.6%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/6 (0%) 2/17 (11.8%) 3/13 (23.1%) 0/6 (0%) 0/42 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/4 (0%) 0/1 (0%) 0/5 (0%) 0/2 (0%) 0/12 (0%) 
      
Diabetes without chronic complication 
     
199 - Hypertension 0/390 (0%) 79/311 (25.4%) 17/107 (15.9%) 0/11 (0%) 0/819 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 2/1669 (0.1%) 289/1748 (16.5%) 87/474 (18.4%) 1/82 (1.2%) 0/3973 (0%) 
197 - Peripheral & Other Vascular Disorders 3/1776 (0.2%) 269/1347 (20%) 87/485 (17.9%) 0/81 (0%) 0/3689 (0%) 
196 - Cardiac Arrest 0/14 (0%) 8/56 (14.3%) 7/81 (8.6%) 1/90 (1.1%) 0/241 (0%) 
194 - Heart Failure 12/1437 (0.8%) 2172/17822 
(12.2%) 
1126/10605 
(10.6%) 
15/1409 (1.1%) 1/31273 (0%) 
193 - Acute & Subacute Endocarditis 0/33 (0%) 14/90 (15.6%) 9/84 (10.7%) 1/49 (2%) 0/256 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 1/3891 (0%) 282/960 (29.4%) 22/97 (22.7%) 0/14 (0%) 1/4962 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
1/1998 (0.1%) 259/1262 (20.5%) 55/507 (10.8%) 2/126 (1.6%) 0/3893 (0%) 
190 - Acute Myocardial Infarction 3/2160 (0.1%) 1007/3917 (25.7%) 531/2992 (17.7%) 2/465 (0.4%) 1/9534 (0%) 
180 - Other Circulatory System Procedures 0/1083 (0%) 32/153 (20.9%) 2/51 (3.9%) 0/25 (0%) 0/1312 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/132 (0%) 24/116 (20.7%) 6/38 (15.8%) 0/8 (0%) 0/294 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 1/302 (0.3%) 33/181 (18.2%) 16/59 (27.1%) 0/5 (0%) 0/547 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/5664 (0%) 329/1256 (26.2%) 66/505 (13.1%) 0/98 (0%) 1/7523 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/3519 (0%) 336/2841 (11.8%) 91/576 (15.8%) 4/300 (1.3%) 0/7236 (0%) 
173 - Other Vascular Procedures 0/1760 (0%) 230/1632 (14.1%) 23/216 (10.6%) 0/126 (0%) 0/3734 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
1/3562 (0%) 478/1898 (25.2%) 48/311 (15.4%) 1/58 (1.7%) 0/5829 (0%) 
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170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/22 (0%) 19/120 (15.8%) 12/75 (16%) 0/9 (0%) 1/226 (0.4%) 
207 - Other Circulatory System Diagnoses 0/289 (0%) 72/431 (16.7%) 25/218 (11.5%) 0/25 (0%) 0/963 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/151 (0%) 47/181 (26%) 6/61 (9.8%) 1/14 (7.1%) 0/407 (0%) 
205 - Cardiomyopathy 0/47 (0%) 19/240 (7.9%) 14/83 (16.9%) 0/15 (0%) 0/385 (0%) 
204 - Syncope & Collapse 0/245 (0%) 71/321 (22.1%) 10/60 (16.7%) 0/2 (0%) 0/628 (0%) 
203 - Chest Pain 0/182 (0%) 21/69 (30.4%) 2/6 (33.3%) 0/0 ( - ) 0/257 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/278 (0%) 45/192 (23.4%) 5/50 (10%) 1/80 (1.2%) 0/600 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/2284 (0%) 523/3287 (15.9%) 215/1585 (13.6%) 0/127 (0%) 0/7283 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/161 (0%) 58/465 (12.5%) 19/154 (12.3%) 0/30 (0%) 0/810 (0%) 
167 - Other Cardiothoracic Procedures 0/97 (0%) 9/82 (11%) 5/37 (13.5%) 0/9 (0%) 0/225 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
1/1386 (0.1%) 163/704 (23.2%) 47/187 (25.1%) 1/25 (4%) 2/2302 (0.1%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/227 (0%) 36/356 (10.1%) 9/97 (9.3%) 0/17 (0%) 0/697 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/646 (0%) 214/1683 (12.7%) 34/305 (11.1%) 1/70 (1.4%) 0/2704 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/32 (0%) 13/161 (8.1%) 12/84 (14.3%) 0/22 (0%) 0/299 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 2/393 (0.5%) 69/459 (15%) 10/50 (20%) 0/16 (0%) 0/918 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/3 (0%) 0/4 (0%) 0/0 ( - ) 0/0 ( - ) 0/7 (0%) 
      
Diabetes with chronic complication 
     
199 - Hypertension 0/22 (0%) 25/121 (20.7%) 8/51 (15.7%) 0/1 (0%) 0/195 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 2/80 (2.5%) 67/399 (16.8%) 22/157 (14%) 0/32 (0%) 0/668 (0%) 
197 - Peripheral & Other Vascular Disorders 7/501 (1.4%) 237/851 (27.8%) 53/285 (18.6%) 0/47 (0%) 0/1684 (0%) 
196 - Cardiac Arrest 0/1 (0%) 2/10 (20%) 0/13 (0%) 0/18 (0%) 0/42 (0%) 
194 - Heart Failure 15/173 (8.7%) 439/4863 (9%) 380/3705 (10.3%) 11/572 (1.9%) 0/9313 (0%) 
193 - Acute & Subacute Endocarditis 0/4 (0%) 7/42 (16.7%) 4/28 (14.3%) 1/17 (5.9%) 0/91 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/178 (0%) 55/230 (23.9%) 11/41 (26.8%) 0/10 (0%) 0/459 (0%) 
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191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/58 (0%) 42/213 (19.7%) 9/81 (11.1%) 1/28 (3.6%) 0/380 (0%) 
190 - Acute Myocardial Infarction 3/90 (3.3%) 100/627 (15.9%) 123/898 (13.7%) 1/154 (0.6%) 0/1769 (0%) 
180 - Other Circulatory System Procedures 1/51 (2%) 28/113 (24.8%) 14/64 (21.9%) 1/17 (5.9%) 3/245 (1.2%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/7 (0%) 4/21 (19%) 3/10 (30%) 1/5 (20%) 1/43 (2.3%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/8 (0%) 6/22 (27.3%) 1/5 (20%) 0/1 (0%) 0/36 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 1/239 (0.4%) 83/287 (28.9%) 15/123 (12.2%) 0/25 (0%) 0/674 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/131 (0%) 66/363 (18.2%) 25/135 (18.5%) 1/72 (1.4%) 0/701 (0%) 
173 - Other Vascular Procedures 5/477 (1%) 190/1146 (16.6%) 30/203 (14.8%) 0/57 (0%) 0/1883 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
1/128 (0.8%) 91/389 (23.4%) 10/67 (14.9%) 0/21 (0%) 0/605 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/1 (0%) 5/26 (19.2%) 0/23 (0%) 0/6 (0%) 0/56 (0%) 
207 - Other Circulatory System Diagnoses 0/15 (0%) 19/97 (19.6%) 0/38 (0%) 0/7 (0%) 0/157 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/25 (0%) 22/86 (25.6%) 8/46 (17.4%) 1/20 (5%) 0/177 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 6/50 (12%) 0/13 (0%) 0/3 (0%) 0/66 (0%) 
204 - Syncope & Collapse 0/12 (0%) 13/58 (22.4%) 2/13 (15.4%) 0/1 (0%) 0/84 (0%) 
203 - Chest Pain 0/6 (0%) 4/16 (25%) 1/1 (100%) 0/0 ( - ) 0/23 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/42 (0%) 6/29 (20.7%) 0/13 (0%) 1/17 (5.9%) 0/101 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 2/108 (1.9%) 91/507 (17.9%) 27/296 (9.1%) 0/33 (0%) 1/944 (0.1%) 
200 - Cardiac Congenital & Valvular Disorders 1/7 (14.3%) 3/53 (5.7%) 1/29 (3.4%) 0/6 (0%) 0/95 (0%) 
167 - Other Cardiothoracic Procedures 0/2 (0%) 6/14 (42.9%) 1/5 (20%) 0/1 (0%) 0/22 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
1/88 (1.1%) 27/100 (27%) 9/39 (23.1%) 0/5 (0%) 0/232 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/13 (0%) 4/52 (7.7%) 0/27 (0%) 0/5 (0%) 0/97 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/36 (0%) 24/116 (20.7%) 3/42 (7.1%) 0/14 (0%) 0/208 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 1/17 (5.9%) 0/12 (0%) 0/1 (0%) 0/30 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/14 (0%) 7/48 (14.6%) 1/9 (11.1%) 0/4 (0%) 0/75 (0%) 
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160 - Major Cardiothoracic Repair of Heart Anomaly 0/0 ( - ) 0/2 (0%) 0/0 ( - ) 0/2 (0%) 0/4 (0%) 
      
Hemiplegia 
     
199 - Hypertension 0/11 (0%) 1/12 (8.3%) 3/10 (30%) 0/2 (0%) 0/35 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/8 (0%) 7/16 (43.8%) 3/16 (18.8%) 1/11 (9.1%) 0/51 (0%) 
197 - Peripheral & Other Vascular Disorders 1/44 (2.3%) 12/38 (31.6%) 5/30 (16.7%) 0/8 (0%) 0/120 (0%) 
196 - Cardiac Arrest 0/2 (0%) 0/0 ( - ) 1/3 (33.3%) 0/10 (0%) 0/15 (0%) 
194 - Heart Failure 0/13 (0%) 9/101 (8.9%) 20/204 (9.8%) 4/89 (4.5%) 0/407 (0%) 
193 - Acute & Subacute Endocarditis 0/2 (0%) 0/4 (0%) 0/22 (0%) 0/16 (0%) 0/44 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/8 (0%) 2/4 (50%) 1/4 (25%) 0/1 (0%) 0/17 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/3 (0%) 1/3 (33.3%) 0/11 (0%) 1/12 (8.3%) 0/29 (0%) 
190 - Acute Myocardial Infarction 0/7 (0%) 7/17 (41.2%) 6/80 (7.5%) 1/46 (2.2%) 0/150 (0%) 
180 - Other Circulatory System Procedures 0/1 (0%) 4/7 (57.1%) 1/3 (33.3%) 0/4 (0%) 0/15 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/1 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/0 ( - ) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/1 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/4 (0%) 3/12 (25%) 0/6 (0%) 0/6 (0%) 0/28 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/16 (0%) 2/18 (11.1%) 0/38 (0%) 2/35 (5.7%) 0/107 (0%) 
173 - Other Vascular Procedures 0/14 (0%) 6/30 (20%) 0/24 (0%) 0/21 (0%) 0/89 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/10 (0%) 8/22 (36.4%) 0/13 (0%) 0/11 (0%) 0/56 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 
207 - Other Circulatory System Diagnoses 0/12 (0%) 5/12 (41.7%) 2/7 (28.6%) 0/4 (0%) 0/35 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/3 (0%) 2/7 (28.6%) 0/6 (0%) 0/4 (0%) 0/20 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 1/5 (20%) 0/2 (0%) 0/3 (0%) 0/10 (0%) 
204 - Syncope & Collapse 0/17 (0%) 5/10 (50%) 0/3 (0%) 0/0 ( - ) 0/30 (0%) 
203 - Chest Pain 0/2 (0%) 1/1 (100%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
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169 - Major Thoracic & Abdominal Vascular Procedures 0/7 (0%) 0/4 (0%) 0/9 (0%) 0/19 (0%) 0/39 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/22 (0%) 13/45 (28.9%) 3/54 (5.6%) 0/17 (0%) 0/138 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/1 (0%) 0/3 (0%) 0/11 (0%) 0/2 (0%) 0/17 (0%) 
167 - Other Cardiothoracic Procedures 0/5 (0%) 1/1 (100%) 0/3 (0%) 0/0 ( - ) 0/9 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/4 (0%) 1/8 (12.5%) 0/11 (0%) 0/8 (0%) 0/31 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/2 (0%) 0/1 (0%) 0/5 (0%) 1/1 (100%) 0/9 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/13 (0%) 3/30 (10%) 1/41 (2.4%) 0/19 (0%) 0/103 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/1 (0%) 0/4 (0%) 1/15 (6.7%) 0/5 (0%) 0/25 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/2 (0%) 0/0 ( - ) 1/3 (33.3%) 0/0 ( - ) 0/5 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/2 (0%) 0/1 (0%) 1/3 (33.3%) 0/2 (0%) 0/8 (0%) 
199 - Hypertension 2/389 (0.5%) 51/394 (12.9%) 79/238 (33.2%) 13/23 (56.5%) 0/1044 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 8/870 (0.9%) 155/1560 (9.9%) 318/759 (41.9%) 92/194 (47.4%) 0/3383 (0%) 
197 - Peripheral & Other Vascular Disorders 16/1634 (1%) 170/1477 (11.5%) 230/1001 (23%) 86/303 (28.4%) 0/4415 (0%) 
196 - Cardiac Arrest 0/17 (0%) 6/65 (9.2%) 53/156 (34%) 72/231 (31.2%) 0/469 (0%) 
194 - Heart Failure 102/2515 (4.1%) 2280/30319 (7.5%) 12903/26512 
(48.7%) 
3012/4514 (66.7%) 2/63860 (0%) 
193 - Acute & Subacute Endocarditis 2/108 (1.9%) 21/195 (10.8%) 60/200 (30%) 42/151 (27.8%) 1/654 (0.2%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 5/1003 (0.5%) 58/448 (12.9%) 37/114 (32.5%) 16/35 (45.7%) 0/1600 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
15/1088 (1.4%) 139/1252 (11.1%) 258/751 (34.4%) 131/341 (38.4%) 2/3432 (0.1%) 
190 - Acute Myocardial Infarction 32/1094 (2.9%) 170/2376 (7.2%) 836/3965 (21.1%) 492/1064 (46.2%) 0/8499 (0%) 
180 - Other Circulatory System Procedures 4/1348 (0.3%) 37/226 (16.4%) 65/187 (34.8%) 25/98 (25.5%) 7/1859 (0.4%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
1/48 (2.1%) 5/69 (7.2%) 9/41 (22%) 7/20 (35%) 0/178 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 4/92 (4.3%) 7/60 (11.7%) 14/36 (38.9%) 4/15 (26.7%) 0/203 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 10/1183 (0.8%) 79/646 (12.2%) 85/386 (22%) 37/169 (21.9%) 0/2384 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 5/1340 (0.4%) 130/1567 (8.3%) 257/671 (38.3%) 216/657 (32.9%) 0/4235 (0%) 
173 - Other Vascular Procedures 7/1127 (0.6%) 122/1033 (11.8%) 163/429 (38%) 76/451 (16.9%) 3/3040 (0.1%) 
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171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
11/1584 (0.7%) 172/1418 (12.1%) 183/487 (37.6%) 57/140 (40.7%) 0/3629 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/17 (0%) 6/109 (5.5%) 33/121 (27.3%) 14/36 (38.9%) 3/283 (1.1%) 
207 - Other Circulatory System Diagnoses 9/817 (1.1%) 174/1003 (17.3%) 273/577 (47.3%) 58/139 (41.7%) 1/2536 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
3/142 (2.1%) 27/203 (13.3%) 51/162 (31.5%) 16/74 (21.6%) 0/581 (0%) 
205 - Cardiomyopathy 1/100 (1%) 24/401 (6%) 99/209 (47.4%) 23/57 (40.4%) 0/767 (0%) 
204 - Syncope & Collapse 4/364 (1.1%) 82/456 (18%) 50/121 (41.3%) 3/5 (60%) 0/946 (0%) 
203 - Chest Pain 1/199 (0.5%) 11/68 (16.2%) 10/22 (45.5%) 0/1 (0%) 0/290 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 3/354 (0.8%) 52/240 (21.7%) 91/212 (42.9%) 49/417 (11.8%) 2/1223 (0.2%) 
201 - Cardiac Arrhythmia & Conduction Disorders 18/2397 (0.8%) 390/4009 (9.7%) 758/2338 (32.4%) 160/375 (42.7%) 1/9119 (0%) 
200 - Cardiac Congenital & Valvular Disorders 8/281 (2.8%) 48/736 (6.5%) 147/357 (41.2%) 48/118 (40.7%) 1/1492 (0.1%) 
167 - Other Cardiothoracic Procedures 3/187 (1.6%) 16/139 (11.5%) 21/78 (26.9%) 10/38 (26.3%) 1/442 (0.2%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
2/560 (0.4%) 58/351 (16.5%) 52/178 (29.2%) 12/59 (20.3%) 0/1148 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
1/109 (0.9%) 15/258 (5.8%) 35/134 (26.1%) 12/41 (29.3%) 0/542 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 6/741 (0.8%) 137/1595 (8.6%) 177/604 (29.3%) 58/231 (25.1%) 0/3171 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/34 (0%) 7/282 (2.5%) 37/166 (22.3%) 20/85 (23.5%) 2/567 (0.4%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/137 (0%) 20/229 (8.7%) 33/80 (41.2%) 15/49 (30.6%) 0/495 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 1/60 (1.7%) 8/46 (17.4%) 20/51 (39.2%) 0/9 (0%) 0/166 (0%) 
      
Any malignancy 
     
199 - Hypertension 0/2 (0%) 29/68 (42.6%) 7/25 (28%) 0/1 (0%) 0/96 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/10 (0%) 90/250 (36%) 31/105 (29.5%) 4/14 (28.6%) 0/379 (0%) 
197 - Peripheral & Other Vascular Disorders 1/95 (1.1%) 445/824 (54%) 124/334 (37.1%) 7/35 (20%) 0/1288 (0%) 
196 - Cardiac Arrest 1/4 (25%) 5/16 (31.2%) 5/14 (35.7%) 1/16 (6.2%) 0/50 (0%) 
194 - Heart Failure 1/15 (6.7%) 225/2216 (10.2%) 366/2039 (17.9%) 30/268 (11.2%) 0/4538 (0%) 
193 - Acute & Subacute Endocarditis 0/1 (0%) 13/38 (34.2%) 7/25 (28%) 1/10 (10%) 0/74 (0%) 
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192 - Cardiac Catheterization for Ischemic Heart Disease 0/4 (0%) 80/114 (70.2%) 9/18 (50%) 0/0 ( - ) 0/136 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/10 (0%) 65/118 (55.1%) 5/35 (14.3%) 0/13 (0%) 0/176 (0%) 
190 - Acute Myocardial Infarction 1/8 (12.5%) 82/266 (30.8%) 143/564 (25.4%) 8/62 (12.9%) 0/900 (0%) 
180 - Other Circulatory System Procedures 0/9 (0%) 36/64 (56.2%) 9/24 (37.5%) 0/7 (0%) 0/104 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 6/13 (46.2%) 1/3 (33.3%) 0/1 (0%) 0/17 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/1 (0%) 9/16 (56.2%) 3/5 (60%) 0/0 ( - ) 0/22 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/7 (0%) 86/137 (62.8%) 9/34 (26.5%) 1/9 (11.1%) 0/187 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/10 (0%) 97/215 (45.1%) 11/41 (26.8%) 1/15 (6.7%) 0/281 (0%) 
173 - Other Vascular Procedures 0/23 (0%) 148/253 (58.5%) 19/59 (32.2%) 1/30 (3.3%) 0/365 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/25 (0%) 214/332 (64.5%) 19/47 (40.4%) 0/5 (0%) 0/409 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/4 (0%) 2/7 (28.6%) 0/2 (0%) 0/13 (0%) 
207 - Other Circulatory System Diagnoses 0/17 (0%) 88/174 (50.6%) 14/53 (26.4%) 2/11 (18.2%) 0/255 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/35 (0%) 107/175 (61.1%) 13/43 (30.2%) 0/12 (0%) 0/265 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 4/23 (17.4%) 1/3 (33.3%) 0/2 (0%) 0/28 (0%) 
204 - Syncope & Collapse 0/14 (0%) 58/116 (50%) 11/24 (45.8%) 0/1 (0%) 0/155 (0%) 
203 - Chest Pain 0/2 (0%) 16/33 (48.5%) 0/4 (0%) 0/0 ( - ) 0/39 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/9 (0%) 29/44 (65.9%) 2/10 (20%) 0/21 (0%) 0/84 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 1/42 (2.4%) 296/664 (44.6%) 85/329 (25.8%) 5/28 (17.9%) 0/1063 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/1 (0%) 12/45 (26.7%) 7/19 (36.8%) 0/2 (0%) 0/67 (0%) 
167 - Other Cardiothoracic Procedures 0/2 (0%) 6/9 (66.7%) 2/7 (28.6%) 0/3 (0%) 1/21 (4.8%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/4 (0%) 20/29 (69%) 2/6 (33.3%) 0/1 (0%) 0/40 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 3/13 (23.1%) 2/6 (33.3%) 0/2 (0%) 0/21 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/1 (0%) 24/70 (34.3%) 4/16 (25%) 1/11 (9.1%) 0/98 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 3/4 (75%) 3/12 (25%) 0/1 (0%) 0/17 (0%) 
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161 - Cardiac Defibrillator & Heart Assist Anomaly 0/1 (0%) 6/13 (46.2%) 1/1 (100%) 0/0 ( - ) 0/15 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
      
Moderate or severe liver disease 
     
199 - Hypertension 0/0 ( - ) 1/5 (20%) 0/2 (0%) 1/2 (50%) 0/9 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/1 (0%) 5/20 (25%) 2/9 (22.2%) 2/5 (40%) 0/35 (0%) 
197 - Peripheral & Other Vascular Disorders 0/8 (0%) 25/54 (46.3%) 13/38 (34.2%) 4/15 (26.7%) 0/115 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 0/1 (0%) 0/1 (0%) 1/7 (14.3%) 0/9 (0%) 
194 - Heart Failure 2/3 (66.7%) 16/264 (6.1%) 92/307 (30%) 61/110 (55.5%) 0/684 (0%) 
193 - Acute & Subacute Endocarditis 0/0 ( - ) 2/11 (18.2%) 4/11 (36.4%) 1/8 (12.5%) 0/30 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/0 ( - ) 3/4 (75%) 1/1 (100%) 0/0 ( - ) 0/5 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/1 (0%) 8/17 (47.1%) 7/12 (58.3%) 1/6 (16.7%) 0/36 (0%) 
190 - Acute Myocardial Infarction 0/0 ( - ) 1/14 (7.1%) 10/43 (23.3%) 4/14 (28.6%) 0/71 (0%) 
180 - Other Circulatory System Procedures 0/1 (0%) 2/3 (66.7%) 2/6 (33.3%) 1/1 (100%) 0/11 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 0/0 ( - ) 0/0 ( - ) 1/3 (33.3%) 0/3 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/2 (0%) 8/12 (66.7%) 0/5 (0%) 1/3 (33.3%) 0/22 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/0 ( - ) 3/7 (42.9%) 2/3 (66.7%) 0/1 (0%) 0/11 (0%) 
173 - Other Vascular Procedures 0/1 (0%) 6/17 (35.3%) 1/5 (20%) 1/7 (14.3%) 0/30 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/2 (0%) 6/16 (37.5%) 5/11 (45.5%) 0/0 ( - ) 0/29 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/0 ( - ) 1/1 (100%) 0/0 ( - ) 0/1 (0%) 
207 - Other Circulatory System Diagnoses 0/1 (0%) 5/16 (31.2%) 7/20 (35%) 1/2 (50%) 0/39 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/0 ( - ) 0/7 (0%) 1/6 (16.7%) 0/3 (0%) 0/16 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 1/10 (10%) 1/3 (33.3%) 2/3 (66.7%) 0/16 (0%) 
204 - Syncope & Collapse 0/0 ( - ) 2/4 (50%) 0/0 ( - ) 0/0 ( - ) 0/4 (0%) 
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203 - Chest Pain 0/1 (0%) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/0 ( - ) 1/1 (100%) 0/0 ( - ) 1/2 (50%) 0/3 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/3 (0%) 9/39 (23.1%) 6/24 (25%) 2/7 (28.6%) 0/73 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/2 (0%) 1/10 (10%) 3/8 (37.5%) 6/6 (100%) 0/26 (0%) 
167 - Other Cardiothoracic Procedures 0/0 ( - ) 2/4 (50%) 1/1 (100%) 1/2 (50%) 0/7 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 1/1 (100%) 1/2 (50%) 1/1 (100%) 0/4 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/0 ( - ) 1/6 (16.7%) 0/5 (0%) 4/10 (40%) 0/21 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/0 ( - ) 0/3 (0%) 0/2 (0%) 0/0 ( - ) 0/5 (0%) 
      
Metastatic solid tumor 
     
199 - Hypertension 0/1 (0%) 2/7 (28.6%) 8/9 (88.9%) 0/0 ( - ) 0/17 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/1 (0%) 13/41 (31.7%) 25/47 (53.2%) 1/4 (25%) 0/93 (0%) 
197 - Peripheral & Other Vascular Disorders 1/11 (9.1%) 121/319 (37.9%) 129/234 (55.1%) 6/24 (25%) 0/588 (0%) 
196 - Cardiac Arrest 1/1 (100%) 1/5 (20%) 6/6 (100%) 0/4 (0%) 0/16 (0%) 
194 - Heart Failure 0/0 ( - ) 27/275 (9.8%) 284/662 (42.9%) 12/81 (14.8%) 0/1018 (0%) 
193 - Acute & Subacute Endocarditis 0/0 ( - ) 1/7 (14.3%) 3/11 (27.3%) 0/2 (0%) 0/20 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/0 ( - ) 3/6 (50%) 8/8 (100%) 0/0 ( - ) 0/14 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/0 ( - ) 2/10 (20%) 1/1 (100%) 1/2 (50%) 0/13 (0%) 
190 - Acute Myocardial Infarction 0/0 ( - ) 11/26 (42.3%) 60/165 (36.4%) 1/23 (4.3%) 0/214 (0%) 
180 - Other Circulatory System Procedures 0/3 (0%) 12/23 (52.2%) 14/23 (60.9%) 1/4 (25%) 1/53 (1.9%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/0 ( - ) 2/2 (100%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/0 ( - ) 5/15 (33.3%) 5/8 (62.5%) 0/2 (0%) 0/25 (0%) 
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174 - Percutaneous Cardiovascular Procedures w/ AMI 0/1 (0%) 6/22 (27.3%) 5/9 (55.6%) 2/6 (33.3%) 0/38 (0%) 
173 - Other Vascular Procedures 0/2 (0%) 14/35 (40%) 10/19 (52.6%) 1/6 (16.7%) 0/62 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/0 ( - ) 7/25 (28%) 5/12 (41.7%) 0/0 ( - ) 0/37 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 
207 - Other Circulatory System Diagnoses 0/1 (0%) 29/68 (42.6%) 28/46 (60.9%) 2/5 (40%) 1/120 (0.8%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/1 (0%) 37/81 (45.7%) 12/24 (50%) 1/3 (33.3%) 0/109 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 0/4 (0%) 1/2 (50%) 0/1 (0%) 0/7 (0%) 
204 - Syncope & Collapse 0/1 (0%) 8/22 (36.4%) 14/15 (93.3%) 0/0 ( - ) 0/38 (0%) 
203 - Chest Pain 0/0 ( - ) 1/6 (16.7%) 4/5 (80%) 1/1 (100%) 0/12 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/1 (0%) 2/3 (66.7%) 1/3 (33.3%) 0/4 (0%) 0/11 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/2 (0%) 38/132 (28.8%) 72/138 (52.2%) 1/8 (12.5%) 0/280 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/0 ( - ) 0/6 (0%) 4/7 (57.1%) 1/2 (50%) 0/15 (0%) 
167 - Other Cardiothoracic Procedures 0/0 ( - ) 3/3 (100%) 0/1 (0%) 0/1 (0%) 0/5 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 1/3 (33.3%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 0/0 ( - ) 1/3 (33.3%) 0/0 ( - ) 0/3 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/0 ( - ) 0/3 (0%) 0/1 (0%) 0/2 (0%) 0/6 (0%) 
      
AIDS/HIV 
     
199 - Hypertension 0/6 (0%) 1/2 (50%) 0/0 ( - ) 0/0 ( - ) 0/8 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/5 (0%) 2/6 (33.3%) 1/1 (100%) 0/0 ( - ) 0/12 (0%) 
197 - Peripheral & Other Vascular Disorders 0/26 (0%) 4/22 (18.2%) 2/8 (25%) 0/0 ( - ) 0/56 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 0/0 ( - ) 1/1 (100%) 0/1 (0%) 0/2 (0%) 
194 - Heart Failure 0/12 (0%) 13/47 (27.7%) 7/38 (18.4%) 0/4 (0%) 0/101 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/9 (0%) 2/5 (40%) 0/0 ( - ) 0/0 ( - ) 0/14 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/11 (0%) 1/7 (14.3%) 3/6 (50%) 0/1 (0%) 0/25 (0%) 
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190 - Acute Myocardial Infarction 0/16 (0%) 7/20 (35%) 1/5 (20%) 0/3 (0%) 0/44 (0%) 
180 - Other Circulatory System Procedures 0/11 (0%) 0/4 (0%) 0/2 (0%) 0/0 ( - ) 0/17 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/18 (0%) 0/3 (0%) 0/4 (0%) 0/1 (0%) 0/26 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/36 (0%) 4/45 (8.9%) 1/4 (25%) 0/2 (0%) 0/87 (0%) 
173 - Other Vascular Procedures 0/36 (0%) 7/34 (20.6%) 3/4 (75%) 0/4 (0%) 0/78 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/11 (0%) 2/4 (50%) 0/1 (0%) 0/0 ( - ) 0/16 (0%) 
207 - Other Circulatory System Diagnoses 0/5 (0%) 1/8 (12.5%) 1/2 (50%) 0/1 (0%) 0/16 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/5 (0%) 1/3 (33.3%) 2/6 (33.3%) 0/1 (0%) 0/15 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 1/5 (20%) 1/2 (50%) 0/0 ( - ) 0/7 (0%) 
204 - Syncope & Collapse 0/4 (0%) 1/4 (25%) 0/1 (0%) 0/0 ( - ) 0/9 (0%) 
203 - Chest Pain 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/3 (0%) 3/7 (42.9%) 0/0 ( - ) 0/1 (0%) 0/11 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/2 (0%) 6/17 (35.3%) 0/4 (0%) 0/0 ( - ) 0/23 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/0 ( - ) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
167 - Other Cardiothoracic Procedures 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/2 (0%) 1/5 (20%) 0/1 (0%) 0/0 ( - ) 0/8 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/2 (0%) 0/4 (0%) 0/5 (0%) 0/0 ( - ) 0/11 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/2 (0%) 0/3 (0%) 1/1 (100%) 0/0 ( - ) 0/6 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
      
Elixhauser comorbidities 
 
SOI 1 SOI 2 SOI 3 SOI 3 Base APR-DRG 
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Congestive heart failure 
     
199 - Hypertension 0/24 (0%) 160/398 (40.2%) 35/172 (20.3%) 0/15 (0%) 0/609 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/264 (0%) 1583/3149 (50.3%) 155/840 (18.5%) 11/154 (7.1%) 0/4407 (0%) 
197 - Peripheral & Other Vascular Disorders 1/74 (1.4%) 538/1296 (41.5%) 126/635 (19.8%) 6/133 (4.5%) 1/2138 (0%) 
196 - Cardiac Arrest 0/9 (0%) 40/93 (43%) 14/111 (12.6%) 3/130 (2.3%) 0/343 (0%) 
194 - Heart Failure 0/656 (0%) 2948/14286 
(20.6%) 
1192/9503 (12.5%) 73/1616 (4.5%) 0/26061 (0%) 
193 - Acute & Subacute Endocarditis 0/7 (0%) 80/183 (43.7%) 27/155 (17.4%) 2/89 (2.2%) 0/434 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/269 (0%) 996/1414 (70.4%) 48/149 (32.2%) 2/27 (7.4%) 0/1859 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/438 (0%) 2243/3090 (72.6%) 158/779 (20.3%) 4/201 (2%) 2/4508 (0%) 
190 - Acute Myocardial Infarction 0/160 (0%) 1235/3503 (35.3%) 1159/4644 (25%) 41/749 (5.5%) 2/9056 (0%) 
180 - Other Circulatory System Procedures 0/30 (0%) 131/228 (57.5%) 20/93 (21.5%) 2/47 (4.3%) 2/398 (0.5%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/70 (0%) 203/291 (69.8%) 13/42 (31%) 1/13 (7.7%) 0/416 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/153 (0%) 532/628 (84.7%) 39/111 (35.1%) 2/10 (20%) 1/902 (0.1%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/319 (0%) 1114/1572 (70.9%) 95/536 (17.7%) 7/141 (5%) 0/2568 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/203 (0%) 1026/2462 (41.7%) 136/621 (21.9%) 31/372 (8.3%) 0/3658 (0%) 
173 - Other Vascular Procedures 0/66 (0%) 582/1190 (48.9%) 57/287 (19.9%) 4/140 (2.9%) 0/1683 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/449 (0%) 2072/3206 (64.6%) 85/400 (21.2%) 5/101 (5%) 0/4156 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/33 (0%) 41/112 (36.6%) 16/81 (19.8%) 0/18 (0%) 0/244 (0%) 
207 - Other Circulatory System Diagnoses 0/56 (0%) 357/884 (40.4%) 45/372 (12.1%) 4/80 (5%) 0/1392 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/39 (0%) 143/289 (49.5%) 29/118 (24.6%) 3/48 (6.2%) 0/494 (0%) 
205 - Cardiomyopathy 0/35 (0%) 639/1058 (60.4%) 45/238 (18.9%) 0/44 (0%) 0/1375 (0%) 
204 - Syncope & Collapse 0/34 (0%) 129/367 (35.1%) 12/72 (16.7%) 0/2 (0%) 0/475 (0%) 
203 - Chest Pain 0/29 (0%) 66/112 (58.9%) 5/13 (38.5%) 0/0 ( - ) 0/154 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/23 (0%) 119/196 (60.7%) 14/77 (18.2%) 1/99 (1%) 0/395 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/662 (0%) 5003/8125 (61.6%) 511/2847 (17.9%) 14/241 (5.8%) 1/11875 (0%) 
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200 - Cardiac Congenital & Valvular Disorders 1/37 (2.7%) 1032/1770 (58.3%) 98/432 (22.7%) 3/90 (3.3%) 2/2329 (0.1%) 
167 - Other Cardiothoracic Procedures 0/101 (0%) 190/315 (60.3%) 18/85 (21.2%) 0/17 (0%) 1/518 (0.2%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/33 (0%) 557/758 (73.5%) 30/114 (26.3%) 0/23 (0%) 0/928 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/4 (0%) 78/202 (38.6%) 5/64 (7.8%) 2/19 (10.5%) 0/289 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/78 (0%) 1622/3415 (47.5%) 83/506 (16.4%) 4/148 (2.7%) 1/4147 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/3 (0%) 84/326 (25.8%) 19/146 (13%) 3/46 (6.5%) 2/521 (0.4%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/502 (0%) 1088/1472 (73.9%) 28/103 (27.2%) 2/38 (5.3%) 0/2115 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/27 (0%) 39/73 (53.4%) 8/29 (27.6%) 0/5 (0%) 0/134 (0%) 
      
Cardiac arrhythmias 
     
199 - Hypertension 0/238 (0%) 86/438 (19.6%) 37/215 (17.2%) 0/17 (0%) 0/908 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 2/944 (0.2%) 301/2149 (14%) 124/652 (19%) 10/127 (7.9%) 0/3872 (0%) 
197 - Peripheral & Other Vascular Disorders 7/705 (1%) 219/1336 (16.4%) 140/794 (17.6%) 3/169 (1.8%) 0/3004 (0%) 
196 - Cardiac Arrest 1/36 (2.8%) 17/99 (17.2%) 22/130 (16.9%) 6/145 (4.1%) 0/410 (0%) 
194 - Heart Failure 11/2251 (0.5%) 4157/34777 (12%) 2760/21443 
(12.9%) 
103/3096 (3.3%) 2/61567 (0%) 
193 - Acute & Subacute Endocarditis 0/60 (0%) 24/168 (14.3%) 20/153 (13.1%) 1/84 (1.2%) 0/465 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/1450 (0%) 240/898 (26.7%) 57/131 (43.5%) 2/21 (9.5%) 0/2500 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
4/1951 (0.2%) 479/2075 (23.1%) 235/931 (25.2%) 16/275 (5.8%) 3/5232 (0.1%) 
190 - Acute Myocardial Infarction 2/1069 (0.2%) 705/3467 (20.3%) 1218/4327 (28.1%) 68/749 (9.1%) 0/9612 (0%) 
180 - Other Circulatory System Procedures 0/407 (0%) 38/204 (18.6%) 14/103 (13.6%) 1/57 (1.8%) 2/771 (0.3%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/634 (0%) 127/380 (33.4%) 69/106 (65.1%) 2/25 (8%) 0/1145 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 5/1437 (0.3%) 253/720 (35.1%) 184/231 (79.7%) 5/19 (26.3%) 4/2407 (0.2%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/1991 (0%) 338/1170 (28.9%) 171/686 (24.9%) 19/164 (11.6%) 1/4011 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 4/1785 (0.2%) 715/2814 (25.4%) 465/1007 (46.2%) 72/571 (12.6%) 0/6177 (0%) 
173 - Other Vascular Procedures 1/1341 (0.1%) 294/1472 (20%) 63/365 (17.3%) 2/213 (0.9%) 0/3391 (0%) 
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171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
2/4134 (0%) 1069/3161 (33.8%) 217/513 (42.3%) 21/109 (19.3%) 2/7917 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/85 (0%) 81/321 (25.2%) 125/227 (55.1%) 9/41 (22%) 11/674 (1.6%) 
207 - Other Circulatory System Diagnoses 2/477 (0.4%) 140/868 (16.1%) 55/372 (14.8%) 4/85 (4.7%) 0/1802 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
2/304 (0.7%) 63/340 (18.5%) 58/162 (35.8%) 1/66 (1.5%) 0/872 (0%) 
205 - Cardiomyopathy 0/224 (0%) 88/752 (11.7%) 49/221 (22.2%) 1/50 (2%) 0/1247 (0%) 
204 - Syncope & Collapse 0/422 (0%) 123/615 (20%) 30/125 (24%) 0/6 (0%) 1/1168 (0.1%) 
203 - Chest Pain 0/151 (0%) 20/94 (21.3%) 6/16 (37.5%) 0/1 (0%) 0/262 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/195 (0%) 76/244 (31.1%) 23/115 (20%) 2/160 (1.2%) 2/714 (0.3%) 
201 - Cardiac Arrhythmia & Conduction Disorders 1/2058 (0%) 577/3253 (17.7%) 304/2338 (13%) 15/176 (8.5%) 0/7825 (0%) 
200 - Cardiac Congenital & Valvular Disorders 2/295 (0.7%) 115/1011 (11.4%) 57/306 (18.6%) 2/65 (3.1%) 2/1677 (0.1%) 
167 - Other Cardiothoracic Procedures 1/196 (0.5%) 30/200 (15%) 37/94 (39.4%) 4/26 (15.4%) 0/516 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
1/671 (0.1%) 150/514 (29.2%) 58/188 (30.9%) 2/42 (4.8%) 0/1415 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/112 (0%) 41/336 (12.2%) 32/128 (25%) 2/26 (7.7%) 1/602 (0.2%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 1/1243 (0.1%) 526/3496 (15%) 354/809 (43.8%) 8/175 (4.6%) 0/5723 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 1/44 (2.3%) 31/414 (7.5%) 68/198 (34.3%) 6/68 (8.8%) 3/724 (0.4%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 1/523 (0.2%) 257/883 (29.1%) 76/144 (52.8%) 9/39 (23.1%) 3/1589 (0.2%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 1/31 (3.2%) 1/22 (4.5%) 6/21 (28.6%) 0/5 (0%) 0/79 (0%) 
      
Valvular disease 
     
199 - Hypertension 1/141 (0.7%) 30/158 (19%) 1/53 (1.9%) 0/6 (0%) 0/358 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 1/557 (0.2%) 113/1113 (10.2%) 21/310 (6.8%) 0/43 (0%) 0/2023 (0%) 
197 - Peripheral & Other Vascular Disorders 0/176 (0%) 45/329 (13.7%) 18/224 (8%) 0/63 (0%) 1/792 (0.1%) 
196 - Cardiac Arrest 0/7 (0%) 6/27 (22.2%) 2/57 (3.5%) 2/57 (3.5%) 0/148 (0%) 
194 - Heart Failure 23/996 (2.3%) 900/15333 (5.9%) 494/9202 (5.4%) 32/1468 (2.2%) 1/26999 (0%) 
193 - Acute & Subacute Endocarditis 0/179 (0%) 36/244 (14.8%) 11/193 (5.7%) 0/108 (0%) 1/724 (0.1%) 
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192 - Cardiac Catheterization for Ischemic Heart Disease 5/1091 (0.5%) 183/879 (20.8%) 12/76 (15.8%) 0/15 (0%) 0/2061 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
7/1317 (0.5%) 247/1587 (15.6%) 50/620 (8.1%) 3/267 (1.1%) 2/3791 (0.1%) 
190 - Acute Myocardial Infarction 6/872 (0.7%) 400/2622 (15.3%) 291/2644 (11%) 6/390 (1.5%) 0/6528 (0%) 
180 - Other Circulatory System Procedures 0/114 (0%) 6/65 (9.2%) 0/44 (0%) 0/32 (0%) 1/255 (0.4%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/49 (0%) 11/81 (13.6%) 2/24 (8.3%) 1/9 (11.1%) 1/163 (0.6%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/133 (0%) 14/98 (14.3%) 6/33 (18.2%) 1/7 (14.3%) 0/271 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 3/909 (0.3%) 172/705 (24.4%) 10/259 (3.9%) 0/89 (0%) 1/1962 (0.1%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 2/962 (0.2%) 152/1507 (10.1%) 25/378 (6.6%) 3/198 (1.5%) 0/3045 (0%) 
173 - Other Vascular Procedures 1/289 (0.3%) 65/454 (14.3%) 8/107 (7.5%) 1/93 (1.1%) 1/943 (0.1%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
3/1522 (0.2%) 255/1553 (16.4%) 15/281 (5.3%) 1/62 (1.6%) 0/3418 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/18 (0%) 12/115 (10.4%) 4/88 (4.5%) 0/19 (0%) 1/240 (0.4%) 
207 - Other Circulatory System Diagnoses 3/408 (0.7%) 54/463 (11.7%) 11/175 (6.3%) 0/43 (0%) 0/1089 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
1/112 (0.9%) 15/178 (8.4%) 6/105 (5.7%) 0/44 (0%) 0/439 (0%) 
205 - Cardiomyopathy 0/55 (0%) 23/345 (6.7%) 4/107 (3.7%) 1/21 (4.8%) 0/528 (0%) 
204 - Syncope & Collapse 3/157 (1.9%) 29/279 (10.4%) 5/51 (9.8%) 0/1 (0%) 1/488 (0.2%) 
203 - Chest Pain 0/90 (0%) 10/51 (19.6%) 2/6 (33.3%) 0/1 (0%) 0/148 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/122 (0%) 14/112 (12.5%) 4/60 (6.7%) 2/65 (3.1%) 1/359 (0.3%) 
201 - Cardiac Arrhythmia & Conduction Disorders 10/1697 (0.6%) 297/2828 (10.5%) 71/1210 (5.9%) 0/94 (0%) 1/5829 (0%) 
200 - Cardiac Congenital & Valvular Disorders 2/202 (1%) 22/476 (4.6%) 8/135 (5.9%) 1/41 (2.4%) 0/854 (0%) 
167 - Other Cardiothoracic Procedures 1/169 (0.6%) 13/132 (9.8%) 3/54 (5.6%) 1/14 (7.1%) 0/369 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
1/228 (0.4%) 30/225 (13.3%) 11/84 (13.1%) 0/15 (0%) 0/552 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/55 (0%) 12/162 (7.4%) 3/63 (4.8%) 0/14 (0%) 0/294 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 4/706 (0.6%) 83/2243 (3.7%) 21/515 (4.1%) 2/150 (1.3%) 1/3614 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/41 (0%) 10/347 (2.9%) 8/145 (5.5%) 1/55 (1.8%) 5/588 (0.9%) 
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161 - Cardiac Defibrillator & Heart Assist Anomaly 0/143 (0%) 22/335 (6.6%) 3/55 (5.5%) 0/19 (0%) 0/552 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/37 (0%) 3/21 (14.3%) 6/32 (18.8%) 0/4 (0%) 0/94 (0%) 
      
Pulmonary circulation disorders 
     
199 - Hypertension 0/4 (0%) 9/49 (18.4%) 6/32 (18.8%) 2/5 (40%) 0/90 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/12 (0%) 17/234 (7.3%) 19/79 (24.1%) 12/25 (48%) 0/350 (0%) 
197 - Peripheral & Other Vascular Disorders 0/18 (0%) 13/94 (13.8%) 217/276 (78.6%) 52/78 (66.7%) 1/466 (0.2%) 
196 - Cardiac Arrest 0/0 ( - ) 1/5 (20%) 1/15 (6.7%) 5/24 (20.8%) 0/44 (0%) 
194 - Heart Failure 0/99 (0%) 331/5328 (6.2%) 390/4091 (9.5%) 157/781 (20.1%) 0/10299 (0%) 
193 - Acute & Subacute Endocarditis 0/8 (0%) 2/32 (6.2%) 20/42 (47.6%) 7/21 (33.3%) 0/103 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/27 (0%) 30/128 (23.4%) 9/22 (40.9%) 1/6 (16.7%) 0/183 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/343 (0%) 210/797 (26.3%) 65/289 (22.5%) 9/50 (18%) 0/1479 (0%) 
190 - Acute Myocardial Infarction 0/5 (0%) 27/206 (13.1%) 58/424 (13.7%) 19/91 (20.9%) 0/726 (0%) 
180 - Other Circulatory System Procedures 0/8 (0%) 3/22 (13.6%) 6/21 (28.6%) 1/16 (6.2%) 0/67 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 2/21 (9.5%) 1/6 (16.7%) 3/5 (60%) 0/32 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/3 (0%) 3/16 (18.8%) 5/8 (62.5%) 1/3 (33.3%) 0/30 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/32 (0%) 32/171 (18.7%) 10/54 (18.5%) 4/20 (20%) 1/277 (0.4%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/16 (0%) 17/100 (17%) 16/53 (30.2%) 6/29 (20.7%) 0/198 (0%) 
173 - Other Vascular Procedures 1/19 (5.3%) 16/172 (9.3%) 14/57 (24.6%) 6/35 (17.1%) 0/283 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/52 (0%) 62/305 (20.3%) 25/71 (35.2%) 6/25 (24%) 0/453 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/1 (0%) 2/24 (8.3%) 2/26 (7.7%) 3/9 (33.3%) 0/60 (0%) 
207 - Other Circulatory System Diagnoses 0/19 (0%) 20/111 (18%) 33/93 (35.5%) 8/27 (29.6%) 0/250 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
1/3 (33.3%) 10/35 (28.6%) 5/27 (18.5%) 5/23 (21.7%) 0/88 (0%) 
205 - Cardiomyopathy 0/12 (0%) 11/134 (8.2%) 7/48 (14.6%) 2/11 (18.2%) 0/205 (0%) 
204 - Syncope & Collapse 0/1 (0%) 3/41 (7.3%) 2/9 (22.2%) 0/0 ( - ) 0/51 (0%) 
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203 - Chest Pain 0/3 (0%) 1/7 (14.3%) 0/0 ( - ) 0/0 ( - ) 0/10 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/6 (0%) 5/26 (19.2%) 3/21 (14.3%) 3/22 (13.6%) 0/75 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/83 (0%) 119/675 (17.6%) 66/360 (18.3%) 22/65 (33.8%) 0/1183 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/47 (0%) 58/403 (14.4%) 16/121 (13.2%) 4/24 (16.7%) 1/595 (0.2%) 
167 - Other Cardiothoracic Procedures 0/88 (0%) 23/97 (23.7%) 6/30 (20%) 3/8 (37.5%) 1/223 (0.4%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/9 (0%) 8/25 (32%) 4/11 (36.4%) 0/1 (0%) 0/46 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/2 (0%) 0/4 (0%) 1/7 (14.3%) 0/6 (0%) 0/19 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/72 (0%) 116/732 (15.8%) 14/185 (7.6%) 5/49 (10.2%) 0/1038 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/5 (0%) 12/133 (9%) 4/63 (6.3%) 1/15 (6.7%) 1/216 (0.5%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 1/6 (16.7%) 10/59 (16.9%) 3/13 (23.1%) 0/1 (0%) 0/79 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/18 (0%) 1/32 (3.1%) 1/24 (4.2%) 1/4 (25%) 0/78 (0%) 
      
Peripheral vascular disorders 
     
199 - Hypertension 0/67 (0%) 6/70 (8.6%) 1/39 (2.6%) 0/1 (0%) 0/177 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 3/400 (0.8%) 34/445 (7.6%) 6/127 (4.7%) 5/30 (16.7%) 0/1002 (0%) 
197 - Peripheral & Other Vascular Disorders 11/1482 (0.7%) 52/1013 (5.1%) 20/401 (5%) 13/108 (12%) 1/3004 (0%) 
196 - Cardiac Arrest 0/2 (0%) 0/5 (0%) 0/11 (0%) 0/20 (0%) 0/38 (0%) 
194 - Heart Failure 8/187 (4.3%) 78/2819 (2.8%) 67/2076 (3.2%) 14/351 (4%) 0/5433 (0%) 
193 - Acute & Subacute Endocarditis 0/9 (0%) 1/24 (4.2%) 1/22 (4.5%) 0/10 (0%) 0/65 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 1/409 (0.2%) 24/239 (10%) 9/34 (26.5%) 1/11 (9.1%) 0/693 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
2/263 (0.8%) 32/264 (12.1%) 6/125 (4.8%) 7/38 (18.4%) 0/690 (0%) 
190 - Acute Myocardial Infarction 14/463 (3%) 108/896 (12.1%) 35/869 (4%) 9/145 (6.2%) 0/2373 (0%) 
180 - Other Circulatory System Procedures 0/106 (0%) 7/105 (6.7%) 2/61 (3.3%) 2/33 (6.1%) 2/305 (0.7%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/12 (0%) 1/18 (5.6%) 0/9 (0%) 0/0 ( - ) 0/39 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/11 (0%) 1/17 (5.9%) 0/4 (0%) 0/2 (0%) 0/34 (0%) 
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175 - Percutaneous Cardiovascular Procedures w/o AMI 1/587 (0.2%) 32/285 (11.2%) 13/153 (8.5%) 5/34 (14.7%) 0/1059 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/350 (0%) 11/394 (2.8%) 12/146 (8.2%) 6/89 (6.7%) 0/979 (0%) 
173 - Other Vascular Procedures 20/1842 (1.1%) 85/1208 (7%) 27/249 (10.8%) 11/176 (6.2%) 2/3475 (0.1%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/215 (0%) 32/252 (12.7%) 3/54 (5.6%) 0/17 (0%) 0/538 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/1 (0%) 1/20 (5%) 1/14 (7.1%) 0/8 (0%) 1/43 (2.3%) 
207 - Other Circulatory System Diagnoses 1/40 (2.5%) 6/70 (8.6%) 4/39 (10.3%) 1/5 (20%) 0/154 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
2/203 (1%) 8/96 (8.3%) 4/39 (10.3%) 0/11 (0%) 0/349 (0%) 
205 - Cardiomyopathy 0/8 (0%) 1/37 (2.7%) 0/9 (0%) 0/0 ( - ) 0/54 (0%) 
204 - Syncope & Collapse 0/39 (0%) 8/74 (10.8%) 2/14 (14.3%) 0/1 (0%) 0/128 (0%) 
203 - Chest Pain 0/17 (0%) 1/14 (7.1%) 1/2 (50%) 0/0 ( - ) 0/33 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 5/363 (1.4%) 6/133 (4.5%) 8/81 (9.9%) 4/120 (3.3%) 0/697 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 2/145 (1.4%) 26/397 (6.5%) 15/231 (6.5%) 1/36 (2.8%) 0/809 (0%) 
200 - Cardiac Congenital & Valvular Disorders 1/55 (1.8%) 10/101 (9.9%) 3/32 (9.4%) 0/6 (0%) 0/194 (0%) 
167 - Other Cardiothoracic Procedures 1/14 (7.1%) 4/38 (10.5%) 7/28 (25%) 1/13 (7.7%) 1/93 (1.1%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/241 (0%) 12/157 (7.6%) 1/46 (2.2%) 0/17 (0%) 0/461 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/49 (0%) 2/107 (1.9%) 3/37 (8.1%) 1/13 (7.7%) 0/206 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 5/486 (1%) 151/1032 (14.6%) 20/166 (12%) 2/41 (4.9%) 0/1725 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/23 (0%) 6/81 (7.4%) 7/45 (15.6%) 1/17 (5.9%) 0/166 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/46 (0%) 8/86 (9.3%) 1/11 (9.1%) 0/4 (0%) 0/147 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/4 (0%) 
      
Hypertension uncomplicated 
     
199 - Hypertension 1/33 (3%) 0/46 (0%) 0/17 (0%) 0/1 (0%) 0/97 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 21/3992 (0.5%) 7/1954 (0.4%) 3/456 (0.7%) 0/75 (0%) 0/6477 (0%) 
197 - Peripheral & Other Vascular Disorders 33/5556 (0.6%) 5/2631 (0.2%) 5/988 (0.5%) 0/221 (0%) 0/9396 (0%) 
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196 - Cardiac Arrest 0/25 (0%) 1/67 (1.5%) 1/73 (1.4%) 0/92 (0%) 0/257 (0%) 
194 - Heart Failure 146/2995 (4.9%) 30/18438 (0.2%) 53/10246 (0.5%) 5/1329 (0.4%) 0/33008 (0%) 
193 - Acute & Subacute Endocarditis 0/98 (0%) 0/140 (0%) 0/110 (0%) 0/61 (0%) 0/409 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 23/9185 (0.3%) 1/1319 (0.1%) 0/115 (0%) 0/23 (0%) 1/10642 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
28/5593 (0.5%) 0/1933 (0%) 4/732 (0.5%) 0/265 (0%) 0/8523 (0%) 
190 - Acute Myocardial Infarction 106/6237 (1.7%) 38/6167 (0.6%) 18/3499 (0.5%) 4/554 (0.7%) 0/16457 (0%) 
180 - Other Circulatory System Procedures 2/3887 (0.1%) 0/247 (0%) 2/64 (3.1%) 0/49 (0%) 2/4247 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
2/357 (0.6%) 1/188 (0.5%) 1/59 (1.7%) 1/5 (20%) 2/609 (0.3%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 3/967 (0.3%) 6/356 (1.7%) 0/89 (0%) 0/8 (0%) 0/1420 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 40/13292 (0.3%) 4/1753 (0.2%) 2/773 (0.3%) 0/143 (0%) 0/15961 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 28/8933 (0.3%) 1/5525 (0%) 6/827 (0.7%) 0/415 (0%) 0/15700 (0%) 
173 - Other Vascular Procedures 33/5603 (0.6%) 1/2730 (0%) 1/358 (0.3%) 1/370 (0.3%) 1/9061 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
58/10739 (0.5%) 7/3302 (0.2%) 5/486 (1%) 0/66 (0%) 3/14593 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
1/61 (1.6%) 1/161 (0.6%) 2/103 (1.9%) 0/15 (0%) 1/340 (0.3%) 
207 - Other Circulatory System Diagnoses 12/1022 (1.2%) 3/692 (0.4%) 2/292 (0.7%) 0/41 (0%) 0/2047 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
7/387 (1.8%) 0/236 (0%) 1/83 (1.2%) 0/21 (0%) 0/727 (0%) 
205 - Cardiomyopathy 0/165 (0%) 1/313 (0.3%) 0/88 (0%) 0/15 (0%) 0/581 (0%) 
204 - Syncope & Collapse 2/890 (0.2%) 0/574 (0%) 1/94 (1.1%) 0/3 (0%) 0/1561 (0%) 
203 - Chest Pain 3/787 (0.4%) 0/106 (0%) 0/18 (0%) 0/1 (0%) 0/912 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 8/1226 (0.7%) 1/493 (0.2%) 3/186 (1.6%) 0/287 (0%) 0/2192 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 60/7634 (0.8%) 6/5073 (0.1%) 14/2264 (0.6%) 1/162 (0.6%) 0/15133 (0%) 
200 - Cardiac Congenital & Valvular Disorders 4/476 (0.8%) 4/725 (0.6%) 0/198 (0%) 0/36 (0%) 0/1435 (0%) 
167 - Other Cardiothoracic Procedures 2/364 (0.5%) 0/154 (0%) 1/64 (1.6%) 0/27 (0%) 0/609 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
22/2950 (0.7%) 0/1277 (0%) 4/287 (1.4%) 0/44 (0%) 1/4558 (0%) 
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165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
6/516 (1.2%) 0/600 (0%) 0/186 (0%) 1/24 (4.2%) 0/1326 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 21/2461 (0.9%) 2/4236 (0%) 5/628 (0.8%) 1/122 (0.8%) 1/7447 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/89 (0%) 0/367 (0%) 1/143 (0.7%) 0/52 (0%) 0/651 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 7/814 (0.9%) 0/668 (0%) 0/64 (0%) 0/19 (0%) 0/1565 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/14 (0%) 0/14 (0%) 0/2 (0%) 0/0 ( - ) 0/30 (0%) 
      
Paralysis 
     
199 - Hypertension 0/11 (0%) 1/12 (8.3%) 3/10 (30%) 0/2 (0%) 0/35 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/8 (0%) 7/16 (43.8%) 3/16 (18.8%) 1/11 (9.1%) 0/51 (0%) 
197 - Peripheral & Other Vascular Disorders 1/44 (2.3%) 12/38 (31.6%) 5/30 (16.7%) 0/8 (0%) 0/120 (0%) 
196 - Cardiac Arrest 0/2 (0%) 0/0 ( - ) 1/3 (33.3%) 0/10 (0%) 0/15 (0%) 
194 - Heart Failure 0/13 (0%) 9/101 (8.9%) 20/204 (9.8%) 4/89 (4.5%) 0/407 (0%) 
193 - Acute & Subacute Endocarditis 0/2 (0%) 0/4 (0%) 0/22 (0%) 0/16 (0%) 0/44 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/8 (0%) 2/4 (50%) 1/4 (25%) 0/1 (0%) 0/17 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/3 (0%) 1/3 (33.3%) 0/11 (0%) 1/12 (8.3%) 0/29 (0%) 
190 - Acute Myocardial Infarction 0/7 (0%) 7/17 (41.2%) 6/80 (7.5%) 1/46 (2.2%) 0/150 (0%) 
180 - Other Circulatory System Procedures 0/1 (0%) 4/7 (57.1%) 1/3 (33.3%) 0/4 (0%) 0/15 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/1 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/0 ( - ) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/1 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/4 (0%) 3/12 (25%) 0/6 (0%) 0/6 (0%) 0/28 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/16 (0%) 2/18 (11.1%) 0/38 (0%) 2/35 (5.7%) 0/107 (0%) 
173 - Other Vascular Procedures 0/14 (0%) 6/30 (20%) 0/24 (0%) 0/21 (0%) 0/89 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/10 (0%) 8/22 (36.4%) 0/13 (0%) 0/11 (0%) 0/56 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 
207 - Other Circulatory System Diagnoses 0/12 (0%) 5/12 (41.7%) 2/7 (28.6%) 0/4 (0%) 0/35 (0%) 
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206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/3 (0%) 2/7 (28.6%) 0/6 (0%) 0/4 (0%) 0/20 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 1/5 (20%) 0/2 (0%) 0/3 (0%) 0/10 (0%) 
204 - Syncope & Collapse 0/17 (0%) 5/10 (50%) 0/3 (0%) 0/0 ( - ) 0/30 (0%) 
203 - Chest Pain 0/2 (0%) 1/1 (100%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/7 (0%) 0/4 (0%) 0/9 (0%) 0/19 (0%) 0/39 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/22 (0%) 13/45 (28.9%) 3/54 (5.6%) 0/17 (0%) 0/138 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/1 (0%) 0/3 (0%) 0/11 (0%) 0/2 (0%) 0/17 (0%) 
167 - Other Cardiothoracic Procedures 0/5 (0%) 1/1 (100%) 0/3 (0%) 0/0 ( - ) 0/9 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/4 (0%) 1/8 (12.5%) 0/11 (0%) 0/8 (0%) 0/31 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/2 (0%) 0/1 (0%) 0/5 (0%) 1/1 (100%) 0/9 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/13 (0%) 3/30 (10%) 1/41 (2.4%) 0/19 (0%) 0/103 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/1 (0%) 0/4 (0%) 1/15 (6.7%) 0/5 (0%) 0/25 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/2 (0%) 0/0 ( - ) 1/3 (33.3%) 0/0 ( - ) 0/5 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/2 (0%) 0/1 (0%) 1/3 (33.3%) 0/2 (0%) 0/8 (0%) 
      
Other neurological disorders 
     
199 - Hypertension 0/46 (0%) 26/80 (32.5%) 8/30 (26.7%) 0/3 (0%) 0/159 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/72 (0%) 58/233 (24.9%) 20/109 (18.3%) 6/29 (20.7%) 0/443 (0%) 
197 - Peripheral & Other Vascular Disorders 0/178 (0%) 71/280 (25.4%) 21/167 (12.6%) 5/40 (12.5%) 0/665 (0%) 
196 - Cardiac Arrest 0/8 (0%) 9/26 (34.6%) 11/45 (24.4%) 33/130 (25.4%) 0/209 (0%) 
194 - Heart Failure 3/67 (4.5%) 155/2130 (7.3%) 211/1865 (11.3%) 32/375 (8.5%) 0/4437 (0%) 
193 - Acute & Subacute Endocarditis 0/6 (0%) 7/29 (24.1%) 0/23 (0%) 2/22 (9.1%) 0/80 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/96 (0%) 14/44 (31.8%) 4/16 (25%) 1/4 (25%) 0/160 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/96 (0%) 32/102 (31.4%) 12/52 (23.1%) 7/54 (13%) 0/304 (0%) 
190 - Acute Myocardial Infarction 1/65 (1.5%) 73/340 (21.5%) 74/541 (13.7%) 20/183 (10.9%) 0/1129 (0%) 
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180 - Other Circulatory System Procedures 0/103 (0%) 6/29 (20.7%) 0/18 (0%) 1/10 (10%) 0/160 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/9 (0%) 6/23 (26.1%) 4/9 (44.4%) 0/1 (0%) 0/42 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 1/9 (11.1%) 7/17 (41.2%) 3/7 (42.9%) 1/2 (50%) 0/35 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/74 (0%) 31/75 (41.3%) 8/40 (20%) 1/26 (3.8%) 0/215 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/98 (0%) 42/192 (21.9%) 16/78 (20.5%) 12/111 (10.8%) 0/479 (0%) 
173 - Other Vascular Procedures 0/76 (0%) 35/156 (22.4%) 7/61 (11.5%) 1/36 (2.8%) 0/329 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
1/262 (0.4%) 128/429 (29.8%) 12/86 (14%) 0/32 (0%) 0/809 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/12 (0%) 3/16 (18.8%) 0/4 (0%) 0/32 (0%) 
207 - Other Circulatory System Diagnoses 0/65 (0%) 23/97 (23.7%) 8/37 (21.6%) 2/21 (9.5%) 0/220 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/10 (0%) 5/33 (15.2%) 4/21 (19%) 1/7 (14.3%) 0/71 (0%) 
205 - Cardiomyopathy 0/3 (0%) 5/16 (31.2%) 3/10 (30%) 1/13 (7.7%) 0/42 (0%) 
204 - Syncope & Collapse 2/118 (1.7%) 52/179 (29.1%) 9/32 (28.1%) 0/0 ( - ) 0/329 (0%) 
203 - Chest Pain 0/25 (0%) 0/14 (0%) 0/1 (0%) 0/1 (0%) 0/41 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/13 (0%) 6/20 (30%) 0/10 (0%) 1/37 (2.7%) 1/80 (1.2%) 
201 - Cardiac Arrhythmia & Conduction Disorders 1/240 (0.4%) 155/654 (23.7%) 53/408 (13%) 10/71 (14.1%) 0/1373 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/19 (0%) 6/52 (11.5%) 3/34 (8.8%) 1/10 (10%) 0/115 (0%) 
167 - Other Cardiothoracic Procedures 0/17 (0%) 1/11 (9.1%) 2/11 (18.2%) 0/5 (0%) 0/44 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/31 (0%) 7/26 (26.9%) 2/19 (10.5%) 0/7 (0%) 0/83 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/2 (0%) 1/22 (4.5%) 1/11 (9.1%) 0/3 (0%) 0/38 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/41 (0%) 31/165 (18.8%) 12/60 (20%) 3/33 (9.1%) 0/299 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/1 (0%) 0/29 (0%) 2/21 (9.5%) 0/11 (0%) 0/62 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/15 (0%) 3/14 (21.4%) 2/9 (22.2%) 0/9 (0%) 0/47 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/4 (0%) 1/4 (25%) 3/7 (42.9%) 0/1 (0%) 0/16 (0%) 
199 - Hypertension 0/107 (0%) 18/158 (11.4%) 6/95 (6.3%) 0/7 (0%) 0/367 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 1/338 (0.3%) 56/727 (7.7%) 16/218 (7.3%) 1/44 (2.3%) 0/1327 (0%) 
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197 - Peripheral & Other Vascular Disorders 1/533 (0.2%) 70/607 (11.5%) 19/271 (7%) 1/65 (1.5%) 0/1476 (0%) 
196 - Cardiac Arrest 0/7 (0%) 3/25 (12%) 3/47 (6.4%) 0/52 (0%) 0/131 (0%) 
194 - Heart Failure 12/1157 (1%) 753/14524 (5.2%) 470/10161 (4.6%) 27/1477 (1.8%) 0/27319 (0%) 
193 - Acute & Subacute Endocarditis 0/23 (0%) 3/66 (4.5%) 4/46 (8.7%) 0/30 (0%) 0/165 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 1/538 (0.2%) 78/344 (22.7%) 5/66 (7.6%) 0/13 (0%) 0/961 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
2/850 (0.2%) 255/1191 (21.4%) 30/412 (7.3%) 1/97 (1%) 0/2550 (0%) 
190 - Acute Myocardial Infarction 8/394 (2%) 105/1032 (10.2%) 114/1256 (9.1%) 2/220 (0.9%) 0/2902 (0%) 
180 - Other Circulatory System Procedures 1/579 (0.2%) 9/95 (9.5%) 4/60 (6.7%) 0/30 (0%) 1/764 (0.1%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/25 (0%) 7/52 (13.5%) 1/19 (5.3%) 0/4 (0%) 0/100 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 2/68 (2.9%) 9/47 (19.1%) 2/14 (14.3%) 0/5 (0%) 0/134 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 1/673 (0.1%) 56/461 (12.1%) 14/172 (8.1%) 0/42 (0%) 1/1348 (0.1%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/574 (0%) 51/643 (7.9%) 20/192 (10.4%) 1/79 (1.3%) 0/1488 (0%) 
173 - Other Vascular Procedures 0/607 (0%) 88/672 (13.1%) 5/137 (3.6%) 1/140 (0.7%) 0/1556 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
3/762 (0.4%) 135/884 (15.3%) 15/178 (8.4%) 1/37 (2.7%) 0/1861 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/14 (0%) 3/56 (5.4%) 5/47 (10.6%) 0/7 (0%) 0/124 (0%) 
207 - Other Circulatory System Diagnoses 3/203 (1.5%) 28/388 (7.2%) 10/197 (5.1%) 0/36 (0%) 1/824 (0.1%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/38 (0%) 19/107 (17.8%) 2/56 (3.6%) 0/31 (0%) 0/232 (0%) 
205 - Cardiomyopathy 0/47 (0%) 16/278 (5.8%) 2/86 (2.3%) 0/14 (0%) 0/425 (0%) 
204 - Syncope & Collapse 0/83 (0%) 14/158 (8.9%) 1/36 (2.8%) 0/2 (0%) 0/279 (0%) 
203 - Chest Pain 0/80 (0%) 3/30 (10%) 0/7 (0%) 0/0 ( - ) 0/117 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/133 (0%) 13/128 (10.2%) 5/63 (7.9%) 0/83 (0%) 0/407 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 4/931 (0.4%) 216/2014 (10.7%) 59/867 (6.8%) 3/93 (3.2%) 0/3905 (0%) 
200 - Cardiac Congenital & Valvular Disorders 1/128 (0.8%) 69/612 (11.3%) 9/177 (5.1%) 0/33 (0%) 1/950 (0.1%) 
167 - Other Cardiothoracic Procedures 0/130 (0%) 24/130 (18.5%) 1/43 (2.3%) 0/12 (0%) 0/315 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/217 (0%) 34/167 (20.4%) 3/51 (5.9%) 0/13 (0%) 0/448 (0%) 
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165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/36 (0%) 2/78 (2.6%) 0/37 (0%) 0/14 (0%) 0/165 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 1/356 (0.3%) 179/1288 (13.9%) 14/261 (5.4%) 1/72 (1.4%) 0/1977 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/15 (0%) 14/180 (7.8%) 7/82 (8.5%) 0/21 (0%) 3/298 (1%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/80 (0%) 20/178 (11.2%) 1/30 (3.3%) 0/7 (0%) 0/295 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/24 (0%) 1/33 (3%) 1/24 (4.2%) 0/4 (0%) 0/85 (0%) 
      
Diabetes uncomplicated 
     
199 - Hypertension 0/382 (0%) 77/299 (25.8%) 16/102 (15.7%) 0/11 (0%) 0/794 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 2/1652 (0.1%) 281/1706 (16.5%) 86/464 (18.5%) 1/80 (1.2%) 0/3902 (0%) 
197 - Peripheral & Other Vascular Disorders 3/1730 (0.2%) 230/1225 (18.8%) 86/446 (19.3%) 0/75 (0%) 0/3476 (0%) 
196 - Cardiac Arrest 0/13 (0%) 8/54 (14.8%) 7/77 (9.1%) 1/85 (1.2%) 0/229 (0%) 
194 - Heart Failure 12/1422 (0.8%) 2093/17184 
(12.2%) 
1111/10245 
(10.8%) 
11/1334 (0.8%) 1/30185 (0%) 
193 - Acute & Subacute Endocarditis 0/32 (0%) 14/89 (15.7%) 9/79 (11.4%) 1/44 (2.3%) 0/244 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 1/3870 (0%) 277/944 (29.3%) 22/96 (22.9%) 0/14 (0%) 1/4924 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
1/1981 (0.1%) 252/1249 (20.2%) 55/498 (11%) 1/124 (0.8%) 0/3852 (0%) 
190 - Acute Myocardial Infarction 3/2134 (0.1%) 993/3834 (25.9%) 527/2889 (18.2%) 1/431 (0.2%) 1/9288 (0%) 
180 - Other Circulatory System Procedures 0/1076 (0%) 28/142 (19.7%) 2/47 (4.3%) 0/23 (0%) 0/1288 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/130 (0%) 24/116 (20.7%) 6/38 (15.8%) 0/7 (0%) 0/291 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 1/297 (0.3%) 33/180 (18.3%) 16/58 (27.6%) 0/5 (0%) 0/540 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/5636 (0%) 324/1238 (26.2%) 65/493 (13.2%) 0/96 (0%) 1/7463 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/3496 (0%) 330/2815 (11.7%) 91/568 (16%) 4/293 (1.4%) 0/7172 (0%) 
173 - Other Vascular Procedures 0/1739 (0%) 210/1549 (13.6%) 23/191 (12%) 0/120 (0%) 0/3599 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
1/3535 (0%) 469/1869 (25.1%) 46/307 (15%) 0/55 (0%) 0/5766 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/22 (0%) 19/118 (16.1%) 12/71 (16.9%) 0/9 (0%) 1/220 (0.5%) 
207 - Other Circulatory System Diagnoses 0/286 (0%) 72/418 (17.2%) 25/214 (11.7%) 0/23 (0%) 0/941 (0%) 
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206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/147 (0%) 45/174 (25.9%) 6/58 (10.3%) 1/13 (7.7%) 0/392 (0%) 
205 - Cardiomyopathy 0/46 (0%) 19/239 (7.9%) 13/79 (16.5%) 0/13 (0%) 0/377 (0%) 
204 - Syncope & Collapse 0/242 (0%) 70/318 (22%) 10/58 (17.2%) 0/2 (0%) 0/620 (0%) 
203 - Chest Pain 0/181 (0%) 20/68 (29.4%) 2/6 (33.3%) 0/0 ( - ) 0/255 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/273 (0%) 42/186 (22.6%) 5/50 (10%) 1/79 (1.3%) 0/588 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/2251 (0%) 507/3225 (15.7%) 212/1548 (13.7%) 0/120 (0%) 0/7144 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/159 (0%) 57/460 (12.4%) 19/152 (12.5%) 0/29 (0%) 0/800 (0%) 
167 - Other Cardiothoracic Procedures 0/96 (0%) 9/82 (11%) 5/37 (13.5%) 0/9 (0%) 0/224 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
1/1382 (0.1%) 155/690 (22.5%) 47/179 (26.3%) 1/24 (4.2%) 2/2275 (0.1%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/225 (0%) 36/351 (10.3%) 9/92 (9.8%) 0/16 (0%) 0/684 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/646 (0%) 213/1672 (12.7%) 34/297 (11.4%) 0/64 (0%) 0/2679 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/32 (0%) 13/159 (8.2%) 12/83 (14.5%) 0/21 (0%) 0/295 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 2/392 (0.5%) 68/457 (14.9%) 10/47 (21.3%) 0/16 (0%) 0/912 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/3 (0%) 0/4 (0%) 0/0 ( - ) 0/0 ( - ) 0/7 (0%) 
      
Diabetes complicated 
     
199 - Hypertension 0/30 (0%) 27/130 (20.8%) 9/55 (16.4%) 0/1 (0%) 0/216 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 2/97 (2.1%) 77/425 (18.1%) 23/165 (13.9%) 0/32 (0%) 0/719 (0%) 
197 - Peripheral & Other Vascular Disorders 7/541 (1.3%) 285/937 (30.4%) 54/310 (17.4%) 0/51 (0%) 0/1839 (0%) 
196 - Cardiac Arrest 0/2 (0%) 2/12 (16.7%) 0/16 (0%) 0/21 (0%) 0/51 (0%) 
194 - Heart Failure 15/188 (8%) 524/5337 (9.8%) 395/3923 (10.1%) 16/625 (2.6%) 0/10073 (0%) 
193 - Acute & Subacute Endocarditis 0/5 (0%) 7/42 (16.7%) 4/29 (13.8%) 1/20 (5%) 0/96 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/199 (0%) 60/239 (25.1%) 11/42 (26.2%) 0/10 (0%) 0/490 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/75 (0%) 50/224 (22.3%) 9/87 (10.3%) 2/29 (6.9%) 0/415 (0%) 
190 - Acute Myocardial Infarction 3/116 (2.6%) 117/694 (16.9%) 128/949 (13.5%) 3/178 (1.7%) 0/1937 (0%) 
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180 - Other Circulatory System Procedures 1/58 (1.7%) 32/121 (26.4%) 14/65 (21.5%) 1/18 (5.6%) 3/262 (1.1%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/9 (0%) 4/21 (19%) 3/10 (30%) 1/6 (16.7%) 1/46 (2.2%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/13 (0%) 6/23 (26.1%) 1/6 (16.7%) 0/1 (0%) 0/43 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 1/266 (0.4%) 88/302 (29.1%) 16/131 (12.2%) 0/27 (0%) 0/726 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/154 (0%) 74/383 (19.3%) 25/138 (18.1%) 1/78 (1.3%) 0/753 (0%) 
173 - Other Vascular Procedures 4/495 (0.8%) 212/1184 (17.9%) 28/209 (13.4%) 0/60 (0%) 0/1948 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
1/154 (0.6%) 100/411 (24.3%) 11/68 (16.2%) 1/23 (4.3%) 0/656 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/1 (0%) 5/28 (17.9%) 0/27 (0%) 0/6 (0%) 0/62 (0%) 
207 - Other Circulatory System Diagnoses 0/18 (0%) 19/105 (18.1%) 0/39 (0%) 0/8 (0%) 0/170 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/29 (0%) 24/91 (26.4%) 8/48 (16.7%) 1/20 (5%) 0/188 (0%) 
205 - Cardiomyopathy 0/1 (0%) 6/51 (11.8%) 1/15 (6.7%) 0/4 (0%) 0/71 (0%) 
204 - Syncope & Collapse 0/15 (0%) 14/59 (23.7%) 2/15 (13.3%) 0/1 (0%) 0/90 (0%) 
203 - Chest Pain 0/7 (0%) 5/17 (29.4%) 1/1 (100%) 0/0 ( - ) 0/25 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/47 (0%) 8/31 (25.8%) 0/13 (0%) 1/18 (5.6%) 0/109 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 2/141 (1.4%) 108/552 (19.6%) 30/326 (9.2%) 1/36 (2.8%) 1/1055 (0.1%) 
200 - Cardiac Congenital & Valvular Disorders 1/9 (11.1%) 4/57 (7%) 1/31 (3.2%) 0/7 (0%) 0/104 (0%) 
167 - Other Cardiothoracic Procedures 0/3 (0%) 6/14 (42.9%) 1/5 (20%) 0/1 (0%) 0/23 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
1/91 (1.1%) 31/107 (29%) 9/43 (20.9%) 0/6 (0%) 0/247 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/15 (0%) 5/53 (9.4%) 0/29 (0%) 0/5 (0%) 0/102 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/36 (0%) 25/125 (20%) 3/46 (6.5%) 1/19 (5.3%) 0/226 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 1/19 (5.3%) 0/12 (0%) 0/2 (0%) 0/33 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/15 (0%) 8/50 (16%) 1/12 (8.3%) 0/4 (0%) 0/81 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/0 ( - ) 0/2 (0%) 0/0 ( - ) 0/2 (0%) 0/4 (0%) 
      
Hypothyroidism 
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199 - Hypertension 0/84 (0%) 0/68 (0%) 1/31 (3.2%) 0/4 (0%) 0/187 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/173 (0%) 1/315 (0.3%) 1/90 (1.1%) 0/10 (0%) 0/588 (0%) 
197 - Peripheral & Other Vascular Disorders 0/230 (0%) 0/191 (0%) 1/93 (1.1%) 0/16 (0%) 0/530 (0%) 
196 - Cardiac Arrest 0/2 (0%) 0/13 (0%) 0/14 (0%) 0/16 (0%) 0/45 (0%) 
194 - Heart Failure 1/370 (0.3%) 29/4609 (0.6%) 23/2899 (0.8%) 2/441 (0.5%) 0/8319 (0%) 
193 - Acute & Subacute Endocarditis 0/9 (0%) 0/21 (0%) 0/14 (0%) 0/7 (0%) 0/51 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/227 (0%) 3/83 (3.6%) 0/15 (0%) 0/1 (0%) 0/326 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/256 (0%) 1/233 (0.4%) 0/103 (0%) 1/32 (3.1%) 1/624 (0.2%) 
190 - Acute Myocardial Infarction 1/200 (0.5%) 4/350 (1.1%) 5/400 (1.2%) 1/63 (1.6%) 1/1013 (0.1%) 
180 - Other Circulatory System Procedures 1/260 (0.4%) 0/27 (0%) 0/15 (0%) 0/5 (0%) 1/307 (0.3%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/18 (0%) 0/22 (0%) 0/4 (0%) 0/2 (0%) 0/46 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/31 (0%) 0/18 (0%) 0/4 (0%) 0/2 (0%) 0/55 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/267 (0%) 1/112 (0.9%) 0/65 (0%) 0/17 (0%) 0/461 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/215 (0%) 1/229 (0.4%) 0/37 (0%) 0/26 (0%) 0/507 (0%) 
173 - Other Vascular Procedures 0/128 (0%) 2/131 (1.5%) 1/38 (2.6%) 0/18 (0%) 0/315 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/458 (0%) 4/305 (1.3%) 0/48 (0%) 0/15 (0%) 0/826 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/2 (0%) 0/24 (0%) 0/10 (0%) 0/4 (0%) 0/40 (0%) 
207 - Other Circulatory System Diagnoses 0/82 (0%) 1/132 (0.8%) 0/72 (0%) 0/8 (0%) 0/294 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/32 (0%) 1/52 (1.9%) 0/17 (0%) 0/10 (0%) 0/111 (0%) 
205 - Cardiomyopathy 0/20 (0%) 1/105 (1%) 0/32 (0%) 0/4 (0%) 0/161 (0%) 
204 - Syncope & Collapse 0/81 (0%) 1/84 (1.2%) 1/7 (14.3%) 0/0 ( - ) 0/172 (0%) 
203 - Chest Pain 0/28 (0%) 0/12 (0%) 0/2 (0%) 0/0 ( - ) 0/42 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/22 (0%) 3/18 (16.7%) 0/10 (0%) 0/10 (0%) 0/60 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/849 (0%) 6/1076 (0.6%) 2/441 (0.5%) 0/51 (0%) 0/2417 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/41 (0%) 3/126 (2.4%) 2/44 (4.5%) 0/11 (0%) 0/222 (0%) 
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167 - Other Cardiothoracic Procedures 0/32 (0%) 1/22 (4.5%) 0/9 (0%) 0/2 (0%) 0/65 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/58 (0%) 1/34 (2.9%) 0/3 (0%) 0/1 (0%) 0/96 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/9 (0%) 0/17 (0%) 0/9 (0%) 0/1 (0%) 0/36 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/117 (0%) 4/263 (1.5%) 0/51 (0%) 0/20 (0%) 0/451 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/5 (0%) 0/15 (0%) 0/15 (0%) 0/5 (0%) 0/40 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/27 (0%) 0/43 (0%) 0/12 (0%) 0/3 (0%) 0/85 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/3 (0%) 0/5 (0%) 0/5 (0%) 0/0 ( - ) 0/13 (0%) 
      
Renal failure 
     
199 - Hypertension 0/107 (0%) 38/355 (10.7%) 43/224 (19.2%) 2/15 (13.3%) 0/701 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 2/322 (0.6%) 227/1400 (16.2%) 127/524 (24.2%) 2/82 (2.4%) 1/2328 (0%) 
197 - Peripheral & Other Vascular Disorders 2/486 (0.4%) 263/1209 (21.8%) 142/599 (23.7%) 9/129 (7%) 1/2423 (0%) 
196 - Cardiac Arrest 0/8 (0%) 4/31 (12.9%) 4/62 (6.5%) 2/53 (3.8%) 0/154 (0%) 
194 - Heart Failure 7/866 (0.8%) 594/17050 (3.5%) 2063/13198 
(15.6%) 
148/1956 (7.6%) 3/33070 (0%) 
193 - Acute & Subacute Endocarditis 0/25 (0%) 18/103 (17.5%) 13/87 (14.9%) 3/44 (6.8%) 0/259 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 2/442 (0.5%) 260/673 (38.6%) 44/93 (47.3%) 0/13 (0%) 0/1221 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/306 (0%) 205/793 (25.9%) 82/357 (23%) 2/94 (2.1%) 1/1550 (0.1%) 
190 - Acute Myocardial Infarction 3/329 (0.9%) 158/1775 (8.9%) 389/2678 (14.5%) 19/396 (4.8%) 0/5178 (0%) 
180 - Other Circulatory System Procedures 1/138 (0.7%) 110/259 (42.5%) 43/127 (33.9%) 1/42 (2.4%) 5/566 (0.9%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/21 (0%) 15/93 (16.1%) 12/32 (37.5%) 1/12 (8.3%) 0/158 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/52 (0%) 16/94 (17%) 6/38 (15.8%) 0/5 (0%) 0/189 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 1/702 (0.1%) 317/759 (41.8%) 78/344 (22.7%) 1/68 (1.5%) 0/1873 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/410 (0%) 235/995 (23.6%) 76/373 (20.4%) 7/152 (4.6%) 0/1930 (0%) 
173 - Other Vascular Procedures 4/530 (0.8%) 416/1459 (28.5%) 79/298 (26.5%) 4/138 (2.9%) 2/2425 (0.1%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
1/718 (0.1%) 245/1305 (18.8%) 71/300 (23.7%) 6/69 (8.7%) 0/2392 (0%) 
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170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/11 (0%) 0/83 (0%) 9/84 (10.7%) 0/16 (0%) 0/194 (0%) 
207 - Other Circulatory System Diagnoses 0/103 (0%) 74/381 (19.4%) 25/169 (14.8%) 1/35 (2.9%) 0/688 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
2/157 (1.3%) 58/265 (21.9%) 27/179 (15.1%) 2/50 (4%) 0/651 (0%) 
205 - Cardiomyopathy 0/25 (0%) 11/244 (4.5%) 15/94 (16%) 2/16 (12.5%) 0/379 (0%) 
204 - Syncope & Collapse 0/74 (0%) 35/252 (13.9%) 26/66 (39.4%) 0/2 (0%) 0/394 (0%) 
203 - Chest Pain 0/21 (0%) 15/55 (27.3%) 3/7 (42.9%) 0/0 ( - ) 0/83 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/63 (0%) 27/95 (28.4%) 7/45 (15.6%) 2/90 (2.2%) 0/293 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 3/630 (0.5%) 372/2469 (15.1%) 211/1491 (14.2%) 7/135 (5.2%) 0/4725 (0%) 
200 - Cardiac Congenital & Valvular Disorders 1/60 (1.7%) 27/369 (7.3%) 35/169 (20.7%) 2/32 (6.2%) 1/630 (0.2%) 
167 - Other Cardiothoracic Procedures 0/19 (0%) 6/63 (9.5%) 4/34 (11.8%) 0/8 (0%) 0/124 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/149 (0%) 41/186 (22%) 5/73 (6.8%) 0/15 (0%) 0/423 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/28 (0%) 8/87 (9.2%) 5/39 (12.8%) 1/17 (5.9%) 0/171 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 2/135 (1.5%) 31/490 (6.3%) 16/154 (10.4%) 1/58 (1.7%) 0/837 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/10 (0%) 5/82 (6.1%) 5/43 (11.6%) 1/14 (7.1%) 0/149 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/72 (0%) 21/208 (10.1%) 11/42 (26.2%) 0/6 (0%) 0/328 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/1 (0%) 1/2 (50%) 0/0 ( - ) 0/1 (0%) 0/4 (0%) 
      
Liver disease 
     
199 - Hypertension 1/51 (2%) 11/47 (23.4%) 3/26 (11.5%) 2/4 (50%) 0/128 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/56 (0%) 32/128 (25%) 16/63 (25.4%) 10/33 (30.3%) 0/280 (0%) 
197 - Peripheral & Other Vascular Disorders 0/227 (0%) 70/239 (29.3%) 23/127 (18.1%) 8/41 (19.5%) 0/634 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 1/8 (12.5%) 5/22 (22.7%) 10/47 (21.3%) 0/77 (0%) 
194 - Heart Failure 20/150 (13.3%) 271/2580 (10.5%) 389/1923 (20.2%) 174/534 (32.6%) 0/5187 (0%) 
193 - Acute & Subacute Endocarditis 0/23 (0%) 13/51 (25.5%) 10/50 (20%) 4/44 (9.1%) 0/168 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/69 (0%) 17/56 (30.4%) 1/9 (11.1%) 1/6 (16.7%) 0/140 (0%) 
161 
 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
1/82 (1.2%) 33/162 (20.4%) 20/89 (22.5%) 11/47 (23.4%) 2/380 (0.5%) 
190 - Acute Myocardial Infarction 3/73 (4.1%) 33/169 (19.5%) 32/264 (12.1%) 31/125 (24.8%) 0/631 (0%) 
180 - Other Circulatory System Procedures 1/99 (1%) 5/32 (15.6%) 3/27 (11.1%) 1/23 (4.3%) 0/181 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/13 (0%) 1/5 (20%) 1/5 (20%) 2/8 (25%) 0/31 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/31 (0%) 1/5 (20%) 0/3 (0%) 0/2 (0%) 0/41 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 2/68 (2.9%) 30/76 (39.5%) 4/33 (12.1%) 2/11 (18.2%) 0/188 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/99 (0%) 20/127 (15.7%) 12/39 (30.8%) 3/73 (4.1%) 1/338 (0.3%) 
173 - Other Vascular Procedures 1/99 (1%) 31/136 (22.8%) 7/42 (16.7%) 4/57 (7%) 0/334 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
1/105 (1%) 37/135 (27.4%) 11/39 (28.2%) 4/23 (17.4%) 0/302 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/10 (0%) 4/7 (57.1%) 2/6 (33.3%) 1/23 (4.3%) 
207 - Other Circulatory System Diagnoses 0/70 (0%) 26/122 (21.3%) 17/69 (24.6%) 6/29 (20.7%) 1/290 (0.3%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/24 (0%) 6/37 (16.2%) 3/26 (11.5%) 2/17 (11.8%) 0/104 (0%) 
205 - Cardiomyopathy 1/19 (5.3%) 8/84 (9.5%) 5/36 (13.9%) 7/24 (29.2%) 0/163 (0%) 
204 - Syncope & Collapse 0/38 (0%) 16/58 (27.6%) 5/14 (35.7%) 0/0 ( - ) 0/110 (0%) 
203 - Chest Pain 0/17 (0%) 4/11 (36.4%) 3/5 (60%) 0/0 ( - ) 0/33 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/23 (0%) 2/16 (12.5%) 3/22 (13.6%) 3/50 (6%) 0/111 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/173 (0%) 75/387 (19.4%) 43/232 (18.5%) 37/96 (38.5%) 0/888 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/16 (0%) 10/62 (16.1%) 8/28 (28.6%) 10/19 (52.6%) 0/125 (0%) 
167 - Other Cardiothoracic Procedures 0/9 (0%) 3/17 (17.6%) 1/6 (16.7%) 3/6 (50%) 0/38 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/24 (0%) 4/11 (36.4%) 1/8 (12.5%) 3/6 (50%) 0/49 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
1/10 (10%) 0/19 (0%) 0/6 (0%) 0/3 (0%) 0/38 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/41 (0%) 10/90 (11.1%) 9/45 (20%) 10/37 (27%) 0/213 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 0/17 (0%) 0/12 (0%) 2/17 (11.8%) 1/46 (2.2%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/15 (0%) 2/22 (9.1%) 3/16 (18.8%) 0/6 (0%) 0/59 (0%) 
162 
 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/4 (0%) 0/1 (0%) 0/5 (0%) 0/2 (0%) 0/12 (0%) 
      
Peptic ulcer disease excluding bleeding 
     
199 - Hypertension 0/5 (0%) 0/8 (0%) 0/1 (0%) 0/1 (0%) 0/15 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/29 (0%) 1/34 (2.9%) 0/7 (0%) 0/3 (0%) 0/73 (0%) 
197 - Peripheral & Other Vascular Disorders 1/34 (2.9%) 2/29 (6.9%) 0/17 (0%) 0/4 (0%) 0/84 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 
194 - Heart Failure 0/21 (0%) 10/309 (3.2%) 2/189 (1.1%) 1/32 (3.1%) 0/551 (0%) 
193 - Acute & Subacute Endocarditis 0/2 (0%) 0/10 (0%) 0/2 (0%) 0/1 (0%) 0/15 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/55 (0%) 2/11 (18.2%) 0/1 (0%) 0/1 (0%) 0/68 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/19 (0%) 2/23 (8.7%) 1/11 (9.1%) 0/5 (0%) 0/58 (0%) 
190 - Acute Myocardial Infarction 0/49 (0%) 9/76 (11.8%) 0/55 (0%) 1/6 (16.7%) 0/186 (0%) 
180 - Other Circulatory System Procedures 0/30 (0%) 0/3 (0%) 0/3 (0%) 0/1 (0%) 0/37 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/2 (0%) 0/5 (0%) 0/0 ( - ) 0/0 ( - ) 0/7 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/5 (0%) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/8 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/42 (0%) 2/15 (13.3%) 0/4 (0%) 0/2 (0%) 0/63 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/54 (0%) 0/39 (0%) 0/9 (0%) 0/2 (0%) 0/104 (0%) 
173 - Other Vascular Procedures 0/41 (0%) 0/39 (0%) 0/4 (0%) 0/10 (0%) 0/94 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/29 (0%) 1/35 (2.9%) 0/7 (0%) 0/3 (0%) 0/74 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/3 (0%) 0/2 (0%) 0/0 ( - ) 0/5 (0%) 
207 - Other Circulatory System Diagnoses 1/15 (6.7%) 1/10 (10%) 0/2 (0%) 0/2 (0%) 0/29 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/9 (0%) 0/0 ( - ) 0/3 (0%) 0/0 ( - ) 0/12 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 1/12 (8.3%) 0/3 (0%) 0/0 ( - ) 0/15 (0%) 
204 - Syncope & Collapse 0/11 (0%) 1/8 (12.5%) 0/0 ( - ) 0/1 (0%) 0/20 (0%) 
203 - Chest Pain 0/10 (0%) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/13 (0%) 
163 
 
169 - Major Thoracic & Abdominal Vascular Procedures 0/15 (0%) 0/5 (0%) 0/2 (0%) 0/4 (0%) 0/26 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 1/39 (2.6%) 3/71 (4.2%) 0/24 (0%) 0/1 (0%) 0/135 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/5 (0%) 0/6 (0%) 0/3 (0%) 0/0 ( - ) 0/14 (0%) 
167 - Other Cardiothoracic Procedures 1/4 (25%) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/7 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/31 (0%) 0/15 (0%) 0/1 (0%) 0/0 ( - ) 0/47 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/2 (0%) 0/7 (0%) 0/1 (0%) 0/0 ( - ) 0/10 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 1/37 (2.7%) 0/46 (0%) 0/6 (0%) 0/2 (0%) 0/91 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 0/6 (0%) 0/0 ( - ) 0/1 (0%) 0/7 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/0 ( - ) 0/7 (0%) 0/2 (0%) 0/0 ( - ) 0/9 (0%) 
      
AIDS_HIV 
     
199 - Hypertension 0/6 (0%) 1/2 (50%) 0/0 ( - ) 0/0 ( - ) 0/8 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/5 (0%) 2/6 (33.3%) 1/1 (100%) 0/0 ( - ) 0/12 (0%) 
197 - Peripheral & Other Vascular Disorders 0/26 (0%) 4/22 (18.2%) 2/8 (25%) 0/0 ( - ) 0/56 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 0/0 ( - ) 1/1 (100%) 0/1 (0%) 0/2 (0%) 
194 - Heart Failure 0/11 (0%) 13/47 (27.7%) 7/38 (18.4%) 0/4 (0%) 0/100 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/9 (0%) 2/5 (40%) 0/0 ( - ) 0/0 ( - ) 0/14 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/10 (0%) 1/7 (14.3%) 3/6 (50%) 0/1 (0%) 0/24 (0%) 
190 - Acute Myocardial Infarction 0/16 (0%) 7/20 (35%) 1/5 (20%) 0/3 (0%) 0/44 (0%) 
180 - Other Circulatory System Procedures 0/11 (0%) 0/4 (0%) 0/2 (0%) 0/0 ( - ) 0/17 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/18 (0%) 0/3 (0%) 0/4 (0%) 0/1 (0%) 0/26 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/36 (0%) 4/45 (8.9%) 1/4 (25%) 0/2 (0%) 0/87 (0%) 
173 - Other Vascular Procedures 0/36 (0%) 7/34 (20.6%) 3/4 (75%) 0/4 (0%) 0/78 (0%) 
164 
 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/11 (0%) 2/4 (50%) 0/1 (0%) 0/0 ( - ) 0/16 (0%) 
207 - Other Circulatory System Diagnoses 0/5 (0%) 1/8 (12.5%) 1/2 (50%) 0/1 (0%) 0/16 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/5 (0%) 1/3 (33.3%) 2/6 (33.3%) 0/1 (0%) 0/15 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 1/5 (20%) 1/2 (50%) 0/0 ( - ) 0/7 (0%) 
204 - Syncope & Collapse 0/4 (0%) 1/4 (25%) 0/1 (0%) 0/0 ( - ) 0/9 (0%) 
203 - Chest Pain 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/3 (0%) 3/7 (42.9%) 0/0 ( - ) 0/1 (0%) 0/11 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/2 (0%) 6/17 (35.3%) 0/4 (0%) 0/0 ( - ) 0/23 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/0 ( - ) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
167 - Other Cardiothoracic Procedures 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/2 (0%) 1/5 (20%) 0/1 (0%) 0/0 ( - ) 0/8 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/2 (0%) 0/4 (0%) 0/5 (0%) 0/0 ( - ) 0/11 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/2 (0%) 0/3 (0%) 1/1 (100%) 0/0 ( - ) 0/6 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
      
Lymphoma 
     
199 - Hypertension 0/1 (0%) 3/8 (37.5%) 1/3 (33.3%) 0/0 ( - ) 0/12 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/5 (0%) 7/31 (22.6%) 0/9 (0%) 0/3 (0%) 0/48 (0%) 
197 - Peripheral & Other Vascular Disorders 0/13 (0%) 53/85 (62.4%) 2/15 (13.3%) 0/1 (0%) 0/114 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 1/2 (50%) 1/2 (50%) 0/0 ( - ) 0/4 (0%) 
194 - Heart Failure 0/7 (0%) 48/420 (11.4%) 22/242 (9.1%) 1/34 (2.9%) 0/703 (0%) 
193 - Acute & Subacute Endocarditis 0/0 ( - ) 0/3 (0%) 2/6 (33.3%) 0/1 (0%) 0/10 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/1 (0%) 5/13 (38.5%) 0/0 ( - ) 0/0 ( - ) 0/14 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/1 (0%) 9/16 (56.2%) 0/4 (0%) 0/0 ( - ) 0/21 (0%) 
165 
 
190 - Acute Myocardial Infarction 1/2 (50%) 14/31 (45.2%) 7/40 (17.5%) 1/7 (14.3%) 0/80 (0%) 
180 - Other Circulatory System Procedures 0/2 (0%) 7/12 (58.3%) 0/3 (0%) 0/2 (0%) 0/19 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 0/2 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/1 (0%) 2/3 (66.7%) 1/1 (100%) 0/0 ( - ) 0/5 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/3 (0%) 6/14 (42.9%) 2/5 (40%) 0/0 ( - ) 0/22 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/2 (0%) 8/16 (50%) 0/5 (0%) 0/1 (0%) 0/24 (0%) 
173 - Other Vascular Procedures 0/3 (0%) 15/34 (44.1%) 0/5 (0%) 0/1 (0%) 0/43 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/4 (0%) 27/41 (65.9%) 1/4 (25%) 0/1 (0%) 0/50 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/3 (0%) 
207 - Other Circulatory System Diagnoses 0/3 (0%) 6/24 (25%) 0/7 (0%) 0/1 (0%) 0/35 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/9 (0%) 13/19 (68.4%) 1/7 (14.3%) 0/5 (0%) 0/40 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 3/6 (50%) 0/0 ( - ) 0/1 (0%) 0/7 (0%) 
204 - Syncope & Collapse 0/1 (0%) 5/14 (35.7%) 0/4 (0%) 0/1 (0%) 0/20 (0%) 
203 - Chest Pain 0/0 ( - ) 1/4 (25%) 0/0 ( - ) 0/0 ( - ) 0/4 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/2 (0%) 6/7 (85.7%) 0/0 ( - ) 0/0 ( - ) 0/9 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/8 (0%) 47/89 (52.8%) 6/41 (14.6%) 0/4 (0%) 0/142 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/0 ( - ) 0/3 (0%) 0/4 (0%) 0/1 (0%) 0/8 (0%) 
167 - Other Cardiothoracic Procedures 0/0 ( - ) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/1 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 1/3 (33.3%) 0/1 (0%) 0/1 (0%) 0/5 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/0 ( - ) 2/8 (25%) 0/0 ( - ) 0/2 (0%) 0/10 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 0/0 ( - ) 1/2 (50%) 0/0 ( - ) 0/2 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/0 ( - ) 0/4 (0%) 0/0 ( - ) 0/0 ( - ) 0/4 (0%) 
      
Metastatic cancer 
     
166 
 
199 - Hypertension 0/1 (0%) 2/7 (28.6%) 8/9 (88.9%) 0/0 ( - ) 0/17 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/1 (0%) 13/41 (31.7%) 25/47 (53.2%) 1/4 (25%) 0/93 (0%) 
197 - Peripheral & Other Vascular Disorders 1/11 (9.1%) 121/319 (37.9%) 129/234 (55.1%) 6/24 (25%) 0/588 (0%) 
196 - Cardiac Arrest 1/1 (100%) 1/5 (20%) 6/6 (100%) 0/4 (0%) 0/16 (0%) 
194 - Heart Failure 0/0 ( - ) 27/275 (9.8%) 284/662 (42.9%) 12/81 (14.8%) 0/1018 (0%) 
193 - Acute & Subacute Endocarditis 0/0 ( - ) 1/7 (14.3%) 3/11 (27.3%) 0/2 (0%) 0/20 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/0 ( - ) 3/6 (50%) 8/8 (100%) 0/0 ( - ) 0/14 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/0 ( - ) 2/10 (20%) 1/1 (100%) 1/2 (50%) 0/13 (0%) 
190 - Acute Myocardial Infarction 0/0 ( - ) 11/26 (42.3%) 60/165 (36.4%) 1/23 (4.3%) 0/214 (0%) 
180 - Other Circulatory System Procedures 0/3 (0%) 12/23 (52.2%) 14/23 (60.9%) 1/4 (25%) 1/53 (1.9%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/0 ( - ) 2/2 (100%) 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/0 ( - ) 5/15 (33.3%) 5/8 (62.5%) 0/2 (0%) 0/25 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/1 (0%) 6/22 (27.3%) 5/9 (55.6%) 2/6 (33.3%) 0/38 (0%) 
173 - Other Vascular Procedures 0/2 (0%) 14/35 (40%) 10/19 (52.6%) 1/6 (16.7%) 0/62 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/0 ( - ) 7/25 (28%) 5/12 (41.7%) 0/0 ( - ) 0/37 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 
207 - Other Circulatory System Diagnoses 0/1 (0%) 29/68 (42.6%) 28/46 (60.9%) 2/5 (40%) 1/120 (0.8%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/1 (0%) 37/81 (45.7%) 12/24 (50%) 1/3 (33.3%) 0/109 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 0/4 (0%) 1/2 (50%) 0/1 (0%) 0/7 (0%) 
204 - Syncope & Collapse 0/1 (0%) 8/22 (36.4%) 14/15 (93.3%) 0/0 ( - ) 0/38 (0%) 
203 - Chest Pain 0/0 ( - ) 1/6 (16.7%) 4/5 (80%) 1/1 (100%) 0/12 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/1 (0%) 2/3 (66.7%) 1/3 (33.3%) 0/4 (0%) 0/11 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/2 (0%) 38/132 (28.8%) 72/138 (52.2%) 1/8 (12.5%) 0/280 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/0 ( - ) 0/6 (0%) 4/7 (57.1%) 1/2 (50%) 0/15 (0%) 
167 
 
167 - Other Cardiothoracic Procedures 0/0 ( - ) 3/3 (100%) 0/1 (0%) 0/1 (0%) 0/5 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 1/3 (33.3%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 0/0 ( - ) 1/3 (33.3%) 0/0 ( - ) 0/3 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/0 ( - ) 0/3 (0%) 0/1 (0%) 0/2 (0%) 0/6 (0%) 
      
Solid tumor without metastasis 
     
199 - Hypertension 0/1 (0%) 19/43 (44.2%) 4/15 (26.7%) 0/1 (0%) 0/60 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/3 (0%) 45/128 (35.2%) 10/39 (25.6%) 0/5 (0%) 0/175 (0%) 
197 - Peripheral & Other Vascular Disorders 0/48 (0%) 168/320 (52.5%) 24/99 (24.2%) 2/14 (14.3%) 0/481 (0%) 
196 - Cardiac Arrest 1/1 (100%) 1/5 (20%) 3/8 (37.5%) 0/10 (0%) 0/24 (0%) 
194 - Heart Failure 0/5 (0%) 81/1139 (7.1%) 130/1054 (12.3%) 6/129 (4.7%) 0/2327 (0%) 
193 - Acute & Subacute Endocarditis 0/0 ( - ) 2/16 (12.5%) 1/7 (14.3%) 1/5 (20%) 0/28 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/1 (0%) 50/67 (74.6%) 5/12 (41.7%) 0/0 ( - ) 0/80 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/4 (0%) 27/58 (46.6%) 1/19 (5.3%) 0/7 (0%) 0/88 (0%) 
190 - Acute Myocardial Infarction 0/1 (0%) 38/128 (29.7%) 64/271 (23.6%) 1/29 (3.4%) 0/429 (0%) 
180 - Other Circulatory System Procedures 0/3 (0%) 13/23 (56.5%) 1/5 (20%) 0/2 (0%) 0/33 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 3/7 (42.9%) 1/2 (50%) 0/0 ( - ) 0/9 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/0 ( - ) 4/7 (57.1%) 2/3 (66.7%) 0/0 ( - ) 0/10 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/2 (0%) 44/74 (59.5%) 3/13 (23.1%) 1/5 (20%) 0/94 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/2 (0%) 53/120 (44.2%) 5/16 (31.2%) 0/7 (0%) 0/145 (0%) 
173 - Other Vascular Procedures 0/9 (0%) 54/109 (49.5%) 4/20 (20%) 0/11 (0%) 0/149 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/9 (0%) 124/197 (62.9%) 8/27 (29.6%) 0/2 (0%) 0/235 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/2 (0%) 0/3 (0%) 0/1 (0%) 0/6 (0%) 
207 - Other Circulatory System Diagnoses 0/2 (0%) 35/70 (50%) 3/18 (16.7%) 0/4 (0%) 0/94 (0%) 
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206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/12 (0%) 28/44 (63.6%) 4/18 (22.2%) 0/0 ( - ) 0/74 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 0/14 (0%) 0/2 (0%) 0/0 ( - ) 0/16 (0%) 
204 - Syncope & Collapse 0/3 (0%) 34/66 (51.5%) 7/14 (50%) 0/0 ( - ) 0/83 (0%) 
203 - Chest Pain 0/2 (0%) 11/19 (57.9%) 0/2 (0%) 0/0 ( - ) 0/23 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/4 (0%) 12/19 (63.2%) 1/5 (20%) 0/13 (0%) 0/41 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/12 (0%) 139/343 (40.5%) 29/144 (20.1%) 1/7 (14.3%) 0/506 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/1 (0%) 9/23 (39.1%) 5/12 (41.7%) 0/1 (0%) 0/37 (0%) 
167 - Other Cardiothoracic Procedures 0/1 (0%) 1/4 (25%) 1/4 (25%) 0/2 (0%) 1/11 (9.1%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/2 (0%) 14/20 (70%) 0/0 ( - ) 0/0 ( - ) 0/22 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 0/3 (0%) 1/2 (50%) 0/2 (0%) 0/7 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/0 ( - ) 11/32 (34.4%) 2/8 (25%) 0/2 (0%) 0/42 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 0/1 (0%) 1/3 (33.3%) 0/0 ( - ) 0/4 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/0 ( - ) 4/6 (66.7%) 1/1 (100%) 0/0 ( - ) 0/7 (0%) 
      
Rheumatoid arthritis/collagen vascular diseases 
     
199 - Hypertension 0/34 (0%) 11/38 (28.9%) 2/15 (13.3%) 0/1 (0%) 0/88 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/63 (0%) 20/113 (17.7%) 4/37 (10.8%) 0/14 (0%) 0/227 (0%) 
197 - Peripheral & Other Vascular Disorders 0/182 (0%) 39/171 (22.8%) 6/92 (6.5%) 0/46 (0%) 0/491 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 0/1 (0%) 0/18 (0%) 0/14 (0%) 0/33 (0%) 
194 - Heart Failure 3/54 (5.6%) 98/1031 (9.5%) 46/794 (5.8%) 1/134 (0.7%) 0/2013 (0%) 
193 - Acute & Subacute Endocarditis 0/10 (0%) 3/18 (16.7%) 2/23 (8.7%) 0/7 (0%) 0/58 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/91 (0%) 9/33 (27.3%) 0/5 (0%) 0/2 (0%) 0/131 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/94 (0%) 21/93 (22.6%) 3/24 (12.5%) 0/11 (0%) 0/222 (0%) 
190 - Acute Myocardial Infarction 3/67 (4.5%) 50/173 (28.9%) 15/234 (6.4%) 0/66 (0%) 0/540 (0%) 
180 - Other Circulatory System Procedures 0/105 (0%) 9/23 (39.1%) 2/10 (20%) 0/8 (0%) 0/146 (0%) 
169 
 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/3 (0%) 1/5 (20%) 0/3 (0%) 0/2 (0%) 0/13 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/8 (0%) 0/5 (0%) 0/1 (0%) 0/2 (0%) 0/16 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/103 (0%) 10/42 (23.8%) 1/23 (4.3%) 0/3 (0%) 0/171 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/111 (0%) 12/111 (10.8%) 4/32 (12.5%) 0/53 (0%) 0/307 (0%) 
173 - Other Vascular Procedures 1/103 (1%) 28/144 (19.4%) 7/73 (9.6%) 1/65 (1.5%) 0/385 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/94 (0%) 25/96 (26%) 4/26 (15.4%) 0/14 (0%) 0/230 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/3 (0%) 0/3 (0%) 0/4 (0%) 0/10 (0%) 
207 - Other Circulatory System Diagnoses 1/57 (1.8%) 19/100 (19%) 3/24 (12.5%) 1/10 (10%) 0/191 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
1/14 (7.1%) 7/32 (21.9%) 0/9 (0%) 0/7 (0%) 0/62 (0%) 
205 - Cardiomyopathy 0/2 (0%) 1/7 (14.3%) 1/6 (16.7%) 0/1 (0%) 0/16 (0%) 
204 - Syncope & Collapse 0/47 (0%) 21/94 (22.3%) 0/21 (0%) 0/0 ( - ) 0/162 (0%) 
203 - Chest Pain 0/23 (0%) 3/8 (37.5%) 1/3 (33.3%) 0/0 ( - ) 0/34 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/15 (0%) 7/22 (31.8%) 1/22 (4.5%) 0/55 (0%) 0/114 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/166 (0%) 43/262 (16.4%) 10/171 (5.8%) 0/17 (0%) 0/616 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/11 (0%) 4/40 (10%) 2/15 (13.3%) 0/1 (0%) 0/67 (0%) 
167 - Other Cardiothoracic Procedures 0/8 (0%) 2/7 (28.6%) 0/4 (0%) 0/1 (0%) 0/20 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/30 (0%) 8/21 (38.1%) 2/5 (40%) 0/1 (0%) 0/57 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/6 (0%) 2/17 (11.8%) 0/3 (0%) 0/5 (0%) 0/31 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/41 (0%) 18/90 (20%) 2/17 (11.8%) 0/4 (0%) 0/152 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/2 (0%) 2/11 (18.2%) 1/3 (33.3%) 0/4 (0%) 0/20 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/8 (0%) 4/14 (28.6%) 1/2 (50%) 0/4 (0%) 0/28 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 0/3 (0%) 
      
Coagulopathy 
     
199 - Hypertension 0/8 (0%) 7/28 (25%) 5/21 (23.8%) 0/4 (0%) 0/61 (0%) 
170 
 
198 - Angina Pectoris & Coronary Atherosclerosis 0/33 (0%) 27/116 (23.3%) 5/57 (8.8%) 1/18 (5.6%) 0/224 (0%) 
197 - Peripheral & Other Vascular Disorders 1/102 (1%) 39/144 (27.1%) 19/107 (17.8%) 4/40 (10%) 0/393 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 1/3 (33.3%) 5/22 (22.7%) 1/47 (2.1%) 0/72 (0%) 
194 - Heart Failure 0/17 (0%) 66/1551 (4.3%) 176/1674 (10.5%) 23/343 (6.7%) 0/3585 (0%) 
193 - Acute & Subacute Endocarditis 0/8 (0%) 2/25 (8%) 3/28 (10.7%) 1/39 (2.6%) 0/100 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/36 (0%) 16/43 (37.2%) 2/9 (22.2%) 0/1 (0%) 0/89 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
1/31 (3.2%) 18/99 (18.2%) 11/62 (17.7%) 0/34 (0%) 0/226 (0%) 
190 - Acute Myocardial Infarction 0/30 (0%) 33/129 (25.6%) 41/286 (14.3%) 1/68 (1.5%) 1/513 (0.2%) 
180 - Other Circulatory System Procedures 0/68 (0%) 4/19 (21.1%) 2/7 (28.6%) 2/12 (16.7%) 0/106 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/2 (0%) 2/10 (20%) 1/4 (25%) 1/6 (16.7%) 0/22 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/4 (0%) 0/3 (0%) 1/6 (16.7%) 0/1 (0%) 0/14 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/39 (0%) 14/62 (22.6%) 1/34 (2.9%) 2/16 (12.5%) 0/151 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/62 (0%) 28/130 (21.5%) 4/25 (16%) 0/65 (0%) 0/282 (0%) 
173 - Other Vascular Procedures 0/40 (0%) 26/98 (26.5%) 13/47 (27.7%) 5/86 (5.8%) 0/271 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/59 (0%) 52/169 (30.8%) 13/50 (26%) 0/20 (0%) 0/298 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/7 (0%) 3/10 (30%) 0/3 (0%) 0/20 (0%) 
207 - Other Circulatory System Diagnoses 0/47 (0%) 22/101 (21.8%) 6/42 (14.3%) 1/27 (3.7%) 0/217 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/9 (0%) 3/29 (10.3%) 5/22 (22.7%) 0/21 (0%) 0/81 (0%) 
205 - Cardiomyopathy 0/2 (0%) 5/55 (9.1%) 4/27 (14.8%) 1/11 (9.1%) 0/95 (0%) 
204 - Syncope & Collapse 0/12 (0%) 15/52 (28.8%) 3/13 (23.1%) 0/0 ( - ) 0/77 (0%) 
203 - Chest Pain 0/6 (0%) 3/10 (30%) 0/0 ( - ) 0/0 ( - ) 0/16 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/13 (0%) 6/23 (26.1%) 3/31 (9.7%) 2/114 (1.8%) 0/181 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/100 (0%) 82/422 (19.4%) 33/244 (13.5%) 2/45 (4.4%) 0/811 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/16 (0%) 13/82 (15.9%) 4/34 (11.8%) 1/17 (5.9%) 0/149 (0%) 
167 - Other Cardiothoracic Procedures 0/7 (0%) 2/23 (8.7%) 4/23 (17.4%) 1/10 (10%) 0/63 (0%) 
171 
 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/17 (0%) 8/21 (38.1%) 3/8 (37.5%) 0/7 (0%) 0/53 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/2 (0%) 0/16 (0%) 1/8 (12.5%) 0/7 (0%) 0/33 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/23 (0%) 37/183 (20.2%) 10/84 (11.9%) 4/46 (8.7%) 0/336 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 1/18 (5.6%) 1/23 (4.3%) 2/22 (9.1%) 0/63 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/9 (0%) 6/19 (31.6%) 1/7 (14.3%) 0/9 (0%) 0/44 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/4 (0%) 0/8 (0%) 1/14 (7.1%) 1/5 (20%) 0/31 (0%) 
      
Obesity 
     
199 - Hypertension 2/360 (0.6%) 2/147 (1.4%) 0/73 (0%) 0/6 (0%) 0/586 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 21/844 (2.5%) 3/576 (0.5%) 0/153 (0%) 0/25 (0%) 0/1598 (0%) 
197 - Peripheral & Other Vascular Disorders 13/867 (1.5%) 3/441 (0.7%) 0/193 (0%) 0/57 (0%) 1/1558 (0.1%) 
196 - Cardiac Arrest 0/4 (0%) 0/16 (0%) 0/29 (0%) 0/33 (0%) 0/82 (0%) 
194 - Heart Failure 209/1555 (13.4%) 89/9358 (1%) 11/6720 (0.2%) 4/1033 (0.4%) 1/18666 (0%) 
193 - Acute & Subacute Endocarditis 0/22 (0%) 0/24 (0%) 0/36 (0%) 0/14 (0%) 0/96 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 25/1682 (1.5%) 0/387 (0%) 0/44 (0%) 0/12 (0%) 0/2125 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
16/1348 (1.2%) 5/655 (0.8%) 2/275 (0.7%) 0/99 (0%) 0/2377 (0%) 
190 - Acute Myocardial Infarction 76/1825 (4.2%) 28/1690 (1.7%) 2/1044 (0.2%) 0/188 (0%) 0/4747 (0%) 
180 - Other Circulatory System Procedures 4/1216 (0.3%) 0/70 (0%) 0/32 (0%) 0/23 (0%) 0/1341 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
1/49 (2%) 0/33 (0%) 0/21 (0%) 0/4 (0%) 0/107 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 1/79 (1.3%) 0/40 (0%) 0/13 (0%) 0/3 (0%) 0/135 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 34/2529 (1.3%) 3/492 (0.6%) 0/287 (0%) 0/41 (0%) 0/3349 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 23/2399 (1%) 7/1594 (0.4%) 1/245 (0.4%) 0/166 (0%) 0/4404 (0%) 
173 - Other Vascular Procedures 9/482 (1.9%) 0/381 (0%) 0/75 (0%) 0/79 (0%) 0/1017 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
25/1347 (1.9%) 4/708 (0.6%) 0/127 (0%) 0/32 (0%) 0/2214 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/18 (0%) 0/48 (0%) 0/46 (0%) 1/7 (14.3%) 1/119 (0.8%) 
172 
 
207 - Other Circulatory System Diagnoses 1/327 (0.3%) 5/248 (2%) 0/130 (0%) 0/20 (0%) 0/725 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
1/54 (1.9%) 0/67 (0%) 0/26 (0%) 0/10 (0%) 0/157 (0%) 
205 - Cardiomyopathy 0/50 (0%) 2/135 (1.5%) 0/30 (0%) 0/8 (0%) 0/223 (0%) 
204 - Syncope & Collapse 3/110 (2.7%) 0/110 (0%) 0/21 (0%) 0/1 (0%) 0/242 (0%) 
203 - Chest Pain 1/144 (0.7%) 0/25 (0%) 0/5 (0%) 0/0 ( - ) 0/174 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 2/110 (1.8%) 1/79 (1.3%) 2/36 (5.6%) 0/57 (0%) 0/282 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 33/1493 (2.2%) 14/1437 (1%) 0/536 (0%) 0/61 (0%) 0/3527 (0%) 
200 - Cardiac Congenital & Valvular Disorders 5/103 (4.9%) 1/207 (0.5%) 0/50 (0%) 0/10 (0%) 0/370 (0%) 
167 - Other Cardiothoracic Procedures 1/91 (1.1%) 1/72 (1.4%) 0/29 (0%) 0/7 (0%) 0/199 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
20/912 (2.2%) 3/374 (0.8%) 0/82 (0%) 0/13 (0%) 0/1381 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
8/184 (4.3%) 2/233 (0.9%) 0/74 (0%) 0/12 (0%) 0/503 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 14/696 (2%) 4/1205 (0.3%) 0/183 (0%) 0/40 (0%) 0/2124 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/15 (0%) 1/119 (0.8%) 0/54 (0%) 0/14 (0%) 0/202 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 7/155 (4.5%) 0/181 (0%) 1/23 (4.3%) 0/6 (0%) 0/365 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 1/2 (50%) 0/1 (0%) 0/2 (0%) 0/0 ( - ) 0/5 (0%) 
      
Weight loss 
     
199 - Hypertension 0/7 (0%) 1/11 (9.1%) 0/5 (0%) 0/0 ( - ) 0/23 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/5 (0%) 2/21 (9.5%) 9/26 (34.6%) 1/5 (20%) 0/57 (0%) 
197 - Peripheral & Other Vascular Disorders 0/23 (0%) 15/47 (31.9%) 41/126 (32.5%) 3/16 (18.8%) 0/212 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 2/4 (50%) 2/4 (50%) 0/4 (0%) 0/12 (0%) 
194 - Heart Failure 1/17 (5.9%) 12/251 (4.8%) 210/673 (31.2%) 36/120 (30%) 0/1061 (0%) 
193 - Acute & Subacute Endocarditis 0/8 (0%) 2/8 (25%) 7/17 (41.2%) 1/8 (12.5%) 0/41 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/1 (0%) 0/0 ( - ) 0/3 (0%) 0/0 ( - ) 0/4 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/21 (0%) 0/15 (0%) 7/21 (33.3%) 0/5 (0%) 0/62 (0%) 
173 
 
190 - Acute Myocardial Infarction 1/10 (10%) 1/25 (4%) 16/88 (18.2%) 5/23 (21.7%) 0/146 (0%) 
180 - Other Circulatory System Procedures 0/4 (0%) 1/4 (25%) 1/4 (25%) 0/1 (0%) 0/13 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/1 (0%) 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/4 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/0 ( - ) 0/0 ( - ) 1/1 (100%) 0/1 (0%) 0/2 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/2 (0%) 1/4 (25%) 1/3 (33.3%) 0/3 (0%) 0/12 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/3 (0%) 1/4 (25%) 3/7 (42.9%) 0/4 (0%) 0/18 (0%) 
173 - Other Vascular Procedures 1/13 (7.7%) 3/24 (12.5%) 12/27 (44.4%) 1/13 (7.7%) 0/77 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/1 (0%) 0/10 (0%) 2/5 (40%) 1/5 (20%) 0/21 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/1 (0%) 0/2 (0%) 0/0 ( - ) 0/3 (0%) 
207 - Other Circulatory System Diagnoses 2/13 (15.4%) 4/28 (14.3%) 9/21 (42.9%) 0/5 (0%) 0/67 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/3 (0%) 2/9 (22.2%) 5/11 (45.5%) 1/5 (20%) 0/28 (0%) 
205 - Cardiomyopathy 0/1 (0%) 2/7 (28.6%) 3/11 (27.3%) 0/2 (0%) 0/21 (0%) 
204 - Syncope & Collapse 0/9 (0%) 2/11 (18.2%) 2/9 (22.2%) 0/0 ( - ) 0/29 (0%) 
203 - Chest Pain 0/3 (0%) 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/5 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/11 (0%) 1/3 (33.3%) 1/6 (16.7%) 0/6 (0%) 0/26 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 2/25 (8%) 2/33 (6.1%) 16/55 (29.1%) 6/17 (35.3%) 0/130 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/13 (0%) 1/8 (12.5%) 5/12 (41.7%) 0/6 (0%) 0/39 (0%) 
167 - Other Cardiothoracic Procedures 0/11 (0%) 1/5 (20%) 0/1 (0%) 0/3 (0%) 0/20 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 0/2 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/1 (0%) 0/3 (0%) 1/5 (20%) 0/1 (0%) 0/10 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/5 (0%) 0/11 (0%) 2/13 (15.4%) 0/1 (0%) 0/30 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 0/4 (0%) 0/3 (0%) 0/4 (0%) 0/11 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/0 ( - ) 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/2 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/9 (0%) 0/8 (0%) 0/3 (0%) 0/2 (0%) 0/22 (0%) 
      
174 
 
Fluid and electrolyte disorders 
     
199 - Hypertension 0/150 (0%) 31/211 (14.7%) 73/172 (42.4%) 7/17 (41.2%) 0/550 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 1/93 (1.1%) 31/396 (7.8%) 141/400 (35.2%) 19/78 (24.4%) 0/967 (0%) 
197 - Peripheral & Other Vascular Disorders 1/118 (0.8%) 63/368 (17.1%) 157/584 (26.9%) 39/164 (23.8%) 0/1234 (0%) 
196 - Cardiac Arrest 0/13 (0%) 7/43 (16.3%) 33/92 (35.9%) 25/132 (18.9%) 0/280 (0%) 
194 - Heart Failure 1/391 (0.3%) 362/8446 (4.3%) 3470/12246 
(28.3%) 
1338/2945 (45.4%) 2/24028 (0%) 
193 - Acute & Subacute Endocarditis 0/21 (0%) 3/56 (5.4%) 31/98 (31.6%) 4/65 (6.2%) 0/240 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/55 (0%) 12/75 (16%) 12/37 (32.4%) 3/15 (20%) 0/182 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/84 (0%) 17/196 (8.7%) 48/262 (18.3%) 31/163 (19%) 0/705 (0%) 
190 - Acute Myocardial Infarction 0/95 (0%) 41/463 (8.9%) 318/1805 (17.6%) 147/567 (25.9%) 0/2930 (0%) 
180 - Other Circulatory System Procedures 0/14 (0%) 5/31 (16.1%) 9/66 (13.6%) 9/44 (20.5%) 0/155 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/6 (0%) 1/12 (8.3%) 4/19 (21.1%) 4/8 (50%) 1/45 (2.2%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 1/4 (25%) 2/15 (13.3%) 2/11 (18.2%) 2/7 (28.6%) 1/37 (2.7%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/53 (0%) 5/88 (5.7%) 11/103 (10.7%) 5/72 (6.9%) 0/316 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/127 (0%) 20/265 (7.5%) 43/215 (20%) 30/256 (11.7%) 0/863 (0%) 
173 - Other Vascular Procedures 0/53 (0%) 21/141 (14.9%) 45/169 (26.6%) 21/188 (11.2%) 0/551 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
1/203 (0.5%) 78/495 (15.8%) 92/265 (34.7%) 20/93 (21.5%) 0/1056 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/1 (0%) 2/31 (6.5%) 8/43 (18.6%) 4/17 (23.5%) 0/92 (0%) 
207 - Other Circulatory System Diagnoses 0/87 (0%) 24/218 (11%) 58/181 (32%) 27/77 (35.1%) 0/563 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/20 (0%) 9/60 (15%) 8/55 (14.5%) 5/39 (12.8%) 0/174 (0%) 
205 - Cardiomyopathy 0/22 (0%) 6/101 (5.9%) 14/77 (18.2%) 5/31 (16.1%) 0/231 (0%) 
204 - Syncope & Collapse 0/90 (0%) 49/223 (22%) 47/90 (52.2%) 3/5 (60%) 0/408 (0%) 
203 - Chest Pain 0/21 (0%) 8/25 (32%) 8/12 (66.7%) 0/2 (0%) 0/60 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/35 (0%) 11/54 (20.4%) 15/56 (26.8%) 9/161 (5.6%) 1/306 (0.3%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/632 (0%) 286/1811 (15.8%) 455/1744 (26.1%) 75/259 (29%) 0/4446 (0%) 
175 
 
200 - Cardiac Congenital & Valvular Disorders 0/30 (0%) 10/126 (7.9%) 31/112 (27.7%) 9/53 (17%) 1/321 (0.3%) 
167 - Other Cardiothoracic Procedures 0/11 (0%) 7/21 (33.3%) 3/21 (14.3%) 2/13 (15.4%) 0/66 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/70 (0%) 17/51 (33.3%) 9/34 (26.5%) 3/18 (16.7%) 0/173 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/10 (0%) 7/46 (15.2%) 5/28 (17.9%) 2/15 (13.3%) 0/99 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/94 (0%) 55/296 (18.6%) 40/155 (25.8%) 12/79 (15.2%) 1/624 (0.2%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/2 (0%) 1/46 (2.2%) 6/52 (11.5%) 2/37 (5.4%) 0/137 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/14 (0%) 3/36 (8.3%) 5/32 (15.6%) 2/21 (9.5%) 0/103 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/5 (0%) 0/12 (0%) 3/16 (18.8%) 0/4 (0%) 0/37 (0%) 
      
Blood loss anemia 
     
199 - Hypertension 0/5 (0%) 2/8 (25%) 2/7 (28.6%) 0/0 ( - ) 0/20 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/14 (0%) 11/56 (19.6%) 3/23 (13%) 0/3 (0%) 0/96 (0%) 
197 - Peripheral & Other Vascular Disorders 1/62 (1.6%) 7/49 (14.3%) 2/33 (6.1%) 0/8 (0%) 0/152 (0%) 
196 - Cardiac Arrest 0/0 ( - ) 0/1 (0%) 0/1 (0%) 0/3 (0%) 0/5 (0%) 
194 - Heart Failure 0/17 (0%) 48/611 (7.9%) 40/363 (11%) 0/57 (0%) 0/1048 (0%) 
193 - Acute & Subacute Endocarditis 0/5 (0%) 0/7 (0%) 0/8 (0%) 0/2 (0%) 0/22 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/7 (0%) 1/9 (11.1%) 0/2 (0%) 0/0 ( - ) 0/18 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/14 (0%) 4/14 (28.6%) 1/8 (12.5%) 0/3 (0%) 0/39 (0%) 
190 - Acute Myocardial Infarction 0/7 (0%) 19/82 (23.2%) 18/109 (16.5%) 0/14 (0%) 0/212 (0%) 
180 - Other Circulatory System Procedures 0/5 (0%) 0/5 (0%) 1/6 (16.7%) 0/3 (0%) 0/19 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 1/3 (33.3%) 0/0 ( - ) 0/1 (0%) 0/4 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/9 (0%) 2/14 (14.3%) 0/6 (0%) 0/5 (0%) 0/34 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/15 (0%) 6/34 (17.6%) 5/21 (23.8%) 0/11 (0%) 0/81 (0%) 
173 - Other Vascular Procedures 0/9 (0%) 0/13 (0%) 1/3 (33.3%) 0/7 (0%) 0/32 (0%) 
176 
 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/26 (0%) 11/50 (22%) 1/12 (8.3%) 0/1 (0%) 0/89 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/1 (0%) 0/0 ( - ) 0/3 (0%) 0/2 (0%) 0/6 (0%) 
207 - Other Circulatory System Diagnoses 0/14 (0%) 6/23 (26.1%) 1/6 (16.7%) 0/0 ( - ) 0/43 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/0 ( - ) 0/7 (0%) 1/4 (25%) 0/3 (0%) 0/14 (0%) 
205 - Cardiomyopathy 0/0 ( - ) 0/4 (0%) 0/2 (0%) 0/1 (0%) 0/7 (0%) 
204 - Syncope & Collapse 0/3 (0%) 2/8 (25%) 0/0 ( - ) 0/0 ( - ) 0/11 (0%) 
203 - Chest Pain 0/0 ( - ) 1/5 (20%) 0/0 ( - ) 0/0 ( - ) 0/5 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/0 ( - ) 0/4 (0%) 0/3 (0%) 0/6 (0%) 0/13 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/30 (0%) 8/92 (8.7%) 3/39 (7.7%) 0/3 (0%) 0/164 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/3 (0%) 3/9 (33.3%) 0/9 (0%) 0/5 (0%) 0/26 (0%) 
167 - Other Cardiothoracic Procedures 0/1 (0%) 0/1 (0%) 0/3 (0%) 0/0 ( - ) 0/5 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 0/5 (0%) 0/0 ( - ) 0/1 (0%) 0/6 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/4 (0%) 0/13 (0%) 1/6 (16.7%) 0/5 (0%) 0/28 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 0/4 (0%) 1/9 (11.1%) 0/3 (0%) 0/16 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/1 (0%) 0/1 (0%) 0/2 (0%) 0/1 (0%) 0/5 (0%) 
      
Deficiency anemia 
     
199 - Hypertension 0/42 (0%) 6/61 (9.8%) 2/30 (6.7%) 0/1 (0%) 0/134 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/88 (0%) 13/268 (4.9%) 1/102 (1%) 0/11 (0%) 0/469 (0%) 
197 - Peripheral & Other Vascular Disorders 0/158 (0%) 12/151 (7.9%) 1/99 (1%) 0/18 (0%) 0/426 (0%) 
196 - Cardiac Arrest 0/1 (0%) 1/7 (14.3%) 0/8 (0%) 0/16 (0%) 0/32 (0%) 
194 - Heart Failure 3/207 (1.4%) 116/3930 (3%) 55/2597 (2.1%) 7/378 (1.9%) 0/7112 (0%) 
193 - Acute & Subacute Endocarditis 0/12 (0%) 0/30 (0%) 2/25 (8%) 0/8 (0%) 0/75 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/51 (0%) 8/52 (15.4%) 0/8 (0%) 0/3 (0%) 0/114 (0%) 
177 
 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/67 (0%) 13/154 (8.4%) 0/69 (0%) 0/19 (0%) 1/309 (0.3%) 
190 - Acute Myocardial Infarction 0/66 (0%) 33/358 (9.2%) 19/487 (3.9%) 1/64 (1.6%) 0/975 (0%) 
180 - Other Circulatory System Procedures 1/19 (5.3%) 2/19 (10.5%) 0/10 (0%) 0/5 (0%) 0/53 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/1 (0%) 3/9 (33.3%) 1/7 (14.3%) 0/2 (0%) 0/19 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/3 (0%) 0/4 (0%) 0/3 (0%) 0/2 (0%) 0/12 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/60 (0%) 11/94 (11.7%) 2/35 (5.7%) 0/11 (0%) 0/200 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/65 (0%) 11/149 (7.4%) 1/43 (2.3%) 0/33 (0%) 0/290 (0%) 
173 - Other Vascular Procedures 0/41 (0%) 6/69 (8.7%) 0/32 (0%) 0/17 (0%) 0/159 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/112 (0%) 14/185 (7.6%) 0/45 (0%) 0/13 (0%) 0/355 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/1 (0%) 0/17 (0%) 0/11 (0%) 0/2 (0%) 0/31 (0%) 
207 - Other Circulatory System Diagnoses 0/55 (0%) 3/106 (2.8%) 1/45 (2.2%) 1/10 (10%) 0/216 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/7 (0%) 3/35 (8.6%) 1/14 (7.1%) 0/3 (0%) 0/59 (0%) 
205 - Cardiomyopathy 0/9 (0%) 2/45 (4.4%) 0/6 (0%) 0/4 (0%) 0/64 (0%) 
204 - Syncope & Collapse 0/49 (0%) 8/74 (10.8%) 0/12 (0%) 0/1 (0%) 0/136 (0%) 
203 - Chest Pain 0/5 (0%) 1/10 (10%) 1/4 (25%) 0/0 ( - ) 0/19 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/3 (0%) 0/8 (0%) 0/7 (0%) 0/7 (0%) 0/25 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/188 (0%) 30/482 (6.2%) 8/240 (3.3%) 0/29 (0%) 0/939 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/26 (0%) 3/95 (3.2%) 2/38 (5.3%) 0/9 (0%) 0/168 (0%) 
167 - Other Cardiothoracic Procedures 0/8 (0%) 1/16 (6.2%) 0/8 (0%) 0/0 ( - ) 0/32 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/10 (0%) 3/13 (23.1%) 0/3 (0%) 0/0 ( - ) 0/26 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/6 (0%) 0/11 (0%) 0/10 (0%) 1/4 (25%) 0/31 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/17 (0%) 5/75 (6.7%) 1/28 (3.6%) 0/10 (0%) 0/130 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/1 (0%) 0/24 (0%) 0/20 (0%) 0/12 (0%) 0/57 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/5 (0%) 2/8 (25%) 0/5 (0%) 0/1 (0%) 0/19 (0%) 
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160 - Major Cardiothoracic Repair of Heart Anomaly 0/1 (0%) 0/2 (0%) 0/1 (0%) 0/1 (0%) 0/5 (0%) 
      
Alcohol abuse 
     
199 - Hypertension 1/94 (1.1%) 3/53 (5.7%) 1/20 (5%) 0/4 (0%) 0/171 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 3/212 (1.4%) 11/188 (5.9%) 2/57 (3.5%) 0/12 (0%) 0/469 (0%) 
197 - Peripheral & Other Vascular Disorders 8/396 (2%) 18/205 (8.8%) 4/108 (3.7%) 0/23 (0%) 0/732 (0%) 
196 - Cardiac Arrest 0/2 (0%) 1/16 (6.2%) 1/24 (4.2%) 1/35 (2.9%) 0/77 (0%) 
194 - Heart Failure 97/726 (13.4%) 230/3182 (7.2%) 104/1557 (6.7%) 0/326 (0%) 0/5791 (0%) 
193 - Acute & Subacute Endocarditis 0/24 (0%) 2/34 (5.9%) 4/53 (7.5%) 1/28 (3.6%) 0/139 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 4/251 (1.6%) 4/87 (4.6%) 0/14 (0%) 0/4 (0%) 0/356 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
19/322 (5.9%) 22/304 (7.2%) 8/132 (6.1%) 1/50 (2%) 1/808 (0.1%) 
190 - Acute Myocardial Infarction 22/431 (5.1%) 22/412 (5.3%) 6/285 (2.1%) 0/70 (0%) 0/1198 (0%) 
180 - Other Circulatory System Procedures 1/106 (0.9%) 1/20 (5%) 0/19 (0%) 0/7 (0%) 0/152 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
1/12 (8.3%) 2/14 (14.3%) 0/2 (0%) 0/3 (0%) 0/31 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/8 (0%) 1/14 (7.1%) 0/4 (0%) 0/1 (0%) 0/27 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 7/237 (3%) 9/108 (8.3%) 2/66 (3%) 0/17 (0%) 0/428 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 2/482 (0.4%) 4/328 (1.2%) 2/62 (3.2%) 0/68 (0%) 0/940 (0%) 
173 - Other Vascular Procedures 10/277 (3.6%) 15/210 (7.1%) 2/39 (5.1%) 0/56 (0%) 0/582 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
7/207 (3.4%) 13/173 (7.5%) 4/43 (9.3%) 0/7 (0%) 0/430 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/4 (0%) 0/8 (0%) 1/13 (7.7%) 0/4 (0%) 0/29 (0%) 
207 - Other Circulatory System Diagnoses 3/140 (2.1%) 7/95 (7.4%) 2/53 (3.8%) 1/23 (4.3%) 0/311 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
1/18 (5.6%) 4/24 (16.7%) 0/20 (0%) 0/5 (0%) 0/67 (0%) 
205 - Cardiomyopathy 3/68 (4.4%) 6/230 (2.6%) 1/72 (1.4%) 0/18 (0%) 0/388 (0%) 
204 - Syncope & Collapse 2/104 (1.9%) 7/64 (10.9%) 1/14 (7.1%) 0/2 (0%) 0/184 (0%) 
203 - Chest Pain 1/38 (2.6%) 0/10 (0%) 0/2 (0%) 0/0 ( - ) 0/50 (0%) 
179 
 
169 - Major Thoracic & Abdominal Vascular Procedures 0/83 (0%) 0/37 (0%) 0/20 (0%) 0/36 (0%) 0/176 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 16/602 (2.7%) 43/595 (7.2%) 14/250 (5.6%) 0/32 (0%) 0/1479 (0%) 
200 - Cardiac Congenital & Valvular Disorders 2/33 (6.1%) 5/52 (9.6%) 3/24 (12.5%) 0/7 (0%) 0/116 (0%) 
167 - Other Cardiothoracic Procedures 0/17 (0%) 0/14 (0%) 0/5 (0%) 0/0 ( - ) 0/36 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
5/190 (2.6%) 1/78 (1.3%) 0/14 (0%) 0/5 (0%) 0/287 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/29 (0%) 0/63 (0%) 0/15 (0%) 0/8 (0%) 0/115 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 14/150 (9.3%) 9/232 (3.9%) 2/56 (3.6%) 0/21 (0%) 0/459 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/10 (0%) 1/23 (4.3%) 0/15 (0%) 0/10 (0%) 0/58 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 3/72 (4.2%) 0/86 (0%) 1/19 (5.3%) 0/9 (0%) 0/186 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/2 (0%) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
      
Drug abuse 
     
199 - Hypertension 0/14 (0%) 1/3 (33.3%) 0/0 ( - ) 0/0 ( - ) 0/17 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 0/23 (0%) 0/10 (0%) 0/1 (0%) 0/1 (0%) 0/35 (0%) 
197 - Peripheral & Other Vascular Disorders 0/112 (0%) 3/21 (14.3%) 2/8 (25%) 0/3 (0%) 0/144 (0%) 
196 - Cardiac Arrest 0/1 (0%) 0/1 (0%) 0/3 (0%) 0/6 (0%) 0/11 (0%) 
194 - Heart Failure 1/37 (2.7%) 5/86 (5.8%) 6/45 (13.3%) 0/6 (0%) 0/174 (0%) 
193 - Acute & Subacute Endocarditis 0/21 (0%) 1/9 (11.1%) 4/12 (33.3%) 1/7 (14.3%) 0/49 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/20 (0%) 1/2 (50%) 0/0 ( - ) 0/0 ( - ) 0/22 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/28 (0%) 0/13 (0%) 0/9 (0%) 0/2 (0%) 0/52 (0%) 
190 - Acute Myocardial Infarction 1/65 (1.5%) 0/39 (0%) 2/16 (12.5%) 1/4 (25%) 0/124 (0%) 
180 - Other Circulatory System Procedures 0/39 (0%) 0/4 (0%) 1/3 (33.3%) 0/1 (0%) 0/47 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/0 ( - ) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/2 (0%) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 1/25 (4%) 2/6 (33.3%) 0/2 (0%) 0/2 (0%) 0/35 (0%) 
180 
 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/86 (0%) 0/64 (0%) 0/3 (0%) 0/5 (0%) 0/158 (0%) 
173 - Other Vascular Procedures 1/66 (1.5%) 1/21 (4.8%) 0/9 (0%) 0/5 (0%) 0/101 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/4 (0%) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/6 (0%) 
207 - Other Circulatory System Diagnoses 0/48 (0%) 0/5 (0%) 0/7 (0%) 1/4 (25%) 0/64 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/6 (0%) 0/1 (0%) 0/3 (0%) 0/2 (0%) 0/12 (0%) 
205 - Cardiomyopathy 0/1 (0%) 0/7 (0%) 0/1 (0%) 1/3 (33.3%) 0/12 (0%) 
204 - Syncope & Collapse 0/9 (0%) 0/6 (0%) 0/0 ( - ) 0/0 ( - ) 0/15 (0%) 
203 - Chest Pain 1/3 (33.3%) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/5 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/11 (0%) 0/3 (0%) 0/6 (0%) 0/3 (0%) 0/23 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 0/29 (0%) 0/12 (0%) 3/6 (50%) 0/1 (0%) 0/48 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/10 (0%) 1/3 (33.3%) 0/1 (0%) 0/0 ( - ) 0/14 (0%) 
167 - Other Cardiothoracic Procedures 0/2 (0%) 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/3 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/5 (0%) 1/3 (33.3%) 0/1 (0%) 0/0 ( - ) 0/9 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/3 (0%) 0/4 (0%) 0/3 (0%) 0/0 ( - ) 0/10 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0/13 (0%) 0/16 (0%) 2/10 (20%) 0/4 (0%) 0/43 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/2 (0%) 0/4 (0%) 0/1 (0%) 0/0 ( - ) 0/7 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 1/8 (12.5%) 0/2 (0%) 0/2 (0%) 0/1 (0%) 0/13 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/0 ( - ) 0/0 ( - ) 0/2 (0%) 0/1 (0%) 0/3 (0%) 
      
Psychoses 
     
199 - Hypertension 0/16 (0%) 0/2 (0%) 0/1 (0%) 0/0 ( - ) 0/19 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 1/16 (6.2%) 1/17 (5.9%) 0/9 (0%) 0/0 ( - ) 0/42 (0%) 
197 - Peripheral & Other Vascular Disorders 2/65 (3.1%) 0/27 (0%) 0/10 (0%) 0/6 (0%) 0/108 (0%) 
196 - Cardiac Arrest 0/1 (0%) 1/1 (100%) 0/2 (0%) 0/6 (0%) 0/10 (0%) 
194 - Heart Failure 11/68 (16.2%) 4/227 (1.8%) 5/173 (2.9%) 0/34 (0%) 0/502 (0%) 
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193 - Acute & Subacute Endocarditis 0/0 ( - ) 0/1 (0%) 0/2 (0%) 0/3 (0%) 0/6 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 0/11 (0%) 1/6 (16.7%) 0/2 (0%) 0/0 ( - ) 0/19 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
0/13 (0%) 0/7 (0%) 0/10 (0%) 0/4 (0%) 0/34 (0%) 
190 - Acute Myocardial Infarction 1/27 (3.7%) 0/38 (0%) 2/44 (4.5%) 0/11 (0%) 0/120 (0%) 
180 - Other Circulatory System Procedures 0/32 (0%) 0/5 (0%) 0/0 ( - ) 0/1 (0%) 0/38 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/4 (0%) 0/0 ( - ) 0/2 (0%) 0/0 ( - ) 0/6 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/3 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/10 (0%) 0/9 (0%) 1/12 (8.3%) 0/1 (0%) 0/32 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 1/29 (3.4%) 1/48 (2.1%) 0/9 (0%) 0/9 (0%) 0/95 (0%) 
173 - Other Vascular Procedures 3/29 (10.3%) 1/15 (6.7%) 0/6 (0%) 0/1 (0%) 0/51 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
0/42 (0%) 0/18 (0%) 1/12 (8.3%) 0/2 (0%) 0/74 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/1 (0%) 
207 - Other Circulatory System Diagnoses 1/17 (5.9%) 0/10 (0%) 0/7 (0%) 0/0 ( - ) 0/34 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/3 (0%) 0/3 (0%) 1/2 (50%) 0/2 (0%) 0/10 (0%) 
205 - Cardiomyopathy 0/1 (0%) 0/3 (0%) 0/0 ( - ) 0/0 ( - ) 0/4 (0%) 
204 - Syncope & Collapse 0/15 (0%) 0/4 (0%) 0/2 (0%) 0/0 ( - ) 0/21 (0%) 
203 - Chest Pain 0/6 (0%) 0/1 (0%) 0/0 ( - ) 0/0 ( - ) 0/7 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/4 (0%) 0/5 (0%) 0/1 (0%) 0/8 (0%) 0/18 (0%) 
201 - Cardiac Arrhythmia & Conduction Disorders 2/49 (4.1%) 1/64 (1.6%) 0/34 (0%) 0/5 (0%) 0/152 (0%) 
200 - Cardiac Congenital & Valvular Disorders 1/7 (14.3%) 0/3 (0%) 0/0 ( - ) 0/1 (0%) 0/11 (0%) 
167 - Other Cardiothoracic Procedures 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/3 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/4 (0%) 0/3 (0%) 0/1 (0%) 0/0 ( - ) 0/8 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/0 ( - ) 0/4 (0%) 0/1 (0%) 0/2 (0%) 0/7 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 1/6 (16.7%) 0/11 (0%) 1/5 (20%) 0/1 (0%) 0/23 (0%) 
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162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/0 ( - ) 0/1 (0%) 0/0 ( - ) 0/1 (0%) 0/2 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/1 (0%) 0/2 (0%) 0/0 ( - ) 0/0 ( - ) 0/3 (0%) 
      
Depression 
     
199 - Hypertension 0/201 (0%) 0/64 (0%) 0/15 (0%) 0/2 (0%) 0/282 (0%) 
198 - Angina Pectoris & Coronary Atherosclerosis 2/302 (0.7%) 1/247 (0.4%) 0/69 (0%) 0/16 (0%) 0/634 (0%) 
197 - Peripheral & Other Vascular Disorders 1/491 (0.2%) 1/248 (0.4%) 0/113 (0%) 0/21 (0%) 0/873 (0%) 
196 - Cardiac Arrest 0/5 (0%) 0/4 (0%) 0/10 (0%) 0/16 (0%) 0/35 (0%) 
194 - Heart Failure 6/395 (1.5%) 18/2811 (0.6%) 3/1803 (0.2%) 0/252 (0%) 0/5261 (0%) 
193 - Acute & Subacute Endocarditis 0/15 (0%) 0/30 (0%) 0/21 (0%) 0/10 (0%) 0/76 (0%) 
192 - Cardiac Catheterization for Ischemic Heart Disease 3/362 (0.8%) 0/89 (0%) 0/14 (0%) 0/3 (0%) 0/468 (0%) 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart 
Disease 
4/340 (1.2%) 0/204 (0%) 0/89 (0%) 0/26 (0%) 0/659 (0%) 
190 - Acute Myocardial Infarction 7/407 (1.7%) 12/405 (3%) 1/343 (0.3%) 0/67 (0%) 0/1222 (0%) 
180 - Other Circulatory System Procedures 0/694 (0%) 0/35 (0%) 0/16 (0%) 0/3 (0%) 0/748 (0%) 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device 
Replacement 
0/17 (0%) 0/16 (0%) 0/4 (0%) 0/2 (0%) 0/39 (0%) 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0/25 (0%) 0/10 (0%) 0/3 (0%) 0/2 (0%) 0/40 (0%) 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0/319 (0%) 2/93 (2.2%) 0/49 (0%) 0/12 (0%) 0/473 (0%) 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0/388 (0%) 4/293 (1.4%) 1/56 (1.8%) 0/35 (0%) 0/772 (0%) 
173 - Other Vascular Procedures 2/195 (1%) 2/134 (1.5%) 0/43 (0%) 0/22 (0%) 0/394 (0%) 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or 
Shock 
5/485 (1%) 0/213 (0%) 0/46 (0%) 0/15 (0%) 0/759 (0%) 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure 
or Shock 
0/5 (0%) 0/15 (0%) 0/13 (0%) 0/2 (0%) 0/35 (0%) 
207 - Other Circulatory System Diagnoses 0/195 (0%) 2/129 (1.6%) 0/59 (0%) 0/5 (0%) 0/388 (0%) 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or 
Proc 
0/24 (0%) 0/48 (0%) 0/22 (0%) 0/7 (0%) 0/101 (0%) 
205 - Cardiomyopathy 0/22 (0%) 0/52 (0%) 0/16 (0%) 0/6 (0%) 0/96 (0%) 
204 - Syncope & Collapse 1/191 (0.5%) 0/89 (0%) 0/15 (0%) 0/0 ( - ) 0/295 (0%) 
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203 - Chest Pain 0/81 (0%) 0/16 (0%) 0/5 (0%) 0/0 ( - ) 0/102 (0%) 
169 - Major Thoracic & Abdominal Vascular Procedures 0/44 (0%) 1/20 (5%) 1/10 (10%) 0/14 (0%) 1/88 (1.1%) 
201 - Cardiac Arrhythmia & Conduction Disorders 4/742 (0.5%) 4/650 (0.6%) 0/249 (0%) 0/24 (0%) 0/1665 (0%) 
200 - Cardiac Congenital & Valvular Disorders 0/41 (0%) 1/88 (1.1%) 0/30 (0%) 0/4 (0%) 0/163 (0%) 
167 - Other Cardiothoracic Procedures 0/37 (0%) 0/11 (0%) 0/5 (0%) 0/2 (0%) 0/55 (0%) 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac 
Procedure 
3/92 (3.3%) 1/44 (2.3%) 0/20 (0%) 0/2 (0%) 0/158 (0%) 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac 
Procedure 
0/16 (0%) 0/47 (0%) 0/17 (0%) 0/1 (0%) 0/81 (0%) 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 1/125 (0.8%) 1/190 (0.5%) 0/45 (0%) 0/11 (0%) 0/371 (0%) 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0/7 (0%) 0/31 (0%) 0/12 (0%) 0/2 (0%) 0/52 (0%) 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0/30 (0%) 0/42 (0%) 0/6 (0%) 0/0 ( - ) 0/78 (0%) 
160 - Major Cardiothoracic Repair of Heart Anomaly 0/1 (0%) 0/1 (0%) 0/1 (0%) 0/0 ( - ) 0/3 (0%) 
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6. How the APR-DRG system responds to the different 
types of hospital procedures? 
  In this third objective of the thesis, we aimed at providing information on coding 
of procedures to assist hospital stakeholders to improve the quality of administrative 
datasets and support the implementation or optimization of their DRG systems. To 
achieve this goal, we employed Support Vector Machine (SVM) models to acknowledge 
how the different types of procedures drive and modify APR-DRG grouping and hospital 
funding in the context of respiratory (MDC 4) and cardiovascular diseases (MDC 5). We 
assessed administrative data from Portugal and Brazil, which are, respectively, countries 
that has and has not implemented a DRG-based system. Even minor diagnostic and 
therapeutic procedures did considerably influence APR-DRG grouping. Procedures seem 
to mostly drive grouping into the base APR-DRG rather than SOI determination. 
Procedures from any category generally place the episodes in a higher-paying APR-DRG, 
except for Brazilian data regarding MDC 4, where minor procedures seemed to place 
episodes into lower-paying APR-DRGs. In Brazil, minor diagnostic procedures drove APR-
DRG classification in a higher proportion of episodes when compared to major 
therapeutic in MDC 5. The results obtained with the SVM models were consistent with 
the APR-DRG grouping logics. 
How different procedure codes drive APR-DRG classification and hospital funding for 
respiratory and circulatory system diseases? An approach using Support Vector Machine 
Resubmitted to Methods of Information in Medicine on April 1, 2019. 
Julio Souza, João Vasco Santos, Domingos Alves, Alberto Freitas 
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Summary  
Background: Diagnosis-Related Groups (DRGs) have become the principal mean of 
hospital payments in several countries worldwide. As a case-mix-based funding model, 
an effective DRG system relies upon coded clinical data held in administrative databases. 
Proper coding of procedures, in particular, plays a major role on DRG allocation. The 
accuracy and completeness of reporting all hospital procedures can be particularly 
difficult to achieve as those considered irrelevant in terms of reimbursement, such as 
routine procedures, tend to be underreported in administrative datasets. In this context, 
acknowledging how the different types of hospital procedures drive DRG classification 
is critical to implement an effective DRG-based payment system and to assess the 
suitability of hospital administrative datasets for DRG grouping.  
Objectives: In this study, the emphasis is to understand the impact of coding more and 
better procedures on DRG classification and hospital funding. We aimed at exploring the 
APR-DRG (All-Patient Refined Diagnosis-Related Groups) technical remuneration in 
order to understand and characterize how the different procedures drive and modify APR-
DRG grouping and thereby hospital funding. 
Methods: Using grouped coded clinical data of admissions due to respiratory and 
circulatory system diseases from a nationwide Portuguese hospitalization database, for 
the period 2011-2015, we built Support Vector Machine (SVM) models to simulate the 
APR-DRG system and assess their response to each procedure code from the ICD-9-CM 
(International Classification of Diseases, Ninth Revision, Clinical Modification) 
classification system. We also studied the individual effects of different types of 
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procedures based on categories defined by the Agency for Health Care Research and 
Quality (AHRQ). The SVM models were further employed in coded clinical data from a 
Brazilian inpatient database to perform the same analyses and to verify the applicability 
of the proposed method to non-DRG based systems. 
Results: Overall, considering the Portuguese dataset, therapeutic procedures alone, either 
minor or major in terms of invasiveness, accounted, respectively, for more than 58 and 
25 million euros in reimbursement for paying episodes of respiratory diseases. The 
financial effects of removing major therapeutic procedures for cardiovascular diseases 
was much higher when compared to respiratory diseases (more than 256 million euros), 
though omitting minor therapeutic procedures accounted for a lower yet elevated amount 
(over 58 million euros). Minor diagnostic procedures presented a very low impact on 
hospital payments for respiratory diseases, whereas accounted for over 33 million euros 
for circulatory system diseases. The opposite was observed for major diagnostic 
procedures, in which the higher effects on hospital payments was observed for respiratory 
system diseases (more than 4 million euros), while it was minimal for circulatory system 
diseases. Regarding Brazilian data, minor and major therapeutic procedures presented a 
much higher financial impact for circulatory diseases (over 1 and 13 million euros, 
respectively) in comparison with respiratory diseases, whereas minor and major 
diagnostic procedures influenced a minimal amount of reimbursement in both diagnosis 
areas. In both countries, as expected, major therapeutic procedures accounted for the 
highest percentage change in APR-DRG for both respiratory and circulatory system 
diseases. Minor diagnostic procedures caused the second highest percentage change in 
APR-DRGs of circulatory system diseases in Portugal and Brazil (34.9 and 60.9, 
respectively), though influenced less the APR-DRG assignment in respiratory diseases 
(around 1 percent of APR-DRG changes in both countries). Procedures mostly drove base 
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APR-DRG classification rather than SOI level assignment in both countries and for both 
diagnosis areas. In general, the results obtained with the SVM models were consistent 
with the APR-DRG grouping logics. 
Conclusions: Our results indicate that procedures, even those considered minor 
diagnostic or therapeutic, can considerably influence APR-DRGs grouping in respiratory 
and circulatory system diseases, reinforcing thus the importance of a more complete 
reporting of all procedures performed during the patient stay. Our findings helped to 
understand and acknowledge how specific hospital procedures and categories of 
procedures drive and modify APR-DRG classification in respiratory and circulatory 
system diseases. Furthermore, we presented a generic and reproducible method that can 
be applied to different datasets, from different DRG systems and, thus, can be used to 
assess the suitability of hospital administrative datasets for DRG implementation and 
optimization.  
 
Keywords: Respiratory System; Circulatory System; Inpatients; Diagnosis-Related 
Groups; International Classification of Diseases; Clinical Coding; Hospital 
Administration; Hospital Procedures; Machine Learning; Support Vector Machine; 
Hospitals; AHRQ 
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1. Introduction 
1.1. Diagnosis Related Groups: concept and evolution 
Coded clinical data abstracted from medical records are used for a variety of 
purposes, namely for determining the complexity of care, supporting clinical and health 
care services research, measuring health care activity and quality, as well as for hospital 
billing [1,2]. Regarding this latter purpose, in several countries, when a patient is admitted 
to a hospital, the facility is reimbursed according to a system based on Diagnosis Related 
Groups (DRGs) [2,3], in which inpatient and, in some cases, outpatient episodes are 
grouped into clinically and economically homogeneous clusters, the so-called DRGs, 
which in turn will be used to determine the reimbursement driven by that group of 
hospitalizations [4]. The main purpose of a DRG-based payment system is to provide an 
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insight regarding the provision of services within hospitals and incentive the efficient use 
of resources by paying hospitals on the basis of the number and type of cases treated [5,6].  
The DRG system was first developed at the Yale School of Organization and 
Management in the late 1960s [5] and was first implemented in the United States in 1983 
as part of a prospective payment system for Medicare [7]. The initial DRGs were later 
redesigned with the creation of MS-DRGs (Medicare Severity Diagnosis Related 
Groups), which stratified individual DRGs into three different complication levels (major 
complication and comorbidities, complications and comorbidities, and no complications 
and comorbidities) in order to obtain smaller and more clinically homogenous groups [8]. 
This adaptation was necessary because not all patients grouped into the same DRG are 
identical in terms of severity and resource use needs. As MS-DRGs were solely created 
for Medicare patients and thus did not accurately compass patients outside of this 
population, a new concept of patient stratification was introduced afterwards with the 
creation of the All-Patient Refined Diagnosis-Related Groups (APR-DRG) system with 
creation of a Severity of Illness (SOI) and Risk of Mortality (ROM) score combined with 
the base DRG [4].  
The APR-DRG system, as the other DRG systems, is organized into 25 Major 
Diagnostic Categories (MDC), with each one representing mutually exclusive diagnosis 
areas. A patient is assigned to a MDC mostly according to the principal diagnosis and is 
later grouped into a base APR-DRG within that MDC [9]. A total of 314 base APR-DRGs 
(version 31) across the 25 MDCs were developed, each of which representing a group of 
patients with the same causes of hospitalization. Episodes are assigned to a base APR-
DRG based upon the principal diagnosis, if it is a medical case, or the main operating 
room procedure, if it is a surgical case [9]. The base APR-DRG is further stratified 
according to a SOI and a ROM level, both ranging sequentially from 1 to 4 (1 - minor; 2 
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- moderate; 3 - major; 4 - extreme), representing increasing reimbursement needs [9]. 
While SOI refers to the degree of loss of function or physiologic decompensation of an 
organ system, ROM reflects the likelihood of death [9]. The determination of SOI and 
ROM combines principal and secondary diagnoses, age, operating and non-operating 
room procedures and multiple operating-room procedures [9]. The APR-DRG system is 
currently employed for reimbursement purposes in some European countries, such as 
Portugal, Belgium, Spain and Italy, some Arab countries and in over 30 states in the US 
[10]. 
 
1.2. Hospital procedures within the DRG structure 
Regardless of the DRG system, the full process associated with the assignment to 
the different DRGs is highly dependent on the diagnoses and procedures presented in 
health records that are further translated into coded clinical data, typically after the 
discharge. Apart from properly recognizing the principal diagnosis as a crucial task, since 
it drives the MDC classification and many of the medical DRGs, considering the medical-
surgical distinction of the DRG system is also essential as the presence of surgical 
procedures consistently affects hospital resources [11].  For this reason, the classic DRG 
structure was divided into medical and surgical DRGs following the MDC assignment, 
with the latter branch comprising DRGs that are mainly characterized by specific codes 
representing the main operating room procedures [11].  
Moreover, since inpatients can present multiple procedures related or not with 
their principal diagnosis, a hierarchical order of surgical DRGs within each MDC was 
defined to address those situations in which certain procedures are more relevant than 
others for grouping purposes [11]. For instance, a patient who was submitted to a coronary 
bypass and an amputation due to a circulatory system disorder will be assigned to the 
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coronary bypass DRG because it is the higher surgical class in the DRG hierarchy within 
the MDC comprising circulatory system diagnoses [12]. Also, if a patient is submitted to 
a procedure that is not in the same MDC as the principal diagnosis and is not directly 
related to any presenting sign or symptom, then that procedure will not necessarily 
determine the DRG, which may affect hospital reimbursement. For instance, a patient 
with a principal diagnosis of gastrointestinal bleed who is later diagnosed with abdominal 
aortic aneurysm and thus submitted to a repair, will be placed in an unrelated surgical 
procedure DRG [4].  
Another important aspect refers to non-operating room procedures, which are not 
routinely performed in an operating room but can often help to identify patients with 
higher resource consumption and costs [13]. For instance, the presence of flow-direct 
pulmonary artery catheter in patients with acute heart failure, combined with a secondary 
diagnosis of hypotension, which typically occurs in acute myocardial infarction patients, 
might indicate a more complicated episode among those grouped into the acute 
myocardial infarction DRG [13]. Furthermore, when hospital payment occurs based on 
DRG classification systems and if coders report mostly for reimbursement purposes, most 
procedures performed in hospitals other than operating room procedures may not be 
coded and therefore not be registered in inpatient databases [14]. There is an estimated of 
more than 1500 non-operating room procedures within ICD-9-CM, of which only about 
116 determine DRG classification. Therefore, about a third of all listed procedures may 
be subject to underreporting, since they are not required to reimbursement via DRGs [14]. 
This issue is of concern not only for hospital authorities that aim to use administrative 
data for DRG grouping, but also for health services researchers and policy-makers that 
use these data sources to examine variations in procedure utilization, outcomes, treatment 
costs and adjusting for patient risk [14]. 
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In this sense, understanding how the different procedures modify and determine 
DRG grouping should help the competent health entities to implement or optimize their 
existing DRG-based payment system. In this article, the emphasis is to understand and 
characterize the impact of a better and complete coding of procedures on DRG 
classification and hospital funding.  
 
2. Methods 
We used grouped coded clinical data from a Portuguese nationwide inpatient 
database to construct Support Vector Machine (SVM) models for APR-DRG 
prediction in order to simulate the response of the APR-DRG system to the different 
procedure codes. This machine learning-based approach was chosen as a way to 
provide and validate a reproducible method that can be applied to assess different 
DRG versions and to be used in data from countries that have not implemented a 
DRG-based system yet. We also assessed the effects of four distinct categories of 
procedures created by the Agency for Health Care Research and Quality (AHRQ) in 
the context of APR-DRG classification.  
We focused on episodes assigned to MDC 4 (Diseases and Disorders of the 
Respiratory System) and MDC 5 (Diseases and Disorders of the Circulatory System), 
which are the two diagnosis areas with the highest number of hospitalizations among 
all MDCs in Portugal, accounting for over one million hospitalizations during the 
period comprised by our data, being thus two relevant areas for authorities due to this 
high hospitalization burden. To perform the same analyses in hospitals that have not 
implemented DRGs and show the applicability of a machine learning based approach, 
we employed the constructed SVM models in a sample of coded clinical data from a 
Brazilian inpatient database. 
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2.1. Clinical Data 
Data used for this study was extracted from the Portuguese national DRG 
database, containing grouped coded clinical data from all public hospitals of the National 
Health System (NHS) in mainland Portugal. We selected all inpatient episodes grouped 
into MDCs 4 and 5 with a discharge date between 2011-2016 (i.e., the period in which 
APR-DRG data was available). A total of 1,107,867 episodes were retrieved. All patient 
characteristics required for APR-DRG grouping were retrieved, namely principal 
diagnosis, up to 30 secondary diagnoses, up to 30 procedures, discharge status, sex and 
age. Diagnoses and procedures were coded in the ICD-9-CM (International Classification 
of Diseases, 9th Revision, Clinical Modification) classification system. These 
hospitalizations comprised episodes grouped into a set of 17 respiratory system APR-
DRGs (MDC 4) and 32 circulatory system APR-DRGs (MDC 5) and other 3 surgical 
DRGs that comprise procedures not related with the principal diagnosis (DRGs 950, 951 
and 952).  
Hospitalization data for Brazil was extracted from a regional administrative 
inpatient database which also contained a sample of coded clinical data of 407,255 
inpatient episodes provided by public, private and charity hospitals located in São Paulo 
State, for the period 2011-2015. Data from 2015 onwards were not available. Each 
inpatient episode was also characterized by age, sex, discharge status, up to 5 diagnosis 
codes (including the principal diagnosis) and up to 3 procedure codes. Diagnoses were 
coded in ICD-10-WHO (International Statistical Classification of Diseases and Related 
Health Problems 10th Revision, World Health Organization version) and procedures were 
also coded in ICD-9-CM.  
 
196 
 
2.2. Data Standardization 
As the SVM models were entirely built with ICD-9-CM data from Portugal, we 
used General Equivalence Mapping (GEM) files to map between ICD-10-WHO codes to 
ICD-9-CM. GEM files allowed the conversion between ICD-10-CM and ICD-9-CM [15]. 
Using the first four characters of ICD-10-WHO codes, we obtained the approximate ICD-
10-CM codes and later used GEM files to convert them to their ICD-9-CM mapping 
codes. To diminish further bias, our final sample only included cases in which the four-
digit approximation mapping between ICD-10-WHO to ICD-10-CM was possible. After 
the terminology conversion process, a total of 251,947 episodes were retrieved. From this 
number, a total of 115,575 episodes (% of the total) reported at least one procedure code. 
We further selected the cases with a principal diagnosis within MDCs 4 and 5 based on a 
principal diagnosis list constructed with the Portuguese data. The final sample contained 
27,992 episodes for MDC 4 and 31,168 episodes for MDC 5. 
 
2.2. Support Vector Machine (SVM) models for APR-DRG prediction 
We used five years of Portuguese inpatient data (2011-2015) to build SVM models 
for APR-DRG prediction. The SVM algorithm finds a separating boundary between the 
different inpatient episodes, the so-called hyperplanes [16], in order to segregate the 
different APR-DRGs (classes) between the episodes. Apart from presenting a high 
performance in solving classification problems in bioinformatics [17], SVM algorithm 
may be suitable for dealing with the APR-DRG classification problem mainly because it 
handles high dimensionality issues [18]. As modeling APR-DRG groping requires the 
combination of several patient attributes, like discharge status, a wide range of diagnosis 
and procedure codes and other patient features, such as age and sex, the SVM algorithm 
seemed to be adequate for this task.  
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For each MDC, we constructed two classification models: one model to classify 
episodes into a base APR-DRG and the other one to determine the SOI level. Thus, the 
target variables (classes) used to build the first and second models were, respectively, the 
base APR-DRG and the patient’s SOI level. Since ROM is not used for payment and we 
were interested on assessing the effects of the different procedures on hospital funding, 
we did not consider ROM classification in our study. 
Regarding the specification of variables, the first model (base APR-DRG 
prediction) included age as numeric attribute, sex and discharge status as categorical 
attributes and all ICD-9-CM diagnosis and procedure codes in the dataset. As SOI 
classification does not consider sex and discharge status, the second model (SOI 
prediction) only included age as numeric attribute, the base APR-DRG assigned by the 
first model as categorical attribute and all diagnosis and procedure codes. Each diagnosis 
and procedure code was treated as an individual binary variable (1 if the episode reported 
the code, 0 otherwise). We trained SVM models on two thirds of the inpatient data for the 
period 2011-2015 (training set) and evaluated their performance on the remaining third 
(testing set). As evaluation metrics, we estimated the percentage of correctly classified 
episodes, as well as recall and precision by each possible class. To add critical validation 
to the models and assess their capacity of generalization we tested the SVM models using 
2016 data and estimated the percentage of correctly classified episodes in each class. The 
evaluation metrics of the SVM models are presented in supplementary table 1. Finally, 
we applied the previously constructed SVM models on Brazilian data to group inpatient 
episodes to an APR-DRG comprised by the MDCs associated with the studied conditions 
(MDCs 4 and 5). 
 
2.3. Analysis  
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  We firstly re-grouped all 2011-2015 episodes into APR-DRGs using the 
previously constructed SVM models. The goal was to use the classification results 
obtained with the complete dataset as baseline for further comparisons. To investigate 
how the different procedures drive APR-DRG classification, we individually removed 
each procedure code from the original dataset and analyzed classification changes. We 
also compared the classification changes in terms of types of procedures taking into 
account the four procedure categories created by the AHRQ: minor diagnostic, which 
consists of non-operating room procedures that are performed for diagnostic reasons; 
minor therapeutic, which also contains non-operating room procedures but that are for 
therapeutic reasons; major diagnostic, which comprises all operating-room procedures 
considered valid by the DRG grouper and that are performed for diagnostic reasons; and 
major therapeutic, which corresponds to all operating-room procedures considered valid 
by the DRG grouper and are performed for therapeutic reasons [19]. 
We estimated the percentage of episodes that changed their DRGs after removing 
each procedure code. Besides evaluating DRG modification, we also assessed changes in 
hospital payments by estimating the total amount to be reimbursed when considering the 
classification results obtained with the complete dataset (baseline results) and after 
removing each procedure code. For this latter analysis, we used official APR-DRG prices 
derived from the 2017 APR-DRG prices and weights table [20], which was defined for 
paying public hospitals within the Portuguese NHS. We further repeated the same 
analyzes using Brazilian hospitalization data, using the same APR-DRG weights and 
prices that were used for Portugal. 
 
2.4.Ethical considerations 
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Since inpatient data used in this study was completely anonymized and only 
contained the discharge year, diagnosis and procedure codes, sex, age, discharge status 
and an arbitrary episode identification number, there was no need for ethical approval. 
 
2.5. Software  
Data processing, training and testing phases of SVM and all the presented analyses 
were performed using Java code in combination with a Weka open source library for Java 
[21], version 3.8.0 
 
3. Results 
Coded clinical data of 935,429 hospitalizations were used for training and testing 
the SVM models. This number corresponded to all Portuguese inpatient episodes assigned 
to a principal diagnosis within MDC 4 (487,156 episodes) and MDC 5 (448,273 episodes) 
in the period 2011-2015. We also tested the SVM models in hospitalization data from 
2016 data (92,475 episodes from MDC 4 and 79,963 episodes from MDC 5) and verified 
a high capacity of generalization, with an overall proportion of correctly classified cases 
of 99.2% (MDC 4) and 99.3% (MDC 5) for base APR-DRG assignment and 89% (MDC 
4) and 88.3% (MDC 5) for SOI determination (see supplementary table 1). When 
considering the combination of both, base APR-DRG and SOI, the SVM models correctly 
classified 88.4% and 87.8% of the episodes from the year of 2016 in MDCs 4 and 5, 
respectively (supplementary table 1). 
Overall results for Portugal and Brazil, namely the percentage of episodes that 
changed their APR-DRG and differences in hospital payments resulted from the removal 
of procedures from each category can be seen in Tables 1 and 2, respectively. Considering 
only Portuguese data, the removal of procedure codes, regardless of the category they 
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belong to, resulted in decreases in hospital reimbursement (Table 1). The same was 
observed after analyzing Brazilian data, except for some results for MDC 4, in which the 
effects of minor procedures resulted in a small increase in hospital reimbursement (Table 
2). For both countries, and as expected, major therapeutic procedures accounted for the 
highest percentage of APR-DRG changes in both MDCs. Nevertheless, in Portugal, minor 
therapeutic procedures accounted for the highest loss in hospital payments in MDC 4, 
reaching over than 58 million euros (Table 1). Moreover, minor diagnostic procedures 
accounted for the second highest percentage of APR-DRG changes in MDC 5 for both 
datasets, while their impact on APR-DRG assignment for MDC 4 was minimal (Tables 1 
and 2). 
Table 3 shows, for Portugal and Brazil, how the different categories of procedures 
modified the base APR-DRG and SOI levels in respiratory and circulatory system 
diseases. Overall, relatively small proportions of episodes had their SOI level affected by 
the removal of procedures. For MDC 4 and for both countries, major diagnostic and 
therapeutic procedures had a much higher impact on base APR-DRG classification when 
compared to the minor categories, though the influence of minor procedures on base 
APR-DRG grouping for MDC 5 was quite higher for both, Portuguese and Brazilian 
datasets (Table 3). 
Supplementary tables 2 and 3 present for MDCs 4 and 5, respectively, a more 
detailed analysis using Portuguese data, showing a descending ranking of procedure 
codes according to the percentage change in APR-DRGs. Differences in hospital 
payments that could have been attributed to the presence of each procedure is also 
presented. In Portugal, major therapeutic procedures 31.79 (Other repair and plastic 
operations on trachea) and 38.15 (Endarterectomy, other thoracic vessels) accounted for 
the highest percentages of APR-DRG changes among MDC 4 episodes (100%) and both 
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procedures only occurred in episodes grouped into APR-DRG 120 (Major Respiratory 
and Chest Procedures) (supplementary table 2). Among MDC 5 episodes, major 
therapeutic procedures 05.25 (Periarterial sympathectomy), 35.06 (Transapical 
replacement of aortic valve), 37.62 (Insertion of temporary non-implantable 
extracorporeal circulatory assist device) and 37.96 (Implantation of automatic 
cardioverter/defibrillator pulse generator only) led to the highest percentage change of 
APR-DRGs and also changed the APR-DRG in all episodes they occurred 
(supplementary table 3). In terms of major diagnostic procedures, the most impacting was 
34.21 (Transpleural thoracoscopy) in both MDCs, as it changed the APR-DRG in over 
80% of the episodes it occurred in MDC 4, affecting mostly APR-DRG 121 (Other 
Respiratory & Chest Procedures), and over 70% of the MDC 5 episodes, changing mostly 
the APR-DRG 951 (Moderately Extensive Procedure Unrelated to Principal Diagnosis) 
(supplementary tables 2 and 3). 
Considering the minor categories, in Portugal, minor therapeutic procedure 96.72 
(Continuous invasive mechanical ventilation for 96 consecutive hours or more) changed 
the APR-DRG in more than 85% of the cases it was performed, being thus responsible 
for the highest percentage change of APR-DRGs among MDC 4 episodes. This code 
mostly affected APR-DRG 130 (Respiratory System Diagnosis with Ventilator Support 
96+ Hours) by shifting most of these episodes to APR-DRG 137 (Major Respiratory 
Infections and Inflammations) (supplementary table 2). Procedure 42.29 (Other 
diagnostic procedures on esophagus) was the minor diagnostic procedure that most 
influenced APR-DRG grouping in MDC 4, causing an increase in the SOI level in 
episodes grouped into APR-DRG 136 (Respiratory Malignancy) and APR-DRG 139 
(Other Pneumonia) (see supplementary table 2). 
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Among MDC 5 episodes, minor therapeutic procedures from the ICD-9-CM 
category 37.7 (Insertion, Revision, Replacement, and Removal of Pacemaker Leads; 
Insertion of Temporary Pacemaker System; or Revision of Pocket) caused most of the 
APR-DRG changes, namely codes 37.70, 37.71 and 37.72, which changed the APR-DRG 
in over 90% they were reported (supplementary table 3). These procedures clearly drove 
the classification into APR-DRGs 170 (Permanent Cardiac Pacemaker Implant w/ AMI, 
Heart Failure or Shock) and 171 (Permanent Cardiac Pacemaker Implant w/o AMI, Heart 
Failure or Shock) (see supplementary table 3). Procedure 37.28 (Intracardiac 
echocardiography) was the minor diagnostic procedure with the highest impact on APR-
DRG classification in MDC 5, changing the DRG in more than 65% of the episodes it 
occurred, mostly shifting APR-DRG 162 (Cardiac Valve Procedures with Cardiac 
Catheterization) to 163 (Cardiac Valve Procedures without Cardiac Catheterization) (see 
supplementary table 3). 
Supplementary tables 4 and 5 present the same analysis, but using Brazilian data, 
showing a descending ranking of procedure codes according to the percentage change in 
APR-DRGs differences in hospital payments in MDCs 4 and 5, respectively. Among 
MDC 4 cases, procedure 34.51 (Decortication of lung) was the most impacting major 
therapeutic procedure, affecting the APR-DRG assignment in all episodes it was 
performed, shifting the episodes from APR-DRG 120 mostly to a medical APR-DRG or 
to APR-DRG 121 (supplementary table 4). In MDC 5, the major therapeutic procedure 
35.73 (Other and unspecified repair of endocardial cushion defect) caused the highest 
changes in APR-DRG (100%), exclusively affecting grouping into APR-DRG 160 
(Major Cardiothoracic Repair of Heart Anomaly) (supplementary table 5). The impact of 
major diagnostic procedures in the Brazilian sample was quite limited in both MDCs. The 
only and most impacting one was procedure 34.21 (Transpleural thoracoscopy), which 
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shifted the APR-DRG in 77.8% of the episodes it was performed in MDC 4. Moreover, 
this procedure affected exclusively the classification into APR-DRG 121 (supplementary 
table 4).  
The influence of minor procedures in Brazilian data was quite subtle among MDC 
4 episodes, with minor therapeutic procedure 311 (Temporary tracheostomy) 
proportionally affecting more cases (6.2%) as it changed the SOI to a lower level among 
APR-DRGs 139 (Other Pneumonia) and 140 (Chronic Obstructive Pulmonary Disease) 
(supplementary table 4). The impact of minor procedures was higher among MDC 5 
episodes, with minor diagnostic procedure 88.57 (Other and unspecified coronary 
arteriography) changing the APR-DRG in over 60% of the cases, and minor therapeutic 
procedure 39.61 (Extracorporeal circulation auxiliary to open heart surgery) placing more 
than 30% of the episodes in a different APR-DRG. The first procedure mostly impacted 
the classification into APR-DRG 174 (Percutaneous Cardiovascular Procedures with 
AMI), whereas the second one mainly affected APR-DRG 160 (Major Cardiothoracic 
Repair of Heart Anomaly) (see supplementary table 5). 
 
4. Discussion 
Hospital care comprises a large share of the total health expenditures in countries 
[22]. In order to increase efficiency in inpatient care and improve transparency in hospital 
services, DRG-based payment systems have been gradually introduced in many countries 
worldwide since its first implementation in 1983, in the United States [22]. However, the 
main concern prior to implement or optimize an existing DRG-based system should be 
ensuring the quality of administrative databases. Therefore, hospitals should find means 
to evaluate whether their data are suitable for DRG grouping, especially concerning 
accurate and complete medical coding. There are many types of coding errors that can 
204 
 
lead episodes to be placed erroneously in a higher or lower-resource intensity DRG, such 
as selecting the wrong principal diagnosis, omitting codes that should have been reported 
or using less specific codes [23]. Procedure guidelines, in particular, state that all 
significant diagnostic and therapeutic procedures should be coded, which includes those 
that are surgical in nature, carry a procedural or anesthetic risk and demand special 
facilities, equipment or training [23]. However, many routine procedures, namely non-
OR procedures, tend to be underreported as they are not required for reimbursement via 
DRG classification. After assessing 1997 data from nonfederal hospital inpatient claims 
from Washington State, Dismuke (2005) found that ICD-9-CM procedure coding was 
considerably underreported and variable, concluding that the frequency of underreporting 
of the studied non-OR procedures was not random [14].  
While DRGs may be difficult to be fully understood, they should be something 
that physicians and other professionals should be comfortable using in order to improve 
data quality and help assist in medical coding and subsequent hospital funding. Physicians 
and other hospital stakeholders should become facile with the whole process og DRG 
allocation to ensure accurate and complete report and coding of procedures and thus 
improve their administrative databases, optimize the performance of the DRG grouper 
and finally achieve fairer hospital funding. In this article, the emphasis was to understand 
the impact of better and comprehensive coding of procedures on the APR-DRG 
classification. We employed a machine learning-based approach based on SVM models 
to provide a method to assess the APR-DRG technical structure and acknowledge how 
this grouper responds to the different types of hospital procedures. Our main goal was to 
provide more detailed insights on the role of each procedure within the APR-DRG 
grouping logic by using a generic and reproducible method that can also be used to 
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investigate different DRG systems and to be used in data from hospitals that have not 
implemented DRGs.  
Overall, in both Brazilian and Portuguese datasets, the removal of procedure codes 
from any category generally placed the episodes in a lower-paying APR-DRG, resulting 
in losses in hospital reimbursement Although major categories were, as expected, where 
the types of procedures that mostly determined APR-DRG grouping, it is important to 
point that minor therapeutic and diagnostic procedures did considerably influence 
grouping and hospital funding in MDC 5 in both countries, accounting for a substantial 
percentage of  APR-DRG changes in the episodes they occurred (Tables 1 and 2). In fact, 
the omission of procedures from minor categories would have cost over 70 million € 
during the studied period in Portugal (Tables 1 and 2). In MDC 4, however, the influence 
of minor categories on APR-DRG changes were much lower, though the financial impact 
of underreporting minor therapeutic procedures was considerably elevated in Portugal, 
accounting for over 58 million € during the studied period (Table 1). These findings 
reflect that the influence of the different types of procedures in the context of APR-DRG 
grouping is domain-specific, though underreporting minor categories, which comprise 
non-OR procedures, may have a very high financial impact on hospital funding, 
especially in the context of circulatory system diseases. 
. We observed that the influence of procedures to determine the different SOI 
levels varied concerning the country, with SOI determination being slightly more 
sensitive to procedures among Brazilian cases (Table 3). Moreover, we observed that the 
impact of procedures, regardless of their category, is much higher on base APR-DRG 
classification than on SOI determination (Table 3). While in MDC 4 the influence of the 
minor categories on base APR-DRG assignment was minimal in Portugal and Brazil, in 
MDC 5, both minor diagnostic and therapeutic procedures drove base APR-DRG 
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classification in a considerable percentage of episodes they occurred in both countries 
(Table 3). Also, minor procedures alone did influence SOI levels in several cases, which 
is line with Hughes et al (1990), who concluded that non-operating room procedures can 
often work as DRG modifiers by helping to identify groups of more severely ill and 
costlier patients, being thus useful to improve the accuracy and fairness of the DRG 
system [13].  
Overall, the results obtained with the SVM models were considerably consistent 
and in line with the APR-DRG grouping logic, reinforcing the validity of this method to 
study technical specificities of the DRG system. We thus presented a generic and 
reproducible method based on SVM models that can be employed in order to study 
different DRG systems and also to assess data from countries that have not used DRGs, 
such as the case of Brazil, providing options to acknowledge how the DRG system 
responds to their data and which information regarding hospital procedures would be 
crucial to implement an effective DRG-based system. Furthermore, the advantages of 
evaluating results from SVM models rather than directly employing the grouper, besides 
its use in different data sources from different DRG versions, include the feasibility to 
simulate different coding behaviors and assess the response of the DRG system to these 
behaviors, as well as the possibility to investigate the effects of specific diagnosis or 
procedures of interest.  
As a limitation of this study, these results rely and are limited to the quality of 
coded clinical data. For instance, certain procedures might have had little to no significant 
impact on the sensitivity for APR-DRG classification because they might simply be 
under-reported and thus the SVM models, which were constructed through patters learned 
from the data, will minimize their importance in terms of classification, being less 
sensitive to their removal. Another important limitation includes the utilization of results 
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obtained with SVM models (which artificially learned how episodes were grouped into 
APR-DRGs) as baseline to compare changes in sensitivity and hospital reimbursement. 
Therefore, existing errors associated with the original SVM models might have 
influenced or been replicated in our results. Another limitation includes the use of ICD-
9-CM data to perform all analyses, as this classification system ceased to be updated in 
2015. The transition to ICD-10-CM in Portugal was enacted in 2017 and it is still an 
ongoing process. Many of the available ICD-10-CM inpatient data was still incomplete, 
being thus not viable to perform this study. Also, it is important to take into account the 
inherent bias of using GEM files to map between ICD-9 and ICD-10 codes, considering 
that, in many cases, this method only finds approximate matches to a given code.  
 
5. Conclusions 
In summary, our findings showed how incomplete coding of procedures alone, 
including those considering non-OR procedures can directly affect proper APR-DRG 
assignment and hospital reimbursement. Also, it is important to keep in mind that poor 
and incomplete coding of procedures may also undermine other tasks related with clinical 
and health care services management and research, such as evaluating resource use, 
adjusting for patient risk, monitoring costs and quality, as well as utilization, outcome 
and policy studies [9, 14].  Additionally, as previous research found that hospitals, even 
with similar complexity, can differ on reporting non-operating room procedures [24], our 
findings were useful to demonstrate that even minor procedures, either for diagnostic or 
therapeutic reasons, might considerably influence base APR-DRG classification, 
especially in the context of circulatory system diseases, and thus should not be neglected. 
Furthermore, our results may help to better understand the role and impact of specific 
procedures in APR-DRG classification for respiratory and circulatory diseases as our 
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method allowed the identification of codes and categories of procedures that are more 
relevant for grouping specific APR-DRGs. Moreover, we presented a generic and 
reproducible method based on SVM models that can be employed to assess different data 
sources, from different DRG systems, or test DRG algorithm in data sources from settings 
that have not begun to implement a DRG system. Our results using SVM models were 
consistent with the APR-DRG grouping logics, reinforcing its validity. We thus highlight 
the importance of accurate and complete coding of hospital procedures as an indicator of 
quality and suitability of administrative data for DRG grouping, considering that other 
actions should be consecutively taken, such as continuous improvements regarding health 
records and patient documentation, mainly in discharge summaries and daily reports, as 
those instruments are the main source of information for clinical coding [25].  
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Table 1. Changes in APR-DRG classification and hospital payments in Portuguese data, by MDC and procedure category 
 
 MDC 4 - Diseases and Disorders of the Respiratory System 
 
MDC 5 - Diseases and Disorders of the Circulatory System 
 
 Percentage of APR-DRG 
Change (%) 
Differences in 
hospital payments 
(€) 
 
Relative 
Percentage 
Change in 
hospital 
payments 
(%) 
Percentage of APR-DRG 
Change (%) 
Differences in 
hospital payments 
(€) 
 
Relative 
Percentag
e Change 
in hospital 
payments 
(%) 
Minor diagnostic 1,3%(611/47887 episodes) -34.615 € ~0 34,9%(44223/126673 episodes) -33.206.988,5 € -8,8 
Minor therapeutic 5,3%(7448/139661 episodes) -58.667.767,5 € -14,4 18,8%(34237/182491 episodes) -38.035.326,8 € -5,6 
Major diagnostic 50,7%(2713/5352 episodes) -4.649.423 € -26,5 33,2%(249/751 episodes) -753.102 € -19,8 
Major therapeutic 86,2%(11204/13004 
episodes) 
-25.768.256,8 € -47 65,5%(93191/142250 episodes) -256.368.054,6 € -41,8 
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Table 2. Changes in APR-DRG classification and hospital payments in Brazilian data, by MDC and procedure category 
 
 MDC 4 - Diseases and Disorders of the Respiratory System 
 
MDC 5 - Diseases and Disorders of the Circulatory System 
 
 Percentage of APR-DRG 
Change (%) 
Differences in 
hospital payments 
(€) 
 
Relative 
Percentage 
Change in 
hospital 
payments 
(%) 
Percentage of APR-DRG 
Change (%) 
Differences in 
hospital payments 
(€) 
 
Relative 
Percentag
e Change 
in hospital 
payments 
(%) 
Minor diagnostic 0,9%(5/546 episodes) 250,20 € 0 60,9%(1019/1672 episodes) -610.565,4 € -18,3 
Minor therapeutic 1,6%(18/1124 episodes) -10.950,6 € -0,6 27,4%(947/3454 episodes) -1.390.037,1 € -19,9 
Major diagnostic 41,2%(42/102 episodes) -71.849,7 € -34,6 37,1%(13/35 episodes) -8.913,6 € -15,2 
Major therapeutic 51,4%(390/759 episodes) -695.092,9 € -40,3 79,2%(9440/11914 episodes) -13.267.813,5 € -48,1 
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Table 3. Proportion of APR-DRG changes, by SOI level and base APR-DRG 
 
 MDC 4  MDC 5 
 Portugal Brazil  Portugal Brazil 
 
Minor Diagnostic 
  
 Minor Diagnostic 
SOI 1 1,4%(261/19071 episodes) 0,2%(1/454 episodes)  1,4%(1067/77456 episodes) 0,4%(5/1331 episodes) 
SOI 2 0,8%(126/15895 episodes) 6,3%(4/63 episodes)  2,5%(838/33968 episodes) 2,9%(6/207 episodes) 
SOI 3 1,6%(170/10490 episodes) 0%(0/21 episodes)  1,6%(183/11488 episodes) 1,7%(2/119 episodes) 
SOI 4 1,2%(28/2431 episodes) 0%(0/8 episodes)  1,4%(54/3761 episodes) 0%(0/15 episodes) 
Another base APR-DRG 0,1%(26/47887 episodes) 0%(0/546 episodes)  33,2%(42081/126673 episodes) 60,2%(1006/1672 episodes) 
      
 
Minor Therapeutic 
 Minor Therapeutic 
 
SOI 1 0,6%(156/25836 episodes) 0,4%(3/838 episodes)  0,5%(366/78668 episodes) 0,4%(11/2625 episodes) 
SOI 2 1,7%(767/46420 episodes) 4,5%(8/178 episodes)  1,4%(839/60779 episodes) 0,3%(1/308 episodes) 
SOI 3 1,9%(1034/54712 episodes) 3,4%(3/89 episodes)  3,8%(1225/32222 episodes) 22,8%(114/501 episodes) 
SOI 4 0,7%(89/12693 episodes) 15,8%(3/19 episodes)  8,8%(953/10822 episodes) 5%(1/20 episodes) 
Another base APR-DRG 3,9%(5402/139661 episodes) 0,1%(1/1124 episodes)  16,9%(30854/182491 episodes) 23,7%(820/3454 episodes) 
      
 
Major Diagnostic 
 Major Diagnostic 
 
SOI 1 1%(31/3004 episodes) 0%(0/88 episodes)  0,9%(2/216 episodes) 0%(0/31 episodes) 
SOI 2 1,4%(18/1324 episodes) 0%(0/8 episodes)  4,5%(13/288 episodes) 33,3%(1/3 episodes) 
SOI 3 4,2%(37/877 episodes) 0%(0/4 episodes)  2,3%(4/176 episodes) 100%(1/1 episodes) 
SOI 4 2%(3/147 episodes) 0%(0/2 episodes)  2,8%(2/71 episodes) - 
Another base APR-DRG 49%(2624/5352 episodes) 41,2%(42/102 episodes)  30,4%(228/751 episodes) 31,4%(11/35 episodes) 
      
 Major Therapeutic  Major Therapeutic 
 
SOI 1 0,2%(16/8797 episodes) 0,7%(4/589 episodes)  0,3%(319/92762 episodes) 0,1%(8/10918 episodes) 
SOI 2 1,2%(28/2373 episodes) 1%(1/101 episodes)  1,1%(408/37130 episodes) 9,9%(67/678 episodes) 
SOI 3 1,3%(17/1289 episodes) 3,7%(2/54 episodes)  2,9%(252/8565 episodes) 2,8%(6/218 episodes) 
SOI 4 0,7%(4/545 episodes) 33,3%(5/15 episodes)  6,7%(254/3793 episodes) 1%(1/100 episodes) 
216 
 
Another base APR-DRG 85,7%(11139/13004 episodes) 49,8%(378/759 episodes)  64,6%(91958/142250 episodes) 78,5%(9358/11914 episodes) 
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Supplementary table 1 - Overview of evaluation metrics obtained with SVM for base APR-DRG and SOI classification 
 
MDC 4 Classification (Diseases and Disorders of the Respiratory System) 
Base APR-DRG Assignment 
APR-DRG Precision Recall % Correctly 
Classified 
% Correctly Classified (2016 unseen data) 
144 - Respiratory System Signs, Symptoms & Other Diagnoses 0.999 0.998 99.8 99.7 
143 - Other Respiratory Diagnosis Except Signs, Symptoms & Minor Diagnoses 0.997 0.997 99.7 94.1 
142 - Interstitial Lung Disease 0.993 0.999 99.9 72.2 
141 - Asthma 0.999 1.000 100.0 99.1 
140 - Chronic Obstructive Pulmonary Disease 0.999 1.000 100.0 100.0 
139 - Other Pneumonia 0.998 0.999 99.9 99.9 
138 - Bronchiolitis & RSV Pneumonia 0.987 1.000 100.0 100 
137 - Major Respiratory Infections & Inflammations 0.989 0.998 99.8 99.8 
136 - Respiratory Malignancy 0.997 0.999 99.9 99.9 
135 - Major Chest & Respiratory Trauma 0.995 0.996 99.6 99.9 
134 - Pulmonary Embolism 0.994 1.000 100 100.0 
133 - Pulmonary Edema & Respiratory Failure 0.990 0.998 99.8 99.9 
132 - BPD & Oth Chronic Respiratory Dis Arising In Perinatal Period 0.967 1.000 100 100.0 
131 - Cystic Fibrosis - Pulmonary Disease 0.985 1.000 100 100.0 
130 - Respiratory System Diagnosis w/ Ventilator Support 96+ Hours 0.963 0.845 84.5 99.6 
121 - Other Respiratory & Chest Procedures 1.000 0.955 95.5 99.6 
120 - Major Respiratory & Chest Procedures 1.000 0.992 99.2 99.7 
     
     
Severity of Illness (SOI) subclass Assignment 
Severity of Illness (SOI) Precision Recall % Correctly 
Classified 
% Correctly Classified (2016 unseen data) 
1 (Minor) 0.918 0.922 92.2 92.1 
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2 (Moderate) 0.870 0.867 86.7 85.3 
3 (Major) 0.878 0.882 88.2 89.2 
4 (Extreme) 0.903 0.879 87.9 88.4 
     
     
MDC 5 Classification (Diseases and Disorders of the Circulatory System) 
Base APR-DRG Assignment 
APR-DRG Precision Recall % Correctly 
Classified 
% Correctly Classified (2016 unseen data) 
199 - Hypertension 0.992 0.999 99.9 91.5 
198 - Angina Pectoris & Coronary Atherosclerosis 0.997 0.999 99.9 98.1 
197 - Peripheral & Other Vascular Disorders 0.993 1.000 100.0 98.1 
196 - Cardiac Arrest 0.980 0.990 99.0 99.8 
194 - Heart Failure 0.999 1.000 100.0 96.9 
193 - Acute & Subacute Endocarditis 0.960 1.000 100.0 100 
192 - Cardiac Catheterization for Ischemic Heart Disease 0.998 1.000 100.0 95.8 
191 - Cardiac Catheterization w/ Circ Disord Exc Ischemic Heart Disease 0.996 0.998 99.8 95.9 
190 - Acute Myocardial Infarction 0.997 1.000 100.0 97.5 
180 - Other Circulatory System Procedures 0.998 0.989 98.9 100 
177 - Cardiac Pacemaker & Defibrillator Revision Except Device Replacement 0.991 0.983 98.3 99.2 
176 - Cardiac Pacemaker & Defibrillator Device Replacement 0.988 0.989 98.9 99.9 
175 - Percutaneous Cardiovascular Procedures w/o AMI 0.999 1.000 100.0 99.8 
174 - Percutaneous Cardiovascular Procedures w/ AMI 0.999 1.000 100.0 98.7 
173 - Other Vascular Procedures 0.998 0.992 99.2 97.4 
171 - Perm Cardiac Pacemaker Implant w/o AMI, Heart Failure or Shock 0.992 0.999 99.9 97.8 
170 - Permanent Cardiac Pacemaker Implant w/ AMI, Heart Failure or Shock 0.963 0.973 97.3 99.9 
207 - Other Circulatory System Diagnoses 0.997 0.992 99.2 99.6 
206 - Malfunction, Reaction & Comp of Cardiac or Vasc Device or Proc 0.979 0.994 99.4 99.9 
219 
 
205 - Cardiomyopathy 0.997 0.994 99.4 100 
204 - Syncope & Collapse 0.995 0.998 99.8 100 
203 - Chest Pain 0.997 1.000 100.0 99.5 
169 - Major Thoracic & Abdominal Vascular Procedures 0.990 0.960 96.0 99.9 
201 - Cardiac Arrhythmia & Conduction Disorders 0.998 0.995 99.5 100 
200 - Cardiac Congenital & Valvular Disorders 0.993 0.996 99.6 100 
167 - Other Cardiothoracic Procedures 0.980 0.949 94.9 99.4 
166 - Coronary Bypass w/o Cardiac Cath Or Percutaneous Cardiac Procedure 0.995 0.999 99.9 98.7 
165 - Coronary Bypass w/ Cardiac Cath Or Percutaneous Cardiac Procedure 0.994 0.978 97.8 100 
163 - Cardiac Valve Procedures w/o Cardiac Catheterization 0.999 0.997 99.7 100 
162 - Cardiac Valve Procedures w/ Cardiac Catheterization 0.981 0.972 97.2 99.6 
161 - Cardiac Defibrillator & Heart Assist Anomaly 0.999 0.977 97.7 100 
160 - Major Cardiothoracic Repair of Heart Anomaly 1.000 0.929 92.9 99.2 
     
     
Severity of Illness (SOI) subclass Assignment 
Severity of Illness (SOI) Precision Recall % Correctly 
Classified 
% Correctly Classified (2016 unseen data) 
1 (Minor) 0.923 0.945 94.5 94.2 
2 (Moderate) 0.855 0.839 83.9 84.3 
3 (Major) 0.822 0.813 81.3 83.8 
4 (Extreme) 0.902 0.819 81.9 81.2 
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Supplementary table 2 – Descending ranking of procedures according to their effects on APR-DRG changes for respiratory system diseases (Portugal) 
Procedure Percentage 
change of 
APR-DRG  
Number of 
episodes that 
changed their 
APR-DRG 
Total 
differences in 
hospital 
payments (€) 
Percentage 
change in 
hospital 
payments 
Procedure 
category 
3179 - Other repair and plastic operations on trachea 100 64/64 episodes -135.441 € -42,5 major therapeutic 
3791 - Open chest cardiac massage 100 6/6 episodes -41.659,90 € -49,4 major therapeutic 
3805 - Incision of vessel, other thoracic vessels 100 8/8 episodes -19.330,20 € -54 major therapeutic 
3815 - Endarterectomy, other thoracic vessels 100 9/9 episodes -30.637 € -57,8 major therapeutic 
9227 - Implantation or insertion of radioactive elements 100 53/53 episodes -66.055,50 € -51,3 major therapeutic 
3474 - Repair of pectus deformity 99 378/382 episodes -798.706,70 € -65,6 major therapeutic 
3241 - Thoracoscopic lobectomy of lung 97,5 230/236 episodes -393.673,20 € -42,2 major therapeutic 
3393 - Puncture of lung 96,7 59/61 episodes -98.642,70 € -39,7 major therapeutic 
3979 - Other endovascular procedures on other vessels 95,9 47/49 episodes -194.976,40 € -68,5 major therapeutic 
9672 - Continuous invasive mechanical ventilation for 96 consecutive hours or more 92,9 5066/5455 episodes -54.963.416,40 
€ 
-67,6 minor therapeutic 
3224 - Percutaneous ablation of lung lesion or tissue 91,7 44/48 episodes -31.199,40 € -24,2 major therapeutic 
3129 - Other permanent tracheostomy 90,7 107/118 episodes -473.057,50 € -58,8 major therapeutic 
8152 - Partial hip replacement 90 18/20 episodes -103.168,40 € -58,4 major therapeutic 
2769 - Other plastic repair of palate 88,9 8/9 episodes -6.018,90 € -41,5 major therapeutic 
4021 - Excision of deep cervical lymph node 88,7 63/71 episodes -108.906,20 € -41,9 major therapeutic 
3199 - Other operations on trachea 88,4 122/138 episodes -204.940,70 € -38,2 major therapeutic 
8417 - Amputation above knee 86,5 64/74 episodes -580.070,80 € -68,5 major therapeutic 
3249 - Other lobectomy of lung 86,4 2184/2529 episodes -3.334.947,10 € -32,3 major therapeutic 
3162 - Closure of fistula of larynx 85,7 6/7 episodes -8.521,20 € -34,9 major therapeutic 
3991 - Freeing of vessel 85,7 6/7 episodes 1.690,40 € 4 major therapeutic 
7861 - Removal of implanted devices from bone, scapula, clavicle, and thorax [ribs and 
sternum] 
85,7 6/7 episodes -7.476,80 € -50,7 major therapeutic 
3259 - Other and unspecified pneumonectomy 85,4 169/198 episodes -265.213,60 € -28,3 major therapeutic 
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3329 - Other diagnostic procedures on lung or bronchus 85,1 63/74 episodes -97.309 € -34 major diagnostic 
3239 - Other and unspecified segmental resection of lung 84,8 933/1100 episodes -1.863.362,40 € -43,1 major therapeutic 
4023 - Excision of axillary lymph node 84,6 33/39 episodes -50.433,50 € -32,5 major therapeutic 
8411 - Amputation of toe 84,6 22/26 episodes -101.886,10 € -53,7 major therapeutic 
5371 - Laparoscopic repair of diaphragmatic hernia, abdominal approach 84,2 16/19 episodes -22.409 € -47,5 major therapeutic 
7811 - Application of external fixator device, scapula, clavicle, and thorax [ribs and 
sternum] 
84,2 16/19 episodes -19.871,40 € -38,1 major therapeutic 
5384 - Other and open repair of diaphragmatic hernia, with thoracic approach 83,3 5/6 episodes 5.685,10 € 22,5 major therapeutic 
7865 - Removal of implanted devices from bone, femur 83,3 5/6 episodes -11.881,30 € -42,6 major therapeutic 
3009 - Other excision or destruction of lesion or tissue of larynx 81,5 22/27 episodes -27.635,20 € -30 major therapeutic 
3451 - Decortication of lung 80,9 702/868 episodes -775.634,70 € -20 major therapeutic 
5718 - Other suprapubic cystostomy 80 8/10 episodes -21.119,10 € -43,9 major therapeutic 
3174 - Revision of tracheostomy 78,3 72/92 episodes -65.987,10 € -21 major therapeutic 
3250 - Thoracoscopic pneumonectomy 77,8 7/9 episodes -15.558,10 € -31,2 major therapeutic 
5503 - Percutaneous nephrostomy without fragmentation 77,8 7/9 episodes -30.330,90 € -41,6 major therapeutic 
8151 - Total hip replacement 77,8 7/9 episodes -30.880 € -65,7 major therapeutic 
7915 - Closed reduction of fracture with internal fixation, femur 76,9 30/39 episodes -323.445 € -64,2 major therapeutic 
3328 - Open biopsy of lung 75,9 397/523 episodes -479.769,40 € -32 major diagnostic 
3398 - Other operations on bronchus 75,8 25/33 episodes -31.496,70 € -21 major therapeutic 
3230 - Thoracoscopic segmental resection of lung 75,6 671/887 episodes -1.258.556,80 € -40,1 major therapeutic 
3885 - Other surgical occlusion of vessels, thoracic vessels 75,6 59/78 episodes -79.471 € -25,6 major therapeutic 
3334 - Thoracoplasty 75 6/8 episodes -8.505,70 € -34,3 major therapeutic 
7935 - Open reduction of fracture with internal fixation, femur 75 18/24 episodes -184.728,80 € -56 major therapeutic 
7936 - Open reduction of fracture with internal fixation, tibia and fibula 75 6/8 episodes -12.457,10 € -30,7 major therapeutic 
3927 - Arteriovenostomy for renal dialysis 73,9 17/23 episodes -105.922,30 € -53,3 major therapeutic 
1769 - Laser interstitial thermal therapy [LITT] of lesion or tissue of other and unspecified 
site under guidance 
73,2 52/71 episodes -189.191,20 € -44,7 major therapeutic 
3173 - Closure of other fistula of trachea 72,4 21/29 episodes -27.346,40 € -31,1 major therapeutic 
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3780 - Insertion of permanent pacemaker, initial or replacement, type of device not 
specified 
71,4 10/14 episodes -52.885 € -40 major therapeutic 
7855 - Internal fixation of bone without fracture reduction, femur 71,4 5/7 episodes -34.887,80 € -58,3 major therapeutic 
3320 - Thoracoscopic lung biopsy 71,1 128/180 episodes -226.966 € -31,7 major diagnostic 
3226 - Other and unspecified ablation of lung lesion or tissue 70 14/20 episodes -20.976,10 € -32,5 major therapeutic 
3325 - Open biopsy of bronchus 70 7/10 episodes -14.879,50 € -43,4 major diagnostic 
3771 - Initial insertion of transvenous lead [electrode] into ventricle 69,1 47/68 episodes -127.715,70 € -30,9 minor therapeutic 
3772 - Initial insertion of transvenous leads [electrodes] into atrium and ventricle 68,5 50/73 episodes -171.371,10 € -33,3 minor therapeutic 
3192 - Lysis of adhesions of trachea or larynx 66,7 4/6 episodes -3.571,20 € -24,6 major therapeutic 
3845 - Resection of vessel with replacement, thoracic vessels 66,7 4/6 episodes -6.910,80 € -17,5 major therapeutic 
4019 - Other diagnostic procedures on lymphatic structures 66,7 12/18 episodes -50.559 € -40 major diagnostic 
3229 - Other local excision or destruction of lesion or tissue of lung 66 919/1393 episodes -1.138.553,90 € -30,8 major therapeutic 
7932 - Open reduction of fracture with internal fixation, radius and ulna 65 13/20 episodes -24.738,50 € -30,1 major therapeutic 
0782 - Other total excision of thymus 64,7 11/17 episodes -17.419,50 € -38,3 major therapeutic 
5372 - Other and open repair of diaphragmatic hernia, abdominal approach 64,7 11/17 episodes -8.008 € -6,5 major therapeutic 
3421 - Transpleural thoracoscopy 64,5 599/929 episodes -1.335.175,60 € -34,8 major diagnostic 
5419 - Other laparotomy 64,3 18/28 episodes -105.296,70 € -32 major therapeutic 
7939 - Open reduction of fracture with internal fixation, other specified bone 63,6 14/22 episodes -3.843,60 € -4,5 major therapeutic 
3209 - Other local excision or destruction of lesion or tissue of bronchus 62,7 42/67 episodes -91.789,80 € -29,6 major therapeutic 
2161 - Turbinectomy by diathermy or cryosurgery 62,5 5/8 episodes -2.215,40 € -19,6 major therapeutic 
3818 - Endarterectomy, lower limb arteries 62,5 5/8 episodes -23.250,10 € -22,4 major therapeutic 
7841 - Other repair or plastic operations on bone, scapula, clavicle, and thorax [ribs and 
sternum] 
62,5 10/16 episodes -8.943,70 € -17,7 major therapeutic 
3198 - Other operations on larynx 60,9 14/23 episodes -27.549,80 € -34,3 major therapeutic 
7761 - Local excision of lesion or tissue of bone, scapula, clavicle, and thorax [ribs and 
sternum] 
60,7 17/28 episodes -21.739,20 € -28,8 major therapeutic 
3942 - Revision of arteriovenous shunt for renal dialysis 60 6/10 episodes -29.717,60 € -36,1 major therapeutic 
5749 - Other transurethral excision or destruction of lesion or tissue of bladder 60 18/30 episodes -35.489,20 € -25,6 major therapeutic 
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3479 - Other repair of chest wall 59,4 38/64 episodes -39.505 € -15,5 major therapeutic 
3782 - Initial insertion of single-chamber device, rate responsive 59 23/39 episodes -69.468,60 € -25,9 minor therapeutic 
3422 - Mediastinoscopy 58,8 365/621 episodes -458.432,10 € -29,2 major diagnostic 
4011 - Biopsy of lymphatic structure 58,3 392/672 episodes -698.385,10 € -26,5 major diagnostic 
3222 - Lung volume reduction surgery 57,9 11/19 episodes -23.479,30 € -36,1 major therapeutic 
4611 - Temporary colostomy 57,9 11/19 episodes -132.688,80 € -42,1 major therapeutic 
5411 - Exploratory laparotomy 57,4 39/68 episodes -89.648,70 € -11,4 major therapeutic 
3950 - Angioplasty of other non-coronary vessel(s) 55,8 24/43 episodes -49.563,70 € -23,2 major therapeutic 
5123 - Laparoscopic cholecystectomy 55,6 5/9 episodes -23.589 € -45,2 major therapeutic 
3808 - Incision of vessel, lower limb arteries 54,5 6/11 episodes -23.425,60 € -14,6 major therapeutic 
4024 - Excision of inguinal lymph node 54,5 6/11 episodes -37.038 € -51,1 major therapeutic 
3429 - Other diagnostic procedures on mediastinum 54,2 13/24 episodes -29.255,50 € -26,4 major diagnostic 
5381 - Plication of the diaphragm 53,6 15/28 episodes -22.063,90 € -20,6 major therapeutic 
4901 - Incision of perianal abscess 52,9 9/17 episodes -51.476,50 € -50,2 major therapeutic 
4573 - Open and other right hemicolectomy 51,7 15/29 episodes -143.594 € -28,7 major therapeutic 
3499 - Other operations on thorax 51,1 23/45 episodes -67.445,60 € -21,2 major therapeutic 
3420 - Thoracoscopic pleural biopsy 50,8 327/644 episodes -565.762,60 € -23,2 major diagnostic 
3220 - Thoracoscopic excision of lesion or tissue of lung 50,7 138/272 episodes -168.437,30 € -23,1 major therapeutic 
3452 - Thoracoscopic decortication of lung 50,4 237/470 episodes -294.675,90 € -16,5 major therapeutic 
0780 - Thymectomy, not otherwise specified 50 3/6 episodes -3.434,80 € -24,6 major therapeutic 
4466 - Other procedures for creation of esophagogastric sphincteric competence 50 3/6 episodes -22.603 € -44,9 major therapeutic 
4469 - Other repair of stomach 50 4/8 episodes -9.836,90 € -32,5 major therapeutic 
5122 - Cholecystectomy 50 12/24 episodes -73.471,90 € -22,1 major therapeutic 
5383 - Laparoscopic repair of diaphragmatic hernia, with thoracic approach 50 3/6 episodes -3.454,20 € -14,1 major therapeutic 
8016 - Other arthrotomy, knee 50 3/6 episodes -1.746 € -12,1 major therapeutic 
8364 - Other suture of tendon 50 3/6 episodes 192,20 € 0,8 major therapeutic 
3339 - Other surgical collapse of lung 47,6 69/145 episodes -104.571,50 € -17,8 major therapeutic 
224 
 
3781 - Initial insertion of single-chamber device, not specified as rate responsive 47,6 20/42 episodes -67.037,80 € -28,6 minor therapeutic 
3427 - Biopsy of diaphragm 47,4 18/38 episodes -18.152,30 € -13,9 major diagnostic 
3223 - Open ablation of lung lesion or tissue 46,2 48/104 episodes -63.786 € -21,5 major therapeutic 
3712 - Pericardiotomy 46,2 24/52 episodes -79.113,30 € -23,5 major therapeutic 
8165 - Percutaneous vertebroplasty 45,5 5/11 episodes -27.124,30 € -40,6 major therapeutic 
3402 - Exploratory thoracotomy 44,8 91/203 episodes -152.687,30 € -14,3 major therapeutic 
3225 - Thoracoscopic ablation of lung lesion or tissue 44,4 12/27 episodes -13.267,40 € -17,9 major therapeutic 
3343 - Closure of laceration of lung 44,4 20/45 episodes -19.534,10 € -9,2 major therapeutic 
8412 - Amputation through foot 44,4 4/9 episodes -34.957,80 € -42,1 major therapeutic 
3121 - Mediastinal tracheostomy 42,9 3/7 episodes -17.046,10 € -44,3 major therapeutic 
3803 - Incision of vessel, upper limb vessels 42,9 3/7 episodes -34.650 € -46,1 major therapeutic 
3929 - Other (peripheral) vascular shunt or bypass 42,9 3/7 episodes 10.798,20 € 21,9 major therapeutic 
7911 - Closed reduction of fracture with internal fixation, humerus 42,9 3/7 episodes -11.099,40 € -34,9 major therapeutic 
3426 - Open mediastinal biopsy 41 34/83 episodes -49.106,50 € -18,5 major diagnostic 
0781 - Other partial excision of thymus 40 4/10 episodes -5.412 € -20,7 major therapeutic 
3473 - Closure of other fistula of thorax 37,6 35/93 episodes -48.812,10 € -10,7 major therapeutic 
3789 - Revision or removal of pacemaker device 37,5 3/8 episodes -7.304,20 € -18,5 major therapeutic 
7851 - Internal fixation of bone without fracture reduction, scapula, clavicle, and thorax 
[ribs and sternum] 
36,7 11/30 episodes 21.620,50 € 12,3 major therapeutic 
4575 - Open and other left hemicolectomy 36,4 4/11 episodes -40.577,70 € -21 major therapeutic 
7931 - Open reduction of fracture with internal fixation, humerus 36,4 4/11 episodes -6.224,10 € -10,1 major therapeutic 
7731 - Other division of bone, scapula, clavicle, and thorax [ribs and sternum] 35,7 5/14 episodes -353,50 € -0,8 major therapeutic 
0066 - Percutaneous transluminal coronary angioplasty [PTCA] 34,4 22/64 episodes -55.366,70 € -9 major therapeutic 
0012 - Administration of inhaled nitric oxide 33,3 2/6 episodes -7.559 € -8 minor therapeutic 
0022 - Intravascular imaging of intrathoracic vessels 33,3 2/6 episodes 1.067,30 € 4,2 minor diagnostic 
0124 - Other craniotomy 33,3 2/6 episodes -24.873,40 € -40,2 major therapeutic 
3342 - Closure of bronchial fistula 33,3 4/12 episodes -8.054,20 € -8,1 major therapeutic 
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3941 - Control of hemorrhage following vascular surgery 33,3 2/6 episodes -6.772,10 € -12,7 major therapeutic 
4022 - Excision of internal mammary lymph node 33,3 3/9 episodes 1.970,60 € 7,6 major therapeutic 
5012 - Open biopsy of liver 33,3 2/6 episodes -3.452,60 € -16,9 major diagnostic 
7869 - Removal of implanted devices from bone, other bones 33,3 2/6 episodes -5.613,10 € -18,2 major therapeutic 
8670 - Pedicle or flap graft, not otherwise specified 33,3 2/6 episodes -1.355,90 € -5,9 major therapeutic 
3482 - Suture of laceration of diaphragm 32 8/25 episodes -12.410,50 € -13,8 major therapeutic 
5091 - Percutaneous aspiration of liver 31,6 6/19 episodes -9.786 € -17,7 minor therapeutic 
3406 - Thoracoscopic drainage of pleural cavity 31,3 181/579 episodes -359.876,80 € -14,5 major therapeutic 
4562 - Other partial resection of small intestine 31 9/29 episodes -127.105,90 € -25,3 major therapeutic 
3399 - Other operations on lung 30,2 42/139 episodes -68.430 € -13,1 major therapeutic 
6829 - Other excision or destruction of lesion of uterus 30 3/10 episodes -8.644,40 € -18,6 major therapeutic 
0159 - Other excision or destruction of lesion or tissue of brain 28,6 2/7 episodes -7.064,30 € -22,9 major therapeutic 
3822 - Percutaneous angioscopy 28,6 2/7 episodes -1.026,60 € -4,2 minor diagnostic 
9670 - Continuous invasive mechanical ventilation of unspecified duration 28 199/711 episodes -201.003,70 € -7 minor therapeutic 
3949 - Other revision of vascular procedure 27,3 3/11 episodes -12.746,60 € -8,3 major therapeutic 
3428 - Other diagnostic procedures on chest wall, pleura, and diaphragm 26,9 7/26 episodes -34.083,70 € -26,5 major diagnostic 
3493 - Repair of pleura 26,7 4/15 episodes -8.704,90 € -11 major therapeutic 
3998 - Control of hemorrhage, not otherwise specified 26,7 23/86 episodes -81.675,30 € -20,8 major therapeutic 
3221 - Plication of emphysematous bleb 26,3 10/38 episodes -10.725 € -9,6 major therapeutic 
0309 - Other exploration and decompression of spinal canal 25 5/20 episodes -14.419,30 € -13,4 major therapeutic 
4620 - Ileostomy, not otherwise specified 25 2/8 episodes -12.093,60 € -8,4 major therapeutic 
5349 - Other open umbilical herniorrhaphy 25 2/8 episodes 2.376,40 € 3,9 major therapeutic 
0046 - Insertion of two vascular stents 23,5 4/17 episodes 5.513,20 € 3,6 minor therapeutic 
8415 - Other amputation below knee 23,1 3/13 episodes -22.312,80 € -17,5 major therapeutic 
0040 - Procedure on single vessel 22,4 22/98 episodes -36.303,90 € -5,3 minor therapeutic 
8674 - Attachment of pedicle or flap graft to other sites 21,9 7/32 episodes -2.064,70 € -1,5 major therapeutic 
3783 - Initial insertion of dual-chamber device 21,7 18/83 episodes -54.900,80 € -10,4 minor therapeutic 
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3484 - Other repair of diaphragm 20,7 6/29 episodes -4.997,10 € -3,4 major therapeutic 
0392 - Injection of other agent into spinal canal 20 4/20 episodes -4.072,80 € -8,2 minor therapeutic 
5300 - Unilateral repair of inguinal hernia, not otherwise specified 20 2/10 episodes -3.871,20 € -5,3 major therapeutic 
5412 - Reopening of recent laparotomy site 20 2/10 episodes 6.839 € 5,4 major therapeutic 
8162 - Fusion or refusion of 2-3 vertebrae 20 3/15 episodes -14.903,20 € -24,3 major therapeutic 
9671 - Continuous invasive mechanical ventilation for less than 96 consecutive hours 19,9 804/4044 episodes -1.014.853,20 € -5,9 minor therapeutic 
3459 - Other excision of pleura 19,8 99/499 episodes -151.540,40 € -7,6 major therapeutic 
4029 - Simple excision of other lymphatic structure 18,8 57/304 episodes 11.440,40 € 1,1 major therapeutic 
2311 - Removal of residual root 18,2 6/33 episodes -12.344,90 € -10,7 minor therapeutic 
2611 - Closed [needle] biopsy of salivary gland or duct 18,2 4/22 episodes 6.921,30 € 14,7 minor diagnostic 
7904 - Closed reduction of fracture without internal fixation, phalanges of hand 17,6 3/17 episodes -1.829,80 € -5 minor therapeutic 
7905 - Closed reduction of fracture without internal fixation, femur 17,6 6/34 episodes -6.358 € -6,4 minor therapeutic 
8052 - Intervertebral chemonucleolysis 17,6 3/17 episodes -1.493,20 € -3,8 minor therapeutic 
0531 - Injection of anesthetic into sympathetic nerve for analgesia 16,7 1/6 episodes -746,70 € -6,8 minor therapeutic 
2001 - Myringotomy with insertion of tube 16,7 1/6 episodes -443,10 € -5 major therapeutic 
5423 - Biopsy of peritoneum 16,7 1/6 episodes -2.358,60 € -5,5 major diagnostic 
5631 - Ureteroscopy 16,7 2/12 episodes -2.417,30 € -4,7 minor diagnostic 
7791 - Total ostectomy, scapula, clavicle, and thorax [ribs and sternum] 16,7 4/24 episodes -4.865,20 € -4,9 major therapeutic 
7741 - Biopsy of bone, scapula, clavicle, and thorax [ribs and sternum] 15,6 7/45 episodes -13.127,80 € -10,7 major diagnostic 
3724 - Biopsy of pericardium 15,4 4/26 episodes -23.241,90 € -13,2 major diagnostic 
4229 - Other diagnostic procedures on esophagus 15,4 2/13 episodes 1.513,60 € 7,9 minor diagnostic 
7781 - Other partial ostectomy, scapula, clavicle, and thorax [ribs and sternum] 15,4 4/26 episodes -9.802,40 € -11,3 major therapeutic 
2729 - Other diagnostic procedures on oral cavity 14,3 3/21 episodes -1.439,10 € -4,3 minor diagnostic 
5791 - Sphincterotomy of bladder 14,3 1/7 episodes -1.691,10 € -2,3 major therapeutic 
8665 - Heterograft to skin 14,3 1/7 episodes -1.795,50 € -5,3 major therapeutic 
2912 - Pharyngeal biopsy 13,6 3/22 episodes 4.147,30 € 5,5 minor diagnostic 
3403 - Reopening of recent thoracotomy site 13,3 12/90 episodes -18.589,60 € -3,4 major therapeutic 
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5424 - Closed [percutaneous] [needle] biopsy of intra-abdominal mass 13,2 5/38 episodes -9.828,50 € -7,9 minor diagnostic 
9983 - Other phototherapy 13 3/23 episodes -42,50 € -0,1 minor therapeutic 
3770 - Initial insertion of lead [electrode], not otherwise specified 12,5 2/16 episodes -4.622,80 € -5 minor therapeutic 
4610 - Colostomy, not otherwise specified 12,5 1/8 episodes -9.123,10 € -7,8 major therapeutic 
9225 - Teleradiotherapy using electrons 12,5 1/8 episodes 2.426,70 € 9,3 minor therapeutic 
4292 - Dilation of esophagus 12,2 5/41 episodes -2.227 € -1,8 minor therapeutic 
3996 - Total body perfusion 12,1 18/149 episodes 1.671,70 € 0,6 minor therapeutic 
9902 - Transfusion of previously collected autologous blood 12 3/25 episodes -4.037,40 € -3,6 minor therapeutic 
5188 - Endoscopic removal of stone(s) from biliary tract 11,4 4/35 episodes -1.921 € -1,4 minor therapeutic 
5198 - Other percutaneous procedures on biliary tract 11,1 1/9 episodes -1.740 € -4,2 minor therapeutic 
5422 - Biopsy of abdominal wall or umbilicus 11,1 1/9 episodes 541,50 € 1,7 major diagnostic 
5717 - Percutaneous cystostomy 10,4 13/125 episodes -12.894 € -2,4 minor therapeutic 
3348 - Other repair and plastic operations on bronchus 10,2 21/206 episodes -17.528,90 € -1,8 major therapeutic 
4719 - Other incidental appendectomy 10 1/10 episodes 653,10 € 1,1 major therapeutic 
6812 - Hysteroscopy 10 1/10 episodes -2.426,70 € -10 minor diagnostic 
3606 - Insertion of non-drug-eluting coronary artery stent(s) 9,7 3/31 episodes -13.018,10 € -4,8 minor therapeutic 
8105 - Dorsal and dorsolumbar fusion of the posterior column, posterior technique 9,6 7/73 episodes -15.195,70 € -7,6 major therapeutic 
8651 - Replantation of scalp 9,5 2/21 episodes 1.051,60 € 1,5 minor therapeutic 
3194 - Injection of locally-acting therapeutic substance into trachea 9,1 1/11 episodes -760 € -1,7 minor therapeutic 
5523 - Closed [percutaneous] [needle] biopsy of kidney 9 8/89 episodes -8.289,30 € -3 minor diagnostic 
8511 - Closed [percutaneous] [needle] biopsy of breast 8,9 7/79 episodes -10.217,60 € -5 minor diagnostic 
3892 - Umbilical vein catheterization 8,8 5/57 episodes -20.565,90 € -4,7 minor therapeutic 
4543 - Endoscopic destruction of other lesion or tissue of large intestine 8,5 4/47 episodes 4.186,10 € 2,4 minor therapeutic 
5733 - Closed [transurethral] biopsy of bladder 8,3 1/12 episodes 443,50 € 1 major diagnostic 
3931 - Suture of artery 7,9 3/38 episodes 1.536,20 € 0,7 major therapeutic 
9228 - Injection or instillation of radioisotopes 7,8 6/77 episodes -3.120,20 € -2,2 minor therapeutic 
2724 - Biopsy of mouth, unspecified structure 7,7 1/13 episodes 1.740 € 6,2 minor diagnostic 
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4576 - Open and other sigmoidectomy 7,7 1/13 episodes 9.032,80 € 4,6 major therapeutic 
4593 - Other small-to-large intestinal anastomosis 7,7 1/13 episodes -1.566,40 € -0,9 major therapeutic 
8669 - Other skin graft to other sites 7,7 1/13 episodes -13.824,20 € -16,9 major therapeutic 
0711 - Closed [percutaneous] [needle] biopsy of adrenal gland 7,1 1/14 episodes -2.144,70 € -6,4 minor diagnostic 
3749 - Other repair of heart and pericardium 6,9 2/29 episodes -12.306,10 € -8,1 major therapeutic 
8104 - Dorsal and dorsolumbar fusion of the anterior column, anterior technique 6,7 1/15 episodes -386,20 € -0,8 major therapeutic 
3193 - Replacement of laryngeal or tracheal stent 6,5 4/62 episodes -3.925,60 € -2 minor therapeutic 
3778 - Insertion of temporary transvenous pacemaker system 6,5 7/107 episodes -35.092,60 € -4,3 minor therapeutic 
8605 - Incision with removal of foreign body or device from skin and subcutaneous tissue 6,4 5/78 episodes 1.176,80 € 0,4 minor therapeutic 
2171 - Closed reduction of nasal fracture 6,2 1/16 episodes -525,80 € -1,5 minor therapeutic 
4519 - Other diagnostic procedures on small intestine 6,2 1/16 episodes 541,50 € 1,3 minor diagnostic 
5498 - Peritoneal dialysis 6,2 9/145 episodes -1.929,90 € -0,6 minor therapeutic 
7906 - Closed reduction of fracture without internal fixation, tibia and fibula 6,1 3/49 episodes 2.950,40 € 2,7 minor therapeutic 
9971 - Therapeutic plasmapheresis 6,1 2/33 episodes -11.719,10 € -6,2 minor therapeutic 
4443 - Endoscopic control of gastric or duodenal bleeding 5,9 9/153 episodes -9.855,20 € -1,4 minor therapeutic 
8452 - Insertion of recombinant bone morphogenetic protein 5,9 1/17 episodes 410,20 € 1 minor therapeutic 
9222 - Orthovoltage radiation 5,8 3/52 episodes 5.220,10 € 3,9 minor therapeutic 
3172 - Closure of external fistula of trachea 5,7 7/122 episodes 9.198,70 € 3,8 major therapeutic 
3990 - Insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s) 5,6 2/36 episodes 2.417,30 € 2,4 minor therapeutic 
3379 - Endoscopic insertion of other bronchial device or substances 5,4 11/202 episodes -11.457 € -1,8 minor therapeutic 
4233 - Endoscopic excision or destruction of lesion or tissue of esophagus 5,3 2/38 episodes -2.417,30 € -1,5 minor therapeutic 
0023 - Intravascular imaging of peripheral vessels 5 1/20 episodes -990,30 € -1,7 minor diagnostic 
8611 - Closed biopsy of skin and subcutaneous tissue 5 17/341 episodes 25.581 € 2,2 minor diagnostic 
9973 - Therapeutic erythrocytapheresis 5 1/20 episodes -12.466,30 € -12,8 minor therapeutic 
4224 - Closed [endoscopic] biopsy of esophagus 4,9 3/61 episodes 704 € 0,4 minor diagnostic 
7909 - Closed reduction of fracture without internal fixation, other specified bone 4,9 4/82 episodes -2.650,40 € -2,2 minor therapeutic 
3471 - Suture of laceration of chest wall 4,8 1/21 episodes 1.792,10 € 2,7 minor therapeutic 
229 
 
5110 - Endoscopic retrograde cholangiopancreatography [ERCP] 4,8 4/83 episodes -2.192,50 € -0,8 minor diagnostic 
5994 - Replacement of cystostomy tube 4,8 1/21 episodes 541,50 € 0,7 minor therapeutic 
8604 - Other incision with drainage of skin and subcutaneous tissue 4,8 8/166 episodes 5.647,40 € 0,9 minor therapeutic 
3723 - Combined right and left heart cardiac catheterization 4,5 4/89 episodes 9.124 € 3,3 minor diagnostic 
5101 - Percutaneous aspiration of gallbladder 4,5 1/22 episodes 2.673,40 € 2,1 minor therapeutic 
4131 - Biopsy of bone marrow 4,3 38/877 episodes -7.855,80 € -0,3 minor diagnostic 
3391 - Bronchial dilation 4,2 2/48 episodes 3.591,80 € 2,5 minor therapeutic 
8396 - Injection of therapeutic substance into bursa 4,2 1/24 episodes -760 € -1,5 minor therapeutic 
8855 - Coronary arteriography using a single catheter 4,2 3/71 episodes 1.495,10 € 0,5 minor diagnostic 
8622 - Excisional debridement of wound, infection, or burn 4,1 10/244 episodes -28.556,80 € -2,5 major therapeutic 
0068 - Intravascular pressure measurement of peripheral arteries 4 4/99 episodes 11.261,60 € 1,1 minor diagnostic 
9226 - Teleradiotherapy of other particulate radiation 4 1/25 episodes 410,20 € 0,7 minor therapeutic 
4281 - Insertion of permanent tube into esophagus 3,9 3/76 episodes 3.510,50 € 1,4 minor therapeutic 
3141 - Tracheoscopy through artificial stoma 3,8 1/26 episodes -9.222 € -9,4 minor diagnostic 
8321 - Open biopsy of soft tissue 3,8 2/52 episodes 2.738,80 € 1,3 major diagnostic 
0018 - Infusion of immunosuppressive antibody therapy 3,7 1/27 episodes -1.740 € -1,8 minor therapeutic 
3607 - Insertion of drug-eluting coronary artery stent(s) 3,7 1/27 episodes -4.421,90 € -1,6 minor therapeutic 
0881 - Linear repair of laceration of eyelid or eyebrow 3,6 1/28 episodes 990,30 € 1,8 minor therapeutic 
4319 - Other gastrostomy 3,6 1/28 episodes -1.552,40 € -1 minor therapeutic 
2309 - Extraction of other tooth 3,5 5/144 episodes -371,50 € -0,1 minor therapeutic 
8607 - Insertion of totally implantable vascular access device [VAD] 3,5 7/202 episodes -3.365,30 € -0,5 minor therapeutic 
2202 - Aspiration or lavage of nasal sinus through natural ostium 3,4 3/87 episodes 2.633,70 € 3,6 minor therapeutic 
3144 - Closed [endoscopic] biopsy of trachea 3,4 1/29 episodes 443,50 € 0,5 minor diagnostic 
3728 - Intracardiac echocardiography 3,4 4/117 episodes 4.895,60 € 1,9 minor diagnostic 
8853 - Angiocardiography of left heart structures 3,4 5/149 episodes -16.562,60 € -3,3 minor diagnostic 
2101 - Control of epistaxis by anterior nasal packing 3,3 6/180 episodes 4.092,20 € 0,7 minor therapeutic 
2121 - Rhinoscopy 3,3 5/151 episodes -3.212,70 € -0,8 minor diagnostic 
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4059 - Radical excision of other lymph nodes 3,3 9/270 episodes -20.324,60 € -1,8 major therapeutic 
4311 - Percutaneous [endoscopic] gastrostomy [PEG] 3,3 18/553 episodes -5.450,40 € -0,3 minor therapeutic 
7740 - Biopsy of bone, unspecified site 3,3 1/30 episodes 990,30 € 1,4 major diagnostic 
0045 - Insertion of one vascular stent 3,2 2/62 episodes -18.246,20 € -3,9 minor therapeutic 
3321 - Bronchoscopy through artificial stoma 3 2/66 episodes 4.822,50 € 2,3 minor diagnostic 
3409 - Other incision of pleura 3 24/801 episodes -37.865,90 € -1,2 minor therapeutic 
7971 - Closed reduction of dislocation of shoulder 3 2/67 episodes -9.831,70 € -5,7 minor therapeutic 
3731 - Pericardiectomy 2,9 1/35 episodes -1.551,30 € -0,8 major therapeutic 
1621 - Ophthalmoscopy 2,8 4/143 episodes 2.881,60 € 0,6 minor diagnostic 
3481 - Excision of lesion or tissue of diaphragm 2,8 1/36 episodes -1.151,40 € -0,7 major therapeutic 
3721 - Right heart cardiac catheterization 2,8 4/143 episodes -3.683,90 € -0,5 minor diagnostic 
7749 - Biopsy of bone, other bones 2,8 4/141 episodes 72 € 0 major diagnostic 
5491 - Percutaneous abdominal drainage 2,7 25/916 episodes 25.282,20 € 0,7 minor therapeutic 
8609 - Other incision of skin and subcutaneous tissue 2,7 1/37 episodes -3.438,70 € -1,8 minor therapeutic 
9905 - Transfusion of platelets 2,7 31/1131 episodes 20.603,60 € 0,4 minor therapeutic 
2103 - Control of epistaxis by cauterization (and packing) 2,4 1/42 episodes -1.307 € -1,3 minor therapeutic 
5839 - Other local excision or destruction of lesion or tissue of urethra 2,4 2/82 episodes 878,80 € 0,5 minor therapeutic 
3722 - Left heart cardiac catheterization 2,3 11/478 episodes 3.615,60 € 0,2 minor diagnostic 
3894 - Venous cutdown 2,3 3/128 episodes 2.034,30 € 0,6 minor therapeutic 
4414 - Closed [endoscopic] biopsy of stomach 2,3 8/341 episodes -10.091,50 € -1,3 minor diagnostic 
9925 - Injection or infusion of cancer chemotherapeutic substance 2,3 43/1896 episodes 17.033 € 0,3 minor therapeutic 
0390 - Insertion of catheter into spinal canal for infusion of therapeutic or palliative 
substances 
2,2 22/1000 episodes -16.700,40 € -0,4 minor therapeutic 
3228 - Endoscopic excision or destruction of lesion or tissue of lung 2,2 1/45 episodes 1.552,40 € 1,4 minor therapeutic 
3401 - Incision of chest wall 2,2 8/364 episodes -21.193,10 € -2,5 minor therapeutic 
5187 - Endoscopic insertion of stent (tube) into bile duct 2,2 1/45 episodes 1.740 € 1,4 minor therapeutic 
6011 - Closed [percutaneous] [needle] biopsy of prostate 2,2 1/45 episodes 541,50 € 0,4 minor diagnostic 
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8852 - Angiocardiography of right heart structures 2,2 2/90 episodes 3.452,60 € 1,7 minor diagnostic 
9901 - Exchange transfusion 2,2 2/93 episodes -4.429 € -1,3 minor therapeutic 
0014 - Injection or infusion of oxazolidinone class of antibiotics 2 22/1127 episodes -3.944,10 € -0,1 minor therapeutic 
8856 - Coronary arteriography using two catheters 2 5/251 episodes -13.827,40 € -1,4 minor diagnostic 
9908 - Transfusion of blood expander 2 19/961 episodes -23.989,50 € -0,6 minor therapeutic 
3142 - Laryngoscopy and other tracheoscopy 1,9 15/796 episodes -21.413,90 € -0,8 minor diagnostic 
3201 - Endoscopic excision or destruction of lesion or tissue of bronchus 1,9 6/324 episodes 4.449,60 € 0,5 minor therapeutic 
3899 - Other puncture of vein 1,9 111/5866 episodes 102.197,30 € 0,9 minor therapeutic 
4523 - Colonoscopy 1,9 62/3219 episodes -75.231,10 € -0,9 minor diagnostic 
9224 - Teleradiotherapy using photons 1,9 6/314 episodes 11.224,60 € 1,3 minor therapeutic 
3322 - Fiber-optic bronchoscopy 1,8 172/9655 episodes 49.835,60 € 0,2 minor diagnostic 
4516 - Esophagogastroduodenoscopy [EGD] with closed biopsy 1,8 24/1338 episodes 11.999,90 € 0,3 minor diagnostic 
7901 - Closed reduction of fracture without internal fixation, humerus 1,8 1/55 episodes -990,30 € -0,7 minor therapeutic 
8191 - Arthrocentesis 1,8 2/114 episodes -2.542,80 € -1 minor therapeutic 
9915 - Parenteral infusion of concentrated nutritional substances 1,8 20/1127 episodes -22.938,70 € -0,3 minor therapeutic 
0391 - Injection of anesthetic into spinal canal for analgesia 1,7 17/1028 episodes 15.479,80 € 0,4 minor therapeutic 
3327 - Closed endoscopic biopsy of lung 1,7 27/1545 episodes -41.880,20 € -1,1 major diagnostic 
4823 - Rigid proctosigmoidoscopy 1,7 1/58 episodes 541,50 € 0,3 minor diagnostic 
5185 - Endoscopic sphincterotomy and papillotomy 1,7 1/59 episodes 410,20 € 0,2 minor therapeutic 
8628 - Nonexcisional debridement of wound, infection or burn 1,7 6/362 episodes -6.767,20 € -0,6 minor therapeutic 
8659 - Closure of skin and subcutaneous tissue of other sites 1,7 12/719 episodes -19.432,60 € -1,2 minor therapeutic 
3143 - Closed [endoscopic] biopsy of larynx 1,6 1/61 episodes -1.740 € -1,2 minor diagnostic 
4525 - Closed [endoscopic] biopsy of large intestine 1,6 10/608 episodes -1.928,10 € -0,1 minor diagnostic 
3492 - Injection into thoracic cavity 1,5 26/1734 episodes -8.526,90 € -0,2 minor therapeutic 
3895 - Venous catheterization for renal dialysis 1,5 22/1438 episodes 87.403,30 € 0,7 minor therapeutic 
3997 - Other perfusion 1,5 34/2286 episodes -8.051,20 € -0,1 minor therapeutic 
4052 - Radical excision of periaortic lymph nodes 1,5 15/968 episodes -48.290,10 € -1,1 major therapeutic 
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4524 - Flexible sigmoidoscopy 1,4 3/221 episodes 2.347,40 € 0,3 minor diagnostic 
5732 - Other cystoscopy 1,4 1/70 episodes -653 € -0,2 minor diagnostic 
8619 - Other diagnostic procedures on skin and subcutaneous tissue 1,4 5/360 episodes -5.676,90 € -0,9 minor diagnostic 
9907 - Transfusion of other serum 1,4 17/1231 episodes -16.331,10 € -0,2 minor therapeutic 
3898 - Other puncture of artery 1,3 56/4217 episodes -46.463,60 € -0,5 minor therapeutic 
4542 - Endoscopic polypectomy of large intestine 1,3 3/233 episodes 4.751,90 € 0,9 minor therapeutic 
8857 - Other and unspecified coronary arteriography 1,3 4/303 episodes -1.613 € -0,1 minor diagnostic 
9903 - Other transfusion of whole blood 1,3 9/708 episodes -6.928,80 € -0,3 minor therapeutic 
0017 - Infusion of vasopressor agent 1,2 27/2314 episodes 25.564,40 € 0,1 minor therapeutic 
5795 - Replacement of indwelling urinary catheter 1,2 10/847 episodes 5.570,60 € 0,2 minor therapeutic 
7902 - Closed reduction of fracture without internal fixation, radius and ulna 1,2 1/85 episodes 677,30 € 0,4 minor therapeutic 
9909 - Transfusion of other substance 1,2 5/428 episodes 4.753,50 € 0,3 minor therapeutic 
3995 - Hemodialysis 1,1 63/5511 episodes -93.721,10 € -0,4 minor therapeutic 
9223 - Radioisotopic teleradiotherapy 1,1 1/92 episodes 972 € 0,3 minor therapeutic 
0331 - Spinal tap 1 25/2461 episodes -39.853,20 € -0,5 minor diagnostic 
0611 - Closed [percutaneous] [needle] biopsy of thyroid gland 1 2/196 episodes 1.373,30 € 0,3 minor diagnostic 
3891 - Arterial catheterization 1 73/7173 episodes -86.221,60 € -0,1 minor therapeutic 
3893 - Venous catheterization, not elsewhere classified 1 142/14857 episodes -270.605,50 € -0,3 minor therapeutic 
4223 - Other esophagoscopy 1 3/286 episodes -5.132,80 € -0,5 minor diagnostic 
3326 - Closed [percutaneous] [needle] biopsy of lung 0,9 51/5717 episodes 47.415,90 € 0,5 minor diagnostic 
9604 - Insertion of endotracheal tube 0,9 91/9644 episodes 98.633,40 € 0,1 minor therapeutic 
4413 - Other gastroscopy 0,8 7/902 episodes 8.008,20 € 0,4 minor diagnostic 
3491 - Thoracentesis 0,7 86/12259 episodes -6.395,40 € 0 minor therapeutic 
4513 - Other endoscopy of small intestine 0,7 41/6183 episodes -31.333,70 € -0,2 minor diagnostic 
3404 - Insertion of intercostal catheter for drainage 0,6 94/14595 episodes -78.003,30 € -0,2 minor therapeutic 
3424 - Other pleural biopsy 0,6 19/2958 episodes 18.050,60 € 0,2 minor diagnostic 
5011 - Closed (percutaneous) [needle] biopsy of liver 0,6 2/316 episodes 2.556,70 € 0,3 minor diagnostic 
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3323 - Other bronchoscopy 0,5 9/1788 episodes 17.035,60 € 0,3 minor diagnostic 
3324 - Closed [endoscopic] biopsy of bronchus 0,4 47/11114 episodes -24.393,50 € -0,1 minor diagnostic 
3425 - Closed [percutaneous] [needle] biopsy of mediastinum 0,4 2/454 episodes 5.550,70 € 0,6 minor diagnostic 
5794 - Insertion of indwelling urinary catheter 0,4 144/33889 episodes -176.350,50 € -0,2 minor therapeutic 
9229 - Other radiotherapeutic procedure 0,4 3/851 episodes -25.829,70 € -1 minor therapeutic 
3897 - Central venous catheter placement with guidance 0,3 1/333 episodes 4.127,60 € 0,2 minor therapeutic 
9605 - Other intubation of respiratory tract 0,3 19/6435 episodes 8.310,10 € 0,1 minor therapeutic 
9904 - Transfusion of packed cells 0,3 68/21479 episodes -75.661,90 € -0,1 minor therapeutic 
1811 - Otoscopy 0,2 7/4289 episodes 7.516,50 € 0,2 minor diagnostic 
9390 - Non-invasive mechanical ventilation 0,2 81/33157 episodes -166.832,70 € -0,2 minor therapeutic 
0013 - Injection or infusion of nesiritide 0 0/7 episodes 0 € 0 minor therapeutic 
0021 - Intravascular imaging of extracranial cerebral vessels 0 0/20 episodes 0 € 0 minor diagnostic 
0028 - Intravascular imaging, other specified vessel(s) 0 0/11 episodes 0 € 0 minor diagnostic 
0041 - Procedure on two vessels 0 0/17 episodes 0 € 0 minor therapeutic 
0110 - Intracranial pressure monitoring 0 0/10 episodes 0 € 0 minor diagnostic 
0396 - Percutaneous denervation of facet 0 0/6 episodes 0 € 0 minor therapeutic 
0411 - Closed [percutaneous] [needle] biopsy of cranial or peripheral nerve or ganglion 0 0/25 episodes 0 € 0 minor diagnostic 
0481 - Injection of anesthetic into peripheral nerve for analgesia 0 0/37 episodes 0 € 0 minor therapeutic 
0601 - Aspiration of thyroid field 0 0/8 episodes 0 € 0 minor therapeutic 
2009 - Other myringotomy 0 0/18 episodes 0 € 0 minor therapeutic 
2100 - Control of epistaxis, not otherwise specified 0 0/15 episodes 0 € 0 minor therapeutic 
2102 - Control of epistaxis by posterior (and anterior) packing 0 0/33 episodes 0 € 0 minor therapeutic 
2122 - Biopsy of nose 0 0/20 episodes 0 € 0 minor diagnostic 
2131 - Local excision or destruction of intranasal lesion 0 0/10 episodes 0 € 0 minor therapeutic 
2200 - Aspiration and lavage of nasal sinus, not otherwise specified 0 0/201 episodes 0 € 0 minor therapeutic 
2211 - Closed [endoscopic] [needle] biopsy of nasal sinus 0 0/8 episodes 0 € 0 minor diagnostic 
2219 - Other diagnostic procedures on nasal sinuses 0 0/13 episodes 0 € 0 minor diagnostic 
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2301 - Extraction of deciduous tooth 0 0/6 episodes 0 € 0 minor therapeutic 
2319 - Other surgical extraction of tooth 0 0/26 episodes 0 € 0 minor therapeutic 
2751 - Suture of laceration of lip 0 0/16 episodes 0 € 0 minor therapeutic 
2911 - Pharyngoscopy 0 0/43 episodes 0 € 0 minor diagnostic 
3195 - Tracheoesophageal fistulization 0 0/6 episodes 0 € 0 minor therapeutic 
3332 - Artificial pneumothorax for collapse of lung 0 0/29 episodes 0 € 0 minor therapeutic 
3349 - Other repair and plastic operations on lung 0 0/10 episodes 0 € 0 major therapeutic 
3371 - Endoscopic insertion or replacement of bronchial valve(s), single lobe 0 0/24 episodes 0 € 0 minor therapeutic 
3373 - Endoscopic insertion or replacement of bronchial valve(s), multiple lobes 0 0/12 episodes 0 € 0 minor therapeutic 
3378 - Endoscopic removal of bronchial device(s) or substances 0 0/47 episodes 0 € 0 minor therapeutic 
3423 - Biopsy of chest wall 0 0/21 episodes 0 € 0 minor diagnostic 
3489 - Other operations on diaphragm 0 0/6 episodes 0 € 0 major therapeutic 
3521 - Open and other replacement of aortic valve with tissue graft 0 0/7 episodes 0 € 0 major therapeutic 
3611 - (Aorto)coronary bypass of one coronary artery 0 0/6 episodes 0 € 0 major therapeutic 
3725 - Biopsy of heart 0 0/9 episodes 0 € 0 minor diagnostic 
3727 - Cardiac mapping 0 0/15 episodes 0 € 0 minor diagnostic 
3733 - Excision or destruction of other lesion or tissue of heart, open approach 0 0/7 episodes 0 € 0 major therapeutic 
3821 - Biopsy of blood vessel 0 0/19 episodes 0 € 0 major diagnostic 
3865 - Other excision of vessels, thoracic vessels 0 0/12 episodes 0 € 0 major therapeutic 
3932 - Suture of vein 0 0/6 episodes 0 € 0 major therapeutic 
3961 - Extracorporeal circulation auxiliary to open heart surgery 0 0/27 episodes 0 € 0 minor therapeutic 
4050 - Radical excision of lymph nodes, not otherwise specified 0 0/16 episodes 0 € 0 major therapeutic 
4064 - Ligation of thoracic duct 0 0/7 episodes 0 € 0 major therapeutic 
4132 - Closed [aspiration] [percutaneous] biopsy of spleen 0 0/8 episodes 0 € 0 minor diagnostic 
4138 - Other diagnostic procedures on bone marrow 0 0/58 episodes 0 € 0 minor diagnostic 
4341 - Endoscopic excision or destruction of lesion or tissue of stomach 0 0/39 episodes 0 € 0 minor therapeutic 
4412 - Gastroscopy through artificial stoma 0 0/12 episodes 0 € 0 minor diagnostic 
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4442 - Suture of duodenal ulcer site 0 0/7 episodes 0 € 0 major therapeutic 
4512 - Endoscopy of small intestine through artificial stoma 0 0/9 episodes 0 € 0 minor diagnostic 
4514 - Closed [endoscopic] biopsy of small intestine 0 0/31 episodes 0 € 0 minor diagnostic 
4591 - Small-to-small intestinal anastomosis 0 0/11 episodes 0 € 0 major therapeutic 
4621 - Temporary ileostomy 0 0/10 episodes 0 € 0 major therapeutic 
4632 - Percutaneous (endoscopic) jejunostomy [PEJ] 0 0/8 episodes 0 € 0 minor therapeutic 
4639 - Other enterostomy 0 0/12 episodes 0 € 0 minor therapeutic 
4673 - Suture of laceration of small intestine, except duodenum 0 0/6 episodes 0 € 0 major therapeutic 
4824 - Closed [endoscopic] biopsy of rectum 0 0/55 episodes 0 € 0 minor diagnostic 
4836 - [Endoscopic] polypectomy of rectum 0 0/27 episodes 0 € 0 minor therapeutic 
4921 - Anoscopy 0 0/24 episodes 0 € 0 minor diagnostic 
4929 - Other diagnostic procedures on anus and perianal tissue 0 0/6 episodes 0 € 0 minor diagnostic 
4947 - Evacuation of thrombosed hemorrhoids 0 0/6 episodes 0 € 0 minor therapeutic 
5211 - Closed [aspiration] [needle] [percutaneous] biopsy of pancreas 0 0/7 episodes 0 € 0 minor diagnostic 
5380 - Repair of diaphragmatic hernia with thoracic approach, not otherwise specified 0 0/9 episodes 0 € 0 major therapeutic 
5421 - Laparoscopy 0 0/14 episodes 0 € 0 major diagnostic 
5425 - Peritoneal lavage 0 0/9 episodes 0 € 0 minor diagnostic 
5459 - Other lysis of peritoneal adhesions 0 0/13 episodes 0 € 0 major therapeutic 
5461 - Reclosure of postoperative disruption of abdominal wall 0 0/14 episodes 0 € 0 major therapeutic 
5593 - Replacement of nephrostomy tube 0 0/13 episodes 0 € 0 minor therapeutic 
5711 - Percutaneous aspiration of bladder 0 0/39 episodes 0 € 0 minor therapeutic 
5822 - Other urethroscopy 0 0/7 episodes 0 € 0 minor diagnostic 
6811 - Digital examination of uterus 0 0/9 episodes 0 € 0 minor diagnostic 
6816 - Closed biopsy of uterus 0 0/36 episodes 0 € 0 major diagnostic 
6959 - Other aspiration curettage of uterus 0 0/8 episodes 0 € 0 minor therapeutic 
7534 - Other fetal monitoring 0 0/24 episodes 0 € 0 minor diagnostic 
7693 - Closed reduction of temporomandibular dislocation 0 0/12 episodes 0 € 0 minor therapeutic 
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7769 - Local excision of lesion or tissue of bone, other bones 0 0/7 episodes 0 € 0 major therapeutic 
7789 - Other partial ostectomy, other bones 0 0/7 episodes 0 € 0 major therapeutic 
7900 - Closed reduction of fracture without internal fixation, unspecified site 0 0/6 episodes 0 € 0 minor therapeutic 
7903 - Closed reduction of fracture without internal fixation, carpals and metacarpals 0 0/19 episodes 0 € 0 minor therapeutic 
7907 - Closed reduction of fracture without internal fixation, tarsals and metatarsals 0 0/9 episodes 0 € 0 minor therapeutic 
7975 - Closed reduction of dislocation of hip 0 0/15 episodes 0 € 0 minor therapeutic 
7979 - Closed reduction of dislocation of other specified sites 0 0/6 episodes 0 € 0 minor therapeutic 
8051 - Excision of intervertebral disc 0 0/9 episodes 0 € 0 major therapeutic 
8108 - Lumbar and lumbosacral fusion of the anterior column, posterior technique 0 0/10 episodes 0 € 0 major therapeutic 
8163 - Fusion or refusion of 4-8 vertebrae 0 0/37 episodes 0 € 0 major therapeutic 
8164 - Fusion or refusion of 9 or more vertebrae 0 0/44 episodes 0 € 0 major therapeutic 
8166 - Percutaneous vertebral augmentation 0 0/7 episodes 0 € 0 major therapeutic 
8192 - Injection of therapeutic substance into joint or ligament 0 0/13 episodes 0 € 0 minor therapeutic 
8314 - Fasciotomy 0 0/7 episodes 0 € 0 major therapeutic 
8339 - Excision of lesion of other soft tissue 0 0/7 episodes 0 € 0 major therapeutic 
8394 - Aspiration of bursa 0 0/19 episodes 0 € 0 minor therapeutic 
8401 - Amputation and disarticulation of finger 0 0/8 episodes 0 € 0 major therapeutic 
8451 - Insertion of interbody spinal fusion device 0 0/86 episodes 0 € 0 minor therapeutic 
8601 - Aspiration of skin and subcutaneous tissue 0 0/28 episodes 0 € 0 minor therapeutic 
8663 - Full-thickness skin graft to other sites 0 0/6 episodes 0 € 0 major therapeutic 
8699 - Other operations on skin and subcutaneous tissue 0 0/6 episodes 0 € 0 minor therapeutic 
8854 - Combined right and left heart angiocardiography 0 0/27 episodes 0 € 0 minor diagnostic 
9221 - Superficial radiation 0 0/23 episodes 0 € 0 minor therapeutic 
9239 - Stereotactic radiosurgery, not elsewhere classified 0 0/16 episodes 0 € 0 minor therapeutic 
9906 - Transfusion of coagulation factors 0 0/167 episodes 0 € 0 minor therapeutic 
9972 - Therapeutic leukopheresis 0 0/19 episodes 0 € 0 minor therapeutic 
9975 - Administration of neuroprotective agent 0 0/10 episodes 0 € 0 minor therapeutic 
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9979 - Other therapeutic apheresis 0 0/6 episodes 0 € 0 minor therapeutic 
9985 - Hyperthermia for treatment of cancer 0 0/14 episodes 0 € 0 minor therapeutic 
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Supplementary table 3 – Descending ranking of procedures according to their effects on APR-DRG changes for respiratory system diseases (Portugal) 
Procedure 
 
Percentage 
change of 
APR-DRG  
Number of 
episodes that 
changed their 
APR-DRG 
Total 
differences in 
hospital 
payments (€) 
Percentage 
change in 
hospital 
payments 
Procedure 
category 
0525 - Periarterial sympathectomy 100 33/33 episodes -27.241,60 € -45,9 major therapeutic 
3506 - Transapical replacement of aortic valve 100 44/44 episodes -367.075,70 € -73,9 major therapeutic 
3754 - Replacement or repair of other implantable component of (total) replacement heart system 100 18/18 episodes -104.038,60 € -83 major therapeutic 
3767 - Implantation of cardiomyostimulation system 100 9/9 episodes -74.178,60 € -78,1 major therapeutic 
3794 - Implantation or replacement of automatic cardioverter/defibrillator, total system [AICD] 99,8 2637/2642 
episodes 
-16.075.760 € -75,8 major therapeutic 
3796 - Implantation of automatic cardioverter/defibrillator pulse generator only 98,6 73/74 episodes -133.764,20 € -48,4 major therapeutic 
3786 - Replacement of any type of pacemaker device with single-chamber device, rate responsive 98,3 575/585 episodes -410.919,80 € -30,8 major therapeutic 
3734 - Excision or destruction of other lesion or tissue of heart, endovascular approach 98,2 5534/5636 
episodes 
-4.050.146,40 
€ 
-28,6 major therapeutic 
3785 - Replacement of any type pacemaker device with single-chamber device, not specified as 
rate responsive 
98,1 403/411 episodes -257.694 € -28,4 major therapeutic 
3798 - Replacement of automatic cardioverter/defibrillator pulse generator only 98 396/404 episodes -457.599,80 € -43,8 major therapeutic 
3552 - Repair of atrial septal defect with prosthesis, closed technique 97,4 666/684 episodes -425.439,40 € -26,1 major therapeutic 
0051 - Implantation of cardiac resynchronization defibrillator, total system [CRT-D] 97,3 2037/2094 
episodes 
-
12.512.540,50 
€ 
-75,9 major therapeutic 
3772 - Initial insertion of transvenous leads [electrodes] into atrium and ventricle 95,9 18146/18921 
episodes 
-
11.243.117,70 
€ 
-26,5 minor therapeutic 
3597 - Percutaneous mitral valve repair with implant 95,7 66/69 episodes -43.600,60 € -19 major therapeutic 
3771 - Initial insertion of transvenous lead [electrode] into ventricle 95,4 9105/9541 
episodes 
-7.913.263,90 
€ 
-33,4 minor therapeutic 
3787 - Replacement of any type pacemaker device with dual-chamber device 95,3 2260/2371 
episodes 
-1.545.649 € -26,5 major therapeutic 
0053 - Implantation or replacement of cardiac resynchronization pacemaker pulse generator only 
[CRT-P] 
95,1 270/284 episodes -225.904,10 € -34,2 major therapeutic 
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3563 - Repair of endocardial cushion defect with tissue graft 94,7 90/95 episodes -92.119,20 € -12,5 major therapeutic 
0050 - Implantation of cardiac resynchronization pacemaker without mention of defibrillation, total 
system [CRT-P] 
93,9 791/842 episodes -813.702,70 € -33,7 major therapeutic 
0529 - Other sympathectomy and ganglionectomy 93,9 46/49 episodes -48.715,10 € -51 major therapeutic 
3599 - Other operations on valves of heart 93,5 172/184 episodes -854.685,90 € -55,2 major therapeutic 
3782 - Initial insertion of single-chamber device, rate responsive 93,3 5863/6283 
episodes 
-4.852.936,40 
€ 
-32,1 minor therapeutic 
3783 - Initial insertion of dual-chamber device 93 17635/18958 
episodes 
-
13.523.823,60 
€ 
-31,9 minor therapeutic 
0057 - Implantation or replacement of subcutaneous device for intracardiac or great vessel 
hemodynamic monitoring 
92,6 25/27 episodes -21.019,50 € -44,8 major therapeutic 
3921 - Caval-pulmonary artery anastomosis 92,2 59/64 episodes -191.267,40 € -35,6 major therapeutic 
3781 - Initial insertion of single-chamber device, not specified as rate responsive 92,1 3246/3525 
episodes 
-2.687.162,80 
€ 
-28,8 minor therapeutic 
3780 - Insertion of permanent pacemaker, initial or replacement, type of device not specified 91,7 467/509 episodes -468.668,80 € -31,5 major therapeutic 
3581 - Total repair of tetralogy of fallot 91,2 114/125 episodes -80.955,60 € -8,4 major therapeutic 
3976 - Endovascular embolization or occlusion of vessel(s) of head or neck using bioactive coils 90,9 10/11 episodes -32.216,20 € -54,5 major therapeutic 
5569 - Other kidney transplantation 90,9 20/22 episodes -72.724,10 € -59,3 major therapeutic 
3573 - Other and unspecified repair of endocardial cushion defect 90,3 56/62 episodes -117.772,30 € -22,8 major therapeutic 
3505 - Endovascular replacement of aortic valve 90,1 336/373 episodes -192.529,70 € -14,6 major therapeutic 
3790 - Insertion of left atrial appendage device 90,1 73/81 episodes -55.384,50 € -23,9 minor therapeutic 
3770 - Initial insertion of lead [electrode], not otherwise specified 89,7 427/476 episodes -122.386,80 € -8,6 minor therapeutic 
3582 - Total repair of total anomalous pulmonary venous connection 89,4 59/66 episodes -159.401,20 € -28,8 major therapeutic 
0054 - Implantation or replacement of cardiac resynchronization defibrillator pulse generator only 
[CRT-D] 
88,9 562/632 episodes -869.128,80 € -39 major therapeutic 
3762 - Insertion of temporary non-implantable extracorporeal circulatory assist device 88,9 8/9 episodes -68.082 € -47,3 major therapeutic 
3768 - Insertion of percutaneous external heart assist device 88,9 8/9 episodes -105.156,60 € -76,1 major therapeutic 
8332 - Excision of lesion of muscle 88,9 8/9 episodes -3.376,60 € -26,7 major therapeutic 
8401 - Amputation and disarticulation of finger 88,9 249/280 episodes -342.125,90 € -33,6 major therapeutic 
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3859 - Ligation and stripping of varicose veins, lower limb veins 88,5 16415/18552 
episodes 
-
12.181.007,60 
€ 
-37,8 major therapeutic 
3521 - Open and other replacement of aortic valve with tissue graft 88,2 6765/7674 
episodes 
-
21.836.695,30 
€ 
-31,6 major therapeutic 
3803 - Incision of vessel, upper limb vessels 88,1 672/763 episodes -1.797.086,40 
€ 
-53,1 major therapeutic 
3501 - Closed heart valvotomy, aortic valve 87,5 28/32 episodes -119.684,20 € -40,5 major therapeutic 
3592 - Creation of conduit between right ventricle and pulmonary artery 86,7 26/30 episodes -38.506,40 € -16,4 major therapeutic 
3596 - Percutaneous balloon valvuloplasty 86,7 396/457 episodes -299.016,90 € -19,2 major therapeutic 
3925 - Aorta-iliac-femoral bypass 86,5 1264/1462 
episodes 
-4.194.107,10 
€ 
-39,1 major therapeutic 
3452 - Thoracoscopic decortication of lung 85,7 6/7 episodes -27.109,70 € -53,7 major therapeutic 
3883 - Other surgical occlusion of vessels, upper limb vessels 85,7 126/147 episodes -293.378,20 € -42,9 major therapeutic 
3797 - Replacement of automatic cardioverter/defibrillator lead(s) only 85,5 59/69 episodes -112.702,40 € -38,9 major therapeutic 
3594 - Creation of conduit between atrium and pulmonary artery 84,6 33/39 episodes -90.500,70 € -24,2 major therapeutic 
3776 - Replacement of transvenous atrial and/or ventricular lead(s) [electrode] 84,2 453/538 episodes -185.935 € -13,3 major therapeutic 
3593 - Creation of conduit between left ventricle and aorta 83,3 5/6 episodes -7.514 € -15,4 major therapeutic 
3862 - Other excision of vessels, other vessels of head and neck 83,3 10/12 episodes -21.537,80 € -54,9 major therapeutic 
3975 - Endovascular embolization or occlusion of vessel(s) of head or neck using bare coils 83,3 15/18 episodes -39.784,40 € -42,8 major therapeutic 
3978 - Endovascular implantation of branching or fenestrated graft(s) in aorta 83,3 25/30 episodes 51.872,70 € 47,1 major therapeutic 
8666 - Homograft to skin 83,3 20/24 episodes -18.583,20 € -30,7 major therapeutic 
8667 - Dermal regenerative graft 83,3 5/6 episodes -17.125,80 € -53,5 major therapeutic 
3513 - Open heart valvuloplasty of pulmonary valve without replacement 82,9 34/41 episodes -121.091,30 € -26,8 major therapeutic 
3009 - Other excision or destruction of lesion or tissue of larynx 82,4 14/17 episodes -12.871,20 € -30,6 major therapeutic 
3972 - Endovascular (total) embolization or occlusion of head and neck vessels 82,4 56/68 episodes -145.923,80 € -47,2 major therapeutic 
3922 - Aorta-subclavian-carotid bypass 82,1 69/84 episodes 102.999,50 € 14,8 major therapeutic 
3863 - Other excision of vessels, upper limb vessels 81,6 31/38 episodes -83.932 € -34,3 major therapeutic 
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3860 - Other excision of vessels, unspecified site 81,2 26/32 episodes -39.139,70 € -27,1 major therapeutic 
0523 - Lumbar sympathectomy 81 124/153 episodes -146.770,10 € -33,6 major therapeutic 
3952 - Other repair of aneurysm 80,8 185/229 episodes -508.636,80 € -29,6 major therapeutic 
3971 - Endovascular implantation of other graft in abdominal aorta 80,7 1060/1314 
episodes 
-3.320.873,20 
€ 
-38,1 major therapeutic 
3584 - Total correction of transposition of great vessels, not elsewhere classified 80 20/25 episodes -67.357,30 € -26,5 major therapeutic 
3832 - Resection of vessel with anastomosis, other vessels of head and neck 80 12/15 episodes -27.979,20 € -48,4 major therapeutic 
3950 - Angioplasty of other non-coronary vessel(s) 79,4 5584/7035 
episodes 
-
11.241.769,50 
€ 
-36,8 major therapeutic 
3555 - Repair of ventricular septal defect with prosthesis, closed technique 78,3 18/23 episodes -13.140,30 € -13 major therapeutic 
3884 - Other surgical occlusion of vessels, aorta, abdominal 78,3 18/23 episodes -98.522,60 € -24,9 major therapeutic 
2743 - Other excision of lesion or tissue of lip 77,8 7/9 episodes -2.437,70 € -20,7 major therapeutic 
3522 - Open and other replacement of aortic valve 77,7 2781/3578 
episodes 
-9.606.594,10 
€ 
-31,4 major therapeutic 
3731 - Pericardiectomy 77,4 82/106 episodes -346.690,80 € -47,5 major therapeutic 
3806 - Incision of vessel, abdominal arteries 77,1 259/336 episodes -443.475,50 € -21,4 major therapeutic 
0522 - Cervical sympathectomy 76,9 10/13 episodes -12.194,10 € -40,3 major therapeutic 
3813 - Endarterectomy, upper limb vessels 76,9 40/52 episodes -110.664,40 € -39,9 major therapeutic 
3979 - Other endovascular procedures on other vessels 75,4 752/997 episodes -1.836.475,30 
€ 
-39,3 major therapeutic 
3779 - Revision or relocation of cardiac device pocket 75,3 512/680 episodes -542.440,90 € -27,6 major therapeutic 
1692 - Excision of lesion of orbit 75 6/8 episodes -4.439,10 € -29,2 major therapeutic 
3421 - Transpleural thoracoscopy 75 48/64 episodes -156.610,80 € -41,1 major diagnostic 
3853 - Ligation and stripping of varicose veins, upper limb vessels 75 9/12 episodes -6.525,30 € -27,2 major therapeutic 
3880 - Other surgical occlusion of vessels, unspecified site 75 6/8 episodes -8.737,80 € -18,2 major therapeutic 
3525 - Open and other replacement of pulmonary valve with tissue graft 74,8 89/119 episodes -370.221,20 € -29,1 major therapeutic 
8402 - Amputation and disarticulation of thumb 73,7 14/19 episodes -25.513,40 € -36,5 major therapeutic 
3554 - Repair of endocardial cushion defect with prosthesis 73,3 11/15 episodes -51.275,40 € -36,6 major therapeutic 
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3833 - Resection of vessel with anastomosis, upper limb vessels 72,4 42/58 episodes -85.981,50 € -30,1 major therapeutic 
3882 - Other surgical occlusion of vessels, other vessels of head and neck 72,2 13/18 episodes -36.731,40 € -26,5 major therapeutic 
8669 - Other skin graft to other sites 71,5 363/508 episodes -389.321,60 € -24,3 major therapeutic 
3977 - Temporary (partial) therapeutic endovascular occlusion of vessel 71,4 5/7 episodes 2.455,20 € 7,1 major therapeutic 
5502 - Nephrostomy 71,4 10/14 episodes -50.170,90 € -37,7 major therapeutic 
3927 - Arteriovenostomy for renal dialysis 71 137/193 episodes -522.973,10 € -44,3 major therapeutic 
8407 - Amputation through humerus 71 22/31 episodes -50.797,10 € -29,4 major therapeutic 
3844 - Resection of vessel with replacement, aorta, abdominal 70,7 597/844 episodes -3.141.490,70 
€ 
-35,8 major therapeutic 
4011 - Biopsy of lymphatic structure 70,1 61/87 episodes -182.822 € -42,9 major diagnostic 
3795 - Implantation of automatic cardioverter/defibrillator lead(s) only 70 35/50 episodes -60.684,50 € -28,4 major therapeutic 
7708 - Sequestrectomy, tarsals and metatarsals 70 7/10 episodes -9.924,50 € -31,4 major therapeutic 
3836 - Resection of vessel with anastomosis, abdominal arteries 69,6 16/23 episodes -47.860,20 € -23,1 major therapeutic 
3511 - Open heart valvuloplasty of aortic valve without replacement 68,6 181/264 episodes -495.471,90 € -21,2 major therapeutic 
3799 - Other operations on heart and pericardium 67,3 70/104 episodes -291.464,90 € -36 major therapeutic 
1751 - Implantation of rechargeable cardiac contractility modulation [CCM], total system 66,7 4/6 episodes 26.326 € 84,5 major therapeutic 
3807 - Incision of vessel, abdominal veins 66,7 12/18 episodes -26.173,80 € -20 major therapeutic 
3842 - Resection of vessel with replacement, other vessels of head and neck 66,7 14/21 episodes -30.833,60 € -25,7 major therapeutic 
3865 - Other excision of vessels, thoracic vessels 66,7 12/18 episodes -26.659,80 € -21,8 major therapeutic 
8665 - Heterograft to skin 66,7 4/6 episodes -13.205,70 € -24,6 major therapeutic 
3973 - Endovascular implantation of graft in thoracic aorta 66,5 183/275 episodes -3.181.365,10 
€ 
-61,2 major therapeutic 
4023 - Excision of axillary lymph node 65,2 15/23 episodes -57.247 € -48,9 major therapeutic 
5493 - Creation of cutaneoperitoneal fistula 64,8 35/54 episodes -108.650,10 € -29,1 major therapeutic 
3524 - Open and other replacement of mitral valve 64,4 1073/1665 
episodes 
-2.802.212,60 
€ 
-17,3 major therapeutic 
3761 - Implant of pulsation balloon 63,9 736/1151 episodes -4.994.961,40 
€ 
-31,4 major therapeutic 
3526 - Open and other replacement of pulmonary valve 63,6 7/11 episodes -28.807 € -21,2 major therapeutic 
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7915 - Closed reduction of fracture with internal fixation, femur 63,6 21/33 episodes -148.851,60 € -54,7 major therapeutic 
3728 - Intracardiac echocardiography 63,5 113/178 episodes -350.908,60 € -19,6 minor diagnostic 
3420 - Thoracoscopic pleural biopsy 63,4 26/41 episodes -83.119,70 € -37,1 major diagnostic 
3843 - Resection of vessel with replacement, upper limb vessels 63,4 26/41 episodes -71.432,60 € -32,4 major therapeutic 
3774 - Insertion or replacement of epicardial lead [electrode] into epicardium 63,2 156/247 episodes -158.743,40 € -12,2 major therapeutic 
3775 - Revision of lead [electrode] 63,1 435/689 episodes -453.952,70 € -23,1 major therapeutic 
3847 - Resection of vessel with replacement, abdominal veins 62,5 5/8 episodes -3.715,60 € -3,5 major therapeutic 
3864 - Other excision of vessels, aorta, abdominal 62,5 25/40 episodes -80.238,40 € -20,8 major therapeutic 
3804 - Incision of vessel, aorta 62 57/92 episodes -130.994,40 € -14,8 major therapeutic 
3503 - Closed heart valvotomy, pulmonary valve 61,5 8/13 episodes -21.834,10 € -29 major therapeutic 
0052 - Implantation or replacement of transvenous lead [electrode] into left ventricular coronary 
venous system 
60,6 220/363 episodes -446.866 € -27,6 major therapeutic 
3773 - Initial insertion of transvenous lead [electrode] into atrium 60,5 181/299 episodes -114.503,30 € -16 minor therapeutic 
3848 - Resection of vessel with replacement, lower limb arteries 60,4 174/288 episodes -415.014 € -31,8 major therapeutic 
3929 - Other (peripheral) vascular shunt or bypass 60,3 2902/4814 
episodes 
-5.870.600,40 
€ 
-25,2 major therapeutic 
3839 - Resection of vessel with anastomosis, lower limb veins 60 12/20 episodes -8.700,40 € -18,5 major therapeutic 
5495 - Incision of peritoneum 60 6/10 episodes -22.626,90 € -34,7 major therapeutic 
3571 - Other and unspecified repair of atrial septal defect 59,9 407/679 episodes -1.153.298,30 
€ 
-27,7 major therapeutic 
3808 - Incision of vessel, lower limb arteries 59,6 1719/2883 
episodes 
-4.185.858,50 
€ 
-27,7 major therapeutic 
3816 - Endarterectomy, abdominal arteries 59,2 100/169 episodes -106.962 € -10,4 major therapeutic 
3866 - Other excision of vessels, abdominal arteries 57,9 11/19 episodes -72.673 € -34,5 major therapeutic 
8660 - Free skin graft, not otherwise specified 57,9 62/107 episodes -73.524,60 € -22 major therapeutic 
3835 - Resection of vessel with anastomosis, other thoracic vessels 57,5 23/40 episodes -55.565,90 € -22,7 major therapeutic 
3616 - Double internal mammary-coronary artery bypass 57,4 1343/2341 
episodes 
-5.880.369,60 
€ 
-37,1 major therapeutic 
3512 - Open heart valvuloplasty of mitral valve without replacement 57,2 1152/2014 
episodes 
-2.994.229,80 
€ 
-16,8 major therapeutic 
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3509 - Endovascular replacement of unspecified heart valve 57,1 4/7 episodes -3.504,10 € -6,2 major therapeutic 
3802 - Incision of vessel, other vessels of head and neck 57,1 8/14 episodes -24.296,90 € -30,4 major therapeutic 
3993 - Insertion of vessel-to-vessel cannula 57,1 16/28 episodes -70.622,70 € -33,9 major therapeutic 
4945 - Ligation of hemorrhoids 57,1 4/7 episodes 3.339,30 € 16,4 major therapeutic 
5749 - Other transurethral excision or destruction of lesion or tissue of bladder 57,1 20/35 episodes -44.224,80 € -19,5 major therapeutic 
7729 - Wedge osteotomy, other bones 57,1 4/7 episodes -4.350,90 € -26,5 major therapeutic 
3999 - Other operations on vessels 56,2 27/48 episodes -87.827,20 € -30,6 major therapeutic 
3712 - Pericardiotomy 56,1 213/380 episodes -428.701,90 € -16,4 major therapeutic 
0061 - Percutaneous angioplasty of extracranial vessel(s) 55,7 44/79 episodes -96.059,90 € -23,2 major therapeutic 
3857 - Ligation and stripping of varicose veins, abdominal veins 55,6 5/9 episodes -12.448,90 € -36,7 major therapeutic 
3953 - Repair of arteriovenous fistula 55,6 75/135 episodes -178.817,60 € -24,8 major therapeutic 
4021 - Excision of deep cervical lymph node 55,6 10/18 episodes -18.356,50 € -27,6 major therapeutic 
7935 - Open reduction of fracture with internal fixation, femur 55,6 15/27 episodes -99.091,10 € -36,8 major therapeutic 
8342 - Other tenonectomy 55,6 5/9 episodes -133,70 € -0,5 major therapeutic 
3834 - Resection of vessel with anastomosis, aorta 55,3 88/159 episodes -355.033,60 € -25,2 major therapeutic 
3741 - Implantation of prosthetic cardiac support device around the heart 54,5 6/11 episodes 7.809,70 € 13,7 major therapeutic 
3846 - Resection of vessel with replacement, abdominal arteries 54,5 54/99 episodes -206.408,20 € -26,4 major therapeutic 
0056 - Insertion or replacement of implantable pressure sensor with lead for intracardiac or great 
vessel hemodynamic monitoring 
53,8 7/13 episodes -6.325,10 € -14,3 major therapeutic 
8165 - Percutaneous vertebroplasty 53,8 7/13 episodes -28.761,80 € -45,3 major therapeutic 
3942 - Revision of arteriovenous shunt for renal dialysis 53,5 54/101 episodes -148.088,30 € -31,5 major therapeutic 
3561 - Repair of atrial septal defect with tissue graft 53,4 312/584 episodes -657.462,30 € -18,8 major therapeutic 
3923 - Other intrathoracic vascular shunt or bypass 53,3 8/15 episodes -38.611 € -29,4 major therapeutic 
3991 - Freeing of vessel 52,2 12/23 episodes -28.709 € -19,6 major therapeutic 
8663 - Full-thickness skin graft to other sites 52,2 72/138 episodes -111.009,50 € -16,9 major therapeutic 
3885 - Other surgical occlusion of vessels, thoracic vessels 52,1 244/468 episodes -609.731,80 € -19,9 major therapeutic 
3868 - Other excision of vessels, lower limb arteries 51,6 32/62 episodes -80.280,20 € -27,8 major therapeutic 
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3402 - Exploratory thoracotomy 50,9 29/57 episodes -214.088,40 € -35,3 major therapeutic 
3523 - Open and other replacement of mitral valve with tissue graft 50,2 511/1018 episodes -1.604.079,80 
€ 
-14,6 major therapeutic 
0125 - Other craniectomy 50 3/6 episodes -7.022,30 € -9,5 major therapeutic 
2612 - Open biopsy of salivary gland or duct 50 3/6 episodes -6.721,10 € -34,4 major diagnostic 
3502 - Closed heart valvotomy, mitral valve 50 5/10 episodes -24.415,20 € -31,5 major therapeutic 
3852 - Ligation and stripping of varicose veins, other vessels of head and neck 50 4/8 episodes -8.929,80 € -21,2 major therapeutic 
5494 - Creation of peritoneovascular shunt 50 3/6 episodes -10.522,20 € -24 major therapeutic 
7738 - Other division of bone, tarsals and metatarsals 50 3/6 episodes -2.019,70 € -12,3 major therapeutic 
3926 - Other intra-abdominal vascular shunt or bypass 48,7 38/78 episodes -132.859,10 € -14,1 major therapeutic 
3805 - Incision of vessel, other thoracic vessels 46,7 14/30 episodes -42.089 € -17,9 major therapeutic 
3886 - Other surgical occlusion of vessels, abdominal arteries 46,7 35/75 episodes -135.347,70 € -16,1 major therapeutic 
5411 - Exploratory laparotomy 46,4 85/183 episodes -584.048,20 € -22,7 major therapeutic 
0062 - Percutaneous angioplasty of intracranial vessel(s) 46,2 6/13 episodes -10.983,50 € -26,1 major therapeutic 
3849 - Resection of vessel with replacement, lower limb veins 45,9 17/37 episodes -26.673,20 € -23,1 major therapeutic 
0131 - Incision of cerebral meninges 45,5 5/11 episodes -55.141,40 € -40,8 major therapeutic 
5718 - Other suprapubic cystostomy 45,5 5/11 episodes -27.038,60 € -29,7 major therapeutic 
8410 - Lower limb amputation, not otherwise specified 45,5 5/11 episodes -18.528,60 € -18,4 major therapeutic 
3541 - Enlargement of existing atrial septal defect 44,4 4/9 episodes 2.752,30 € 6,2 minor therapeutic 
3789 - Revision or removal of pacemaker device 44,1 180/408 episodes -278.054 € -17,9 major therapeutic 
3724 - Biopsy of pericardium 43,7 52/119 episodes -147.240,60 € -21,5 major diagnostic 
3850 - Ligation and stripping of varicose veins, unspecified site 42,9 6/14 episodes -6.822,10 € -16,2 major therapeutic 
3951 - Clipping of aneurysm 42,9 12/28 episodes -81.444,20 € -24,5 major therapeutic 
6829 - Other excision or destruction of lesion of uterus 42,9 3/7 episodes -5.588,40 € -21,1 major therapeutic 
9983 - Other phototherapy 42,9 3/7 episodes -40.671,90 € -57,9 minor therapeutic 
5503 - Percutaneous nephrostomy without fragmentation 42,3 11/26 episodes -47.409,20 € -22,4 major therapeutic 
5419 - Other laparotomy 40,7 48/118 episodes -340.709,10 € -21,3 major therapeutic 
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3603 - Open chest coronary artery angioplasty 40,5 32/79 episodes -131.216,10 € -23,6 major therapeutic 
8339 - Excision of lesion of other soft tissue 39,3 11/28 episodes -4.153,30 € -8,3 major therapeutic 
4709 - Other appendectomy 38,9 7/18 episodes -3.275,80 € -4,2 major therapeutic 
4946 - Excision of hemorrhoids 38,9 7/18 episodes -4.673,80 € -7,7 major therapeutic 
3615 - Single internal mammary-coronary artery bypass 38,8 3453/8906 
episodes 
-8.672.086,50 
€ 
-13,1 major therapeutic 
8674 - Attachment of pedicle or flap graft to other sites 38,8 19/49 episodes -7.719,60 € -3,2 major therapeutic 
3229 - Other local excision or destruction of lesion or tissue of lung 37,5 6/16 episodes -8.747,20 € -6,8 major therapeutic 
4610 - Colostomy, not otherwise specified 37,5 6/16 episodes -48.492,10 € -16,5 major therapeutic 
6849 - Other and unspecified total abdominal hysterectomy 37,5 6/16 episodes -4.280,30 € -10,2 major therapeutic 
2109 - Control of epistaxis by other means 36,4 4/11 episodes -2.900,10 € -9,1 major therapeutic 
3528 - Open and other replacement of tricuspid valve 36,4 12/33 episodes -41.876,30 € -9,6 major therapeutic 
5300 - Unilateral repair of inguinal hernia, not otherwise specified 36,4 4/11 episodes -8.561,40 € -17,7 major therapeutic 
8606 - Insertion of totally implantable infusion pump 36,4 4/11 episodes -8.018,80 € -22,9 major therapeutic 
3527 - Open and other replacement of tricuspid valve with tissue graft 35 21/60 episodes -73.626,30 € -10,7 major therapeutic 
3838 - Resection of vessel with anastomosis, lower limb arteries 34,5 51/148 episodes -108.352,60 € -15,9 major therapeutic 
1341 - Phacoemulsification and aspiration of cataract 33,3 2/6 episodes -1.557,20 € -8,5 major therapeutic 
3199 - Other operations on trachea 33,3 2/6 episodes -19.609,60 € -37,9 major therapeutic 
3321 - Bronchoscopy through artificial stoma 33,3 2/6 episodes 766,60 € 4,1 minor diagnostic 
3766 - Insertion of implantable heart assist system 33,3 2/6 episodes -6.220,90 € -10,8 major therapeutic 
3810 - Endarterectomy, unspecified site 33,3 2/6 episodes -7.588,90 € -12,4 major therapeutic 
5421 - Laparoscopy 33,3 8/24 episodes -41.357,60 € -20,4 major diagnostic 
5423 - Biopsy of peritoneum 33,3 3/9 episodes -26.234,50 € -33,2 major diagnostic 
7788 - Other partial ostectomy, tarsals and metatarsals 33,3 3/9 episodes -872,60 € -2,9 major therapeutic 
8670 - Pedicle or flap graft, not otherwise specified 33,3 3/9 episodes -4.612,70 € -10,5 major therapeutic 
3699 - Other operations on vessels of heart 32,8 19/58 episodes -59.774,90 € -13,1 major therapeutic 
3889 - Other surgical occlusion of vessels, lower limb veins 32,7 593/1812 episodes -451.751,70 € -13,7 major therapeutic 
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8152 - Partial hip replacement 32 8/25 episodes -47.333,80 € -25,2 major therapeutic 
3949 - Other revision of vascular procedure 31,9 357/1120 episodes -808.403 € -12,6 major therapeutic 
3800 - Incision of vessel, unspecified site 31,8 7/22 episodes -16.923 € -17,2 major therapeutic 
3749 - Other repair of heart and pericardium 31 75/242 episodes -334.596,30 € -12,1 major therapeutic 
3845 - Resection of vessel with replacement, thoracic vessels 31 527/1701 episodes 416.237 € 2,7 major therapeutic 
3777 - Removal of lead(s) [electrode] without replacement 30,3 80/264 episodes -101.287,40 € -7,4 major therapeutic 
1756 - Atherectomy of other non-coronary vessel(s) 30 3/10 episodes -24.330,50 € -32,2 major therapeutic 
5994 - Replacement of cystostomy tube 30 3/10 episodes 1.257 € 2,7 minor therapeutic 
8403 - Amputation through hand 30 3/10 episodes -8.361,70 € -18,1 major therapeutic 
8672 - Advancement of pedicle graft 30 6/20 episodes -3.301,40 € -3,6 major therapeutic 
3809 - Incision of vessel, lower limb veins 28,6 42/147 episodes -81.627,40 € -13,2 major therapeutic 
3887 - Other surgical occlusion of vessels, abdominal veins 28,6 8/28 episodes -16.536,10 € -5 major therapeutic 
7781 - Other partial ostectomy, scapula, clavicle, and thorax [ribs and sternum] 28,6 2/7 episodes -231,50 € -0,3 major therapeutic 
3613 - (Aorto)coronary bypass of three coronary arteries 28,3 72/254 episodes -350.551,30 € -16,6 major therapeutic 
3818 - Endarterectomy, lower limb arteries 28,2 386/1371 episodes -923.732,10 € -14,2 major therapeutic 
3562 - Repair of ventricular septal defect with tissue graft 28 45/161 episodes -1.320,50 € -0,1 major therapeutic 
3572 - Other and unspecified repair of ventricular septal defect 27,9 34/122 episodes -29.244,80 € -2,7 major therapeutic 
3328 - Open biopsy of lung 27,8 5/18 episodes -22.101,60 € -12,1 major diagnostic 
3974 - Endovascular removal of obstruction from head and neck vessel(s) 27,8 5/18 episodes -45.637,80 € -26,2 major therapeutic 
9672 - Continuous invasive mechanical ventilation for 96 consecutive hours or more 27,7 957/3461 episodes -6.589.438,50 
€ 
-16 minor therapeutic 
3723 - Combined right and left heart cardiac catheterization 26,4 1487/5642 
episodes 
-706.293,10 € -5,1 minor diagnostic 
0055 - Insertion of drug-eluting stent(s) of other peripheral vessel(s) 26,3 35/133 episodes 7.412,30 € 1,1 minor therapeutic 
3888 - Other surgical occlusion of vessels, lower limb arteries 25,9 28/108 episodes -55.514,90 € -10,4 major therapeutic 
3943 - Removal of arteriovenous shunt for renal dialysis 25,5 35/137 episodes -83.776,70 € -13,9 major therapeutic 
3422 - Mediastinoscopy 25 3/12 episodes -9.313 € -16,8 major diagnostic 
3619 - Other bypass anastomosis for heart revascularization 25 9/36 episodes -5.369,70 € -2,1 major therapeutic 
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6909 - Other dilation and curettage 25 2/8 episodes -1.846,30 € -10 major diagnostic 
8689 - Other repair and reconstruction of skin and subcutaneous tissue 25 3/12 episodes -29.455,70 € -36,4 major therapeutic 
3931 - Suture of artery 24,1 156/647 episodes -495.848,30 € -15,9 major therapeutic 
3733 - Excision or destruction of other lesion or tissue of heart, open approach 23,6 240/1016 episodes -907.651,70 € -10,9 major therapeutic 
8417 - Amputation above knee 23,5 187/796 episodes -616.456,90 € -10,6 major therapeutic 
3614 - (Aorto)coronary bypass of four or more coronary arteries 23,1 3/13 episodes -12.716 € -13,2 major therapeutic 
3959 - Other repair of vessel 23,1 127/549 episodes -315.770,50 € -7,5 major therapeutic 
8852 - Angiocardiography of right heart structures 23 129/562 episodes -152.633,60 € -9,3 minor diagnostic 
3932 - Suture of vein 22,4 22/98 episodes -30.507,20 € -4,6 major therapeutic 
3129 - Other permanent tracheostomy 22,2 4/18 episodes -21.585,70 € -8,1 major therapeutic 
3474 - Repair of pectus deformity 22,2 2/9 episodes 10.009,70 € 9,7 major therapeutic 
3617 - Abdominal-coronary artery bypass 22,2 2/9 episodes -10.722,30 € -27,5 major therapeutic 
4019 - Other diagnostic procedures on lymphatic structures 22,2 2/9 episodes -620,60 € -2,7 major diagnostic 
5551 - Nephroureterectomy 22,2 4/18 episodes -9.348,40 € -7,5 major therapeutic 
8016 - Other arthrotomy, knee 22,2 2/9 episodes 6.780,50 € 21,1 major therapeutic 
8413 - Disarticulation of ankle 22,2 2/9 episodes -1.946,60 € -3,1 major therapeutic 
3721 - Right heart cardiac catheterization 22 869/3947 episodes -485.123,50 € -4,1 minor diagnostic 
3791 - Open chest cardiac massage 21,9 16/73 episodes -116.563,60 € -11,3 major therapeutic 
8858 - Negative-contrast cardiac roentgenography 21,9 7/32 episodes -8.408,60 € -7,1 minor diagnostic 
3535 - Operations on trabeculae carneae cordis 21,7 5/23 episodes -15.196,60 € -9,1 major therapeutic 
4576 - Open and other sigmoidectomy 21,4 6/28 episodes -74.118,80 € -13,6 major therapeutic 
3553 - Repair of ventricular septal defect with prosthesis, open technique 21,1 37/175 episodes -119.241,60 € -8 major therapeutic 
3736 - Excision, destruction, or exclusion of left atrial appendage (LAA) 21 74/352 episodes -139.872,70 € -4,7 minor therapeutic 
0060 - Insertion of drug-eluting stent(s) of superficial femoral artery 20,8 30/144 episodes -67.421,40 € -13,6 minor therapeutic 
0021 - Intravascular imaging of extracranial cerebral vessels 20,7 6/29 episodes -2.803,20 € -4,2 minor diagnostic 
3726 - Catheter based invasive electrophysiologic testing 20,4 1417/6959 
episodes 
-1.299.864,50 
€ 
-7,4 minor diagnostic 
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3869 - Other excision of vessels, lower limb veins 20 311/1557 episodes -239.931,70 € -7,7 major therapeutic 
4573 - Open and other right hemicolectomy 20 9/45 episodes -72.030,80 € -10 major therapeutic 
4901 - Incision of perianal abscess 20 3/15 episodes -3.095 € -5,2 major therapeutic 
9670 - Continuous invasive mechanical ventilation of unspecified duration 19,6 110/561 episodes -133.846,80 € -3,7 minor therapeutic 
5349 - Other open umbilical herniorrhaphy 17,8 8/45 episodes -4.741 € -3,1 major therapeutic 
0058 - Insertion of intra-aneurysm sac pressure monitoring device (intraoperative) 17,6 3/17 episodes 11.659,20 € 8,8 minor diagnostic 
3732 - Excision of aneurysm of heart 17,3 23/133 episodes -62.071,10 € -4,7 major therapeutic 
3239 - Other and unspecified segmental resection of lung 16,7 2/12 episodes -5.434,60 € -4,4 major therapeutic 
3924 - Aorta-renal bypass 16,7 6/36 episodes -1.597,90 € -0,4 major therapeutic 
7722 - Wedge osteotomy, humerus 16,7 1/6 episodes -392,30 € -1,8 major therapeutic 
7932 - Open reduction of fracture with internal fixation, radius and ulna 16,7 1/6 episodes -5.878,60 € -13,5 major therapeutic 
8452 - Insertion of recombinant bone morphogenetic protein 16,7 7/42 episodes 3.779,90 € 4,3 minor therapeutic 
8491 - Amputation, not otherwise specified 16,7 1/6 episodes -3.841,30 € -17,4 major therapeutic 
8621 - Excision of pilonidal cyst or sinus 16,7 1/6 episodes -1.322,30 € -9,1 major therapeutic 
8683 - Size reduction plastic operation 16,7 1/6 episodes -2.358,60 € -12,7 major therapeutic 
8412 - Amputation through foot 15,9 77/483 episodes -184.214,90 € -6,2 major therapeutic 
3610 - Aortocoronary bypass for heart revascularization, not otherwise specified 15,8 3/19 episodes -29.712,50 € -12,5 major therapeutic 
4593 - Other small-to-large intestinal anastomosis 15,8 3/19 episodes -40.755,50 € -15,2 major therapeutic 
4591 - Small-to-small intestinal anastomosis 15,6 5/32 episodes -41.799,30 € -7,8 major therapeutic 
7902 - Closed reduction of fracture without internal fixation, radius and ulna 15,6 5/32 episodes 5.703,10 € 8,3 minor therapeutic 
8309 - Other incision of soft tissue 15,6 7/45 episodes -10.258,10 € -5 major therapeutic 
3691 - Repair of aneurysm of coronary vessel 15,4 2/13 episodes 4.447,50 € 3,6 major therapeutic 
3822 - Percutaneous angioscopy 15,2 5/33 episodes 7.057,40 € 7,4 minor diagnostic 
3595 - Revision of corrective procedure on heart 14,8 47/317 episodes -234.735,10 € -6,5 major therapeutic 
7731 - Other division of bone, scapula, clavicle, and thorax [ribs and sternum] 14,8 4/27 episodes 14.893,20 € 6,2 major therapeutic 
0093 - Transplant from cadaver 14,3 1/7 episodes 2.986 € 10,2 minor therapeutic 
0781 - Other partial excision of thymus 14,3 2/14 episodes -8.447,90 € -8,1 major therapeutic 
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3406 - Thoracoscopic drainage of pleural cavity 14,3 2/14 episodes -4.708,50 € -4,4 major therapeutic 
3570 - Other and unspecified repair of unspecified septal defect of heart 14,3 1/7 episodes 1.668,30 € 1,8 major therapeutic 
4389 - Open and other partial gastrectomy 14,3 1/7 episodes 2.152,90 € 2,3 major therapeutic 
4526 - Open biopsy of large intestine 14,3 1/7 episodes -1.440,20 € -2,5 major diagnostic 
4651 - Closure of stoma of small intestine 14,3 1/7 episodes -2.986 € -2,5 major therapeutic 
5187 - Endoscopic insertion of stent (tube) into bile duct 14,3 3/21 episodes 4.420,40 € 5,9 minor therapeutic 
7817 - Application of external fixator device, tibia and fibula 14,3 1/7 episodes -2.819,20 € -5 major therapeutic 
8389 - Other plastic operations on fascia 14,3 1/7 episodes -1.440,20 € -4,9 major therapeutic 
8454 - Implantation of other internal limb lengthening device 14,3 1/7 episodes 690,50 € 3,4 minor therapeutic 
8699 - Other operations on skin and subcutaneous tissue 14,3 1/7 episodes -1.366,20 € -5 minor therapeutic 
3598 - Other operations on septa of heart 14 6/43 episodes -23.628,30 € -6,8 major therapeutic 
4029 - Simple excision of other lymphatic structure 14 6/43 episodes -17.770 € -6,6 major therapeutic 
8415 - Other amputation below knee 13,9 50/361 episodes -110.412,50 € -4,7 major therapeutic 
3539 - Operations on other structures adjacent to valves of heart 13,6 11/81 episodes 20.226,40 € 2,4 major therapeutic 
8344 - Other fasciectomy 13,3 2/15 episodes -2.924,10 € -2,2 major therapeutic 
5459 - Other lysis of peritoneal adhesions 13,2 5/38 episodes -22.002,50 € -4,2 major therapeutic 
3957 - Repair of blood vessel with synthetic patch graft 13,1 27/206 episodes -80.481,60 € -6,7 major therapeutic 
3958 - Repair of blood vessel with unspecified type of patch graft 13 6/46 episodes 24.607,60 € 5,8 major therapeutic 
5425 - Peritoneal lavage 13 3/23 episodes -39.466,80 € -9,4 minor diagnostic 
9224 - Teleradiotherapy using photons 13 3/23 episodes -3.175,90 € -5,2 minor therapeutic 
9229 - Other radiotherapeutic procedure 12,9 8/62 episodes -2.287,10 € -1,3 minor therapeutic 
2419 - Other diagnostic procedures on teeth, gums, and alveoli 12,5 1/8 episodes 3.162,70 € 17,4 minor diagnostic 
2722 - Biopsy of uvula and soft palate 12,5 1/8 episodes -976,20 € -2,4 major diagnostic 
3955 - Reimplantation of aberrant renal vessel 12,5 2/16 episodes 2.452,30 € 1,1 major therapeutic 
4442 - Suture of duodenal ulcer site 12,5 1/8 episodes -766,80 € -1,1 major therapeutic 
5321 - Unilateral repair of femoral hernia with graft or prosthesis 12,5 2/16 episodes -612,40 € -1 major therapeutic 
5461 - Reclosure of postoperative disruption of abdominal wall 12,2 5/41 episodes 27.486 € 6,7 major therapeutic 
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4524 - Flexible sigmoidoscopy 12,1 21/174 episodes 16.525,80 € 1,9 minor diagnostic 
7740 - Biopsy of bone, unspecified site 11,8 2/17 episodes -1.750,10 € -3,5 major diagnostic 
3941 - Control of hemorrhage following vascular surgery 11,5 23/200 episodes -74.149,40 € -4,1 major therapeutic 
4562 - Other partial resection of small intestine 11,5 9/78 episodes -26.434,70 € -2,2 major therapeutic 
0392 - Injection of other agent into spinal canal 11,1 1/9 episodes 861,20 € 3,9 minor therapeutic 
2911 - Pharyngoscopy 11,1 1/9 episodes 1.190,30 € 3,2 minor diagnostic 
5110 - Endoscopic retrograde cholangiopancreatography [ERCP] 11,1 6/54 episodes 4.862,30 € 2,8 minor diagnostic 
8662 - Other skin graft to hand 11,1 1/9 episodes -1.440,20 € -6,9 major therapeutic 
4024 - Excision of inguinal lymph node 10,9 7/64 episodes -6.594 € -3,8 major therapeutic 
3425 - Closed [percutaneous] [needle] biopsy of mediastinum 10,5 2/19 episodes -11.454,70 € -22,3 minor diagnostic 
6011 - Closed [percutaneous] [needle] biopsy of prostate 10,5 2/19 episodes 1.996,60 € 3,1 minor diagnostic 
3514 - Open heart valvuloplasty of tricuspid valve without replacement 10,4 145/1392 episodes -254.091,20 € -2 major therapeutic 
9671 - Continuous invasive mechanical ventilation for less than 96 consecutive hours 10,4 644/6172 episodes -1.246.746 € -2,7 minor therapeutic 
0064 - Percutaneous insertion of other extracranial artery stent(s) 10,3 3/29 episodes -15.659,30 € -12,4 minor therapeutic 
3323 - Other bronchoscopy 10,2 9/88 episodes 55.966,30 € 10,2 minor diagnostic 
0139 - Other incision of brain 10 1/10 episodes -132,10 € -0,1 major therapeutic 
3451 - Decortication of lung 10 2/20 episodes -17.981,10 € -8,4 major therapeutic 
6811 - Digital examination of uterus 10 1/10 episodes 897,50 € 4,2 minor diagnostic 
8405 - Amputation through forearm 10 1/10 episodes -1.058,60 € -2,3 major therapeutic 
3542 - Creation of septal defect in heart 9,5 2/21 episodes -4.999,40 € -2,4 major therapeutic 
3812 - Endarterectomy, other vessels of head and neck 9,5 19/199 episodes -23.445,50 € -1,8 major therapeutic 
5011 - Closed (percutaneous) [needle] biopsy of liver 9,5 8/84 episodes 5.639,80 € 2,3 minor diagnostic 
6816 - Closed biopsy of uterus 9,5 2/21 episodes -448,50 € -0,7 major diagnostic 
3611 - (Aorto)coronary bypass of one coronary artery 9,2 484/5242 episodes -730.481 € -1,9 major therapeutic 
0066 - Percutaneous transluminal coronary angioplasty [PTCA] 9,1 4472/48990 
episodes 
-4.112.571 € -2,6 major therapeutic 
2103 - Control of epistaxis by cauterization (and packing) 9,1 8/88 episodes 13.351,50 € 5,6 minor therapeutic 
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5304 - Other and open repair of indirect inguinal hernia with graft or prosthesis 9,1 2/22 episodes -985,80 € -2,4 major therapeutic 
7916 - Closed reduction of fracture with internal fixation, tibia and fibula 9,1 1/11 episodes -3.534,70 € -6,3 major therapeutic 
8396 - Injection of therapeutic substance into bursa 9,1 1/11 episodes 897,60 € 2 minor therapeutic 
3612 - (Aorto)coronary bypass of two coronary arteries 8,8 227/2587 episodes -585.899,90 € -3,2 major therapeutic 
0124 - Other craniotomy 8,3 1/12 episodes -1.604,80 € -1,2 major therapeutic 
2102 - Control of epistaxis by posterior (and anterior) packing 8,3 5/60 episodes -3.324,90 € -1,5 minor therapeutic 
7749 - Biopsy of bone, other bones 8,3 3/36 episodes 875,10 € 0,9 major diagnostic 
9925 - Injection or infusion of cancer chemotherapeutic substance 8,1 21/259 episodes -12.633,10 € -1,7 minor therapeutic 
4443 - Endoscopic control of gastric or duodenal bleeding 8 21/261 episodes 39.723,60 € 3,4 minor therapeutic 
4233 - Endoscopic excision or destruction of lesion or tissue of esophagus 7,8 8/102 episodes 14.152,80 € 2,6 minor therapeutic 
0049 - Supersaturated oxygen therapy 7,7 2/26 episodes -2.106,80 € -2,5 minor therapeutic 
2751 - Suture of laceration of lip 7,7 1/13 episodes -195,80 € -0,6 minor therapeutic 
4229 - Other diagnostic procedures on esophagus 7,7 1/13 episodes 1.440,20 € 3,2 minor diagnostic 
8418 - Disarticulation of hip 7,7 1/13 episodes 3.534,70 € 4,1 major therapeutic 
8607 - Insertion of totally implantable vascular access device [VAD] 7,5 12/161 episodes -14.624 € -2,9 minor therapeutic 
0023 - Intravascular imaging of peripheral vessels 7,4 2/27 episodes 1.385,20 € 3,4 minor diagnostic 
3892 - Umbilical vein catheterization 7,4 2/27 episodes -2.880,50 € -1,3 minor therapeutic 
5717 - Percutaneous cystostomy 7,2 9/125 episodes -7.918,70 € -1,1 minor therapeutic 
3507 - Endovascular replacement of pulmonary valve 7,1 1/14 episodes -3.516,60 € -9,1 major therapeutic 
3930 - Suture of unspecified blood vessel 7,1 1/14 episodes 1.556,30 € 1 major therapeutic 
8651 - Replantation of scalp 7,1 1/14 episodes 195,80 € 0,2 minor therapeutic 
9902 - Transfusion of previously collected autologous blood 7,1 2/28 episodes 3.482,10 € 2 minor therapeutic 
5795 - Replacement of indwelling urinary catheter 6,8 19/279 episodes 14.371,50 € 1,5 minor therapeutic 
4671 - Suture of laceration of duodenum 6,7 1/15 episodes -1.753,10 € -0,7 major therapeutic 
5303 - Other and open repair of direct inguinal hernia with graft or prosthesis 6,7 1/15 episodes -3.789,40 € -7,1 major therapeutic 
7901 - Closed reduction of fracture without internal fixation, humerus 6,7 1/15 episodes 861,20 € 2,5 minor therapeutic 
8511 - Closed [percutaneous] [needle] biopsy of breast 6,7 3/45 episodes 2.985,40 € 2,8 minor diagnostic 
253 
 
3479 - Other repair of chest wall 6,6 5/76 episodes 45.399,30 € 4,1 major therapeutic 
3606 - Insertion of non-drug-eluting coronary artery stent(s) 6,4 876/13623 
episodes 
-614.449,10 € -1,3 minor therapeutic 
8314 - Fasciotomy 6,4 17/266 episodes -6.571,20 € -0,4 major therapeutic 
0068 - Intravascular pressure measurement of peripheral arteries 6,2 6/97 episodes 16.113,60 € 2,4 minor diagnostic 
3142 - Laryngoscopy and other tracheoscopy 6,2 12/195 episodes -13.050,60 € -1,4 minor diagnostic 
3998 - Control of hemorrhage, not otherwise specified 6,2 22/353 episodes -13.667,90 € -0,4 major therapeutic 
7971 - Closed reduction of dislocation of shoulder 6,2 1/16 episodes 795,40 € 2,4 minor therapeutic 
3961 - Extracorporeal circulation auxiliary to open heart surgery 6,1 1257/20537 
episodes 
-2.744.417,10 
€ 
-1,6 minor therapeutic 
8609 - Other incision of skin and subcutaneous tissue 6,1 9/147 episodes 12.729,90 € 2,2 minor therapeutic 
9972 - Therapeutic leukopheresis 6,1 2/33 episodes -3.258,60 € -2,3 minor therapeutic 
2311 - Removal of residual root 6 11/183 episodes 24.008,50 € 2 minor therapeutic 
8857 - Other and unspecified coronary arteriography 6 1852/30860 
episodes 
-1.403.883,50 
€ 
-1,5 minor diagnostic 
0063 - Percutaneous insertion of carotid artery stent(s) 5,9 4/68 episodes -1.967,80 € -0,6 minor therapeutic 
3956 - Repair of blood vessel with tissue patch graft 5,9 49/833 episodes -55.080,20 € -0,9 major therapeutic 
4439 - Other gastroenterostomy without gastrectomy 5,9 1/17 episodes -14.567,30 € -5,9 major therapeutic 
5412 - Reopening of recent laparotomy site 5,9 3/51 episodes -4.132,70 € -0,5 major therapeutic 
8414 - Amputation of ankle through malleoli of tibia and fibula 5,9 1/17 episodes -3.534,70 € -2,8 major therapeutic 
9909 - Transfusion of other substance 5,9 17/286 episodes 100.245,90 € 7 minor therapeutic 
3722 - Left heart cardiac catheterization 5,8 4924/84353 
episodes 
-2.838.288,60 
€ 
-1,1 minor diagnostic 
3609 - Other removal of coronary artery obstruction 5,6 82/1464 episodes -104.038,50 € -1,9 major therapeutic 
5123 - Laparoscopic cholecystectomy 5,6 1/18 episodes 7,10 € 0 major therapeutic 
3327 - Closed endoscopic biopsy of lung 5,3 4/75 episodes -8.661,10 € -2,9 major diagnostic 
3727 - Cardiac mapping 5,3 54/1018 episodes 5.804,70 € 0,2 minor diagnostic 
4444 - Transcatheter embolization for gastric or duodenal bleeding 5,3 1/19 episodes -1.190,30 € -1,4 minor therapeutic 
1811 - Otoscopy 5,2 12/233 episodes -8.357,40 € -1,2 minor diagnostic 
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8611 - Closed biopsy of skin and subcutaneous tissue 5,1 16/311 episodes -4.068,90 € -0,4 minor diagnostic 
2100 - Control of epistaxis, not otherwise specified 5 1/20 episodes -725 € -1 minor therapeutic 
3471 - Suture of laceration of chest wall 5 2/40 episodes -4.447,50 € -0,9 minor therapeutic 
8191 - Arthrocentesis 5 6/120 episodes 12.971,70 € 3,2 minor therapeutic 
8605 - Incision with removal of foreign body or device from skin and subcutaneous tissue 5 13/262 episodes -5.269,30 € -0,6 minor therapeutic 
0390 - Insertion of catheter into spinal canal for infusion of therapeutic or palliative substances 4,8 49/1015 episodes -26.122,10 € -0,5 minor therapeutic 
0611 - Closed [percutaneous] [needle] biopsy of thyroid gland 4,8 5/105 episodes 1.531,40 € 0,5 minor diagnostic 
3720 - Noninvasive programmed electrical stimulation [NIPS] 4,8 13/269 episodes -42.812 € -5,6 minor diagnostic 
4575 - Open and other left hemicolectomy 4,7 2/43 episodes -16.202,90 € -1,9 major therapeutic 
0391 - Injection of anesthetic into spinal canal for analgesia 4,5 44/979 episodes 49.014,10 € 0,9 minor therapeutic 
0881 - Linear repair of laceration of eyelid or eyebrow 4,5 1/22 episodes 690,50 € 1,3 minor therapeutic 
4224 - Closed [endoscopic] biopsy of esophagus 4,5 1/22 episodes 523,90 € 0,8 minor diagnostic 
2101 - Control of epistaxis by anterior nasal packing 4,4 12/272 episodes 776 € 0,1 minor therapeutic 
3403 - Reopening of recent thoracotomy site 4,3 9/210 episodes -94.120,30 € -3,4 major therapeutic 
3424 - Other pleural biopsy 4,3 20/470 episodes 12.945,50 € 1 minor diagnostic 
3829 - Other diagnostic procedures on blood vessels 4,3 1/23 episodes 2.223,80 € 3,7 major diagnostic 
2309 - Extraction of other tooth 4,2 23/549 episodes -27.699,70 € -0,9 minor therapeutic 
3711 - Cardiotomy 4,2 44/1048 episodes -25.584,60 € -0,3 major therapeutic 
7906 - Closed reduction of fracture without internal fixation, tibia and fibula 4,2 1/24 episodes 455,20 € 0,6 minor therapeutic 
5732 - Other cystoscopy 4 4/100 episodes 7.168,70 € 1,8 minor diagnostic 
8601 - Aspiration of skin and subcutaneous tissue 4 2/50 episodes 15.428,60 € 7,4 minor therapeutic 
4514 - Closed [endoscopic] biopsy of small intestine 3,8 1/26 episodes 2.242,30 € 3,4 minor diagnostic 
9903 - Other transfusion of whole blood 3,8 19/506 episodes -34.862,70 € -1,6 minor therapeutic 
9915 - Parenteral infusion of concentrated nutritional substances 3,8 21/549 episodes -31.504,90 € -0,6 minor therapeutic 
3963 - Cardioplegia 3,7 174/4764 episodes -217.282,70 € -0,6 minor therapeutic 
1755 - Transluminal coronary atherectomy 3,6 2/56 episodes -328,10 € -0,2 major therapeutic 
3534 - Infundibulectomy 3,6 1/28 episodes 4.657,30 € 1,8 major therapeutic 
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3824 - Intravascular imaging of coronary vessel(s) by optical coherence tomography [OCT] 3,6 2/55 episodes -877,90 € -0,6 minor diagnostic 
4341 - Endoscopic excision or destruction of lesion or tissue of stomach 3,6 2/56 episodes -1.585,10 € -0,7 minor therapeutic 
8411 - Amputation of toe 3,6 69/1894 episodes -43.563,10 € -0,4 major therapeutic 
8854 - Combined right and left heart angiocardiography 3,4 53/1542 episodes -77.616,40 € -1,8 minor diagnostic 
4131 - Biopsy of bone marrow 3,3 17/514 episodes 14.785,80 € 0,9 minor diagnostic 
8856 - Coronary arteriography using two catheters 3,2 1825/56217 
episodes 
-1.377.685,10 
€ 
-0,9 minor diagnostic 
3996 - Total body perfusion 3,1 19/621 episodes -30.691,40 € -1,7 minor therapeutic 
3533 - Annuloplasty 3 25/840 episodes -108.389 € -1,3 major therapeutic 
3725 - Biopsy of heart 3 13/435 episodes -28.900,70 € -3,2 minor diagnostic 
9906 - Transfusion of coagulation factors 3 10/338 episodes 60.373,80 € 1,9 minor therapeutic 
2319 - Other surgical extraction of tooth 2,9 2/68 episodes 6.154,60 € 2,5 minor therapeutic 
4519 - Other diagnostic procedures on small intestine 2,9 1/34 episodes 861,20 € 0,9 minor diagnostic 
8855 - Coronary arteriography using a single catheter 2,9 270/9320 episodes -232.781,30 € -0,8 minor diagnostic 
0331 - Spinal tap 2,8 16/567 episodes 10.454,30 € 0,4 minor diagnostic 
2349 - Other dental restoration 2,8 1/36 episodes 4.153,50 € 1,7 minor therapeutic 
5498 - Peritoneal dialysis 2,8 6/214 episodes -4.978,10 € -0,5 minor therapeutic 
3532 - Operations on chordae tendineae 2,7 1/37 episodes -766,80 € -0,3 major therapeutic 
4542 - Endoscopic polypectomy of large intestine 2,7 7/259 episodes -36.289 € -3,2 minor therapeutic 
3322 - Fiber-optic bronchoscopy 2,6 19/735 episodes -19.885 € -0,5 minor diagnostic 
4543 - Endoscopic destruction of other lesion or tissue of large intestine 2,6 2/78 episodes 1.758,80 € 0,5 minor therapeutic 
4824 - Closed [endoscopic] biopsy of rectum 2,6 1/38 episodes 897,50 € 0,5 minor diagnostic 
9908 - Transfusion of blood expander 2,6 40/1524 episodes -52.683,60 € -0,4 minor therapeutic 
3898 - Other puncture of artery 2,5 38/1519 episodes -65.735,10 € -1,1 minor therapeutic 
3324 - Closed [endoscopic] biopsy of bronchus 2,4 15/615 episodes -16.375,90 € -0,5 minor diagnostic 
3814 - Endarterectomy, aorta 2,4 15/621 episodes -30.870,60 € -0,6 major therapeutic 
3326 - Closed [percutaneous] [needle] biopsy of lung 2,3 2/87 episodes 1.714,20 € 0,6 minor diagnostic 
256 
 
4413 - Other gastroscopy 2,3 14/601 episodes -12.893,60 € -0,8 minor diagnostic 
8619 - Other diagnostic procedures on skin and subcutaneous tissue 2,3 1/44 episodes 1.096,60 € 1,3 minor diagnostic 
8853 - Angiocardiography of left heart structures 2,3 605/26474 
episodes 
-1.710.891,90 
€ 
-2,4 minor diagnostic 
0048 - Insertion of four or more vascular stents 2,2 30/1374 episodes -40.600,80 € -0,9 minor therapeutic 
4414 - Closed [endoscopic] biopsy of stomach 2,2 5/229 episodes 3.902,30 € 0,7 minor diagnostic 
5491 - Percutaneous abdominal drainage 2,2 26/1184 episodes -15.734,50 € -0,4 minor therapeutic 
4525 - Closed [endoscopic] biopsy of large intestine 2,1 12/571 episodes 13.696,10 € 0,7 minor diagnostic 
4611 - Temporary colostomy 2,1 1/48 episodes -5.201,10 € -0,6 major therapeutic 
3401 - Incision of chest wall 2 1/51 episodes -897,50 € -0,5 minor therapeutic 
3962 - Hypothermia (systemic) incidental to open heart surgery 2 123/6017 episodes -104.722 € -0,2 minor therapeutic 
0059 - Intravascular pressure measurement of coronary arteries 1,9 8/423 episodes 4.796,60 € 0,5 minor diagnostic 
3404 - Insertion of intercostal catheter for drainage 1,9 32/1690 episodes -180.064 € -1,6 minor therapeutic 
3792 - Injection of therapeutic substance into heart 1,9 1/53 episodes -2.068,40 € -1,2 minor therapeutic 
4823 - Rigid proctosigmoidoscopy 1,9 1/54 episodes -3.357,80 € -1,4 minor diagnostic 
8659 - Closure of skin and subcutaneous tissue of other sites 1,9 10/532 episodes 3.151,70 € 0,2 minor therapeutic 
9901 - Exchange transfusion 1,9 3/162 episodes 3.318,50 € 0,6 minor therapeutic 
3964 - Intraoperative cardiac pacemaker 1,8 49/2789 episodes -47.974,60 € -0,2 minor therapeutic 
5523 - Closed [percutaneous] [needle] biopsy of kidney 1,8 3/164 episodes 6.316 € 1,5 minor diagnostic 
0043 - Procedure on four or more vessels 1,7 7/420 episodes -5.025,60 € -0,3 minor therapeutic 
3607 - Insertion of drug-eluting coronary artery stent(s) 1,7 569/33394 
episodes 
-176.184,10 € -0,2 minor therapeutic 
3997 - Other perfusion 1,7 13/747 episodes 13.557,30 € 0,6 minor therapeutic 
3894 - Venous cutdown 1,6 1/63 episodes -861,20 € -0,3 minor therapeutic 
9604 - Insertion of endotracheal tube 1,6 150/9153 episodes -79.030,30 € -0,1 minor therapeutic 
0014 - Injection or infusion of oxazolidinone class of antibiotics 1,5 8/535 episodes -27.006,40 € -0,7 minor therapeutic 
3891 - Arterial catheterization 1,5 218/14952 
episodes 
267.490,90 € 0,2 minor therapeutic 
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3897 - Central venous catheter placement with guidance 1,5 5/337 episodes 1.755,60 € 0,1 minor therapeutic 
3899 - Other puncture of vein 1,5 169/11309 
episodes 
251.901,60 € 0,9 minor therapeutic 
3995 - Hemodialysis 1,5 125/8328 episodes 55.215 € 0,1 minor therapeutic 
2121 - Rhinoscopy 1,4 1/70 episodes -19.212 € -5,6 minor diagnostic 
0017 - Infusion of vasopressor agent 1,3 89/6704 episodes -270.803,90 € -0,5 minor therapeutic 
0031 - Computer assisted surgery with CT/CTA 1,3 1/79 episodes -666,50 € -0,3 minor diagnostic 
3893 - Venous catheterization, not elsewhere classified 1,3 214/17061 
episodes 
-773.876,80 € -0,6 minor therapeutic 
9905 - Transfusion of platelets 1,3 18/1389 episodes -17.500,60 € -0,1 minor therapeutic 
1621 - Ophthalmoscopy 1,2 3/245 episodes -3.877,90 € -0,4 minor diagnostic 
0047 - Insertion of three vascular stents 1,1 40/3631 episodes -70.098 € -0,6 minor therapeutic 
3409 - Other incision of pleura 1,1 2/176 episodes 14.553,40 € 1,1 minor therapeutic 
3601 - not found 1,1 5/453 episodes 3.869,20 € 0,3 major therapeutic 
3604 - Intracoronary artery thrombolytic infusion 1,1 6/569 episodes -3.762,70 € -0,2 minor therapeutic 
9907 - Transfusion of other serum 1,1 41/3758 episodes -41.911,50 € -0,1 minor therapeutic 
3729 - Other diagnostic procedures on heart and pericardium 1 1/101 episodes -254,80 € -0,2 minor diagnostic 
8604 - Other incision with drainage of skin and subcutaneous tissue 1 7/724 episodes 14.955,60 € 0,5 minor therapeutic 
3778 - Insertion of temporary transvenous pacemaker system 0,9 43/5056 episodes -93.410,20 € -0,5 minor therapeutic 
4523 - Colonoscopy 0,9 26/2944 episodes -22.857,10 € -0,2 minor diagnostic 
9605 - Other intubation of respiratory tract 0,9 4/428 episodes -5.088,70 € -0,3 minor therapeutic 
0024 - Intravascular imaging of coronary vessels 0,7 6/913 episodes -11.538,80 € -0,5 minor diagnostic 
3551 - Repair of atrial septal defect with prosthesis, open technique 0,7 1/136 episodes -3.338,80 € -0,4 major therapeutic 
3895 - Venous catheterization for renal dialysis 0,7 22/3119 episodes 44.841,10 € 0,2 minor therapeutic 
4223 - Other esophagoscopy 0,7 23/3226 episodes 20.584,40 € 0,1 minor diagnostic 
0045 - Insertion of one vascular stent 0,6 181/32170 
episodes 
-110.523,90 € -0,1 minor therapeutic 
0046 - Insertion of two vascular stents 0,6 75/11806 episodes -54.900,30 € -0,1 minor therapeutic 
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5794 - Insertion of indwelling urinary catheter 0,6 134/20800 
episodes 
-159.739,70 € -0,2 minor therapeutic 
8628 - Nonexcisional debridement of wound, infection or burn 0,6 4/707 episodes 1.521,40 € 0,1 minor therapeutic 
0040 - Procedure on single vessel 0,5 205/43022 
episodes 
160.835 € 0,1 minor therapeutic 
0041 - Procedure on two vessels 0,5 49/10499 episodes 96.404,20 € 0,3 minor therapeutic 
3491 - Thoracentesis 0,5 25/5043 episodes 9.851,80 € 0,1 minor therapeutic 
4513 - Other endoscopy of small intestine 0,5 22/4517 episodes 66.981,10 € 0,5 minor diagnostic 
4516 - Esophagogastroduodenoscopy [EGD] with closed biopsy 0,5 6/1210 episodes 4.343,80 € 0,1 minor diagnostic 
9390 - Non-invasive mechanical ventilation 0,5 81/15667 episodes -158.896,70 € -0,3 minor therapeutic 
9904 - Transfusion of packed cells 0,5 114/21285 
episodes 
-467.908,80 € -0,4 minor therapeutic 
3605 - not found 0,4 1/230 episodes 2.068,40 € 0,3 major therapeutic 
3992 - Injection of sclerosing agent into vein 0,4 1/228 episodes -861,20 € -0,2 major therapeutic 
0044 - Procedure on vessel bifurcation 0,3 4/1316 episodes -17.662,80 € -0,4 minor therapeutic 
3990 - Insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s) 0,3 11/3154 episodes -3.434,30 € 0 minor therapeutic 
8622 - Excisional debridement of wound, infection, or burn 0,3 8/3167 episodes -35.009,20 € -0,3 major therapeutic 
0010 - Implantation of chemotherapeutic agent 0 0/6 episodes 0 € 0 minor therapeutic 
0016 - Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance 0 0/8 episodes 0 € 0 minor therapeutic 
0018 - Infusion of immunosuppressive antibody therapy 0 0/10 episodes 0 € 0 minor therapeutic 
0025 - Intravascular imaging of renal vessels 0 0/7 episodes 0 € 0 minor diagnostic 
0028 - Intravascular imaging, other specified vessel(s) 0 0/14 episodes 0 € 0 minor diagnostic 
0042 - Procedure on three vessels 0 1/2018 episodes -1.440,20 € 0 minor therapeutic 
0065 - Percutaneous insertion of intracranial vascular stent(s) 0 0/9 episodes 0 € 0 minor therapeutic 
0067 - Intravascular pressure measurement of intrathoracic arteries 0 0/17 episodes 0 € 0 minor diagnostic 
0110 - Intracranial pressure monitoring 0 0/23 episodes 0 € 0 minor diagnostic 
0309 - Other exploration and decompression of spinal canal 0 0/23 episodes 0 € 0 major therapeutic 
0601 - Aspiration of thyroid field 0 0/6 episodes 0 € 0 minor therapeutic 
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0782 - Other total excision of thymus 0 0/14 episodes 0 € 0 major therapeutic 
1771 - Non-coronary intra-operative fluorescence vascular angiography [IFVA] 0 0/44 episodes 0 € 0 minor diagnostic 
2122 - Biopsy of nose 0 0/8 episodes 0 € 0 minor diagnostic 
2131 - Local excision or destruction of intranasal lesion 0 0/22 episodes 0 € 0 minor therapeutic 
2132 - Local excision or destruction of other lesion of nose 0 0/7 episodes 0 € 0 minor therapeutic 
2171 - Closed reduction of nasal fracture 0 0/8 episodes 0 € 0 minor therapeutic 
2181 - Suture of laceration of nose 0 0/8 episodes 0 € 0 minor therapeutic 
2301 - Extraction of deciduous tooth 0 0/7 episodes 0 € 0 minor therapeutic 
2431 - Excision of lesion or tissue of gum 0 0/7 episodes 0 € 0 minor therapeutic 
2499 - Other dental operations 0 0/7 episodes 0 € 0 minor therapeutic 
2611 - Closed [needle] biopsy of salivary gland or duct 0 0/20 episodes 0 € 0 minor diagnostic 
2724 - Biopsy of mouth, unspecified structure 0 0/8 episodes 0 € 0 minor diagnostic 
3143 - Closed [endoscopic] biopsy of larynx 0 0/9 episodes 0 € 0 minor diagnostic 
3249 - Other lobectomy of lung 0 0/6 episodes 0 € 0 major therapeutic 
3372 - Endoscopic pulmonary airway flow measurement 0 0/8 episodes 0 € 0 minor therapeutic 
3459 - Other excision of pleura 0 0/7 episodes 0 € 0 major therapeutic 
3472 - Closure of thoracostomy 0 0/11 episodes 0 € 0 minor therapeutic 
3492 - Injection into thoracic cavity 0 0/69 episodes 0 € 0 minor therapeutic 
3499 - Other operations on thorax 0 0/10 episodes 0 € 0 major therapeutic 
3583 - Total repair of truncus arteriosus 0 0/10 episodes 0 € 0 major therapeutic 
3602 - not found 0 0/7 episodes 0 € 0 major therapeutic 
3710 - Incision of heart, not otherwise specified 0 0/6 episodes 0 € 0 major therapeutic 
3764 - Removal of external heart assist system(s) or device(s) 0 0/26 episodes 0 € 0 major therapeutic 
3765 - Implant of single ventricular (extracorporeal) external heart assist system 0 0/6 episodes 0 € 0 major therapeutic 
3811 - Endarterectomy, intracranial vessels 0 0/7 episodes 0 € 0 major therapeutic 
3815 - Endarterectomy, other thoracic vessels 0 0/12 episodes 0 € 0 major therapeutic 
3821 - Biopsy of blood vessel 0 0/39 episodes 0 € 0 major diagnostic 
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3825 - Intravascular imaging of non-coronary vessel(s) by optical coherence tomography [OCT] 0 0/21 episodes 0 € 0 minor diagnostic 
4059 - Radical excision of other lymph nodes 0 0/6 episodes 0 € 0 major therapeutic 
4138 - Other diagnostic procedures on bone marrow 0 0/18 episodes 0 € 0 minor diagnostic 
4311 - Percutaneous [endoscopic] gastrostomy [PEG] 0 0/39 episodes 0 € 0 minor therapeutic 
4412 - Gastroscopy through artificial stoma 0 0/6 episodes 0 € 0 minor diagnostic 
4528 - Other diagnostic procedures on large intestine 0 0/8 episodes 0 € 0 minor diagnostic 
4530 - Endoscopic excision or destruction of lesion of duodenum 0 0/8 episodes 0 € 0 minor therapeutic 
4572 - Open and other cecectomy 0 0/6 episodes 0 € 0 major therapeutic 
4579 - Other and unspecified partial excision of large intestine 0 0/12 episodes 0 € 0 major therapeutic 
4582 - Open total intra-abdominal colectomy 0 0/11 episodes 0 € 0 major therapeutic 
4620 - Ileostomy, not otherwise specified 0 0/13 episodes 0 € 0 major therapeutic 
4621 - Temporary ileostomy 0 0/26 episodes 0 € 0 major therapeutic 
4639 - Other enterostomy 0 0/14 episodes 0 € 0 minor therapeutic 
4672 - Closure of fistula of duodenum 0 0/7 episodes 0 € 0 major therapeutic 
4673 - Suture of laceration of small intestine, except duodenum 0 0/12 episodes 0 € 0 major therapeutic 
4719 - Other incidental appendectomy 0 0/11 episodes 0 € 0 major therapeutic 
4832 - Other electrocoagulation of rectal lesion or tissue 0 0/7 episodes 0 € 0 minor therapeutic 
4836 - [Endoscopic] polypectomy of rectum 0 0/27 episodes 0 € 0 minor therapeutic 
4862 - Anterior resection of rectum with synchronous colostomy 0 0/8 episodes 0 € 0 major therapeutic 
4921 - Anoscopy 0 0/18 episodes 0 € 0 minor diagnostic 
4942 - Injection of hemorrhoids 0 0/8 episodes 0 € 0 minor therapeutic 
5013 - Transjugular liver biopsy 0 0/7 episodes 0 € 0 minor diagnostic 
5022 - Partial hepatectomy 0 0/9 episodes 0 € 0 major therapeutic 
5101 - Percutaneous aspiration of gallbladder 0 0/21 episodes 0 € 0 minor therapeutic 
5122 - Cholecystectomy 0 0/59 episodes 0 € 0 major therapeutic 
5185 - Endoscopic sphincterotomy and papillotomy 0 0/37 episodes 0 € 0 minor therapeutic 
5188 - Endoscopic removal of stone(s) from biliary tract 0 0/30 episodes 0 € 0 minor therapeutic 
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5305 - Repair of inguinal hernia with graft or prosthesis, not otherwise specified 0 0/10 episodes 0 € 0 major therapeutic 
5341 - Other and open repair of umbilical hernia with graft or prosthesis 0 0/7 episodes 0 € 0 major therapeutic 
5351 - Incisional hernia repair 0 0/12 episodes 0 € 0 major therapeutic 
5359 - Repair of other hernia of anterior abdominal wall 0 0/10 episodes 0 € 0 major therapeutic 
5361 - Other open incisional hernia repair with graft or prosthesis 0 0/9 episodes 0 € 0 major therapeutic 
5422 - Biopsy of abdominal wall or umbilicus 0 0/26 episodes 0 € 0 major diagnostic 
5424 - Closed [percutaneous] [needle] biopsy of intra-abdominal mass 0 0/34 episodes 0 € 0 minor diagnostic 
5462 - Delayed closure of granulating abdominal wound 0 0/8 episodes 0 € 0 major therapeutic 
5463 - Other suture of abdominal wall 0 0/9 episodes 0 € 0 major therapeutic 
5474 - Other repair of omentum 0 0/8 episodes 0 € 0 major therapeutic 
5492 - Removal of foreign body from peritoneal cavity 0 0/8 episodes 0 € 0 major therapeutic 
5499 - Other operations of abdominal region 0 0/12 episodes 0 € 0 minor therapeutic 
5631 - Ureteroscopy 0 0/8 episodes 0 € 0 minor diagnostic 
5733 - Closed [transurethral] biopsy of bladder 0 0/13 episodes 0 € 0 major diagnostic 
6029 - Other transurethral prostatectomy 0 0/7 episodes 0 € 0 major therapeutic 
6561 - Other removal of both ovaries and tubes at same operative episode 0 0/10 episodes 0 € 0 major therapeutic 
6812 - Hysteroscopy 0 0/7 episodes 0 € 0 minor diagnostic 
7534 - Other fetal monitoring 0 0/14 episodes 0 € 0 minor diagnostic 
7768 - Local excision of lesion or tissue of bone, tarsals and metatarsals 0 0/7 episodes 0 € 0 major therapeutic 
7851 - Internal fixation of bone without fracture reduction, scapula, clavicle, and thorax [ribs and 
sternum] 
0 0/15 episodes 0 € 0 major therapeutic 
7867 - Removal of implanted devices from bone, tibia and fibula 0 0/8 episodes 0 € 0 major therapeutic 
7905 - Closed reduction of fracture without internal fixation, femur 0 0/15 episodes 0 € 0 minor therapeutic 
7975 - Closed reduction of dislocation of hip 0 0/7 episodes 0 € 0 minor therapeutic 
8051 - Excision of intervertebral disc 0 0/8 episodes 0 € 0 major therapeutic 
8052 - Intervertebral chemonucleolysis 0 0/7 episodes 0 € 0 minor therapeutic 
8105 - Dorsal and dorsolumbar fusion of the posterior column, posterior technique 0 0/7 episodes 0 € 0 major therapeutic 
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8162 - Fusion or refusion of 2-3 vertebrae 0 0/6 episodes 0 € 0 major therapeutic 
8192 - Injection of therapeutic substance into joint or ligament 0 0/12 episodes 0 € 0 minor therapeutic 
8212 - Fasciotomy of hand 0 0/6 episodes 0 € 0 major therapeutic 
8244 - Other suture of flexor tendon of hand 0 0/9 episodes 0 € 0 major therapeutic 
8245 - Other suture of other tendon of hand 0 0/6 episodes 0 € 0 major therapeutic 
8321 - Open biopsy of soft tissue 0 0/21 episodes 0 € 0 major diagnostic 
8364 - Other suture of tendon 0 0/20 episodes 0 € 0 major therapeutic 
8365 - Other suture of muscle or fascia 0 0/27 episodes 0 € 0 major therapeutic 
8382 - Graft of muscle or fascia 0 0/16 episodes 0 € 0 major therapeutic 
8395 - Aspiration of other soft tissue 0 0/9 episodes 0 € 0 minor therapeutic 
8461 - Insertion of partial spinal disc prosthesis, cervical 0 0/8 episodes 0 € 0 major therapeutic 
8471 - Application of external fixator device, monoplanar system 0 0/9 episodes 0 € 0 minor therapeutic 
8623 - Removal of nail, nail bed, or nail fold 0 0/28 episodes 0 € 0 minor therapeutic 
8671 - Cutting and preparation of pedicle grafts or flaps 0 0/13 episodes 0 € 0 major therapeutic 
8692 - Electrolysis and other epilation of skin 0 0/7 episodes 0 € 0 minor therapeutic 
9221 - Superficial radiation 0 0/6 episodes 0 € 0 minor therapeutic 
9900 - Perioperative autologous transfusion of whole blood or blood components 0 0/52 episodes 0 € 0 minor therapeutic 
9971 - Therapeutic plasmapheresis 0 0/30 episodes 0 € 0 minor therapeutic 
9973 - Therapeutic erythrocytapheresis 0 0/9 episodes 0 € 0 minor therapeutic 
9975 - Administration of neuroprotective agent 0 0/8 episodes 0 € 0 minor therapeutic 
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Supplementary table 4 – Descending ranking of procedures according to their effects on APR-DRG changes for respiratory system diseases (Brazil) 
Procedure Percentage 
change of 
APR-DRG  
Number of episodes 
that changed their 
APR-DRG 
Total 
differences in 
hospital 
payments (€) 
Percentage 
change in 
hospital 
payments 
Procedure category 
3328 - Open biopsy of lung 100 12/12 episodes -18.125,30 € -56,5 major diagnostic 
3451 - Decortication of lung 96,9 31/32 episodes -57.468,70 € -57,8 major therapeutic 
3179 - Other repair and plastic operations on trachea 91,7 11/12 episodes -39.991,80 € -69,8 major therapeutic 
3402 - Exploratory thoracotomy 86 98/114 episodes -142.573,60 € -49,5 major therapeutic 
3129 - Other permanent tracheostomy 82,5 132/160 episodes -304.863,50 € -53,2 major therapeutic 
3421 - Transpleural thoracoscopy 81,2 13/16 episodes -20.379,90 € -48,8 major diagnostic 
3229 - Other local excision or destruction of lesion or tissue of lung 75 6/8 episodes -5.598,50 € -32,4 major therapeutic 
4029 - Simple excision of other lymphatic structure 75 6/8 episodes -5.839,30 € -33,8 major therapeutic 
3422 - Mediastinoscopy 63,6 7/11 episodes -22.839,30 € -52,6 major diagnostic 
5411 - Exploratory laparotomy 50 5/10 episodes -13.166,90 € -43,7 major therapeutic 
4011 - Biopsy of lymphatic structure 42,9 3/7 episodes -2.399,70 € -16,1 major diagnostic 
8622 - Excisional debridement of wound, infection, or burn 33,3 5/15 episodes -12.133,30 € -23,4 major therapeutic 
3428 - Other diagnostic procedures on chest wall, pleura, and diaphragm 16,7 1/6 episodes -1.235,90 € -17,1 major diagnostic 
3721 - Right heart cardiac catheterization 12 3/25 episodes -143,10 € -0,4 minor diagnostic 
4319 - Other gastrostomy 9,1 1/11 episodes 541,50 € 4,3 minor therapeutic 
8607 - Insertion of totally implantable vascular access device [VAD] 5,6 1/18 episodes -541,50 € -2,3 minor therapeutic 
3324 - Closed [endoscopic] biopsy of bronchus 4,8 1/21 episodes 760 € 2,4 minor diagnostic 
3409 - Other incision of pleura 3,3 4/122 episodes -7.486,10 € -4,3 minor therapeutic 
3404 - Insertion of intercostal catheter for drainage 0,6 3/506 episodes 2.647,20 € 0,3 minor therapeutic 
3323 - Other bronchoscopy 0,4 1/277 episodes -366,70 € -0,1 minor diagnostic 
3142 - Laryngoscopy and other tracheoscopy 0 0/35 episodes 0 € 0 minor diagnostic 
3175 - Reconstruction of trachea and construction of artificial larynx 0 0/9 episodes 0 € 0 major therapeutic 
3322 - Fiber-optic bronchoscopy 0 0/44 episodes 0 € 0 minor diagnostic 
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3326 - Closed [percutaneous] [needle] biopsy of lung 0 0/12 episodes 0 € 0 minor diagnostic 
3327 - Closed endoscopic biopsy of lung 0 0/48 episodes 0 € 0 major diagnostic 
3424 - Other pleural biopsy 0 0/41 episodes 0 € 0 minor diagnostic 
3425 - Closed [percutaneous] [needle] biopsy of mediastinum 0 0/11 episodes 0 € 0 minor diagnostic 
3491 - Thoracentesis 0 0/128 episodes 0 € 0 minor therapeutic 
3609 - Other removal of coronary artery obstruction 0 0/9 episodes 0 € 0 major therapeutic 
3610 - Aortocoronary bypass for heart revascularization, not otherwise specified 0 0/9 episodes 0 € 0 major therapeutic 
3770 - Initial insertion of lead [electrode], not otherwise specified 0 0/8 episodes 0 € 0 minor therapeutic 
3993 - Insertion of vessel-to-vessel cannula 0 0/6 episodes 0 € 0 major therapeutic 
4413 - Other gastroscopy 0 0/15 episodes 0 € 0 minor diagnostic 
4513 - Other endoscopy of small intestine 0 0/21 episodes 0 € 0 minor diagnostic 
5491 - Percutaneous abdominal drainage 0 0/10 episodes 0 € 0 minor therapeutic 
8917 - Polysomnogram 0 0/11 episodes 0 € 0 minor diagnostic 
8932 - Esophageal manometry 0 0/9 episodes 0 € 0 minor diagnostic 
9604 - Insertion of endotracheal tube 0 0/28 episodes 0 € 0 minor therapeutic 
9723 - Replacement of tracheostomy tube 0 0/11 episodes 0 € 0 minor therapeutic 
9921 - Injection of antibiotic 0 0/10 episodes 0 € 0 minor therapeutic 
9925 - Injection or infusion of cancer chemotherapeutic substance 0 0/25 episodes 0 € 0 minor therapeutic 
9928 - Injection or infusion of biological response modifier [BRM] as an antineoplastic 
agent 
0 0/12 episodes 0 € 0 minor therapeutic 
9929 - Injection or infusion of other therapeutic or prophylactic substance 0 0/9 episodes 0 € 0 minor therapeutic 
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Supplementary table 5 – Descending ranking of procedures according to their effects on APR-DRG changes for circulatory system diseases (Brazil) 
Procedure Percentage 
change of 
APR-DRG  
Number of 
episodes that 
changed their 
APR-DRG 
Total 
differences in 
hospital 
payments (€) 
Percentage 
change in 
hospital 
payments 
Procedure 
category 
1692 - Excision of lesion of orbit 100 6/6 episodes -6.829,40 € -54,7 major therapeutic 
3421 - Transpleural thoracoscopy 100 8/8 episodes -2.777,70 € -20,6 major diagnostic 
3573 - Other and unspecified repair of endocardial cushion defect 100  13/13 episodes -38.739,40 € -50,6 major therapeutic 
3581 - Total repair of tetralogy of fallot 100 19/19 episodes -75.156,30 € -67,1 major therapeutic 
3723 - Combined right and left heart cardiac catheterization 100 8/8 episodes -6.842,90 € -44 minor diagnostic 
3731 - Pericardiectomy 100 6/6 episodes -23.560,70 € -74 major therapeutic 
3775 - Revision of lead [electrode] 100 9/9 episodes -5.691,70 € -35,9 major therapeutic 
3785 - Replacement of any type pacemaker device with single-chamber device, not specified 
as rate responsive 
100 9/9 episodes -14.300 € -46,6 major therapeutic 
3794 - Implantation or replacement of automatic cardioverter/defibrillator, total system 
[AICD] 
100 25/25 episodes -157.103,10 € -78,9 major therapeutic 
3836 - Resection of vessel with anastomosis, abdominal arteries 100 12/12 episodes -23.848,50 € -45,3 major therapeutic 
3953 - Repair of arteriovenous fistula 100 14/14 episodes -31.865,10 € -68,8 major therapeutic 
8401 - Amputation and disarticulation of finger 100 7/7 episodes -5.075,20 € -42,7 major therapeutic 
3859 - Ligation and stripping of varicose veins, lower limb veins 99,7 6568/6587 
episodes 
-4.778.095,10 € -42,5 major therapeutic 
3734 - Excision or destruction of other lesion or tissue of heart, endovascular approach 99,3 279/281 
episodes 
-353.381,40 € -58 major therapeutic 
3776 - Replacement of transvenous atrial and/or ventricular lead(s) [electrode] 97,4 74/76 episodes -43.358,40 € -30,6 major therapeutic 
3524 - Open and other replacement of mitral valve 96,7 175/181 
episodes 
-1.042.670,80 € -76,4 major therapeutic 
3596 - Percutaneous balloon valvuloplasty 94,7 18/19 episodes -17.934,50 € -38,8 major therapeutic 
3882 - Other surgical occlusion of vessels, other vessels of head and neck 93,8 15/16 episodes -34.065,80 € -64,6 major therapeutic 
8857 - Other and unspecified coronary arteriography 93,3 180/193 
episodes 
-109.585,40 € -34,4 minor diagnostic 
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3780 - Insertion of permanent pacemaker, initial or replacement, type of device not specified 92,9 26/28 episodes -19.701,70 € -26,4 major therapeutic 
3869 - Other excision of vessels, lower limb veins 90,9 10/11 episodes -7.250,30 € -38,8 major therapeutic 
3800 - Incision of vessel, unspecified site 90,5 38/42 episodes -82.863,20 € -61,9 major therapeutic 
3402 - Exploratory thoracotomy 90,2 46/51 episodes -192.189,60 € -69,6 major therapeutic 
3561 - Repair of atrial septal defect with tissue graft 90 9/10 episodes -30.733,70 € -60,1 major therapeutic 
3921 - Caval-pulmonary artery anastomosis 90 9/10 episodes -33.130,20 € -60,8 major therapeutic 
3952 - Other repair of aneurysm 88,9 8/9 episodes -55.193,90 € -66,5 major therapeutic 
3603 - Open chest coronary artery angioplasty 88,6 39/44 episodes -137.831,80 € -67,8 major therapeutic 
8417 - Amputation above knee 88 22/25 episodes -42.262,40 € -55,7 major therapeutic 
3834 - Resection of vessel with anastomosis, aorta 87,9 29/33 episodes -198.952,40 € -57,3 major therapeutic 
3522 - Open and other replacement of aortic valve 86,4 172/199 
episodes 
-1.047.503,80 € -71,4 major therapeutic 
3844 - Resection of vessel with replacement, aorta, abdominal 86,2 50/58 episodes -288.664 € -52,8 major therapeutic 
3803 - Incision of vessel, upper limb vessels 85,7 18/21 episodes -39.510,90 € -54,4 major therapeutic 
3860 - Other excision of vessels, unspecified site 85,7 6/7 episodes -13.394,70 € -66,7 major therapeutic 
3971 - Endovascular implantation of other graft in abdominal aorta 85,6 77/90 episodes -190.191,90 € -31,8 major therapeutic 
3808 - Incision of vessel, lower limb arteries 85,3 180/211 
episodes 
-437.063 € -55 major therapeutic 
3451 - Decortication of lung 83,3 5/6 episodes -14.507,50 € -61,8 major therapeutic 
3845 - Resection of vessel with replacement, thoracic vessels 83,3 5/6 episodes -30.952,10 € -71,3 major therapeutic 
3866 - Other excision of vessels, abdominal arteries 83,3 5/6 episodes -15.746,60 € -61,9 major therapeutic 
3868 - Other excision of vessels, lower limb arteries 83,3 5/6 episodes -11.162,20 € -58 major therapeutic 
8411 - Amputation of toe 82,1 46/56 episodes -36.299,70 € -30,6 major therapeutic 
3925 - Aorta-iliac-femoral bypass 80,5 33/41 episodes -77.682 € -35 major therapeutic 
8410 - Lower limb amputation, not otherwise specified 80 12/15 episodes -5.194,20 € -17,7 major therapeutic 
3864 - Other excision of vessels, aorta, abdominal 79,4 27/34 episodes -115.300,80 € -51,9 major therapeutic 
3582 - Total repair of total anomalous pulmonary venous connection 77,8 7/9 episodes -14.932 € -35,4 major therapeutic 
3571 - Other and unspecified repair of atrial septal defect 77,7 73/94 episodes -262.512,50 € -57,8 major therapeutic 
267 
 
3880 - Other surgical occlusion of vessels, unspecified site 76,9 10/13 episodes -22.178,50 € -56,8 major therapeutic 
8415 - Other amputation below knee 76,5 13/17 episodes -30.568,90 € -49,8 major therapeutic 
3512 - Open heart valvuloplasty of mitral valve without replacement 75 9/12 episodes -44.208,40 € -61,3 major therapeutic 
3721 - Right heart cardiac catheterization 74,7 733/981 
episodes 
-413.860,10 € -19,9 minor diagnostic 
3929 - Other (peripheral) vascular shunt or bypass 74,6 88/118 episodes -200.648,70 € -42,6 major therapeutic 
3950 - Angioplasty of other non-coronary vessel(s) 72,8 107/147 
episodes 
-230.820,30 € -45,6 major therapeutic 
3818 - Endarterectomy, lower limb arteries 70,6 12/17 episodes -25.193,30 € -40,9 major therapeutic 
3812 - Endarterectomy, other vessels of head and neck 70 7/10 episodes -15.627,20 € -55,3 major therapeutic 
3959 - Other repair of vessel 70 21/30 episodes -66.201,10 € -51,9 major therapeutic 
8412 - Amputation through foot 70 7/10 episodes -10.999,30 € -41,7 major therapeutic 
3931 - Suture of artery 66,7 8/12 episodes -45.559,30 € -59,8 major therapeutic 
3927 - Arteriovenostomy for renal dialysis 64,7 11/17 episodes -7.781,60 € -26,4 major therapeutic 
3726 - Catheter based invasive electrophysiologic testing 63 75/119 episodes -69.230,10 € -29,8 minor diagnostic 
3979 - Other endovascular procedures on other vessels 62,8 27/43 episodes -210.837,90 € -51,3 major therapeutic 
3809 - Incision of vessel, lower limb veins 62 31/50 episodes -37.535,40 € -25,9 major therapeutic 
3885 - Other surgical occlusion of vessels, thoracic vessels 60,5 26/43 episodes -48.514,20 € -22,5 major therapeutic 
3732 - Excision of aneurysm of heart 54,5 6/11 episodes -19.967 € -55,1 major therapeutic 
8853 - Angiocardiography of left heart structures 50 16/32 episodes -9.395,90 € -20,3 minor diagnostic 
3584 - Total correction of transposition of great vessels, not elsewhere classified 48,1 13/27 episodes 10.893,30 € 12 major therapeutic 
3606 - Insertion of non-drug-eluting coronary artery stent(s) 47,1 795/1689 
episodes 
-1.132.640,90 € -30,1 minor therapeutic 
3572 - Other and unspecified repair of ventricular septal defect 44,2 23/52 episodes -84.635,80 € -34,3 major therapeutic 
3991 - Freeing of vessel 44 11/25 episodes -148.492 € -54,6 major therapeutic 
3949 - Other revision of vascular procedure 42,9 3/7 episodes -2.163,40 € -9,5 major therapeutic 
3609 - Other removal of coronary artery obstruction 35,8 487/1362 
episodes 
-612.893,50 € -20,8 major therapeutic 
3886 - Other surgical occlusion of vessels, abdominal arteries 35,7 5/14 episodes -8.823,50 € -17,9 major therapeutic 
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3961 - Extracorporeal circulation auxiliary to open heart surgery 34,8 16/46 episodes -75.044,90 € -25,7 minor therapeutic 
5411 - Exploratory laparotomy 25,9 7/27 episodes -24.739 € -10,1 major therapeutic 
3563 - Repair of endocardial cushion defect with tissue graft 25 2/8 episodes 7.983,30 € 76,3 major therapeutic 
8314 - Fasciotomy 18,2 4/22 episodes -4.350,90 € -8 major therapeutic 
5421 - Laparoscopy 16,7 1/6 episodes -1.058,60 € -12,7 major diagnostic 
5494 - Creation of peritoneovascular shunt 16,7 1/6 episodes 2.986 € 16,5 major therapeutic 
3610 - Aortocoronary bypass for heart revascularization, not otherwise specified 15,7 95/604 episodes -238.333,50 € -23,1 major therapeutic 
3810 - Endarterectomy, unspecified site 14,3 1/7 episodes -861,20 € -5,9 major therapeutic 
3770 - Initial insertion of lead [electrode], not otherwise specified 13,8 109/792 
episodes 
-139.445,10 € -12,4 minor therapeutic 
3541 - Enlargement of existing atrial septal defect 12,5 1/8 episodes -588,60 € -2,1 minor therapeutic 
5569 - Other kidney transplantation 12,5 1/8 episodes 523,90 € 4,9 major therapeutic 
3129 - Other permanent tracheostomy 12 3/25 episodes -6.441 € -11,8 major therapeutic 
3583 - Total repair of truncus arteriosus 11,1 1/9 episodes -865,80 € -3,7 major therapeutic 
0124 - Other craniotomy 10 1/10 episodes -394,80 € -2,4 major therapeutic 
3783 - Initial insertion of dual-chamber device 10,8 14/130 episodes -17.147,20 € -9,1 minor therapeutic 
3727 - Cardiac mapping 9,1 2/22 episodes -1.186,80 € -2,5 minor diagnostic 
8607 - Insertion of totally implantable vascular access device [VAD] 5,9 1/17 episodes -1.440,20 € -4,6 minor therapeutic 
3323 - Other bronchoscopy 5,3 1/19 episodes 9.032,80 € 25,2 minor diagnostic 
3602 - not found 3,3 1/30 episodes -712,90 € -1,1 major therapeutic 
3601 - not found 2,8 17/615 episodes -1.293,60 € -0,1 major therapeutic 
8622 - Excisional debridement of wound, infection, or burn 2,2 4/184 episodes -979,80 € -0,4 major therapeutic 
3409 - Other incision of pleura 2,1 1/47 episodes -897,60 € -1 minor therapeutic 
3404 - Insertion of intercostal catheter for drainage 1,3 3/236 episodes -19.593,20 € -3,8 minor therapeutic 
0159 - Other excision or destruction of lesion or tissue of brain 0 0/6 episodes 0 € 0 major therapeutic 
3424 - Other pleural biopsy 0 0/22 episodes 0 € 0 minor diagnostic 
3491 - Thoracentesis 0 0/86 episodes 0 € 0 minor therapeutic 
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3528 - Open and other replacement of tricuspid valve 0 0/6 episodes 0 € 0 major therapeutic 
3535 - Operations on trabeculae carneae cordis 0 0/10 episodes 0 € 0 major therapeutic 
3605 - not found 0 0/11 episodes 0 € 0 major therapeutic 
3778 - Insertion of temporary transvenous pacemaker system 0 0/20 episodes 0 € 0 minor therapeutic 
3881 - Other surgical occlusion of vessels, intracranial vessels 0 0/18 episodes 0 € 0 major therapeutic 
3893 - Venous catheterization, not elsewhere classified 0 0/7 episodes 0 € 0 minor therapeutic 
3895 - Venous catheterization for renal dialysis 0 0/15 episodes 0 € 0 minor therapeutic 
3990 - Insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s) 0 0/49 episodes 0 € 0 minor therapeutic 
3995 - Hemodialysis 0 0/15 episodes 0 € 0 minor therapeutic 
4413 - Other gastroscopy 0 0/12 episodes 0 € 0 minor diagnostic 
4513 - Other endoscopy of small intestine 0 0/22 episodes 0 € 0 minor diagnostic 
4523 - Colonoscopy 0 0/8 episodes 0 € 0 minor diagnostic 
5491 - Percutaneous abdominal drainage 0 0/15 episodes 0 € 0 minor therapeutic 
5498 - Peritoneal dialysis 0 0/6 episodes 0 € 0 minor therapeutic 
5523 - Closed [percutaneous] [needle] biopsy of kidney 0 0/11 episodes 0 € 0 minor diagnostic 
8416 - Disarticulation of knee 0 0/10 episodes 0 € 0 major therapeutic 
8604 - Other incision with drainage of skin and subcutaneous tissue 0 0/6 episodes 0 € 0 minor therapeutic 
8628 - Nonexcisional debridement of wound, infection or burn 0 0/34 episodes 0 € 0 minor therapeutic 
8741 - Computerized axial tomography of thorax 0 0/12 episodes 0 € 0 minor diagnostic 
8840 - Arteriography using contrast material, unspecified site 0 0/21 episodes 0 € 0 minor diagnostic 
8841 - Arteriography of cerebral arteries 0 0/9 episodes 0 € 0 minor diagnostic 
8842 - Aortography 0 0/35 episodes 0 € 0 minor diagnostic 
8847 - Arteriography of other intra-abdominal arteries 0 0/11 episodes 0 € 0 minor diagnostic 
8848 - Arteriography of femoral and other lower extremity arteries 0 0/74 episodes 0 € 0 minor diagnostic 
8849 - Arteriography of other specified sites 0 0/19 episodes 0 € 0 minor diagnostic 
8850 - Angiocardiography, not otherwise specified 0 0/18 episodes 0 € 0 minor diagnostic 
8872 - Diagnostic ultrasound of heart 0 0/24 episodes 0 € 0 minor diagnostic 
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9205 - Cardiovascular and hematopoietic scan and radioisotope function study 0 0/11 episodes 0 € 0 minor diagnostic 
9357 - Application of other wound dressing 0 0/12 episodes 0 € 0 minor therapeutic 
9604 - Insertion of endotracheal tube 0 0/23 episodes 0 € 0 minor therapeutic 
9904 - Transfusion of packed cells 0 0/7 episodes 0 € 0 minor therapeutic 
9921 - Injection of antibiotic 0 0/11 episodes 0 € 0 minor therapeutic 
9922 - Injection of other anti-infective 0 0/32 episodes 0 € 0 minor therapeutic 
9962 - Other electric countershock of heart 0 0/47 episodes 0 € 0 minor therapeutic 
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7. Discussion and Conclusions 
In this thesis, we focused on the importance of the quality of clinical data held in 
administrative datasets for implementing and optimizing DRG-based classification 
systems, with emphasis on accurate and complete coding of secondary diagnoses 
representing comorbidities and inpatient procedures.  Among other factors, such as the 
capacity of generating clinical and costing data and linking them using an adequate 
information technology system [Mathauer and Wittenbecher, 2013], DRGs heavily rely on 
the expertise of clinical coders, who extract information on diseases and procedures from 
largely unstructured notes and medical records and translate them using a set of complex 
rules and official guidelines which are subject to the different interpretations, besides an 
extensive list of diagnosis and procedure codes [Spencer, 2016].  
The assignment of episodes to the DRGs is a complex method of summarizing the 
numerous permutations of diagnoses and procedures into a manageable number of 
clinically and economically homogenous groups. The individual role of the several 
diagnoses, comorbidities, complications and procedures on DRG grouping is not 
straightforward and is domain-specific. Since its creation, the DRG structure has been 
modified multiple times, becoming a more complex and often confusing process [Aiello 
et al., 2017]. Clinicians, providers and other hospital professionals working with inpatient 
documentation and coding should, however, become comfortable and facile with the 
system. Therefore, a way to improve data quality for implementing an effective DRG 
system is by acknowledging how and which codes are the drivers in the different DRG 
disease domains, as well as how common issues such as using less-specific codes, under-
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coding of comorbidities or procedures would affect DRG classification and hospital 
funding. 
In this thesis, we considered that understanding and characterizing the effects of 
secondary diagnoses representing comorbidities and the variety of hospital procedures 
would be a key process for assessing coded clinical data quality in administrative 
databases in the context of DRG classification. Furthermore, we employed a machine 
learning-based approach using SVM models to provide a methodology to explore the APR-
DRG remuneration technical structure and coded clinical data in order to acknowledge 
and characterize how this system responds to the different Charlson and Elixhauser 
comorbidities and types of hospital procedures. Our main goal was to provide more 
detailed insights on the role of each one of these codes within the APR-DRG grouping 
logic and hospital payments by using a generic and reproducible methodology that can 
also be used to investigate different DRG systems and to be used in data from hospitals 
that have not implemented DRGs, such as the case of Brazil,  specified on the study 
described in chapter 6. 
 Clinical coding guidelines generally state that additional conditions to be coded 
as secondary diagnoses should be those affecting patient care, especially the ones 
requiring the use of diagnostic procedures, clinical evaluation, therapeutic treatment, 
longer hospital stay and increased nursing care or monitoring, resulting in a higher use of 
hospital resources [Centers for Disease Control and Prevention, 2011]. Those definitions 
allow medical coders the capacity to include diseases that could influence episodes to be 
grouped into more complex and resource-demanding DRGs. In Portuguese hospitals 
within the National Health Service (NHS), each inpatient episode should be coded by a 
trained coder based upon a discharge summary, combined with other information from 
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daily medical reports, emergency room records and surgical and pathological anatomy 
reports [Administração Central do Sistema de Saúde, 2014]. Medical coding of diagnoses 
in Portugal is based on the official guidelines provided by The CMS and the National 
Center for Health Statistics (NCHS), two departments within the U.S. Federal 
Government’s Department of Health and Human Services (DHHS) [Centers for Disease 
Control and Prevention, 2011]. Those guidelines do not contain specific rules for coding 
comorbidities, apart from a set of rules on coding additional diagnoses, including 
preexisting conditions, which can thereby influence coding of comorbidities [Centers for 
Disease Control and Prevention, 2011].  
[Freitas et al., 2016] found that the number of comorbidities reported by inpatient 
episode has increased in the period 2000-2010 in Portuguese administrative datasets, 
with the average number of Elixhauser and Charlson comorbidities by episode increasing, 
respectively, by 81% and 48%. Nevertheless, this increasing trend was found to be not 
equal for all comorbidities. The proportion of episodes with Charlson’s AIDS/HIV and 
peptic ulcer disease, as well as Elixhauser’s drug abuse, blood loss anemia, peptic ulcer 
disease excluding bleeding and complicated diabetes has in fact decreased over the 
studied period. On the other hand, the proportion of episodes with Charlson’s myocardial 
infarction, dementia and renal disease, as well as Elixhauser’s complicated and 
uncomplicated hypertension, uncomplicated diabetes, hypothyroidism, renal failure, 
coagulopathy, obesity and depression have increased above 100%. Those discrepancies 
in reporting certain comorbidities, which was also described elsewhere in the literature, 
should be of utmost concern due to their impact on morbidity and resource use. Thus, 
investigating and acknowledging how each comorbidity affects the different base APR-
DRGs and knowing whether and which comorbidities are key within the grouping logic 
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across the different diseases is a relevant matter to improve the quality of coded clinical 
data and raise awareness on the importance of a comprehensive report of these 
conditions. 
In line with the general grouping logic of the APR-DRG and previous studies 
[Dewilde et al., 2018], higher SOI levels were clearly the most affected by Charlson and 
Elixhauser comorbidities. Our results strengthened these previous findings on the role 
and importance of comorbidities regarding SOI determination by adding information that 
included all respiratory and cardiovascular diseases and conditions represented in the 
APR-DRG structure. Also, our findings were in accordance with the basic clinical principle 
of the APR-DRG classification as our scenario showed that the influence of comorbidities 
for determining SOI was disease-specific and their significance depends upon the 
underlying problem, which is generally characterized by the base APR-DRG. The 
consistency of our results on comorbidities strengthens the methodology based on SVM 
models. 
By estimating the financial consequences of underreporting comorbidities in the 
study described in chapter 5, we confirmed that most of the assessed comorbidities 
would lead to a substantial impact on hospital payments due to their influence on SOI 
determination. Hospitals that admit proportionally more patients with higher SOI would 
be underfunded when clinical data fail to provide a more precise SOI calculation, with 
comorbid conditions playing a crucial role in this task. Apart from affecting the 
performance of the grouper software and thus hospital funding, incomplete coding of 
comorbidities can make unfeasible the reutilization of clinical data for health care quality 
measurement, which often relies on coded clinical data for the calculation of quality 
indicators (e.g. risk-adjusted in-hospital mortality), for biomedical research and for other 
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tasks related to health care management, as the use of APR-DRGs in conjunction with SOI 
can also be applied for evaluating resource use and establishing patient care guidelines 
[Averill et al., 2013].  
We then reinforce that a comprehensive reporting of secondary diagnoses 
representing comorbidities is imperative for APR-DRG grouping as our findings, in line 
with previous research, showed that such group of diagnoses, if not properly coded, may 
undermine the correct identification of most resource-consuming patients and thus 
underestimate hospital funding. Efforts should be made to conduct better documentation 
of comorbidities, which in turn should lead to more accurate grouping into higher SOI 
levels in the APR-DRG system. Finally, collecting information on preexisting or newly 
acquired comorbidities should always be encouraged in hospitals and the inclusion of 
more specific rules in guidelines focusing on coding of comorbidities is then highly 
recommended to achieve a more comprehensive report of such conditions and thus 
improve the quality of clinical data. 
Concerning inpatient procedures, coding guidelines elsewhere usually state that 
all significant diagnostic and therapeutic procedures should be coded, which includes 
those that are surgical in nature, carry a procedural or anesthetic risk and demand special 
facilities, equipment or training [Reid et al., 1999]. In general, coders tend to not code 
routine procedures, which are performed in most stays and occur several times during a 
hospitalization (e.g. ultrasound, electrocardiography, computed tomography, 
catheterization, magnetic resonance, etc.) [Reid et al., 1999]. In fact, when hospital 
reimbursement is via DRGs, coding of inpatient procedures is usually required when the 
presence of the procedure (usually surgical) affects DRG assignment, even though there 
are occasions in which procedures are coded for another reasons, such as specific hospital 
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policies, medical coder training and to justify costs [Dismuke, 2004]. That occur because 
the typical DRG classification starts with the patient’s stay being assigned to 1 of 25 MDCs 
according to the principal diagnosis, followed by a second classification phase, based 
either on diagnoses or procedures that are normally performed in the operating room, in 
addition to other patient characteristics such as age, gender and discharge status. 
Consequently, if coders report mostly for reimbursement purposes, most procedures 
performed in settings other than the operating room may not be coded and thus will not 
be found in inpatient databases. There is an estimated of more than 1500 non-operating 
room procedures within ICD-9-CM list, of which only about 116 determine DRG 
classification, which corresponds to about a third of all listed procedures that are subject 
to underreporting, since they are not required to reimbursement via DRGs [Dismuke et 
al., 2005]. This issue is of concern not only for health services researchers and policy-
makers that aim to use administrative data to examine variations in procedure utilization, 
outcomes and treatment costs, but also for grouping into SOI and ROM levels, as well as 
other risk-adjustment methodologies [Dismuke et al., 2005]. 
In chapter 4, we described a significant variability between hospitals with burn 
units in Portugal with regard to coding of non-operating room procedures, namely 
insertion of endotracheal tube, excisional debridement, venous catheterization, 
continuous invasive mechanical ventilation, packed cell transfusion, serum transfusion 
and fiber-optic bronchoscopy. Although the role of this type of procedures within APR-
DRG technical structure may not be determinant in most cases, findings elsewhere have 
reported that non-operating room procedures serve as markers of costlier and 
complicated hospitalizations [Hughes et al., 1989] and thus, especially when combined 
with certain principal diagnoses and certain APR-DRGs, can be linked with higher SOI 
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levels and thus higher reimbursement. In chapter 6, after evaluating Portuguese inpatient 
data, we reported that non-operating room procedures such as continuous invasive 
mechanical ventilation and certain diagnostic procedures on esophagus impacted the 
assignment to respiratory APR-DRGs in  a substantial proportion of episodes they 
occurred, whereas insertion, removal, replacement and revision of peacemaker, as well 
as intracardiac echocardiography drove the classification into circulatory system APR-
DRGs in a considerable proportion of cases. For Brazilian data, however, we found that 
non-operating room procedures were, in general, much smaller and limited, with 
coronary arteriography and extracorporeal circulation auxiliary to open heart surgery 
driving a high proportion of circulatory system APR-DRGs being the most noticeable cases. 
Moreover, and in general, non-operating room procedures influenced SOI determination 
in some cases, though in a quite small proportion. 
Apart from significant inter-hospital dissimilarities concerning coding of non-
operating room procedures, we found in the study from chapter 4 that facilities also 
differed significantly in reporting some crucial diagnosis codes for grouping burns 
hospitalizations into their correct APR-DRG, such as the case of extensive third-degree 
burns, as well as some comorbidities, such as hypertension, depressive disorder and 
obesity. The comprehensiveness’ of coding should thus be monitored across the different 
hospitals and a feasible way to perform such task would be based on the methodology 
described in chapter 4, with separate code counts for each APR-DRG combined with the 
SOI level. In our study, we assumed that the evaluated hospitals were comparable because 
they were the five facilities in Portugal to present a burn unit and thus should not differ 
greatly in the context of burns hospitalizations, which is a small diagnosis area, with less 
variety of conditions and procedures if compared to other areas. In this sense, to properly 
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monitor variability in coding between hospitals and include several other relevant 
diagnosis areas, we support the use of case-mix or complexity adjusted code counts for 
each APR-DRG, in order to address differences in hospital that could naturally account for 
discrepancies in the frequencies of diagnoses and procedures. 
When assessing the effects of different AHRQ procedure categories on APR-DRG 
grouping, which is described in chapter 6, we found that in both Brazilian and Portuguese 
data, and as expected, major procedures affected more APR-DRG grouping when 
compared to the minor categories in respiratory and cardiovascular diseases. Although 
major categories were the most crucial in determining APR-DRGs, it is important to point 
that minor therapeutic procedures did considerably influence grouping in cardiovascular 
diseases in both countries’ datasets, accounting for a substantial amount of hospital 
reimbursement.  In the Brazilian database, coding patterns of procedures were 
considerably different when compared to the Portuguese data, with a much lower 
incidence and variety of inpatient procedures, especially those considered non-operating 
room procedures. However, the effects in terms of APR-DRG changes in circulatory system 
diseases were similar between the two countries because the minor categories continued 
affecting a much higher proportion of episodes when compared to respiratory APR-DRGs. 
Despite the smaller influence In MDC 4 regarding APR-DRG changes, the financial impact 
of underreporting minor therapeutic procedures, in particular, was considerably elevated 
when assessing data from Portugal. Our findings also reflected that the influence of the 
different types of procedures in APR-DRG grouping is domain-specific, though 
underreporting minor categories, which comprise non-operating room procedures, may 
have a very high financial impact on hospital funding, especially in the context of 
circulatory system diseases. 
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Overall, regarding the studies presented in chapters 5 and 6, the results obtained 
with this machine-learning approach to assess the impact of comorbidities and 
procedures were consistent and in line with the APR-DRG grouping logic, reinforcing then 
its validity to study DRG classification. Thus, we also presented in this thesis a generic and 
reproducible methodology that can be applied to study different DRG versions and also 
to evaluate data from countries that have not used DRGs, such as the case of Brazil, 
providing ways to acknowledge how the DRG system responds to their data and which 
information would be crucial to implement an effective DRG-based system in different 
contexts and settings. Therefore, the advantages of employing a methodology based on 
machine learning rather than directly using the grouper software, besides the possibility 
of being used in different data sources from different DRG versions, include the feasibility 
to simulate different coding behaviors and assess the response of the DRG system to these 
behaviors, as well as the possibility to investigate the impact of specific diagnosis or 
procedures in domains of interest. Finally, to the best of our knowledge, our findings add 
evidence on the applicability of a machine learning-based approach for DRG prediction to 
the results obtained by [Gartner et al., 2015], in which machine learning techniques were 
employed to group inpatient episodes into DRGs based on early admission rather than 
discharge data in order to create resource allocation models. 
As a limitation, we mention that this thesis was based upon results from studies 
that rely and are limited to the reality abstracted from the coded clinical data extracted 
from Portugal’s National DRG Database. For instance, certain procedures or comorbidities 
might have had little to no significant impact on APR-DRG classification because they 
might simply be under-reported in some hospitals and thus the SVM models, which were 
artificially constructed through patterns learned from the data, will minimize their 
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importance in terms of classification. Another important limitation includes the utilization 
of classification results obtained with SVM models applied on the original data as baseline 
to compare changes in APR-DRGs and hospital reimbursement and to characterize the 
roles of the different medical codes. Therefore, existing errors associated with the original 
SVM models might have influenced or been replicated in our results. Another limitation 
includes the use of ICD-9-CM data to perform all analyses, as this classification system 
ceased to be updated in 2015. The transition to ICD-10-CM in Portugal was enacted in 
2017 and it is still an ongoing process and much of the available ICD-10-CM inpatient data 
was still incomplete, being thus not viable to perform this study. Furthermore, we should 
take into account the inherent bias of using GEM files to map between ICD-9 and ICD-10 
codes for Brazilian data, as this method, in many cases, only finds approximate matches 
to a given code. 
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